LegalizeHistorie novel
Vyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek
22 verzí
· 1997-03-28
2004-01-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
2003-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
2002-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
2002-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Změny ze dne 2002-06-30
@@ -125,21 +125,21 @@
| ks | kus |
| RG | mikrogram |
Léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek
#### ODDÍL B
**Léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek**
#### **ODDÍL B**
| 1 | A01AA | léčiva k profylaxi zubního kazu (fluorid sodný) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.1 | MG | 0,88 | |
| 64958 | ZYMAFLUOR 1/4MG | tbl 200x0.55mg | NCH | CH | | | |
| 56281 | ZYMAFLUOR 1/4MG | tbl 400x0.55mg | NCH | CH | | | |
| 64958 | ZYMAFLUOR 1/4MG | tbl 200x0.55mg | NCH | CH | | | |
| 2 | A01AB | protiinfekční léčiva pro lokální aplikaci | lok. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 2.1 | A01AB10 | natamycin | lok. | 20 | MG | 7,48 | |
| | | | | | | | |
| 2.2 | A01AB03 | Chlorhexidin | lok. | 100 0 | ML | 178,70 | H |
| 3 | A01AC | kortikosteriody pro lokální aplikaci | lok. | L/DER,STO, ORL | | | |
| 2.2 | A01AB03 | chlorhexidin | lok. | 1000 | ML | 178,70 | H |
| 3 | A01AC | kortikosteriody pro lokální aplikaci | lok. | L/DER,STO,ORL | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 3.1 | A01AC01 | triamcinolon | lok. | 1 | GM | 13,69 | L/DER,STO, ORL |
| | | | | | | | |
@@ -160,44 +160,43 @@
| 5 | A02BA | antiulceróza ze skupiny H2-antagonistů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 5.1 | A02BA01 | cimetidin | p.o. | 0.80 | GM | 4,05 | |
| 87755 | CIMETIDINE CADILA | tbl obd 100x200mg | CAD | IND | | | |
| 5.2 | A02BA02 | ranitidin nad 75 miligramů do 150 miligramů včetně v jedné tabletě | p.o. | 0.30 | GM | 4,05 | |
| 64926 | LOCK-2 | tbl obd 100x200mg | CAI | IND | | | |
| 5.2 | A02BA02 | ranitidin nad 75 mg do 150 mg včetně v jedné tabletě | p.o. | 0.30 | GM | 4,05 | |
| 80541 | RANITIN 150 | tbl obd 100x150mg | TRT | IND | | | |
| 56514 | ULRAN 150 | tbl obd 20x150mg | KRK | SLO | | | |
| 68844 | APO-RANITIDINE | tbl obd 100x150mg | APT | CND | | | |
| 45321 | RANISAN | tbl obd 500x150mg | PMP | CZ | | | |
| 12346 | HISTAC 150 | tbl obd 20x150mg | RXY | IND | | | |
| 96056 | RANISAN | tbl obd 30x150mg | PMP | CZ | | | |
| 02777 | RANITIN 150 | tbl obd 30x150mg | TRT | IND | | | |
| 96056 | RANISAN | tbl obd 30x150mg | PMP | CZ | | | |
| 91280 | RANITAL 150MG | tbl obd 30x150mg | LEK | SLO | | | |
| 45321 | RANISAN | tbl obd 500x150mg | PMP | CZ | | | |
| 80541 | RANITIN 150 | tbl obd 100x150mg | TRT | IND | | | |
| 5.3 | A02BA02 | ranitidin nad 150 miligramů v jedné tabletě | p.o. | 0.30 | GM | 3,85 | |
| 5.3 | A02BA02 | ranitidin nad 150 mg v jedné tabletě | p.o. | 0.30 | GM | 3,85 | |
| 76477 | RANITAL 300MG | tbl obd 30x300mg | LEK | SLO | | | |
| 02729 | RANITIN 300 | tbl obd 30x300mg | TRT | IND | | | |
| 12347 | HISTAC 300 | tbl obd 10x300mg | RXY | IND | | | |
| 56515 | ULRAN 300 | tbl obd 30x300mg | KRK | SLO | | | |
| 80542 | RANITIN 300 | tbl obd 100x300mg | TRT | IND | | | |
| 56515 | ULRAN 300 | tbl obd 30x300mg | KRK | SLO | | | |
| 02729 | RANITIN 300 | tbl obd 30x300mg | TRT | IND | | | |
| 76477 | RANITAL 300MG | tbl obd 30x300mg | LEK | SLO | | | |
| 5.4 | A02BA03 | famotidin do 20 mg včetně v 1 tabletě | p.o. | 40 | MG | 4,05 | |
| 59595 | FAMOSAN 20MG | tbl obd 50x20mg | PMP | CZ | | | |
| 96193 | FAMOSAN | tbl obd 20x20mg | PMP | CZ | | | |
| 66194 | FAMOTIDIN 20-SL | tbl obd 30x20mg | SLO | SK | | | |
| 75832 | ÄPO-FAMOTIDINE 20MG (LEKOVKA) | tbl obd 100x20mg | APT | CND | | | |
| 47262 | FAMOSAN 20MG | tbl obd 500x20mg | PMP | CZ | | | |
| 80537 | QUAMATEL 20MG | tbl obd 28x20mg | GED | H | | | |
| 47262 | FAMOSAN 20MG | tbl obd 500x20mg | PMP | CZ | | | |
| 96193 | FAMOSAN | tbl obd 20x20mg | PMP | CZ | | | |
| 75832 | APO-FAMOTIDINE 20MG (LEKOVKA) | tbl obd 100x20mg | APT | CND | | | |
| 66194 | FAMOTIDIN 20-SL | tbl obd 30x20mg | SLO | SK | | | |
| 59595 | FAMOSAN 20MG | tbl obd 50x20mg | PMP | CZ | | | |
| 94207 | ULFAMID 20 | tbl 20x20mg | KRK | SLO | | | |
| 5.5 | A02BA03 | famotidin nad 20 mg v 1 tabletě | p.o. | 40 | MG | 3,85 | |
| 47263 | FAMOSAN 40MG | tbl obd 500x40mg | PMP | CZ | | | |
| 67539 | ULCERAN 40 | tbl obd 500x40mg | MOE | CY | | | |
| 83206 | FAMOSAN | tbl obd 10x40mg | PMP | CZ | | | |
| 67537 | ULCERAN 40 | tbl obd 30x40mg | MOE | CY | | | |
| 10769 | FAMOTIDIN 40-SL | tbl obd 100x40mg | SLO | SK | | | |
| 66193 | FAMOTIDIN 40-SL | tbl obd 10x40mg | SLO | SK | | | |
| 67536 | ULCERAN 40 | tbl obd 10x40mg | MOE | CY | | | |
| 96194 | FAMOSAN | tbl obd 20x40mg | PMP | CZ | | | |
| 80629 | QUAMATEL 40MG | tbl obd 28x40mg | GED | H | | | |
| 10769 | FAMOTIDIN 40-SL | tbl obd 100x40mg | SLO | SK | | | |
| 59596 | FAMOSAN 40MG | tbl obd 50x40mg | PMP | CZ | | | |
| 67537 | ULCERAN 40 | tbl obd 30x40mg | MOE | CY | | | |
| 80538 | QUAMATEL 40MG | tbl obd 14x40mg | GED | H | | | |
| 66193 | FAMOTIDIN 40-SL | tbl obd 10x40mg | SLO | SK | | | |
| 98035 | ULFAMID 40 | tbl 10x40mg | KRK | SLO | | | |
| 67536 | ULCERAN 40 | tbl obd 10x40mg | MOE | CY | | | |
| 47263 | FAMOSAN 40MG | tbl obd 500x40mg | PMP | CZ | | | |
| 75836 | APO-FAMOTIDINE 40MG (LEKOVKA) | tbl obd 100x40mg | APT | CND | | | |
| 59596 | FAMOSAN 40MG | tbl obd 50x40mg | PMP | CZ | | | |
| 67539 | ULCERAN 40 | tbl obd 500x40mg | MOE | CY | | | |
| 5.6 | A02BA04 | nizatidin | p.o. | 0.30 | GM | 4,05 | |
| | | | | | | | |
| 5.7 | A02BA06 | roxatidin | p.o. | 0.15 | GM | 4,05 | |
@@ -205,7 +204,7 @@
| 5.8 | A02BA07 | ranitidin bismut citrát | p.o. | 0.8 | GM | 30,01 | |
| 6 | A02BA | antiulceróza ze skupiny H2-antagonistů | Parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 6.1 | A02BA01 | Cimetidin | parent. | 0.80 | GM | 32,06 | H |
| 6.1 | A02BA01 | cimetidin | parent. | 0.80 | GM | 32,06 | H |
| | | | | | | | |
| 6.2 | A02BA02 | ranitidin | parent. | 0.30 | GM | 68,43 | H |
| | | | | | | | |
@@ -213,43 +212,40 @@
| 7 | A02BB | antiulceróza ze skupiny prostaglandinů | p.o. | Z | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 7.1 | A02BB01 | misoprostol | p.o. | 0.80 | MG | 47,36 | Z |
| 97404 | CYTOTEC | tbl 50x200rg | SEA | GB | | | |
| 8 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | p.o. | L/GIT,INT | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 8.1 | A02BC01 | Omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 22,50 | L/GIT,INT |
| 8.1 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 19,10 | |
| 57408 | HELICID 10 | cps 28x10mg | LEX | CZ | | | |
| 53974 | HELICID 10 | cps 14x10mg | LEX | CZ | | | |
| 57408 | HELICID 10 | cps 28x10mg | LEX | CZ | | | |
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 12,00 | L/GIT,INT |
| 75974 | LOMAC | cps 14x20mg | CIA | IND | | | |
| 58201 | OMEPROL 20 MG | cps 15x20mg | SFS | D | | | |
| 58202 | OMEPROL 20 MG | cps 30x20mg | SFS | D | | | |
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 10,20 | |
| 59897 | HELICID 20 | cps 28x20mg | LEX | CZ | | | |
| 70933 | ORTANOL | cps 28x20mg | LEK | SLO | | | |
| 12507 | GASEC-20 | cps 14x20mg | MHA | CH | | | |
| 58226 | OMEPRAZOL-E | cps ent 28x20mg | EGI | H | | | |
| 53346 | GASEC-20 | cps 28x20mg | MHA | CH | | | |
| 60160 | ULTOP | cps 14x20mg | KRK | SLO | | | |
| 58225 | OMEPRAZOL-E | cps ent 14x20mg | EGI | H | | | |
| 75166 | ORTANOL | cps 14x20mg | LEK | SLO | | | |
| 03076 | LOMAC | cps 28x20mg | CIA | IND | | | |
| 03077 | LOMAC | cps 56x20mg | CIA | IND | | | |
| 58203 | OMEPROL 20 MG | cps 60x20mg | SFS | D | | | |
| 58225 | OMEPRAZOL-E | cps ent 14x20mg | EGI | H | | | |
| 58226 | OMEPRAZOL-E | cps ent 28x20mg | EGI | H | | | |
| 75166 | ORTANOL | cps 14x20mg | LEK | SLO | | | |
| 12507 | GASEC-20 | cps 14x20mg | MHA | CH | | | |
| 53346 | GASEC-20 | cps 28x20mg | MHA | CH | | | |
| 70933 | ORTANOL | cps 28x20mg | LEK | SLO | | | |
| 60160 | ULTOP | cps 14x20mg | KRK | SLO | | | |
| 8.3 | A02BC02 | pantoprazol | p.o. | 40 | MG | 12,00 | L/GIT,INT |
| | | | | | | | |
| 8.4 | A02BC03 | lansoprazol | p.o. | 30 | MG | 12,00 | L/GIT,INT |
| 75974 | LOMAC | cps 14x20mg | CIA | IND | | | |
| 56500 | HELICID 20 | cps 14x20mg | LEX | CZ | | | |
| 8.3 | A02BC02 | pantoprazol | p.o. | 40 | MG | 10,20 | |
| | | | | | | | |
| 8.4 | A02BC03 | lansoprazol | p.o. | 30 | MG | 10,20 | |
| | | | | | | | |
| 8.5 | A02BC05 | esomeprazol (do 20mg v jedné dávce včetně) | p.o. | 20 | MG | 12,00 | L/GIT,INT |
| | | | | | | | |
| 8.6 | A02BC05 | esomeprazol (nad 20mg v jedné dávce ) | p.o. | 20 | MG | 6,00 | L/GIT,INT |
| 8.6 | A02BC05 | esomeprazol (nad 20mg v jedné dávce ) | p.o. | 20 | MG | 6,67 | L/GIT,INT |
| 9 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | Parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 9.1 | A02BC01 | Omeprazol | parent. | 20 | MG | 185,06 | H |
| 76644 | LOSEC 40MG PRO INFUS. | inj sic 5x40mg | AST | S | | | |
| 9.2 | A02BC02 | pantoprazol | parent. | 40 | MG | 185,06 | H |
| 9.1 | A02BC01 | omeprazol | parent. | 20 | MG | 170,00 | H |
| 31739 | HELICID 40 INF | inf plv sol1x40mg | LEX | CZ | | | |
| 9.2 | A02BC02 | pantoprazol | parent. | 40 | MG | 170,00 | H |
| 10 | A02BX | ostatní léčiva peptického vředu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 10.1 | A02BX02 | sukralfát | p.o. | 4 | GM | 10,46 | |
| 91217 | VENTER | tbl 50x1gm | KRK | SLO | | | |
| 93131 | VENTER | gra 50x2gm 1gm/2gm | KRK | SLO | | | |
| 10.2 | A02BX03 | pirenzepin | p.o. | 0.1 | GM | 8,55 | |
| | | | | | | | |
| 10.3 | A02BX05 | zásaditý citronan bismutitý | p.o. | 0.48 | GM | 23,07 | |
@@ -260,17 +256,16 @@
| 11.1 | A02BX03 | pirenzepin | parent. | 20 | MG | 105,58 | H |
| 12 | A02DA | antiflatulencia a spasmolytika ATC skupiny A03A | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 12.1 | A02DA01 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 11,24 | |
| 12.1 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 4,94 | |
| | | | | | | | |
| 12.2 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 4,94 | |
| | | | | | | | |
| 12.3 | A03AX13 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 10,91 | |
| 91846 | CEOLAT | ctb 20x80mg | SVP | D | | | |
| 12.2 | A02DA01 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 19,89 | |
| 12.4 | A03AX13 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 18,85 | |
| 55950 | SAB SIMPLEX | sus 50x15ml(sacky) | PDA | D | | | |
| 93500 | SAB SIMPLEX | sus 1x30ml | PDA | D | | | |
| 84580 | LEFAX | sus 1x50ml | ASH | D | | | |
| 55950 | SAB SIMPLEX | sus 50x15ml(sacky) | PDA | D | | | |
| 12.3 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 4,94 | |
| | | | | | | | |
| 12.4 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 4,94 | |
| | | | | | | | |
| 12.5 | A03AX58 | alverin | p.o. | 0.18 | GM | 4,94 | |
| 12.5 | A03AX58 | alverin (kombinace se silikony) | p.o. | 0.18 | GM | 7,90 | |
| 13 | A03AB | anticholinergika s kvarterní oniovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 13.1 | A03AB03 | oxyfenon | p.o. | 25 | MG | 2,30 | |
@@ -281,185 +276,183 @@
| | | | | | | | |
| 13.4 | A03AB20 | trospium chlorid | p.o. | 40 | MG | 12,42 | |
| 12528 | SPASMEX 15 | tbl 50x15mg | PFL | D | | | |
| 12527 | SPASMEX 15 | tbl 30x15mg | PFL | D | | | |
| 12525 | SPASMEX 5 | tbl 30x5mg | PFL | D | | | |
| 12527 | SPASMEX 15 | tbl 30x15mg | PFL | D | | | |
| 14 | A03AD | muskulotropní spasmolytika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 14.1 | A03AD01 | papaverin | p.o. | 0.1 | GM | 0,68 | |
| | | | | | | | |
| 14.2 | A03AD02 | drotaverin | p.o. | 0.1 | GM | 4,94 | |
| 02551 | NO-SPA | tbl 20x40mg | CHN | H | | | |
| 46628 | NO-SPA FORTE | tbl 20x80mg | CHN | H | | | |
| 46627 | NO-SPA FORTE | tbl 10x80mg | CHN | H | | | |
| 02551 | NO-SPA | tbl 20x40mg | CHN | H | | | |
| 15 | A03AD | muskulotropní spasmolytika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 15.1 | A03AD01 | papaverin | parent. | 0.1 | GM | 17,94 | |
| 03576 | PAPAVERIN SPOFA | inj 10x2ml/60mg | SPX | CZ | | | |
| 15.2 | A03AD02 | drotaverin | parent. | 0.1 | GM | 25,32 | |
| 59649 | NO-SPA | inj 5x4ml/80mg | CHN | H | | | |
| 16 | A03BA | alkaloidy beladony s terciální aminovou skupinou | p.o. | | | | |
| 16 | A03BA | alkaloidy beladony s terciálni aminovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 16.1 | A03BA01 | atropin | p.o. | 1.5 | MG | 0,49 | |
| 17 | A03BA | alkaloidy beladony s terciální aminovou skupinou | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 17.1 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.5 | MG | 15,15 | |
| | | | | | | | |
| 17.2 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.5 | MG | 7,91 | |
| 17.2 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.5 | MG | 7,92 | |
| 00394 | ATROPIN BIOTIKA 1MG | inj 10x1ml/1mg | HBS | SK | | | |
| 18 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 18.1 | A03BB01 | butylskopolamin | p.o. | 60 | MG | 14,31 | |
| 18.1 | A03BB01 | butylskopolamin | p.o. | 60 | MG | 14,10 | |
| 01317 | BUSCOPAN | drg 20x10mg | BOE | D | | | |
| 19 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 19.1 | A03BB01 | butylskopolamin | p.rect. | 60 | MG | 14,66 | |
| 20 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 20.1 | A03BB01 | butylskopolamin | parent. | 60 | MG | 38,16 | |
| 20.1 | A03BB01 | butylskopolamin | parent. | 60 | MG | 37,62 | |
| 98169 | BUSCOPAN | inj 5x1ml/20mg | BOE | E | | | |
| 21 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 21.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2 | DF | 3,96 | |
| | | | | | | | |
| 21.2 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2 | DF | 3,96 | |
| 21.2 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2 | DF | 4,11 | |
| 88708 | ALGIFEN | tbl 20 | LEX | CZ | | | |
| 21.3 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2 | ML | 5,28 | |
| 21.3 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2 | ML | 5,82 | |
| 91981 | ALGIFEN | gtt 1x10ml 500mg/ml | IVX | CZ | | | |
| 22 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 22.1 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2 | DF | 12,90 | |
| 22.1 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2 | DF | 13,48 | |
| 91517 | ALGIFEN | sup 5 | LEX | CZ | | | |
| 23 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 23.1 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2 | DF | 46,00 | |
| 88709 | ALGIFEN | inj 5x5ml | HBS | SK | | | |
| 24 | A03EA | spasmolytika, psycholeptika, analgetika v kombinaci | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 24.1 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2 | DF | 12,17 | |
| 24 | A03EA | spasmolytika,psycholeptika, analgetika v kombinaci | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 24.1 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2 | DF | 12,72 | |
| 91261 | SPASMOPAN | sup 5 | LEX | CZ | | | |
| 25 | A03FA | prokinetika (cisaprid) | p.o. | L/GIT,INT,PDD,PSY | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30 | MG | 31,10 | L/GIT,INT, PDD,PSY |
| | | | | | | | |
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30 | MG | 28,00 | L/GIT,INT, PDD,PSY |
| | | | | | | | |
| 25.3 | A03FA02 | cisaprid (tekuté lékové formy) s obsahem 1 mg v 1 ml | p.o. | 30 | MG | 58,26 | L/GIT,INT, PDD,PSY |
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30 | MG | 26,00 | L/GIT,INT, PDD,PSY |
| | | | | | | | |
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30 | MG | 22,50 | L/GIT,INT, PDD,PSY |
| | | | | | | | |
| 25.3 | A03FA02 | cisaprid (tekuté lékové formy) s obsahem 1 mg v 1 ml | p.o. | 30 | MG | 57,39 | L/GIT,INT, PDD,PSY |
| 93393 | PREPULSID | sus 1x100ml | JAN | B | | | |
| 93392 | PREPULSID | sus 1x200ml | JAN | B | | | |
| 25.4 | A03FA02 | cisaprid (tekuté lékové formy dělené - sáčky) | p.o. | 30 | MG | 31,10 | L/GIT,INT, PDD,PSY |
| 25.4 | A03FA02 | cisaprid (tekuté lékové formy dělené - sáčky) | p.o. | 30 | MG | 26,00 | L/GIT,INT, PDD,PSY |
| 26 | A03FA | prokinetika (ostatní) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 26.1 | A03FA01 | metoclopramid hydrochlorid | p.o. | 30 | MG | 4,15 | |
| 56694 | MCP HEXAL 10 | tbl 20x10mg | FST | D | | | |
| 93104 | DEGAN | Tbl 40x10mg | LEK | SLO | | | |
| 56695 | MCP HEXAL 10 | tbl 50x10mg | FST | D | | | |
| 56696 | MCP HEXAL 10 | tbl 100x10mg | FST | D | | | |
| 56698 | MCP HEXAL KAPKY | gtt 1x100ml/400mg | WPH | D | | | |
| 03376 | CERUCAL | tbl 50x10mg | VAD | D | | | |
| 56696 | MCP HEXAL 10 | tbl 100x10mg | FST | D | | | |
| 56695 | MCP HEXAL 10 | tbl 50x10mg | FST | D | | | |
| 56698 | MCP HEXAL KAPKY | gtt 1x100ml/400mg | WPH | D | | | |
| 26.2 | A03FA03 | Domperidon | p.o. | 30 | MG | 4,15 | |
| 93104 | DEGAN | tbl 40x10mg | LEK | SLO | | | |
| 26.2 | A03FA03 | domperidon | p.o. | 30 | MG | 4,15 | |
| | | | | | | | |
| 26.3 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 4,15 | |
| | | | | | | | |
| 26.4 | A03FA | itoprid | p.o. | 0.15 | GM | 30,00 | |
| 26.4 | A03FA | itoprid | p.o. | 0.15 | GM | 28,00 | L/GIT,INT, PDD, PSY |
| | | | | | | | |
| 26.5 | A03AE02 | tegaserod | p.o. | 12 | MG | 30,00 | |
| 27 | A03FA | prokinetika | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 27.1 | A03FA01 | metoclopramid | p.rect. | 30 | MG | 41,50 | |
| | | | | | | | |
| 27.2 | A03FA02 | cisaprid | p.rect. | 30 | MG | 48,92 | |
| 27.2 | A03FA02 | cisaprid | p.rect. | 30 | MG | 47,57 | |
| 64695 | PREPULSID | sup 6x30mg | CIL | CH | | | |
| 27.3 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 41,50 | |
| 28 | A03FA | prokinetika | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 28.1 | A03FA01 | metoclopramid | parent. | 30 | MG | 21,43 | O |
| 28 | A03FA | prokinetika | parent. | parent. | O | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 28.1 | A03FA01 | metoclopramid | parent. | 30 | MG | 21,10 | O |
| 93105 | DEGAN | inj 50x2ml/10mg | LEK | SLO | | | |
| 28.2 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,47 | O |
| 29 | A04AA | antiemetika ze skupiny serotoninových antagonistů | p.o. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 29.1 | A04AA01 | ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 826,30 | X |
| 29.1 | A04AA01 | ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 743,70 | X |
| 04004 | EMETRON 4MG | por tbl flm 10x4mg | GED | H | | | |
| 84794 | EMESET- 4 | tbl obd 10x6x4mg | CIA | IND | | | |
| 57531 | ZOFRAN 4MG | tbl obd 10x4mg | GWE | GB | | | |
| 84744 | EMESET- 4 | tbl obd 1x6x4mg | CIA | IND | | | |
| 84794 | EMESET- 4 | tbl obd 10x6x4mg | CIA | IND | | | |
| 04004 | EMETRON 4MG | por tbl flm 10x4mg | GED | H | | | |
| 98170 | ZOFRAN | tbl 10x4mg | GLA | GB | | | |
| 29.2 | A04AA01 | ondansetron (pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 612,50 | X |
| 29.2 | A04AA01 | ondansetron (pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 551,25 | X |
| 57532 | ZOFRAN 8MG | tbl obd 10x8mg | GWE | GB | | | |
| 04005 | EMETRON 8MG | por tbl flm 10x8mg | GED | H | | | |
| 98177 | ZOFRAN | tbl 10x8mg | GLA | GB | | | |
| 84793 | EMESET- 8 | tbl obd 10x6x8mg | CIA | IND | | | |
| 84443 | EMESET- 8 | tbl obd 1x6x8mg | CIA | IND | | | |
| 84793 | EMESET- 8 | tbl obd 10x6x8mg | CIA | IND | | | |
| 29.3 | A04AA01 | ondansetron (pevné rychle rozpustné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 944,40 | X |
| 29.3 | A04AA01 | ondansetron (pevné rychle rozpustné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 850,00 | X |
| 53485 | ZOFRAN ZYDIS 4MG | tbl sol 10x4mg | GOW | GB | | | |
| 29.4 | A04AA01 | ondansetron (pevné rychle rozpustné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 700,00 | X |
| 58080 | ZOFRAN ZYDIS 4 MG | tbl sol 10x4mg | RPS | GB | | | |
| 29.4 | A04AA01 | ondansetron (pevné rychle rozpustné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 630,00 | X |
| 53486 | ZOFRAN ZYDIS 8MG | tbl sol 10x8mg | GOW | GB | | | |
| 29.5 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16 | MG | 882,60 | X |
| 58204 | ZOFRAN ZYDIS 8 MG | tbl sol 10x8mg | RPS | GB | | | |
| 29.5 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16 | MG | 838,50 | X |
| | | | | | | | |
| 29.6 | A04AA01 | ondansetron (léková forma čípků) | p.rect. | 16 | MG | 774,65 | X |
| 56742 | ZOFRAN | sup 1x16mg | GWE | F | | | |
| 29.7 | A04AA02 | granisetron | p.o. | 2 | MG | 612,50 | X |
| 03274 | KYTRIL 1 MG TBL. OBD. | tbl obd 10x1mg | SKC | GB | | | |
| 29.8 | A04AA03 | tropisetron | p.o. | 5 | MG | 612,50 | X |
| 62529 | NAVOBAN | cps 5x5mg | SAN | CH | | | |
| 29.9 | A04AA04 | dolasetron | p.o. | 200 | MG | 612,50 | X |
| 30 | A04AA | antiemetika ze skupiny serotoninových antagonistů | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 30.1 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16 | MG | 1326,60 | X |
| 29.7 | A04AA02 | granisetron | p.o. | 2 | MG | 551,25 | X |
| | | | | | | | |
| 29.8 | A04AA03 | tropisetron | p.o. | 5 | MG | 551,25 | X |
| | | | | | | | |
| 29.9 | A04AA04 | dolasetron | p.o. | 200 | MG | 551,25 | X |
| 30 | A04AA | antiemetaka ze skupiny serotoninových antagonistů | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 30.1 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16 | MG | 1193,95 | X |
| 04002 | EMETRON 4MG | inj sol 5x2ml/4mg | GED | H | | | |
| 84441 | EMESET | inj 5x2ml/4mg | CIA | IND | | | |
| 30.2 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16 | MG | 1114,90 | X |
| 80480 | ZOFRAN | inj 5x4ml 2mg/ml | GLA | I | | | |
| 30.2 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16 | MG | 1003,40 | X |
| 04003 | EMETRON 8MG | inj sol 5x4ml/8mg | GED | H | | | |
| 84442 | EMESET | inj 5x4ml/8mg | CIA | IND | | | |
| 30.3 | A04AA02 | granisetron | parent. | 3 | MG | 731,90 | X |
| 03279 | KYTRIL INJ/INF | inj 5x3mg/3ml | SKC | GB | | | |
| 30.4 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5 | MG | 731,90 | X |
| 96863 | NAVOBAN | inj 1x5ml/5mg | SAN | CH | | | |
| 66849 | NAVOBAN | inj 10x5ml/5mg | SAN | CH | | | |
| 30.5 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5 | MG | 1259,60 | X |
| 56247 | NAVOBAN | inj 1x2ml/2mg | NPA | CH | | | |
| 30.6 | A04AA04 | dolasetron | parent. | 100 | MG | 731,90 | X |
| 30.3 | A04AA02 | granisetron | parent. | 3 | MG | 658,70 | X |
| | | | | | | | |
| 30.4 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5 | MG | 1133,60 | X |
| | | | | | | | |
| 30.5 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5 | MG | 658,70 | X |
| | | | | | | | |
| 30.6 | A04AA04 | dolasetron | parent. | 100 | MG | 658,70 | X |
| 31 | A04AD | různá antiemetika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 | MG | 3,30 | |
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 MG | 3,31 | | |
| 88321 | MEDRIN | tbl 20x25mg | LEX | CZ | | | |
| 31.2 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.1 | GM | 3,32 | |
| 31.2 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.1 | GM | 3,31 | |
| | | | | | | | |
| 31.3 | A04AD | různá antiemetika (meklozin) | p.o. | 50 | MG | 3,31 | |
| 32 | A04AD | různá antiemetika | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 32.1 | A04AD01 | různá antiemetika (theoklát moxastinu) | p.rect. | 0.1 | GM | 9,38 | |
| 33 | A05AA | hepatika ze skupiny žlučových kyselin | p.o. | L/GIT,INF | | | |
| 33 | A05AA | hepatika ze skupiny žlučových kyselin | po. | L/GIT,INF | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 33.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1 | GM | 21,46 | L/GIT,INF |
| | | | | | | | |
| 33.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 27,08 | L/GIT,INF |
| 97864 | URSOSAN | cps 50x250mg | PMP | CZ | | | |
| 33.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 24,89 | L/GIT,INF |
| 91017 | URSOFALK | cps 100x250mg | FAK | D | | | |
| 34 | A05AX | ostatní hepatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 34.1 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3 | DF | 2,32 | |
| 34.1 | A05AX | jiná léčiva onemocněni žlučníku (fenipentol) | p.o. | 3 | DF | 2,32 | |
| 00146 | FEBICHOL | cps 50x100mg | SLO | SK | | | |
| 34.2 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5,96 | |
| 97881 | ISOCHOL (BLISTR 3X10) | drg 30x400mg | LEX | CZ | | | |
| 35 | A05BA | léčiva onemocnění jater | p.o. | | | | |
| 35 | A05BA | léčiva onemocněni jater | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 35.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4 | DF | 11,73 | |
| | | | | | | | |
| 35.2 | A05BA | léčiva onemocnění jater (Silymarin v kombinaci) | p.o. | 0.21 | GM | 5,81 | |
| | | | | | | | |
| 35.3 | A05BA03 | Silymarin (do 70 mg včetně v jedné tabletě) | p.o. | 0.21 | GM | 5,81 | |
| 35.2 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 5,71 | |
| | | | | | | | |
| 35.3 | A05BA03 | silymarin (do 70 mg včetně v jedné tabletě) | p.o. | 0.21 | GM | 5,71 | |
| 76762 | SILYMARIN AL 50 | drg 30x50mg | APA | D | | | |
| 35.4 | A05BA03 | silymarin (nad 70 mg v jedné tabletě) | p.o. | 0.21 | GM | 4,40 | |
| 36 | A05BA | léčiva onemocnění jater | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 36.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1 | DF | 43,64 | H |
| 36.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1 | DF | 42,98 | H |
| 92325 | ESSENTIALE N | inj 5x5ml | NAT | D | | | |
| 36.2 | A05BA03 | silymarin | parent. | 0.35 | GM | 2395,68 | H |
| 36.2 | A05BA03 | silymarin | parent. | 0.35 | GM | 2359,75 | H |
| 31341 | LEGALON SIL | inj sic 4x350mg | MAU | D | | | |
| 37 | A06A | osmoticky působící nevstřebatelné cukry | p.o., p.rect. | L/GIT,INT,GER | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 37.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4 | DF | 242,70 | |
| | | | | | | | |
| 37.2 | A06AD11 | laktulóza | p.o. | 6,7 | GM | 5,28 | L/GIT,INT, GER, PDD,CHI |
| 86612 | LACTULOSA INFUSIA | sir 1x250ml 50% | IHO | CZ | | | |
| 02816 | LACTULOSA INFUSIA | sir 1 x500ml 50% | IHO | CZ | | | |
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 3,71 | L/GIT,INT, GER, CHI |
| 37.2 | A06AD11 | laktulóza | p.o. | 6,7 | GM | 5,45 | L/GIT,INT, GER, PDD,CHI |
| | | | | | | | |
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 3,71 | L/GIT,INT, GER,CHI |
| | | | | | | | |
| 37.4 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2 | DF | 174,01 | |
| 92489 | YAL | sol 10x67.5ml | TRM | D | | | |
@@ -470,8 +463,8 @@
| 38.2 | A07AA02 | nystatin | p.o. | 1.5 | MU | 5,96 | |
| | | | | | | | |
| 38.3 | A07AA03 | natamycin | p.o. | 0.3 | GM | 41,01 | |
| 02046 | PIMAFUCIN | tbl obd 20x100mg | YEU | NL | | | |
| 38.4 | A07AA11 | rifaximin | p.o. | 0.8 | GM | 75,00 | P |
| | | | | | | | |
| 38.4 | A07AA11 | rifaximin | p.o. | 0.8 | GM | 85,00 | P |
Přípravek je indikován k použití u:
@@ -481,67 +474,68 @@
3) pseudomembranosní kolitidě
4) bakteriálních infekcí provázejících nespecifická zánětlivá onemocnění střev (Crohnovy choroby a ulcerosní colitidy) citlivých na rifaximin.
4) bakteriálních infekcí provázejících nespecifická zánětlivá onemocnění střev (Crohnovy choroby a ulcerosní colitidy) citlivých na rifaximin
5) prokázané divertikulitidě tráčníku, citlivé na rifaximin.
| 39 | A07EA | kortikosteroidy pro rektální aplikaci nebo působící v tlustém střevu | p.rect., p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 39.1 | A07EA06 | budesonid | p.rect. | 2 | MG | 250,00 | L/GIT,INT |
| | | | | | | | |
| 39.2 | A07EA06 | budesonid | p.o. | 9 | MG | 117,56 | P |
| 39.2 | A07EA06 | budesonid | p.o. | 9 | MG | 108,80 | P |
Léčbu perorálním budesonidem ordinuje gastroenterolog nebo internista v akutní atace, popřípadě v chronické fázi Crohnovy choroby, zejména tam, kde vzniká potřeba léčby steroidy a současně nutnost minimalizovat jejich systémové účinky.
| 64786 | BUDENOFALK | cps ent 50x3mg | FAK | D | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 64787 | BUDENOFALK | cps ent 100x3mg | FAK | D | | | |
| 12701 | ENTOCORT 3MG | cps 50x3mg | APN | S | | | |
| 12702 | ENTOCORT 3MG | cps 100x3mg | APN | S | | | |
| 39.3 | A07EB01 | natrium kromoglykát | p.o. | 800 | MG | 75,10 | P |
Diagnózu prokazuje a léčbu indikuje alergolog a klinický imunolog na základě alergologického vyšetření kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek: při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit.
| 39.3 | A07EB01 | natrium kromoglykát | p.o. | 800 | MG | 73,58 | P |
Diagnózu prokazuje a léčbu indikuje alergolog a klinický imunolog na základě alergologického vyšetřeni kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek: při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit.
| 93797 | NALCROM | cps 100x100mg | FIS | GB | | | |
| 40 | A07EC | aminosalicylová kyselina a její deriváty | p.o. | L/GIT,INT | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 40.1 | A07EC01 | sulfasalazin | p.o. | 2 | GM | 17,21 | L/GIT,INT,REV |
| 72968 | SALAZOPYRIN EN | tbl 100x500mg | KBP | S | | | |
| 02159 | SULFASALAZIN K | tbl obd 50x500mg | KRK | SLO | | | |
| 04304 | SULFASALAZIN K-EN | tbl ent 100x500mg | KRK | SLO | | | |
| 72968 | SALAZOPYRIN EN | tbl 100x500mg | KBP | S | | | |
| 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 26,30 | L/GIT,INT |
| 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 25,14 | L/GIT,INT |
| 75567 | SALOFALK 500 | tblobd ent100x500mg | FAK | D | | | |
| 45835 | SALOFALK 250 | tbl ent 50x250mg | FAK | D | | | |
| 93235 | SALOFALK 250 | tbl ent 100x250mg | FAK | D | | | |
| 75567 | SALOFALK 500 | tblobd ent100x500mg | FAK | D | | | |
| 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 46,44 | P |
Mesalazin per os - tablety s řízeným uvolňováním:
Je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida). Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až při selhání ostatních aminosalicylátů.
| 86616 | PENTASA SR 500MG (BLISTR) | tbl ret 100x500mg | FEI | DK | | | |
| 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 44,12 | P |
Mesalazin per os – tablety s řízeným uvolňováním:
Je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé časti tlustého střeva (ileokolitida). Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až při selhání ostatních aminosalicylátů.
| 41 | A07EC | aminosalicylová kyselina a její deriváty | p.rect. | L/GIT,INT | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 41.1 | A07EC02 | mesalazin (enm.) | p.rect. | 1.5 | GM | 76,22 | L/GIT |
| 41.1 | A07EC02 | mesalazin (enm.) | p.rect. | 1.5 | GM | 71,57 | L/GIT |
| 93770 | SALOFALK 4GM | enm 7x60ml/4gm | FAK | D | | | |
| 41.2 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.5 | GM | 142,78 | L/GIT |
| 41.2 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.5 | GM | 131,41 | L/GIT |
| 93238 | SALOFALK 250 | sup 10x250mg | FAK | D | | | |
| 93239 | SALOFALK 250 | sup 30x250mg | FAK | D | | | |
| 41.3 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.5 | GM | 119,40 | L/GIT |
| 41.3 | IA07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.5 | GM | 105,98 | L/GIT |
| 75569 | SALOFALK 500 | sup 30x500mg | FAK | D | | | |
| 75568 | SALOFALK 500 | sup 10x500mg | FAK | D | | | |
| 75569 | SALOFALK 500 | sup 30x500mg | FAK | D | | | |
| 83135 | PENTASA | sup 28x1gm | FEI | DK | | | |
| 76704 | ASACOL | sup 20x500mg | TLT | CH | | | |
| 42 | A07FA | protiprůjmové mikroorganismy | p.o. | L/PDD,GIT,GER | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 42.1 | A07FA01 | organismy produkující kyselinu mléčnou, tekuté lékové formy | p.o. | 2 | ML | 3,76 | L/PDD,GIT, GER |
| 42.1 | A07FA01 | organismy produkující kyselinu mléčnou, tekuté lékové formy | p.o. | 2 | ML | 3,61 | L/PDD,GIT,GER |
| 09159 | HYLAK FORTE | gtt 1x100ml | MCK | D | | | |
| 09158 | HYLAK FORTE | gtt 1x30ml | MCK | D | | | |
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou, pevné lékové formy | p.o. | 4 | DF | 3,86 | L/PDD,GIT, GER |
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou, pevné lékové formy | p.o. | 4 | DF | 3,86 | L/PDD,GIT,GER |
| | | | | | | | |
| 42.3 | A07FA02 | saccharomyces boulardii sicatus | p.o. | 1 | DF | 5,50 | P |
Přípravek je indikován k léčbě infekčních průjmů, k profylaxí a léčbě průjmů u pacientů živených gastrickou nebo enterální výživou pomocí sondy.Nelze jej předepisovat (a hradit z prostředků veřejného zdravotního pojištění) pro profylaxi a léčbu cestovatelských průjmů.
| 42.4 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), lékové formy tobolek | p.o. | 2 | DF | 3,60 | |
| | | | | | | | |
Přípravek je indikován k léčbě infekčních průjmů, k profylaxi a léčbě průjmů u pacientů živených gastrickou nebo enterální výživou pomoci sondy.Nelze jej předepisovat (a hradit z prostředků veřejného zdravotního pojištění) pro profylaxi a léčbu cestovatelských průjmů.
| 42.4 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), lékové formy tobolek | p.o. | 2 | DF | 25,14 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Přípravek je indikován k udržovací léčbě u nespecifických střevních zánětů.
| 42.5 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), tekuté lékové formy | p.o. | 1 | DF | 43,99 | L/PDD |
| | | | | | | | |
| 42.6 | A07BC05 | diosmectit (plv. susp.) | p.o. | 1 | DF | 3,86 | L/PDD |
@@ -551,7 +545,6 @@
Léčbu Wobenzymem indikuje onkolog, chirurg nebo lymfolog u lymfedému po radikálních operacích pro malignitu.
| 43.1 | A09AA | enzymové přípravky (s pankreatinem, dle lipázy) | p.o. | 5000 | U | 1,03 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 04139 | PANZYNORM FORTE | drg 30 | KRK | SLO | | | |
| 43.2 | A09AA | multienzymy (Wobenzym) | p.o. | 6 | DF | 8,80 | P |
| | | | | | | | |
@@ -563,11 +556,6 @@
| 43.5 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 U včetně v jedné tabletě) - formy mikropelet | p.o. | 5000 | U | 1,90 | |
| | | | | | | | |
| 43.6 | A09AA02 | multienzymy (dle lipázy, nad 20.000 U v jedné tabletě) | p.o. | 5000 | U | 1,61 | |
| | | | | | | | |
| 43.7 | B06AA07 | trypsin | parent. | 0,625 | MG | 19,80 | P |
Léčbu indikuje internista u lymfedému na podkladě chronického zánětu žil různé etiologie (akutní povrchové i hluboké trombózy a tromboflebitidy, recidivujíci tromboflebitidy, chronický varikózní komplex, recidivující erysipel) anebo ortoped u pacientů s reakltivní postinfekční artritis a u dekompenzovaných atróz (gonartróza, coxatróza) s indukovaným zánětem.
| 44 | A09AC | pepsin a kyselinotvorné látky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 44.1 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2 | DF | 2,79 | |
@@ -612,28 +600,40 @@
| 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | CZ | | | |
| 48.3 | A10AE30 | insulin kombinace zvířecí dlouhodobě účinkující | parent. | 40 | U | 12,66 | |
| | | | | | | | |
| 48.4 | A10AE30 | insulin hovězí středně dlouze účinkující - lahv. | parent. | 40 | U | 12,66 | |
| 48.4 | A10AC02 | insulin hovězí středné dlouze účinkující - lahv. | parent. | 40 | U | 12,66 | |
| 42368 | HYPURIN BOVINE ISOPHANE | inj 1x10ml/1ku | CBF | GB | | | |
| 48.5 | A10AL | insulin hovězí středně dlouze účinkující - cartridge | parent. | 40 | U | 21,60 | L/DIA |
| 42369 | HYPURIN BOVINE ISOPHANE | inj 5x1,5ml/150ut | CBF | GB | | | |
| 48.6 | A10AL | insulin hovězí dlouhodobě účinkující - lahv. | parent. | 40 | U | 12,46 | |
| 42370 | HYPURIN BOVINE PROTAMIN ZINC INSULIN | inj 1x10ml/1ku | CBF | GB | | | |
| 48.5 | A10AC02 | insulin hovězí středně dlouze účinkující - cartridge | parent. | 40 | U | 21,60 | L/DIA |
| | | | | | | | |
| 48.6 | A10AE02 | insulin hovězí dlouhodobě účinkující - lahv. | parent. | 40 | U | 12,46 | |
| 42370 | HYPURIN BOVINE PROT.ZINC.SULF. | inj 1x10ml/1000ut | CBF | GB | | | |
| 49 | A10BA | léčiva snižující hladinu cukru ze skupiny derivátů biguanidu a inhibitorů alfa-glukosidáz | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 49.1 | A10BA02 | metformin hydrochlorid | p.o. | 2 | GM | 7,00 | |
| 06657 | METFIREX 850 MG | por tbl flm60x850mg | CHN | H | | | |
| 41506 | METFIREX 850 MG | por tblflm 120x850mg | CHN | H | | | |
| 41507 | METFIREX 500 MG | por tblflm120x500mg | CHN | H | | | |
| 68349 | GLUFORMIN | tbl obd 30x850mg | PLI | CHO | | | |
| 58123 | DIAPHAGE 850 | por tblflm 100x850mg | SVS | CZ | | | |
| 53961 | METFORMIN 850 LECIVA | tbl obd 50x850mg | LEX | CZ | | | |
| 92478 | GLUCOPHAGE 850MG | tbl obd 100x850mg | LIP | F | | | |
| 53960 | METFORMIN 500 LECIVA | tbl obd 100x500mg | LEX | CZ | | | |
| 58125 | DIAPHAGE 500 | por tblflm 50x500mg | SVS | CZ | | | |
| 64642 | ADIMET | tbl obd 120x850mg | MCK | D | | | |
| 06668 | METFIREX 500 MG | por tbl flm60x500mg | CHN | H | | | |
| 58124 | DIAPHAGE 500 | por tblflm100x500mg | SVS | CZ | | | |
| 58121 | DIAPHAGE 850 | por tblflm 30x850mg | SVS | CZ | | | |
| 30294 | ADIMET | tbl obd 60x850mg | MCK | D | | | |
| 56504 | SIOFOR 850 | tbl obd 60x850mg | BCE | D | | | |
| 56503 | SIOFOR 500 | tbl obd 60x500mg | BCE | D | | | |
| 58126 | DIAPHAGE 500 | por tblflm 30x500mg | SVS | CZ | | | |
| 05643 | METFORMIN 850 LÉČIVA | tbl obd 100x850mg | LEX | CZ | | | |
| 56503 | SIOFOR 500 | tbl obd 60x500mg | BCE | D | | | |
| 68349 | GLUFORMIN | tbl obd 30x850mg | PLI | CHO | | | |
| 31957 | GLUFORMIN | tbl obd 60x850mg | PLI | CHO | | | |
| 53961 | METFORMIN 850 LECIVA | tbl obd 50x850mg | LEX | CZ | | | |
| 53960 | METFORMIN 500 LECIVA | tbl obd 100x500mg | LEX | CZ | | | |
| 30294 | ADIMET | tbl obd 60x850mg | MCK | D | | | |
| 92478 | GLUCOPHAGE 850MG | tbl obd 100x850mg | LIP | F | | | |
| 58122 | DIAPHAGE 850 | por tblflm 50x850mg | SVS | CZ | | | |
| 92694 | GLUCOPHAGE 500MG | tbl obd 50x500mg | LIP | F | | | |
| 92477 | GLUCOPHAGE 850MG | tbl obd 30x850mg | LIP | F | | | |
| 92694 | GLUCOPHAGE 500MG | tbl obd 50x500mg | LIP | F | | | |
| 49.2 | A10BA03 | buformin | p.o. | 0.2 | GM | 3,47 | |
| | | | | | | | |
| 45812 | SILUBIN RETARD | tbl obd 60x100mg | ANO | E | | | |
| 02558 | SILUBIN RETARD | tbl obd 60x100mg | GRU | D | | | |
| 49.3 | A10BF01 | akarboza | p.o. | 0.3 | GM | 10,26 | |
| | | | | | | | |
| 49.4 | A10BG02 | rosiglitason s obsahem 4 mg v jedné tabletě | p.o. | 1 | DF | 38,50 | P |
@@ -642,9 +642,9 @@
| | | | | | | | |
| 49.6 | A10BG03 | pioglitazon s obsahem 30 mg v jedné tabletě | p.o. | 1 | DF | 44,27 | P |
Deriváty thiazolidindionů jsou určeny ke kombinační léčbě diabetiků 2.typu s vyjádřenou inzulinovou rezistencí. Indikovány jsou jednak (a)v kombinaci se sulfonylureou, kde nelze použít metformin pro jeho nesnášenlivost, jednak(b) v kombinaci s metforminem kde monoterapie tímto preparátem nedosáhla požadované kompenzace diabetu, přičemž přetrvává neuspokojivá kompenzace diabetu (glykémie nalačno vyšší než 8.0 mmol/l, postprandiální glykémie vyšší než 10mmol/l, resp. glykovaný hemoglobin vyšší než 8.5%) a současně je přítomno zvýšené riziko kardiovaskulárního onemocnění (arteriální hypertenze, dyslipidémie a zvýšená albuminurie nad 20 µg/min nebo 2.5 g/mol kreatininu).Denní dávka hrazená z prostředků veřejného zdravotního pojištění je 4mg (1tbl.) rosiglitazonu nebo 15mg (1 tbl.) pioglitazonu nebo 30gm (1 tbl.) pioglitazonu.
| 50 | A10BB | léčiva snižujíci hladinu cukru ze skupiny derivátů sulfonylmočoviny | p.o. | | | | |
Deriváty thiazolidindionů jsou určeny ke kombinační léčbě diabetiků 2.typu s vyjádřenou inzulinovou rezistencí. Indikovány jsou jednak (a)v kombinaci se sulfonylureou, kde nelze použit metformin pro jeho nesnášenlivost, jednak (b) v kombinaci s metforminem, kde monoterapie tímto preparátem nedosáhla požadované kompenzace diabetu, přičemž přetrvává neuspokojivá kompenzace diabetu (glykémie nalačno vyšší než 8.0 mmol/l, postprandiální glykémie vyšší než 10 mmol/l, resp. glykovaný hemoglobin vyšší než 8.5%) a současně je přítomno zvýšené riziko kardiovaskulárního onemocnění (arteriální hypertenze, dyslipidémie a zvýšená albuminurie nad 20 μg/min nebo 2.5 g/mol kreatininu).Denní dávka hrazená z prostředků veřejného zdravotního pojištění je 4mg (1 tbl.) rosiglitazonu nebo 15mg (1 tbl.) pioglitazonu nebo 30gm (1 tbl.) pioglitazonu.
| 50 | A10BB | léčiva snižující hladinu cukru ze skupiny derivátů sulfonylmočoviny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 50.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10 | MG | 2,30 | |
| | | | | | | | |
@@ -652,7 +652,7 @@
| 45107 | BETANASE | tbl 100x5mg | CAI | IND | | | |
| 91880 | MANINIL 5 | tbl 120x5mg | BCE | D | | | |
| 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7 | MG | 1,37 | |
| 94523 | GLUCOBENE 1,75MG | tbl 120x1.75mg | MCK | D | | | |
| 94523 | GLUCOBENE 1.75MG | tbl 120x1.75mg | MCK | D | | | |
| 50.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 0,93 | |
| 94525 | GLUCOBENE 3,5MG | tbl 120x3.5mg | MCK | D | | | |
| 50.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,78 | |
@@ -671,13 +671,13 @@
| | | | | | | | |
| 50.12 | A10BB09 | gliklazid, retardované lékové formy | p.o. | 2 | DF | 6,55 | |
| | | | | | | | |
| 50.13 | A10BB12 | glymepirid do 2 mg v jedné tabletě včetně | p.o. | 2 | MG | 6,55 | |
| 50.13 | A10BB12 glymepirid do 2 mg v jedné tabletě včetně | p.o. | 2 | MG | 6,55 | | |
| | | | | | | | |
| 50.14 | A10BB12 | glymepirid nad 2 mg v jedné tabletě | p.o. | 2 | MG | 5,45 | |
| | | | | | | | |
| 50.15 | A10BD02 | metformin a glibenklamid - kombinace | p.o. | 3 | DF | 5,85 | |
| | | | | | | | |
| 50.16 | A10BX02 | repaglinid | p.o. | 1 | DF | 5,00 | Z |
| 50.16 | A10BX02 | repaglinid | p.o. 1 | DF | 5,00 | Z | |
| 51 | A11CA | vitamin A a jeho deriváty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | KU | 1,17 | |
@@ -705,80 +705,84 @@
| 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 | KU | 13,10 | |
| | | | | | | | |
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 | KU | 0,78 | |
| 00716 | INFADIN | gtt 1x10ml 10mg/1ml | SLO | SK | | | |
| 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | KU | 0,54 | |
| 00353 | VITAMIN D SLOVAKOFARMA | cps 1x300ku | SLO | SK | | | |
| 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 17,13 | |
| 94445 | TACHYSTIN | gtt 1x20ml/20mg | ANW | D | | | |
| 54.5 | A11CC03 | alfakalcidol | p.o. | 1 | RG | 27,40 | P |
| 94445 | TACHYSTIN | gtt 1x20ml/20mg | CHV | D | | | |
| 54.5 | A11CC03 | alfakalcidol do 0,50 rg včetně | p.o. | 1 | RG | 27,40 | P |
| | | | | | | | |
| 54.6 | A11CC03 | alfakalcidol nad 0,50 rg | p.o. | 1 | RG | 23,30 | P |
Léčbu alfakalcidolem ordinuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce:
- a) léčba renální osteodystrofie u nemocných s chronickou renální insuficiencií (především u dialyzovaných nemocných),
- b) léčba křivíce rezistentní na vitamin D,
- b) léčba křivice rezistentní na vitamin D,
- c) léčba osteomalacie rezistentní na vitamin D,
- d) léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem.
| 54.6 | A11CC05 | cholekalciferol - tekuté lékové formy | p.o. | 0.5 | MG | 3,91 | |
| | | | | | | | |
| 54.7 | A11CC05 | cholekalciferol - pevné lékové formy | p.o. | 0.5 | MG | 1,04 | |
- d) léčba hypoparathyreózy rezistentní na léčbu vitamínem D a vápníkem.
| 54.7 | A11CC05 | cholekalciferol - tekuté lékové formy | p.o. | 0.5 MG | 3,86 | | |
| 12023 | VIGANTOL OEL | ole 1x10ml 500rg/ml | MEC | D | | | |
| 54.8 | A11CC05 | cholekalciferol - pevné lékové formy | p.o. | 0.5 | MG | 1,04 | |
| 05877 | VITAMIN D 800-SLOVAKOFARMA | cps 30x800rg | SLO | SK | | | |
| 55 | A11CC | vitamin D a jeho deriváty (kalcitriol) | parent. | P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje internista, endokrinolog, urolog, pediatr nebo lékař pracující na dialyzační jednotce: léčba těžkých forem renální osteopatie nereagující na perorální léčbu kalcitriolem.
Léčbu ordinuje internista, endokrinolog, urolog, pediatr nebo lékař pracující na dialyzační jednotce:
léčba těžkých forem renální osteopatie nereagující na perorální léčbu kalcitriolem.
| 55.1 | A11CC04 | kalcitriol | parent. | 1 | RG | 174,20 | P |
| 56 | A11CC | vitamin D a jeho deriváty (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 56.1 | A11CC01 | ergokalciferol | parent. | 6 | KU | 0,78 | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1 ml/7.5mg | BTA | SK | | | |
| 56677 | CALCIFEROL BIOTIKA FORTE | inj 5x1ml/7.5mg | BTA | SK | | | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1ml/7.5mg | BTA | SK | | | |
| 56677 | CALCIFEROL BIOTIKA FORTE | inj 5x1 ml/7.5mg | BTA | SK | | | |
| 56.2 | A11CC05 | cholekalciferol | parent. | 1 | KU | 0,93 | |
| 11093 | VIGANTOL 50000 | inj 5x1ml/1.25mg | MEC | D | | | |
| 57 | A11DA | vitamin B1 a jeho deriváty | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 57.1 | A11DA | thiamin (vít. B1), prostý | parent. | 75 | MG | 5,38 | H |
| | | | | | | | |
| 57.2 | A11DA01 | thiamin (vit. B1) | parent. | 50 | MG | 5,38 | H |
| 00616 | THIAMIN LECIVA | inj 10x2ml/100mg | LEX | CZ | | | |
| 57.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75 | MG | 5,53 | H |
| | | | | | | | |
| 57.2 | A11DA01 | thiamin (vit. B1) | parent. | 50 | MG | 5,53 | H |
| 92502 | THIABENE | inj 6x2ml/100mg | MCK | D | | | |
| 58 | A11GA | vitamin C | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 58.1 | A11GA01 | kyselina askorbová (vitamín C) | parent. | 0.2 | GM | 3,91 | H |
| 58.1 | A11GA01 | kyselina askorbová (vitamin C) | parent. | 0.2 | GM | 3,91 | H |
| 92730 | ACIDUM ASCORBICUM BIOTIKA | inj 50x5ml/500mg | HBS | SK | | | |
| 92729 | ACIDUM ASCORBICUM BIOTIKA | inj 5x5ml/500mg | HBS | SK | | | |
| 59 | A11HA | vitamin B2, B6 a E | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 59.1 | A11HA02 | pyridoxin hydrochlorid (vitamín B6) | parent. | 0.16 | GM | 15,84 | H |
| 59.1 | A11HA02 | pyridoxin hydrochlorid (vitamín B6) | parent. | 0.16 | GM | 16,58 | H |
| 00584 | PYRIDOXIN LECIVA | inj 5x1ml/50mg | LEX | CZ | | | |
| 59.2 | A11HA03 | tokoferol (vitamín E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 69,90 | H |
| | | | | | | | |
| 59.3 | A11HA03 | tokoferol (vitamín E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,58 | H |
| | | | | | | | |
| 59.4 | A11HA04 | riboflavin (vitamín B2) | parent. | 20 | MG | 6,11 | H |
| 60 | A11JA | kombinace vitamínů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 121,42 | H |
| 94847 | VITALIPID N INFANT | inf 10x10ml | KBP | S | | | |
| 60.2 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10 | ML | 121,42 | H |
| 11485 | MILGAMMA N | inj 5x2ml | SLH | D | | | |
| 11487 | MILGAMMA N | inj 100x2ml | SLH | D | | | |
| 67072 | MILGAMMA N | inj 5x2ml | WGP | D | | | |
| 67073 | MILGAMMA N | inj 25x2ml | WGP | D | | | |
| 67075 | MILGAMMA N | inj 500x2ml | WGP | D | | | |
| 11488 | MILGAMMA N | inj 500x2ml | SLH | D | | | |
| 59.2 | A11HA03 | tokoferol (vitamin E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 69,90 | H |
| | | | | | | | |
| 59.3 | A11HA03 | tokoferol (vitamin E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,58 | H |
| | | | | | | | |
| 59.4 | A11HA04 | riboflavin (vitamin B2) | parent. | 20 | MG | 6,11 | H |
| 60 | A11JA | kombinace vitaminů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 96,90 | H |
| | | | | | | | |
| 60.2 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10 | ML | 96,90 | H |
| 11486 | MILGAMMA N | inj 25x2ml | SLH | D | | | |
| 67074 | MILGAMMA N | inj 100x2ml | WGP | D | | | |
| 61 | A12A | soli vápníku včetně kombinací vápníku a fluoru | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 61.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 0,59 | |
| 67075 | MILGAMMA N | inj 500x2ml | WGP | D | | | |
| 11485 | MILGAMMA N | inj 5x2ml | SLH | D | | | |
| 11488 | MILGAMMA N | inj 500x2ml | SLH | D | | | |
| 11487 | MILGAMMA N | inj 100x2ml | SLH | D | | | |
| 61 | A12A | soli vápníku včetně kombinaci vápníku a fluoru | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 61.1 | A12AA03 glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 0,59 | | |
| | | | | | | | |
| 61.2 | A12AA04 | uhličitan vápenatý (na obsah vápníku) tablety | p.o. | 0.5 | GM | 2,34 | |
| 70536 | TBL.CALCII CARBON.PRAEC.0.5 MVM | tbl 1000x0.5gm | MVM | CZ | | | |
| 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku), léková forma šumivé tabety, | p.o. | 0.5 | GM | 2,34 | |
| 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku), léková forma šumivé tablety | p.o. | 0.5 | GM | 2,34 | |
| | | | | | | | |
| 61.4 | A12AA04 | uhličitan vápenatý(na obsah vápníku), léková forma prášky | p.o. | 0.5 | GM | 2,34 | |
| | | | | | | | |
@@ -793,7 +797,7 @@
| 61.9 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 500 mg vápníku v 1 dávce včetně a nad 500 rg cholekalciferolu v 1 dávce | p.o. | 1 | DF | 4,00 | |
| | | | | | | | |
| 61.10 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) nad 500 mg vápníku v 1 dávce | p.o. | 1 | DF | 6,51 | |
| | | | | | | | |
| 46472 | CALTRATE PLUS | tbl obd 30 | JDC | USA | | | |
| 61.11 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1 | DF | 5,38 | L/INT,GYN,ORT REV |
| | | | | | | | |
| 61.12 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1 | DF | 4,01 | L/INT,GYN,ORT REV |
@@ -804,7 +808,7 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 62.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3 | GM | 59,93 | |
| 00407 | CALCIUM BIOTIKA | inj 10x10ml/1gm | HBS | SK | | | |
| 62.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.2 | GM | 2,98 | |
| 62.2 | A12AA07 | Chlorid vápenatý (na obsah vápníku) | parent. | 0.2 GM | 2,98 | | |
| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10ml 10% | HBS | SK | | | |
| 63 | A12BA | soli draslíku | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -812,28 +816,27 @@
| | | | | | | | |
| 63.2 | A12BA | draslík (na obsah draslíku) | p.o. | 1.5 | GM | 2,44 | |
| | | | | | | | |
| 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,64 | |
| 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,68 | |
| 91600 | KALNORMIN | tbl 30x1gm | IDA | H | | | |
| 55661 | KALIUM CHLORATUM INFUSIA-BLISTR | tbl obd 100x500mg | IHO | CZ | | | |
| 64 | A12BA | soli draslíku | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 64.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1 | DF | 13,20 | O |
| 02132 | CARDI LAN | inj 10x10ml | HBS | SK | | | |
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 50,54 | O |
| 02132 | CARDILAN | inj 10x10ml | HBS | SK | | | |
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 52,88 | O |
| 02486 | KALIUM CHLORATUM LECIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ | | | |
| 65 | A12CC | soli hořčíku (na obsah hořčíku) | p.o. | L/INT,NEU,PSY | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 65.1 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.2 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.3 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.4 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| 70535 | TBL.MAGNESII LACTICI 0.5 MVM | tbl 1000x0.5gm | MVM | CZ | | | |
| 65.5 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.6 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| 65.1 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.2 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.3 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.4 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.5 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN |
| | | | | | | | |
| 65.6 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN |
| 99891 | MAGNESIUM 250MG PHARMAVIT | tbl eff 20 | PVI | H | | | |
| 66 | A12CC | soli hořčíku | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -848,93 +851,93 @@
| 09495 | OSSIN RETARDDRAGEES | tbl obd 100x40mg | GRU | D | | | |
| 68 | A14A | anabolické steroidy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 68.1 | A14AB01 | nandrolon phenpropionát | parent. | 2 | MG | 2,98 | |
| 68.1 | A14AB01 | nandrolon phenpropionát | parent. | 2 | MG | 3,11 | |
| 00609 | SUPERANABOLON | inj 5x1ml/25mg | SPX | CZ | | | |
| 69 | A16A | ostatní léčiva alimentárního traktu | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 69.1 | A16AA01 | levokarnitin | parent. | 2 | GM | 356,82 | O |
| | | | | | | | |
| 69.2 | A16AX01 | tioktová kyselina | parent. | 0.2 | GM | 94,19 | O |
| 69.2 | A16AX01 | kyselina tioktová | parent. | 0.2 | GM | 87,18 | O |
| 84379 | THIOGAMMA 600 INJECT | inj 10x20ml/600mg | SLH | D | | | |
| 84382 | THIOGAMMA 600 INJECT | inj 1000x20ml/600mg | SLH | D | | | |
| 55380 | THIOGAMMA 600 INJECT | inj 20x20ml/600mg | SLH | D | | | |
| 84380 | THIOGAMMA 600 INJECT | inj 50x20ml/600mg | SLH | D | | | |
| 55381 | THIOGAMMA 600 INJECT | inj 500x20ml/600mg | SLH | D | | | |
| 84382 | THIOGAMMA 600 INJECT | inj 1000x20ml/600mg | SLH | D | | | |
| 84378 | THIOGAMMA 600 INJECT | inj 5x20ml/600mg | SLH | D | | | |
| 84380 | THIOGAMMA 600 INJECT | inj 50x20ml/600mg | SLH | D | | | |
| 84381 | THIOGAMMA 600 INJECT | inj 100x20ml/600mg | SLH | D | | | |
| 84379 | THIOGAMMA 600 INJECT | inj 10x20ml/600mg | SLH | D | | | |
| 69.3 | A16AA02 | ademetionin | parent. | 0,5 | GM | 108,54 | Z |
| 69.3 | A16AA02 | ademetionin | parent. | 0,5 | GM | 106,90 | Z |
| 12319 | TRANSMETIL 500MG INJEKCE | inj sic 5x500mg+5ml | KNO | I | | | |
| 69.4 | A16AA02 | ademetionin | p.o. | 1 | GM | 59,83 | Z |
| | | | | | | | |
| 69.5 | A16AB02 | imiglucerasa | parent. | 200 | U | 40341,80, | Z |
| 69.5 | A16AB02 | imiglucerasa | parent. | 200 | U | 40341,80 | Z |
| | | | | | | | |
| 69.6 | A08AA10 | sibutramin s obsahem 10 mg v jedné tabletě | p.o. | 15 | MG | 118,50 | P |
| | | | | | | | |
| 69.7 | A08AA10 | sibutramin s obsahem 15 mg v jedné tabletě | p.o. | 15 | MG | 89,00 | P |
| | | | | | | | |
| 69.8 | A08AB01 | orlistat | p.o. | 360 | MG | 89,00 | P |
| 69.7 | A08AA10 | sibutramin s obsahem 15 mg v jedné tabletě | p.o. | 15 | MG | 88,45 | P |
| | | | | | | | |
| 69.8 | A08AB01 | orlistat | p.o. | 360 | MG | 88,45 | P |
Sibutramin nebo orlistat předepisuje diabetolog pacientům s diabetes mellitus 2.typu a zároveň BMI vyšším než 35 kg/m2, u nichž je diagnostikována arteriální hypertenze, hyperlipoproteinémie nebo ICHS (u sibutraminu viz kontraindikace) vyžadující farmakologickou léčbu. U pacienta musí současně dojít k poklesu tělesné hmotnosti nejméně o 3 kg v průběhu 6 týdnů za použití pouze režimových (dietních a pohybových) opatření. Tolerance léčby je vyhodnocena po 4 týdnech od zahájení léčby, účinnost po 3 měsících léčby antiobesitikem. Kritériem účinnosti léčby antiobesitikem je pokles aspoň o 5% původní tělesné hmotnosti a současně zlepšení kompenzace diabetu (glykémie na lačno či glykovaného hemoglobinu HbA1c). Není-li léčba účinná, je podávání antiobesitika po 3 měsících přerušeno. Léčba antiobesitiky je indikována nejdéle na dobu 12 měsíců.
| 70 | B01AA | antithrombotika ze skupiny antagonistů vitaminu K | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 70.1 | B01AA03 | warfarin | p.o. | 7.5 | MG | 3,22 | |
| 58161 | LAWARIN 2 | tbl 50x2mg | PVL | CZ | | | |
| 12849 | LAWARIN 5 | tbl 100x5mg | PVL | CZ | | | |
| 58162 | LAWARIN 5 | tbl 50x5mg | PVL | CZ | | | |
| 59675 | WARFARIN 5-SL | por tbl nob 100x5mg | SLO | SK | | | |
| 59674 | WARFARIN 3-SL | por tbl nob 100x3mg | SLO | SK | | | |
| 59675 i | WARFARIN 5-SL | por tbl nob 100x5mg | SLO | SK | | | |
| 58162 | LAWARIN 5 | tbl 50x5mg | PVL | CZ | | | |
| 12849 | LAWARIN 5 | tbl 100x5mg | PVL | CZ | | | |
| 70.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.6 | GM | 4,59 | |
| | | | | | | | |
| 70.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.6 | GM | 5,47 | |
| 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) parent. | U | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 29367,29 | U |
| | | | | | | | |
| 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 29367,29 | U |
| 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) | parent. | U | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 27587,39 | U |
| 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 27587,39 | U |
| 85772 | KYBERNIN P | inj 1x1ku+20ml aqua | CTO | D | | | |
| 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | CTO | A | | | |
| 85771 | KYBERNIN P | inj 1x500ut+10ml aq | CTO | D | | | |
| 66533 | KYBERNIN P | inj 1x500ut+10ml aq | CTO | A | | | |
| 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | CTO | A | | | |
| 94229 | ANTITHROMBIN III GRIFOLS | inj sic 1000ut+20ml | GFO | E | | | |
| 94228 | ANTITHROMBIN III GRIFOLS | inj sic 500ut+10ml | GFO | E | | | |
| 72 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (heparin) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,35 | U |
| 00477 | HEPARIN FORTE LECIVA | inj 5x1ml/25ku | LEX | CZ | | | |
| 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,35 | O |
| 74999 | HEPARIN BIOCHEMIE 25000UT | inj 100x5ml/25ku | BCA | A | | | |
| 93746 | HEPARIN LECIVA | inj 1x10ml/50ku | LEX | CZ | | | |
| 73 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (ostatní) | p.o.,parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 73.1 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3 | KU | 87,04 | O |
| 94857 | FRAGMIN 2500M.J.(ANTI-XA)/0.2ML | inj 10x0.2ml/2.5ku | PAU | S | | | |
| 73.1 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3 | KU | 80,56 | O |
| | | | | | | | |
| 73.2 | B01AB04 | dalteparin nad 2,5 KU do 5 KU včetně v jedné ampuli | parent. | 3 | KU | 80,50 | O |
| 94858 | FRAGMIN 5000M.J.(ANTI-XA)/0.2ML | inj 10x0.2ml/5ku | PAU | S | | | |
| | | | | | | | |
| 73.3 | B01AB04 | dalteparin nad 5 KU v jedné ampuli | parent. | 3 | KU | 62,00 | O |
| 94856 | FRAGMIN 2500M.J.(ANTI-XA)/ML | inj 10x4ml/10ku | PAU | S | | | |
| 94855 | FRAGMIN 10000M.J.(ANTI-XA)/ML | inj 10x1ml/10ku | PAU | S | | | |
| 73.4 | B01AB05 | enoxaparin do 20 mg včetně v jedné ampuli | parent. | 3 | KU | 87,04 | 0 |
| | | | | | | | |
| 73.5 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3 | KU | 80,50 | 0 |
| | | | | | | | |
| 73.4 | B01AB05 | enoxaparin do 20 mg včetně v jedné ampuli | parent. | 3 | KU | 80,56 | O |
| | | | | | | | |
| 73.5 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3 | KU | 80,50 | O |
| | | | | | | | |
| 73.6 | B01AB05 | enoxaparin nad 40 mg do 80 mg včetně v jedné ampuli | parent. | 3 | KU | 74,68 | O |
| | | | | | | | |
| 73.7 | B01AB05 | enoxaparin nad 80 mg v jedné ampuli | parent. | 3 | KU | 62,00 | O |
| | | | | | | | |
| 73.8 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3 | KU | 87,04 | O |
| 73.8 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3 | KU | 80,56 | O |
| | | | | | | | |
| 73.9 | B01AB06 | nadroparin nad 2,85 do 3,8 KU včetně v jedné ampuli | parent. | 3 | KU | 80,50 | O |
| | | | | | | | |
| 73.10 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3 | KU | 74,68 | O |
| | | | | | | | |
| 73.11 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. | 3 | KU | 62,00 | O |
| 73.11 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. 3 | KU | 62,00 | O | |
| | | | | | | | |
| 73.12 | B01AB06 | nadroparin nad 10 KU v jedné ampuli | parent. | 3 | KU | 55,00 | O |
| | | | | | | | |
| 73.13 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU | 87,04 | O |
| 05997 | FLUXUM 3200 I.U. AXA | inj 6x0.3ml/3200ut | LEX | CZ | | | |
| 73.13 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU | 80,56 | O |
| | | | | | | | |
| 73.14 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3 | KU | 80,50 | O |
| 05998 | FLUXUM 4250 I.U. AXA | inj 6x0.4ml/4250ut | LEX | CZ | | | |
| | | | | | | | |
| 73.15 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3 | KU | 74,68 | O |
| 05999 | FLUXUM 6400 I.U. AXA | inj 6x0.6ml/6400ut | LEX | CZ | | | |
| 73.16 | B01AB08 | reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3 | KU | 87,04 | O |
| | | | | | | | |
| 73.16 | B01AB08 | reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3 | KU | 80,56 | O |
| | | | | | | | |
| 73.17 | B01AB08 | reviparin nad 1,432 KU v jedné ampuli | parent. | 3 | KU | 80,50 | O |
| | | | | | | | |
@@ -942,7 +945,7 @@
| | | | | | | | |
| 73.19 | B01AB11 | sulodexid | p.o. | 250 | U | 12,46 | L/OPH,INT, NEU, DIA,GER |
| | | | | | | | |
| 73.20 | B01AB | certoparin | parent. | 3 | KU | 87,04 | O |
| 73.20 | B01AB | certoparin | parent. | 3 | KU | 80,56 | O |
| 31316 | TROPARIN AMPOULE | inj 10x0.5ml/32mg | BCA | A | | | |
| 53406 | TROPARIN DISPOSABLE SYRINGE | inj 5x0.3ml/32mg | BCA | A | | | |
| 74 | B01AC | antiagregancia trombocytů | p.o. | P | | | |
@@ -964,25 +967,27 @@
Léčbu dipyridamolem včetně kombinací indikuje neurolog nebo internista k sekundární prevenci ischemických mozkových příhod u pacientů, kteří netolerují vyšší dávky kyseliny acetylosalicylové nebo při selhání antiagregační léčby, které se projeví cévní mozkovou příhodou.
| 74.1 | B01AC04 | Clopidogrel | p.o. | 75 | MG | 33,92 | P |
| 74.1 | B01AC04 | clopidogrel | p.o. | 75 | MG | 33,92 | P |
| | | | | | | | |
| 74.2 | B01AC05 | ticlopidin | p.o. | 0.5 | GM | 25,00 | P |
| 66938 | TAGREN | tbl 30x250mg | KRK | SLO | | | |
| 02518 | IPATON 250 MG | tbl obd 20x250mg | EGI | H | | | |
| 02973 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 30x250mg | MCK | D | | | |
| 02974 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 90x250mg | MCK | D | | | |
| 02984 | APO-TIC | por tbl obd30x250mg | APT | CND | | | |
| 02985 | APO-TIC | por tblobd100x250mg | APT | CND | | | |
| 02518 | IPATON 250 MG | tbl obd 20x250mg | EGI | H | | | |
| 74.3 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,68 | |
| 72812 | ANOPYRIN 30MG | tbl 50x30mg | SLO | SK | | | |
| 72813 | ANOPYRIN 30MG | tbl 20x30mg | SLO | SK | | | |
| 74.4 | B01AC06 | kyselina acetylsalicylová (nad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,98 | |
| | | | | | | | |
| 74.5 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,68 | |
| 74.4 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,68 | |
| 99295 | ANOPYRIN 100MG | tbl 20x100mg | SLO | SK | | | |
| 71960 | ANOPYRIN 100MG | tbl 50x100mg | SLO | SK | | | |
| 01286 | GODASAL 100 | tbl 20 | PFL | D | | | |
| 01288 | GODASAL 100 | tbl 50 | PFL | D | | | |
| 01286 | GODASAL 100 | tbl 20 | PFL | D | | | |
| 71960 | ANOPYRIN 100MG | tbl 50x100mg | SLO | SK | | | |
| 74.5 | B01AC06 | kyselina acetylsalicylová (nad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,98 | |
| | | | | | | | |
| 74.6 | B01AC07 | dipyridamol | p.o. | 400 | MG | 8,65 | P |
| 57381 | PERSANTIN | tbl obd 50x75mg | BOE | F | | | |
| | | | | | | | |
| 74.7 | B01AC10 | indobufen | p.o. | 0.3 | GM | 10,50 | P |
| | | | | | | | |
| 74.8 | B01AC30 | dipyridamol a kyselina acetylosalicylová v kombinaci | p.o. | 2 | DF | 12,00 | P |
@@ -994,17 +999,22 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 75.1 | B01AC07 | dipyridamol | parent. | 0.2 | GM | 224,45 | H |
| | | | | | | | |
| 75.2 | B01AC10 | indobufen | parent. | 0.3 | GM | 89,35 | H |
| | | | | | | | |
| 75.3 | B01AC11 | iloprost | parent. | 50 | RG | 660,60 | X |
| | | | | | | | |
| 75.4 | B01AC13 | abciximab | parent. | 1 | DF | 9594,00 | H |
| 56610 | REOPRO 2MG/ML | inj 1x5ml | CEO | NL | | | |
| 75.5 | B01AC16 | eptifibatide injekce | parent. | 1 | DF | 930,27 | H |
| | | | | | | | |
| 75.6 | B01AC16 | eptifibatide infuze | parent. | 1 | DF | 2930,36 | H |
| | | | | | | | |
| 75.7 | B01AC17 | tirofiban | parent. | 1 | DF | 5437,00 | H |
| 75.2 | B01AC09 | epoprostenol | parent. | 0.5 | MG | 5330,00 | X |
| 41499 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GWB | GB | | | |
| 58143 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GOK | GB | | | |
| 41467 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GOK | GB | | | |
| 41501 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GWB | GB | | | |
| 75.3 | B01AC10 | indobufen | parent. | 0.3 | GM | 89,35 | H |
| | | | | | | | |
| 75.4 | B01AC11 | iloprost | parent. | 50 | RG | 660,60 | X |
| | | | | | | | |
| 75.5 | B01AC13 | abciximab | parent. | 1 | DF | 11131,00 | H |
| | | | | | | | |
| 75.6 | B01AC16 | eptifibatide injekce | parent. | 1 | DF | 930,27 | H |
| | | | | | | | |
| 75.7 | B01AC16 | eptifibatide infuze | parent. | 1 | DF | 2930,36 | H |
| | | | | | | | |
| 75.8 | B01AC17 | tirofiban | parent. | 1 | DF | 5437,00 | H |
| 76 | B01AD | trombolytika | parent. | U | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1018,10 +1028,9 @@
- b) trombolýza akutních a subakutních uzávěrů periferních cév.
| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3608,44 | U |
| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3405,60 | U |
| 10937 | STREPTASE | inj sic 1x750ku | HMD | D | | | |
| 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3426,91 | U |
| 94697 | KABIKINASE | inj sic 1x1.5mu | KBP | S | | | |
| 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3234,40 | U |
| 62461 | STREPTASE | inj sic 1x1.5mu | HMD | D | | | |
| 76.3 | B01AD02 | alteplaza | parent. | 0.1 | GM | 43265,44 | U/P |
| | | | | | | | |
@@ -1038,13 +1047,12 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 38,86 | |
| | | | | | | | |
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 40,72 | |
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 GM | 40,72 | | |
| | | | | | | | |
| 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 38,57 | |
| 97412 | EXACYL | sol 5x10ml/1gm | SWI | F | | | |
| 57480 | EXACYL | tbl obd 20x500mg | SWT | P | | | |
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 19,72 | |
| 02123 | PAMBA | tbl 10x250mg | CWO | D | | | |
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 19,42 | |
| 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 65,01 | |
@@ -1056,7 +1064,7 @@
| 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 664,66 | H |
| 02787 | ANTILYSIN SPOFA | inj 5x10ml/100ku | SPX | CZ | | | |
| 02787 | ANTILYSIN SPOFA | nj 5x10ml/100ku | SPX | CZ | | | |
| 80 | B02BA | vitamin K a jeho deriváty a další lokální hemostyptika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 10,66 | |
@@ -1066,14 +1074,14 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 81.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10 | MG | 14,27 | |
| | | | | | | | |
| 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 15,84 | |
| 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 15,88 | |
| 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK | | | |
| 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 83,29 | O |
| 02213 | DICYNONE 250 | inj 100x2ml/250mg | OMR | CH | | | |
| 01821 | DICYNONE 250 | inj 20x2ml/250mg | OMR | CH | | | |
| 82 | B02BB | lidský fibrinogen | parent. | U | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 5260,50 | U |
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 5343,00 | U |
| 52772 | FIBRINOGEN IMMUNO I.V. 1000MG | inj sic 1000mg+50ml | IMM | A | | | |
| 83 | B02BC | lokální hemostatika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1086,7 +1094,7 @@
| 83.4 | B02BC01 | absorbovatelná želatinová houba | lok. | 1 | C2 | 2,69 | |
| | | | | | | | |
| 83.5 | B02BC06 | thrombin (houba) | lok. | 1 | DF | 56,80 | |
| 84 | B02BD | koagulačni faktory (faktor VIII a faktor IX) | parent. | B/P | | | |
| 84 | B02BD | koagulační faktory (faktor VIII a faktor IX) | parent. | B/P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu koagulačním faktorem VIII ordinuje hematolog:
@@ -1123,13 +1131,10 @@
| | | | | | | | |
| 84.9 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350 | U | 4174,27 | B/P |
| | | | | | | | |
| 84.10 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.5 | KU | 1508,65 | B/P |
| 84.10 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.5 | MU | 1357800,00 | B/P |
| 92641 | NOVOSEVEN 4.8MG(=240KU) | inj sic 1x4.8mg+sol | NOO | DK | | | |
| 89825 | NOVOSEVEN 1.2MG(=60KU) | inj sic 1x1.2mg+sol | NOO | DK | | | |
| 89826 | NOVOSEVEN 2.4MG(=120KU) | inj sic 1x2.4mg+sol | NOO | DK | | | |
| 58497 | NOVOSEVEN 240KIU (4.8MG) | inj sic4.8mg+so+str | NOO | DK | | | |
| 92641 | NOVOSEVEN 4.8MG(=240KU) | inj sic 1x4.8mg+sol | NOO | DK | | | |
| 58496 | NOVOSEVEN 120KIU (2.4MG) | inj sic2.4mg+so+str | NOO | DK | | | |
| 58495 | NOVOSEVEN 60KIU (1.2MG) | inj sic1.2mg+so+str | NOO | DK | | | |
| 89825 | NOVOSEVEN 1.2MG(=60KU) | inj sic 1x1.2mg+sol | NOO | DK | | | |
| 85 | B02BD | koagulační faktory (ostatní koagulační faktory) | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 85.1 | B02BD | srážecí faktory | parent. | 350 | U | 2975,02 | X |
@@ -1139,70 +1144,67 @@
| 85.3 | B02BD07 | koagulační faktor XIII | parent. | 350 | U | 2975,02 | X |
| 86 | B03AA | soli dvojmocného železa | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 2,74 | |
| | | | | | | | |
| 86.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 2,98 | |
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 GM | 1,12 | | |
| | | | | | | | |
| 86.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.1 GM | 2,98 | | |
| 00677 | FERRONAT | sus 1x100ml/3gm | GNO | CZ | | | |
| 86.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 86.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 86.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 86.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,67 | |
| 86.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,12 | |
| | | | | | | | |
| 86.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 4,00 | |
| | | | | | | | |
| 86.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,12 | |
| | | | | | | | |
| 86.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.1 GM | 4,00 | | |
| | | | | | | | |
| 86.7 | B03AA07 | síran železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,12 | |
| | | | | | | | |
| 86.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 86.9 | B03AB | soli trojmocného železa (tekuté lékové formy) | p.o. | 0.1 | GM | 5,47 | |
| 87 | B03AC | soli trojmocného železa | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 87.1 | B03AC | železo trojmocné | parent. | 0.1 | GM | 42,59 | O |
| 86.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 4,00 | |
| | | | | | | | |
| 86.9 | B03AB | soli trojmocného železa (tekuté lékové formy) | p.o. | 0.1 | GM | 4,00 | |
| 87 | B03AC | soli trojmocného železa | parent | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 87.1 | B03AC | železo trojmocné | parent. | 0.1 | GM | 41,95 | O |
| 04084 | FERRUM LEK I.M. | inj 50x2ml/100mg | LEK | SLO | | | |
| 03418 | FERRLECIT | inj 5x5ml/62.5mg | NAT | D | | | |
| 87.2 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.1 | GM | 25,56 | O |
| 88 | B03AD | soli dvojmocného železa v kombinaci s kyselinou listovou | p.o. | L/GYN,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 88.1 | B03AD | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
| | | | | | | | |
| 88.2 | B03AD | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
| | | | | | | | |
| 88.3 | B03AD02 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 2,10 | L/GYN,HEM, INT |
| 89141 | FERRETAB COMP. | cps 100 | LAR | A | | | |
| 89140 | FERRETAB COMP. | cps 30 | LAR | A | | | |
| 88.4 | B03AD03 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
| 88.1 | B03AD | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM |
| | | | | | | | |
| 88.2 | B03AD | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM |
| | | | | | | | |
| 88.3 | B03AD02 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM, INT |
| | | | | | | | |
| 88.4 | B03AD03 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM |
| 89 | B03AE | soli dvojmocného železa v ostatních kombinacích | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 89.1 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.1 | GM | 5,57 | |
| | | | | | | | |
| 89.2 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 89.3 | B03AE10 | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 89.4 | B03AE10 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 89.5 | B03AE10 | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,33 | |
| | | | | | | | |
| 89.6 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.1 | GM | 1,70 | |
| | | | | | | | |
| 89.7 | B03AE10 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 5,30 | |
| 96043 | AKTIFERRIN COMPOSITUM | cps 100 | MCK | A | | | |
| 89.8 | B03AE10 | síran železnatý/serin (pevné lékové formy) | p.o. | 0.1 | GM | 5,00 | |
| 89.1 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.1 | GM | 4,30 | |
| | | | | | | | |
| 89.2 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.1 | GM | 4,30 | |
| | | | | | | | |
| 89.3 | B03AE10 | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | |
| | | | | | | | |
| 89.4 | B03AE10 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | |
| | | | | | | | |
| 89.5 | B03AE10 | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | |
| | | | | | | | |
| 89.6 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.1 | GM | 4,00 | |
| 97402 | SORBIFER DURULES | tbl obd 50x100mg | EGI | H | | | |
| 89.7 | B03AE10 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | |
| | | | | | | | |
| 89.8 | B03AE10 | síran železnatý/serin (pevné lékové formy) | p.o. | 0.1 | GM | 4,00 | |
| | | | | | | | |
| 89.9 | B03AE10 | síran železnatý/serin -tekuté lékové formy (kapky) | p.o. | 0.1 | GM | 6,89 | |
| 99138 | AKTIFERRIN | gtt 1x30ml | MCK | D | | | |
| 89.10 | B03AE10 | síran železnatý/serin -tekuté lékové formy (sirup) | p.o. | 0.1 | GM | 9,00 | |
| 90 | B03BA | vitamin B12 a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 90.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,49 | |
| 90.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,51 | |
| 00641 | VITAMIN B12 LECIVA 300RG | inj 5x1ml/300rg | LEX | CZ | | | |
| 90.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0,20 | |
| 92503 | NEUROBENE | inj 6x1ml/1000rg | MCK | D | | | |
| 00643 | VITAMIN B12 LECIVA 1000RG | inj 5x1ml/1000rg | LEX | CZ | | | |
| 91 | B03BB | kyselina listová a její deriváty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 91.1 | IB03BB01 | kyselina listová | p.o. | 10 | MG | 1,33 | |
| 91.1 | B03BB01 | kyselina listová | p.o. | 10 | MG | 1,39 | |
| 76064 | ACIDUM FOLICUM LECIVA | drg 30x10mg | LEX | CZ | | | |
| 92 | B03XA | ostatní protianemická léčiva | parent. | K/P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1215,27 +1217,27 @@
- c) léčba těžké anémie nezralých dětí.
| 92.1 | B03XA01 | erythropoetin do 10 KU v jedné ampuli včetně | parent. | 2 | KU | 1011,84 | K/P |
| 85532 | EPREX 10000 | inj 6x1ml/10ku+str. | CIL | CH | | | |
| 92.2 | B03XA01 | erythropoetin více než 10 KU v jedné ampuli | parent. | 2 | KU | 860,00 | K/P |
| 92.1 | B03XA01 | erythropoetin do 500 IU v jedné ampuli včetně | parent. | 1 | KU | 500,50 | K/P |
| 64814 | NEORECORMON 500 IU | inj 6x0.3ml/500iu | ROC | D | | | |
| 92.2 | B03XA01 | erythropoetin více než 500 IU do 10 KU v jedné ampuli včetně | parent. | 1 | KU | 455,00 | K/P |
| | | | | | | | |
| 92.3 | B03XA01 | erythropoetin více než 10 KU v jedné ampuli | parent. | 1 | KU | 430,00 | K/P |
| 93 | B05AA | substituenty plazmy a plazmatické proteiny (albumin) | parent. | B | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2815,72 | B |
| | | | | | | | |
| 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2815,72 | B |
| 10117 | HUMAN ALBUMIN 20% | inf 1x50ml | BTP | D | | | |
| 97908 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x500ml | GFO | E | | | |
| 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2676,90 | B |
| | | | | | | | |
| 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2676,90 | B |
| 98147 | ALBUMIN LIDSKY SP 20% SEVAC | inj 5x1ml | USO | CZ | | | |
| 62472 | HUMAN ALBUMIN 5% IMMUNO | inf 1x250ml | IMM | A | | | |
| 20818 | HUMAN ALBUMIN 50 DESSAU | inf 1x100ml 5% | PDE | D | | | |
| 10790 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x10ml | GFO | E | | | |
| 20819 | HUMAN ALBUMIN 50 DESSAU | inf 1x250ml 5% | PDE | D | | | |
| 97907 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x250ml | GFO | E | | | |
| 42144 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x10ml | GFO | E | | | |
| 62471 | HUMAN ALBUMIN 20% IMMUNO | inf 1x100ml | IMM | A | | | |
| 97909 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x50ml | GFO | E | | | |
| 97908 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x500ml | GFO | E | | | |
| 97910 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x100ml | GFO | E | | | |
| 10117 | HUMAN ALBUMIN 20% | inf 1x50ml | BTP | D | | | |
| 10124 | HUMAN ALBUMIN 20% | inf 1x100ml | BTP | D | | | |
| 97909 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x50ml | GFO | E | | | |
| 97907 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x250ml | GFO | E | | | |
| 97910 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x100ml | GFO | E | | | |
| 93.3 | IB05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 952,16 | B |
| 93.3 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 952,16 | B |
| 94 | B05AA | substituenty plazmy a plazmatické proteiny (ostatní) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 94.1 | B05AA05 | dextran (koncentrace 10%) | parent. | 500 | ML | 185,84 | O |
@@ -1244,157 +1246,182 @@
| | | | | | | | |
| 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 123,86 | O |
| | | | | | | | |
| 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 227,87 | O |
| 56063 | GELIFUNDOL | inf 10x500ml | BTP | D | | | |
| 62639 | HAEMACCEL 3.5% | inf 10x500ml | HMD | D | | | |
| 02536 | GELIFUNDOL | inf 1x500ml | BTP | D | | | |
| 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 173,90 | O |
| 56412 | GELOFUSINE | inf 1x500ml | BME | CH | | | |
| 94.5 | B05AA07 | hydroxyethyl- škrob | parent. | 500 | ML | 390,05 | O |
| 98352 | ELOHAST 6% | inf 1x500ml(plast) | LPD | A | | | |
| 72154 | HAES-STERIL 6% | inf 1x500ml(sklo) | FRE | D | | | |
| 72155 | HAES-STERIL 6% | inf 1x500ml(plast) | FRE | D | | | |
| 98351 | ELOHAST 6% | inf 1x500ml(sklo) | LPD | A | | | |
| 94.5 | B05AA07 | hydroxyethylškrob | parent. | 500 | ML | 291,60 | O |
| 55897 | HEMOHES 6% | inf 10x500ml(pe) | BME | D | | | |
| 44467 | HEMOHES 10% | inf 1x500ml(pe) | BME | D | | | |
| 55902 | HEMOHES 10% | inf 10x500ml(pe) | BME | D | | | |
| 44431 | HEMOHES 6% | inf 1x500ml(pe) | BME | D | | | |
| 55897 | HEMOHES 6% | inf 10x500ml(pe) | BME | D | | | |
| 95 | B05BA | roztoky k parenterální výživě (glukóza až do 40% koncentrace) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 95.1 | B05BA03 | glukóza 10% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,71 | O |
| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 31433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | I | | | |
| 59437 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 43919 | 10% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I | | | |
| 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 59437 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 31432 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | I | | | |
| 59433 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 92531 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(sklo) | SFR | I | | | |
| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 66872 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 95.2 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,94 | O |
| 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 95.2 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom baleni včetně) | parent. | 100 | ML | 6,04 | O |
| 96877 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BMM | D | | | |
| 97736 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 97737 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 47000 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | E | | | |
| 31437 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I | | | |
| 59419 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 71735 | OMFISOP GLUCOSI 100 G/L MVM G10 | inf 1x500ml | MVM | CZ | | | |
| 92534 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I | | | |
| 47017 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | CH | | | |
| 71735 | INFUSIO GLUCOSI 100 G/L MVM G10 | inf 1x500ml | MVM | CZ | | | |
| 47000 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | E | | | |
| 59419 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 97736 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 92534 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I | | | |
| 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 28,84 | O |
| 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 28,00 | O |
| 31430 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I | | | |
| 59436 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | |
| 31431 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 49x100ml-sk | FKI | I | | | |
| 59432 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I | | | |
| 59436 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | |
| 62374 | INFUSIO GLUCOSI 10 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | |
| 43918 | 10% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I | | | |
| 62374 | INFUSIO GLUCOSI 10 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | |
| 92530 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(sklo) | SFR | I | | | |
| 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ML | 5,82 | O |
| 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ml | 5,82 | O |
| 47001 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | E | | | |
| 92535 | 10% DEXTROSE“ IN WATER F.INJ.USP | inf 1x1000ml(pp) | SFR | I | | | |
| 31450 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 4x2000ml-va | FKI | I | | | |
| 31449 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I | | | |
| 31447 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I | | | |
| 43927 | 10% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | |
| 31439 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-pp | FKI | I | | | |
| 92533 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(sklo) | SFR | I | | | |
| 92539 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I | | | |
| 92535 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(pp) | SFR | I | | | |
| 92533 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(sklo) | SFR | I | | | |
| 92540 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I | | | |
| 47018 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | CH | | | |
| 31436 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-sk | FKI | I | | | |
| 43922 | 10% DEXTROSE IN WATER USP SIFRA | inf 12x1000ml(pp) | SFR | I | | | |
| 31440 | 10% DEXTROSE IN WATER FRESENIUS | inf sol12x1000ml-pp | FKI | I | | | |
| 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 96878 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BMM | D | | | |
| 59438 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 47018 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | CH | | | |
| 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 96878 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BMM | D | | | |
| 43922 | 10% DEXTROSE IN WATER USP SIFRA | inf 12x1000ml(pp) | SFR | I | | | |
| 43927 | 10% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | |
| 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 30,01 | O |
| 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 29,10 | O |
| 57750 | GLUCOSE 20% INFUSION-HUMAN | inf 1x100ml | HUA | H | | | |
| 55623 | INFUSIO GLUCOSI 20 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | |
| 95.6 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100 | ML | 6,70 | O |
| 95.6 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100 | ML | 6,46 | O |
| 59422 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 95.7 | B05BA03 | glukóza 5% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,90 | O |
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 86966 | ARDEANUTRISOL G 5 | inf 1x250ml | ARD | CZ | | | |
| 97729 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 59414 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 96872 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BMM | D | | | |
| 59414 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 47012 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | CH | | | |
| 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 97729 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 46995 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | E | | | |
| 43929 | 5% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I | | | |
| 43934 | 5% DEXTROSE IN WATER USP SIFRA | inf 30x250ml(vak) | SFR | I | | | |
| 53818 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(pvc) | IHO | CZ | | | |
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 92520 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(sklo) | SFR | I | | | |
| 47012 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | CH | | | |
| 43929 | 5% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I | | | |
| 31464 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-vak | FKI | I | | | |
| 46995 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | E | | | |
| 31453 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | I | | | |
| 31454 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | I | | | |
| 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 97732 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(plast) | BFF | I | | | |
| 92526 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(vak) | SFR | I | | | |
| 92520 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(sklo) | SFR | I | | | |
| 31465 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 30x250ml-va | FKI | I | | | |
| 95.8 | B05BA03 | glukóza 5% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,89 | O |
| 46996 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | E | | | |
| 47013 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | CH | | | |
| 31455 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-skl | FKI | I | | | |
| 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf 1x500ml | MVM | CZ | | | |
| 31456 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 12x500ml-sk | FKI | I | | | |
| 31458 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I | | | |
| 31459 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-pp | FKI | I | | | |
| 31467 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-va | FKI | I | | | |
| 59415 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 43935 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(vak) | SFR | I | | | |
| 43931 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(pp) | SFR | I | | | |
| 43930 | 5% DEXTROSE IN WATER USP SIFRA | inf 12x500ml(sklo) | SFR | I | | | |
| 86341 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x500ml(plast) | IHO | CZ | | | |
| 43930 | 5% DEXTROSE IN WATER USP SIFRA | inf 12x500ml(sklo) | SFR | I | | | |
| 31466 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-vak | FKI | I | | | |
| 97730 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 97733 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 92527 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(vak) | SFR | I | | | |
| 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf 1x500ml | MVM | CZ | | | |
| 43935 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(vak) | SFR | I | | | |
| 57748 | GLUCOSE 5% INFUSION-HUMAN | inf 1x500ml(plast) | HUA | H | | | |
| 96873 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BMM | D | | | |
| 92523 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I | | | |
| 92521 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(sklo) | SFR | I | | | |
| 96873 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BMM | D | | | |
| 46996 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | E | | | |
| 47013 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | CH | | | |
| 97730 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 43931 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(pp) | SFR | I | | | |
| 59415 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 97733 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 95.9 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 27,76 | O |
| 92525 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(vak) | SFR | I | | | |
| 47011 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BMC | CH | | | |
| 46994 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | E | | | |
| 97728 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(sklo) | BFF | I | | | |
| 31452 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 49x100ml-sk | FKI | I | | | |
| 92519 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(sklo) | SFR | I | | | |
| 96871 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BMM | D | | | |
| 31462 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-vak | FKI | I | | | |
| 31463 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 40x100ml-va | FKI | I | | | |
| 59413 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | |
| 31451 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I | | | |
| 43928 | 5% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I | | | |
| 62370 | INFUSIO GLUCOSI 5 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | |
| 86200 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x100ml(sklo) | IHO | CZ | | | |
| 97731 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(plast) | BFF | I | | | |
| 97728 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(sklo) | BFF | I | | | |
| 46994 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | E | | | |
| 92519 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(sklo) | SFR | I | | | |
| 86200 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x100ml(sklo) | IHO | CZ | | | |
| 96871 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BMM | D | | | |
| 43928 | 5% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I | | | |
| 59413 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | |
| 92525 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(vak) | SFR | I | | | |
| 43933 | 5% DEXTROSE IN WATER USP SIFRA | inf 40x100ml(vak) | SFR | I | | | |
| 47011 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | CH | | | |
| 95.10 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100 | ML | 3,96 | O |
| 43936 | 5% DEXTROSE IN WATER USP SIFRA | inf 10x1000ml(vak) | SFR | I | | | |
| 43937 | 5% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | |
| 31469 | 5% DEXTROSE IN WATER FRESENIUS | inf sol10x1000ml-va | FKI | I | | | |
| 92529 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I | | | |
| 92528 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I | | | |
| 95.11 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 91,31 | O |
| 43936 | 5% DEXTROSE IN WATER USP SIFRA | inf 10x1000ml(vak) | SFR | I | | | |
| 31471 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 4x2000ml-va | FKI | I | | | |
| 31470 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I | | | |
| 43937 | 5% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | |
| 31468 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I | | | |
| 95.11 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 23,90 | O |
| 47241 | GLUKOZA 5 BRAUN | inj 20x10ml(plast) | BMM | D | | | |
| 95.12 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 98,74 | O |
| | | | | | | | |
| 95.13 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 18,18 | O |
| 95.12 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100 | ml | 98,74 | O |
| | | | | | | | |
| 95.13 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ml | 18,18 | O |
| 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ | | | |
| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ | | | |
| 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 31,97 | O |
| 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ml | 31,97 | O |
| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | |
| 95.15 | B05BA03 | glukóza nad 20% (nad 250 ml v jednom balení) | parent. | 100 | ML | 8,26 | O |
| | | | | | | | |
| 95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli ) | parent. | 100 | ML | 98,64 | O |
| 95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli ) | parent. | 100 | ML | 83,15 | O |
| 02588 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | E | | | |
| 02587 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | D | | | |
| 02588 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | E | | | |
| 02589 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | CH | | | |
| 96 | B05BA | roztoky k parenterální výživě (ostatní) | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 96.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100 | ML | 38,76 | H |
| | | | | | | | |
| 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 74,49 | H |
| 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 63,44 | H |
| 75521 | AMINOPLASMAL 15% E | inf 1x1000ml | BME | D | | | |
| 58907 | ELOAMIN 15% PUR | inf 6x1000ml | FRK | A | | | |
| 96.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100 | ML | 77,86 | H |
| 96.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100 | ML | 70,48 | H |
| 55971 | SALVIAMIN 12.5 E | inf 1x1000ml | CTT | F | | | |
| 55969 | SALVIAMIN 12.5 E | inf 1x500ml | CTT | F | | | |
| 96.4 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10 % včetně) | parent. | 100 | ML | 48,39 | H |
| 96.4 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10 % včetně) | parent. | 100 | ML | 47,42 | H |
| 92631 | SALVIAMIN 10 E | inf 1x1000ml | CTT | F | | | |
| 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100 | ML | 175,28 | H |
| 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100 | ML | 173,20 | H |
| 32004 | INTRALIPID 10 % | inf 10x100ml-vak | FRK | S | | | |
| 45303 | INTRALIPID 10% | inf 1x100ml | PAU | S | | | |
| 04299 | INTRALIPID 10 % | inf 12x100ml-sklo | FRK | S | | | |
| 20909 | INTRALIPID 10 % | inf 1x100ml-vak | FRK | S | | | |
| 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100 | ML | 196,40 | H |
| 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balerní) | parent. | 100 | ML | 55,48 | H |
| | | | | | | | |
| 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balerní) | parent. | 100 | ML | 53,83 | H |
| 59154 | IVELIP 10% | inf 6x1000ml | CTT | F | | | |
| 75442 | INTRALIPID | inf 12x500ml 10% | PAU | S | | | |
| 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100 | ML | 74,20 | H |
| 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100 | ML | 67,58 | H |
| 59158 | IVELIP 20% | inf 6x1000ml | CTT | F | | | |
| 57247 | INTRALIPID 20 % | inf 6x1000ml-sklo | FRK | S | | | |
| 57162 | INTRALIPID 20 % | inf 1x1000ml-sklo | FRK | S | | | |
| 96.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100 | ML | 14,47 | H |
| | | | | | | | |
| 96.10 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100 | ML | 17,74 | H |
| | | | | | | | |
| 96.11 | B05BA03 | fruktóza (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 15,54 | H |
| | | | | | | | |
| 96.12 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100 | ML | 8,02 | H |
| 96.12 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100 | ML | 7,66 | H |
| 71729 | INFUSIO SORBITOLI 50 G/L MVM | inf 1x500ml | MVM | CZ | | | |
| 96.13 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100 | ML | 11,10 | H |
| | | | | | | | |
| 96.14 | B05BA03 | sorbitol (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 8,60 | H |
| 96.14 | B05BA03 | sorbitol (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 8,14 | H |
| 71730 | INFUSIO SORBITOLI 100 G/L MVM | inf 1x500ml | MVM | CZ | | | |
| 96.15 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100 | ML | 16,62 | H |
| | | | | | | | |
@@ -1402,199 +1429,193 @@
| | | | | | | | |
| 96.17 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100 | ML | 13,20 | H |
| | | | | | | | |
| 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 61,83 | H |
| 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 55,76 | H |
| 45377 | AMINOROZTOK NEO SX 4% INFUSIA | inf 1x500ml | IHO | CZ | | | |
| 02460 | NUTRIFLEX BASAL | inf 5x1000ml | BMB | CH | | | |
| 02461 | NUTRIFLEX BASAL | inf 5x2000ml | BMB | CH | | | |
| 02462 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x2000ml | BMB | CH | | | |
| 02458 | NUTRIFLEX PLUS | inf 5x1000ml | BMB | CH | | | |
| 72160 | AMINO-MEL 3.5% G | inf 6x1000ml | LPD | A | | | |
| 72159 | AMINO-MEL 3.5% G | inf 10x500ml | LPD | A | | | |
| 02452 | NUTRIFLEX SPECIAL | inf 5x1000ml | BMB | CH | | | |
| 02453 | NUTRIFLEX SPECIAL | inf 5x1500ml | BMB | CH | | | |
| 46810 | CLINOMEL N6-900 | inf 4x2000ml pe vak | CTT | F | | | |
| 46807 | CLINOMEL N5-800 | inf 4x2000ml pe vak | CTT | F | | | |
| 46808 | CLINOMEL N5-800 | inf 4x1500ml pe vak | CTT | F | | | |
| 40178 | AMINOPLASMAL 10% E | inf 1x1000ml | BME | D | | | |
| 02463 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x1000ml | BMB | CH | | | |
| 45383 | AMINOROZTOK NEO SX 8% INFUSIA | inf 1x500ml | IHO | CZ | | | |
| 02454 | NUTRIFLEX PERI | inf 5x1000ml | BMB | CH | | | |
| 02455 | NUTRIFLEX PERI | inf 5x2000ml | BMB | CH | | | |
| 46805 | CLINOMEL N4-550 | inf 4x1500ml pe vak | CTT | F | | | |
| 46814 | CLINOMEL N7-1000 | inf 4x1500ml pe vak | CTT | F | | | |
| 02456 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1000ml | BMB | CH | | | |
| 02463 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x1000ml | BMB | CH | | | |
| 02454 | NUTRIFLEX PERI | inf 5x1000ml | BMB | CH | | | |
| 02462 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x2000ml | BMB | CH | | | |
| 02461 | NUTRIFLEX BASAL | inf 5x2000ml | BMB | CH | | | |
| 02452 | NUTRIFLEX SPECIAL | inf 5x1000ml | BMB | CH | | | |
| 02455 | NUTRIFLEX PERI | inf 5x2000ml | BMB | CH | | | |
| 72162 | AMINO-MEL 5% G | inf 6x1000ml | LPD | A | | | |
| 02453 | NUTRIFLEX SPECIAL | inf 5x1500ml | BMB | CH | | | |
| 46804 | CLINOMEL N4-550 | inf 4x2000ml pe vak | CTT | F | | | |
| 46813 | CLINOMEL N7-1000 | inf 4x2000ml pe vak | CTT | F | | | |
| 46811 | CLINOMEL N6-900 | inf 4x1500ml pe vak | CTT | F | | | |
| 02457 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1500ml | BMB | CH | | | |
| 02459 | NUTRIFLEX PLUS | inf 5x2000ml | BMB | CH | | | |
| 72164 | AMINO-MEL 5% G | inf 6x900ml | LPD | A | | | |
| 02457 | NUTRIFLEX SPECIAL BEZ ELEKTROL. | inf 5x1500ml | BMB | CH | | | |
| 72163 | AMINO-MEL 5% G | inf 10x500ml | LPD | A | | | |
| 45383 | AMINOROZTOK NEO SX 8% INFUSIA | inf 1x500ml | IHO | CZ | | | |
| 02460 | NUTRIFLEX BASAL | inf 5x1000ml | BMB | CH | | | |
| 56629 | NUTRIFLEX PLUS | inf 5x2000ml | VIF | CH | | | |
| 46804 | CLINOMEL N4-550 | inf 4x2000ml pe vak | CTT | F | | | |
| 46811 | CLINOMEL N6-900 | inf 4x1500ml pe vak | CTT | F | | | |
| 46807 | CLINOMEL N5-800 | inf 4x2000ml pe vak | CTT | F | | | |
| 46810 | CLINOMEL N6-900 | inf 4x2000ml pe vak | CTT | F | | | |
| 46814 | CLINOMEL N7-1000 | inf 4x1500ml pe vak | CTT | F | | | |
| 56624 | NUTRIFLEX BASAL | inf 5x1000ml | VIF | CH | | | |
| 46813 | CLINOMEL N7-1000 | inf 4x2000ml pe vak | CTT | F | | | |
| 56628 | NUTRIFLEX PLUS | inf 5x1000ml | VIF | CH | | | |
| 45377 | AMINOROZTOK NEO SX 4% INFUSIA | inf 1x500ml | IHO | CZ | | | |
| 46808 | CLINOMEL N5-800 | inf 4x1500ml pe vak | CTT | F | | | |
| 56630 | NUTRIFLEX PERI | inf 5x1000ml | VIF | CH | | | |
| 56631 | NUTRIFLEX PERI | inf 5x2000ml | VIF | CH | | | |
| 56632 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x1000ml | VIF | CH | | | |
| 56633 | NUTRIFLEX PLUS BEZ ELEKTROLYTU | inf 5x2000ml | VIF | CH | | | |
| 46805 | CLINOMEL N4-550 | inf 4x1500ml pe vak | CTT | F | | | |
| 56625 | NUTRIFLEX BASAL | inf 5x2000ml | VIF | CH | | | |
| 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9%) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 97.1 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100 | ML | 11,54 | O |
| 97682 | CHLORID SODNÝ 0.9% BRAUN | inf 1x250ml(plast) | BMM | D | | | |
| 62328 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 97749 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(sklo) | BFF | I | | | |
| 97752 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFF | I | | | |
| 92515 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(vak) | SFR | I | | | |
| 86047 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 57683 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFH | E | | | |
| 92509 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(sklo) | SFR | I | | | |
| 97 | B0GBB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,09%) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 97.1 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100 | ML | 7,40 | O |
| 70525 | INFUSIO NATRII CHLOR.ISOTON.MVM | inf 1x250ml | MVM | CZ | | | |
| 43907 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 16x250ml(sklo) | SFR | I | | | |
| 46070 | CHLORID SODNY 0.9% BRAUN | inf 1x250ml(pe) | BMR | E | | | |
| 43912 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 30x250ml(vak) | SFR | I | | | |
| 46080 | CHLORID SODNY 0.9% BRAUN | inf 1x250ml(pe) | BME | CH | | | |
| 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 22,09 | O |
| 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 21,08 | O |
| 96882 | CHLORID SODNÝ 0.9% BRAUN | inf 1x100ml(sklo) | BMM | D | | | |
| 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFH | E | | | |
| 96887 | CHLORID SODNÝ 0.9% BRAUN | inj 20x20ml(pl.amp) | BMM | D | | | |
| 46065 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BMR | E | | | |
| 97748 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(sklo) | BFF | I | | | |
| 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFH | E | | | |
| 92508 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x100ml(sklo) | SFR | I | | | |
| 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFF | I | | | |
| 46069 | CHLORID SODNY 0.9% BRAUN | inj 20x20ml(pl.amp) | BMR | E | | | |
| 46075 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BME | CH | | | |
| 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFF | I | | | |
| 46065 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BMR | E | | | |
| 96882 | CHLORID SODNÝ 0.9% BRAUN | inf 1x100ml(sklo) | BMM | D | | | |
| 43906 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 49x100ml(sklo) | SFR | I | | | |
| 97.3 | B05BB01 | chlorid sodný 0.9% (nad než 250 ml v balení) | parent. | 100 | ML | 3,81 | O |
| 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(plast) | BFH | E | | | |
| 46079 | CHLORID SODNY 0.9% BRAUN | inj 20x20ml(pl.amp) | BME | CH | | | |
| 97.3 | B05BB01 | Chlorid sodný 0.9% (nad 250 ml v baleni) | parent. | 100 | ML | 3,77 | O |
| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 43915 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 4x2000ml(vak) | SFR | I | | | |
| 92511 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(sklo) | SFR | I | | | |
| 92518 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x2000ml(vak) | SFR | I | | | |
| 92511 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(sklo) | SFR | I | | | |
| 43915 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 4x2000ml(vak) | SFR | I | | | |
| 31500 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | infsol1x2000ml(vak) | FKI | I | | | |
| 31487 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | infsol1x1000ml(skl) | FKI | I | | | |
| 69181 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(plast) | BFF | I | | | |
| 31490 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol1x1000ml(pp) | FKI | I | | | |
| 31501 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | infsol4x2000ml(vak) | FKI | I | | | |
| 03122 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak i) | BFH | E | | | |
| 03126 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak i) | BFH | E | | | |
| 97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ML | 42,82 | O |
| 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(plast) | BFH | E | | | |
| 97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. 100 | ML | 39,65 | O | |
| 46068 | CHLORID SODNY 0.9% BRAUN | inj 20x10ml(pl.amp) | BMR | E | | | |
| 46078 | CHLORID SODNY 0.9% BRAUN | inj 20x10ml(pl.amp) | BME | CH | | | |
| 96886 | CHLORID SODNÝ 0.9% BRAUN | | inj 20x10ml(pl.amp) | BMM | D | | |
| 96886 | CHLORID SODNÝ 0.9% BRAUN | inj 20x10ml(pl.amp) | BMM | D | | | |
| 98 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (ostatní) | parent. | 92518 | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 98.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100 | ML | 10,46 | H |
| | | | | | | | |
| 98.2 | B05BB01 | elektrolyty | parent. | 100 | ML | 8,07 | H |
| 11154 | HARTMANN´S SOL. BP FRESENIUS | inf 1x1000ml(vak) | FKI | I | | | |
| 70529 | INFUSIO RINGERI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 05870 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 69235 | RINGER´S INJECTION U.S.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 69695 | ARDEAELYTOSOL RL 1/1 | inf 1x500ml | ARD | CZ | | | |
| 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ | | | |
| 70524 | INFUSIO HARTMANNI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 05869 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 05860 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x3000ml(vak) | INK | CZ | | | |
| 11380 | RINGER'S INJECTION FRESENIUS | inf 12x1000ml-sklo | FKI | I | | | |
| 92600 | INFUSIO DARROWI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 70530 | INFUSIO RINGERI C.NATR.LACT.MVM | inf 1x500ml | MVM | CZ | | | |
| 92599 | INFUSIO DARROWI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 70527 | INFUSIO DARROWI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 93050 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x500ml(sklo) | SFR | I | | | |
| 11222 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-vak | FKI | I | | | |
| 11197 | HARTMANN'S SOL. BP FRESENIUS | inf 6x1000ml(sklo) | FKI | I | | | |
| 11196 | HARTMANN'S SOL. BP FRESENIUS | inf 1x1000ml(sklo) | FKI | I | | | |
| 11155 | HARTMANN´S SOL. BP FRESENIUS | inf 10x1000ml(vak) | FKI | I | | | |
| 97015 | RINGER INFUSION-HUMAN | inf 1x500ml | HUA | H | | | |
| 97014 | INFUSIO HARTMANNI BP-HUMAN | inf 1x500ml | HUA | H | | | |
| 93063 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 1x1000ml(sklo) | SFR | I | | | |
| 85896 | INFUSIO DARROWI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BXF | GB | | | |
| 93059 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 10x1000ml(vak) | SFR | I | | | |
| 93055 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x1000ml(sklo) | SFR | I | | | |
| 44100 | HARTMANNUV ROZTOK BRAUN BP | inf 1x500ml(plast) | BMM | D | | | |
| 93051 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x1000ml(sklo) | SFR | I | | | |
| 11376 | RINGER'S INJECTION FRESENIUS | inf 12x500ml-sklo | FKI | I | | | |
| 93047 | RINGER'S INJECTION U.S.P.SIFRA | inf 10x1000ml(vak) | SFR | I | | | |
| 11305 | RINGER'S INJECTION FRESENIUS | inf 10x1000ml-vak | FKI | I | | | |
| 11323 | RINGER'S INJECTION FRESENIUS | inf 1x500ml-sklo | FKI | I | | | |
| 44103 | HARTMANNUV ROZTOK BRAUN BP | inf 10x1000ml-plast | BMM | D | | | |
| 96892 | RINGER'S BRAUN | inf 1x1000ml | BMM | D | | | |
| 44102 | HARTMANNUV ROZTOK BRAUN BP | inf 10x500ml(plast) | BMM | D | | | |
| 44101 | HARTMANNUV ROZTOK BRAUN BP | inf 1x1000ml(plast) | BMM | D | | | |
| 44100 | HARTMANNUV ROZTOK BRAUN BP | inf 1x500ml(plast) | BMM | D | | | |
| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 85896 | INFUSIO DARROWI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 69695 | ARDEAELYTOSOL RL 1/1 | inf 1x500ml | ARD | CZ | | | |
| 05869 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 70524 | INFUSIO HARTMANNI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 05860 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x3000ml(vak) | INK | CZ | | | |
| 70530 | INFUSIO RINGERI C.NATR.LACT.MVM | inf 1x500ml | MVM | CZ | | | |
| 70527 | INFUSIO DARROWI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 12610 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x1000ml(vak) | SFR | I | | | |
| 70529 | INFUSIO RINGERI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 69235 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 11328 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-sklo | FKI | I | | | |
| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 93067 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 6x1000ml(sklo) | SFR | I | | | |
| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml(vak) | MKS | CZ | | | |
| 96891 | RINGER´S INJECTION BRAUN | inf 1x500ml | BMM | D | | | |
| 93054 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x500ml(sklo) | SFR | I | | | |
| 89861 | INFUSIO RINGERI INFUSIA R 1/1 | inf 1x500ml(sklo) | IHO | CZ | | | |
| 12374 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 1x1000ml(vak) | SFR | I | | | |
| 59375 | RINGER´S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 59374 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 59369 | RINGER´S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 59366 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(Idpe) | BME | CH | | | |
| 59365 | RINGERUV ROZTOK BRAUN | inf 10x500ml(ldpe) | BME | CH | | | |
| 59362 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(ldpe) | BME | E | | | |
| 9361 | RINGERUV ROZTOK BRAUN | inf 10x500ml(ldpe) | BME | E | | | |
| 59361 | RINGERUV ROZTOK BRAUN | inf 10x500ml(ldpe) | BME | E | | | |
| 59358 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(ldpe) | BMM | D | | | |
| 59357 | RINGERUV ROZTOK BRAUN | inf 10x500ml(ldpe) | BMM | D | | | |
| 44102 | HARTMANNUV ROZTOK BRAUN BP | inf 10x500ml(plast) | BMM | D | | | |
| 05870 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 44103 | HARTMANNUV ROZTOK BRAUN BP | inf 10x1000ml-plast | BMM | D | | | |
| 59375 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 87250 | INFUSIO HARTMANNI INFUSIA H 1/1 | inf 1x500ml(sklo) | IHO | CZ | | | |
| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BXF | GB | | | |
| 59366 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(ldpe) | BME | CH | | | |
| 12374 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 1x1000ml(vak) | SFR | I | | | |
| 93051 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x1000ml(sklo) | SFR | I | | | |
| 59369 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 92600 | INFUSIO DARROWI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml(vak) | MKS | CZ | | | |
| 97015 | RINGER INFUSION-HUMAN | inf 1x500ml | HUA | H | | | |
| ;2599 | INFUSIO DARROWI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 97014 | INFUSIO HARTMANNI BP-HUMAN | inf 1x500ml | HUA | H | | | |
| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 96892 | RINGER'S BRAUN | inf 1x1000ml | BMM | D | | | |
| 96891 | RINGER'S INJECTION BRAUN | inf 1x500ml | BMM | D | | | |
| 93047 | RINGER'S INJECTION U.S.P.SIFRA | inf 10x1000ml(vak) | SFR | I | | | |
| 93050 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x500ml(sklo) | SFR | I | | | |
| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 93063 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 1x1000ml(sklo) | SFR | I | | | |
| 93054 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x500ml(sklo) | SFR | I | | | |
| 89861 | INFUSIO RINGERI INFUSIA R 1/1 | inf 1x500ml(sklo) | IHO | CZ | | | |
| 93055 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x1000ml(sklo) | SFR | I | | | |
| 12610 | RINGER´S INJECTION U.S.P.SIFRA | inf 1x1000ml(vak) | SFR | I | | | |
| 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 93059 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 10x1000ml(vak) | SFR | I | | | |
| 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ | | | |
| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 93067 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 6x1000ml(sklo) | SFR | I | | | |
| 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ML | 9,04 | H |
| 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ml | 9,04 | H |
| 12390 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x3000ml(vak) | IMA | SK | | | |
| 12403 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x3000ml(vak) | IMA | SK | | | |
| 85566 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x1000ml(vak) | IMA | SK | | | |
| 69580 | ARDEAELYTOSOL D 2/3 | inf 1x500ml | ARD | CZ | | | |
| 12401 | INFUSIO NATR.CHL.ISOT. 1/3+GLUC. | inf 1x1000ml(vak) | IMA | SK | | | |
| 92625 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x3000ml(vak) | IMA | SK | | | |
| 12395 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x500ml(sklo) | IMA | SK | | | |
| 92624 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x2000ml(vak) | IMA | SK | | | |
| 69660 | ARDEAELYTOSOL F 1/2 | inf 1x500ml | ARD | CZ | | | |
| 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 12402 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x2000ml(vak) | IMA | SK | | | |
| 12389 | INFUSIO NATR.CHL.ISOT. 1/5+GLUC. | inf 1x2000ml(vak) | IMA | SK | | | |
| 70552 | INFUSIO HRS MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 62369 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x500ml(sklo) | IMA | SK | | | |
| 71732 | INFUSIO NATR.CHL.+GLUC.F1/2 MVM | inf 1x500ml | MVM | CZ | | | |
| 71733 | INFUSIO NATR.CHL.+GLUC.F1/3 MVM | inf 1x500ml | MVM | CZ | | | |
| 12403 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x3000ml(vak) | IMA | SK | | | |
| 83918 | ARDEAELYTOSOL H 1/2 | inf 1x500ml | ARD | CZ | | | |
| 12382 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x500ml(sklo) | IMA | SK | | | |
| 12388 | INFUSIO NATR.CHL.ISOT. 1/5+GLUC. | inf 1x1000ml(vak) | IMA | SK | | | |
| 56702 | INFUSIO F 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 69583 | ARDEAELYTOSOL D 1/2 | inf 1x500ml | ARD | CZ | | | |
| 69580 | ARDEAELYTOSOL D 2/3 | inf 1x500ml | ARD | CZ | | | |
| 92624 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x2000ml(vak) | IMA | SK | | | |
| 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 69657 | ARDEAELYTOSOL F 2/3 | inf 1x500ml | ARD | CZ | | | |
| 71732 | INFUSIO NATR.CHL.+GLUC.F1/2 MVM | inf 1x500ml | MVM | CZ | | | |
| 12402 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x2000ml(vak) | IMA | SK | | | |
| 12401 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x1000ml(vak) | IMA | SK | | | |
| 69617 | ARDEAELYTOSOL EL 1/3 | inf 1x500ml | ARD | CZ | | | |
| 92625 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x3000ml(vak) | IMA | SK | | | |
| 12390 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x3000ml(vak) | IMA | SK | | | |
| 69660 | ARDEAELYTOSOL F 1/2 | inf 1x500ml | ARD | CZ | | | |
| 12389 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x2000ml(vak) | IMA | SK | | | |
| 85566 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x1000ml(vak) | IMA | SK | | | |
| 70552 | INFUSIO HRS MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 69666 | ARDEAELYTOSOL F 1/5 | inf 1x500ml | ARD | CZ | | | |
| 12382 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x500ml(sklo) | IMA | SK | | | |
| 69589 | ARDEAELYTOSOL D 1/5 | inf 1x500ml | ARD | CZ | | | |
| 62369 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x500ml(sklo) | IMA | SK | | | |
| 12395 | INFUSIO NATR.CHL.ISOT.1/3+GLUC. | inf 1x500ml(sklo) | IMA | SK | | | |
| 12388 | INFUSIO NATR.CHL.ISOT.1/5+GLUC. | inf 1x1000ml(vak) | IMA | SK | | | |
| 98.4 | B05BB03 | trometamol | parent. | 100 | ML | 23,02 | H |
| 99 | B05BC | roztoky k osmotické diuréze | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 99.1 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml v jednom balení) | parent. | 100 | ML | 12,17 | H |
| 31365 | MANNISOL A INFUSION-HUMAN | inf 1x500ml | HUA | H | | | |
| 75517 i | INFUSIO MANNITOLI 10 IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 46027 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 97744 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 74984 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 89155 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 46028 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 75517 | INFUSIO MANNITOLI 10 IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 74984 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 46027 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 31365 | MANNISOL A INFUSION-HUMAN | inf 1x500ml | HUA | H | | | |
| 97744 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 99.2 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 19,31 | H |
| 89154 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 80494 | INFUSIO MANNITOLI 100 G/L MVM | inf 1x250ml | MVM | CZ | | | |
| 74983 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 90530 | INFUSIO MANNITOLI 10 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 97743 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 74983 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 80494 | INFUSIO MANNITOLI 100 G/L MVM | inf 1x250ml | MVM | CZ | | | |
| 46026 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 99.3 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml v jednom balení) | parent. | 100 | ML | 13,78 | H |
| 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 44584 | 20% MANNITOL IN WATER F.INJ.USP | inf 6x1000ml | SFR | I | | | |
| 59743 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 31477 | 20% MANNITOL IN WATER FRESENIUS | inf 1x500ml | FKI | I | | | |
| 31479 | 20% MANNITOL IN WATER FRESENIUS | inf 1x1000ml | FKI | I | | | |
| 43765 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x500ml | SFR | I | | | |
| 44583 | 20% MANNITOL IN WATER F.INJ.USP | inf 12x500ml | SFR | I | | | |
| 31480 | 20% MANNITOL IN WATER FRESENIUS | inf 6x1000ml | FKI | I | | | |
| 97747 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 44584 | 20% MANNITOL IN WATER F.INJ.USP | inf 6x1000ml | SFR | I | | | |
| 44583 | 20% MANNITOL IN WATER F.INJ.USP | inf 12x500ml | SFR | I | | | |
| 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 43765 I | 20% MANNITOL IN WATER F.INJ.USP | inf 1x500ml | SFR | I | | | |
| 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(skío) | BFF | I | | | |
| 43766 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x1000ml | SFR | I | | | |
| 31478 | 20% MANNITOL IN WATER FRESENIUS | inf 12x500ml | FKI | I | | | |
| 99.4 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 21,70 | H |
| 44382 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 59741 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 59742 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 44582 | 20% MANNITOL IN WATER F.INJ.USP | inf 16x250ml | SFR | I | | | |
| 44382 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 43764 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x250ml | SFR | I | | | |
| 59741 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 31475 | 20% MANNITOL IN WATER FRESENIUS | inf 1x250ml | FKI | I | | | |
| 80497 | INFUSIO MANNITOLI 200 G/L MVM | inf 1x250ml | MVM | CZ | | | |
| 31476 | 20% MANNITOL IN WATER FRESENIUS | inf 16x250ml | FKI | I | | | |
| 99.5 | B05BC02 | karbamid | parent. | 90 | GM | 1133,11 | H |
| 100 | B05C | roztoky k irigaci | lok. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1607,138 +1628,129 @@
| 100.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1000 | ML | 54,04 | H |
| 101 | B05D | roztoky k peritoneální dialýze | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 101.1 | B05DA | přípravky pro peritoneální dialýzu isotonické | parent. | 1000 | ML | 138,72 | H |
| | | | | | | | |
| 101.2 | B05DB | přípravky pro peritoneální dialýzu hypertonické | parent. | 1000 | ML | 138,72 | H |
| 45632 | GAMBROSOL 10 H SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 45645 | GAMBROSOL 10 H GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 45644 | GAMBROSOL 10 H GEMINI 10 | sol 4x2000ml(vak) | BJS | I | | | |
| 45640 | GAMBROSOL 10 H SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 45638 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 45634 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2000ml(vak) | BJS | I | | | |
| 45636 | GAMBROSOL 10 M GEMINI 10 | sol 4x2000ml(vak) | BJS | I | | | |
| 101.1 | B05DA | přípravky pro peritoneálni dialýzu isotonické | parent. | 1000 | ML | 138,04 | H |
| | | | | | | | |
| 101.2 | B05DB | přípravky pro peritoneální dialýzu hypertonické | parent. | 1000 | ML | 138,04 | H |
| 68460 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | BAS | I | | | |
| 01218 | GAMBROSOL TRIO 40 | sol 2x5000ml(sy10) | BJS | I | | | |
| 58516 | GAMBROSOL 10 H | sol 5x2000ml(ge10) | GBL | S | | | |
| 55846 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2500ml(vak) | BFF | I | | | |
| 55848 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2500ml(vak) | BFF | I | | | |
| 68321 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | BJS | I | | | |
| 01215 | GAMBROSOL TRIO 40 | sol 4x2500ml(sy10) | BJS | I | | | |
| 01198 | GAMBROSOL TRIO 10 | sol 4x2500ml(ge10) | BJS | I | | | |
| 55847 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2500ml(vak) | BFF | I | | | |
| 98267 | CAPD 3 | sol 1x5000ml | FRE | D | | | |
| 98265 | CAPD 3 | sol 1x2000ml | FRE | D | | | |
| 98255 | CAPD 2 | sol 1x5000ml | FRE | D | | | |
| 46927 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 46925 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 46916 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 46909 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 58506 | GAMBROSOL 10 H | sol 2x4500ml(sy10) | GBL | S | | | |
| 45711 | GAMBROSOL 10 L GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 45702 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2000ml(vak) | BJS | I | | | |
| 45700 | GAMBROSOL 10 L SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 45677 | GAMBROSOL 10 M GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 45668 | GAMBROSOL 10 M SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 46907 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 45674 | GAMBROSOL 10 M SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 46916 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 45672 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 46925 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 45706 | GAMBROSOL 10 L SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 45670 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2000ml(vak) | BJS | I | | | |
| 55848 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2500ml(vak) | BFF | I | | | |
| 58531 | GAMBROSOL 10 M | sol 5x2000ml(ge10) | GBL | S | | | |
| 55846 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2500ml(vak) | BFF | I | | | |
| 58533 | GAMBROSOL 10 M | sol 3x3000ml(ge10) | GBL | S | | | |
| 46907 | DIANEL PDT GL. 1.36%/13.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 98254 | CAPD 2 | sol 1x2500ml | FRE | D | | | |
| 98253 | CAPD 2 | sol 1x2000ml | FRE | D | | | |
| 69304 | GAMBROSOL 10 H | sol 5x2000ml(ge10) | BJS | I | | | |
| 52995 | PERITON.DIAL.+DEXT.2.5%+0.18CA | sol 4x2500ml(vak) | BFF | I | | | |
| 98277 | CAPD 4 | sol 1x5000ml | FRE | D | | | |
| 76634 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x5000ml(vak) | BXT | IRL | | | |
| 76632 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x2500ml(vak) | BXT | IRL | | | |
| 69318 | GAMBROSOL 10 H | sol 3x3000ml(ge10) | BJS | I | | | |
| 76625 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x5000ml(vak) | BXT | IRL | | | |
| 76623 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x2500ml(vak) | BXT | IRL | | | |
| 76616 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x5000ml(vak) | BXT | IRL | | | |
| 76614 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2500ml(vak) | BXT | IRL | | | |
| 98275 | CAPD 4 | sol 1x2000ml | FRE | D | | | |
| 69183 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x5000ml(vak) | BFF | I | | | |
| 01184 | GAMBROSOL TRIO 10 | sol 4x2500ml(sy10) | BJS | I | | | |
| 01186 | GAMBROSOL TRIO 10 | sol 2x5000ml(sy10) | BJS | I | | | |
| 52993 | PERITON.DIAL.+DEXT.1.5%+0.18CA | sol 4x2500ml | BFF | I | | | |
| 58546 | GAMBROSOL 10 M | sol 2x4500ml(sy10) | GBL | S | | | |
| 58571 | GAMBROSOL 10 L | sol 3x3000ml(ge10) | GBL | S | | | |
| 58569 | GAMBROSOL 10 L | sol 5x2000ml(ge10) | GBL | S | | | |
| 58506 | GAMBROSOL 10 H | sol 2x4500ml(sy10) | GBL | S | | | |
| 58552 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | GBL | S | | | |
| 65936 | GAMBROSOL 10 M | sol 3x3000ml(ge10) | BJS | I | | | |
| 68515 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | BJS | I | | | |
| 01236 | GAMBROSOL TRIO 40 | sol 4x2500ml(ge10) | BJS | I | | | |
| 58551 | GAMBROSOL 10 L | sol 4x2500ml(sy10) | GBL | S | | | |
| 85926 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x5000ml(vak) | BFF | I | | | |
| 58550 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | GBL | S | | | |
| 85924 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x5000ml(vak) | BFF | I | | | |
| 58549 | GAMBROSOL 10 L | sol 2x4500ml(sy10) | GBL | S | | | |
| 58515 | GAMBROSOL 10 H | sol 4x2500ml(ge10) | GBL | S | | | |
| 58547 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | GBL | S | | | |
| 58570 | GAMBROSOL 10 L | sol 4x2500ml(ge10) | GBL | S | | | |
| 58545 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | GBL | S | | | |
| 58514 | GAMBROSOL 10 H | sol 3x3000ml(ge10) | GBL | S | | | |
| 58544 | GAMBROSOL 10 M | sol 4x2500ml(sy10) | GBL | S | | | |
| 58543 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | GBL | S | | | |
| 58542 | GAMBROSOL 10 M | sol 6x1500ml(sy10) | GBL | S | | | |
| 58502 | GAMBROSOL 10 H | sol 6x1500ml(sy10) | GBL | S | | | |
| 58507 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | GBL | S | | | |
| 58533 | GAMBROSOL 10 M | sol 3x3000ml(ge10) | GBL | S | | | |
| 58531 | GAMBROSOL 10 M | sol 5x2000ml(ge10) | GBL | S | | | |
| 58532 | GAMBROSOL 10 M | sol 4x2500ml(ge10) | GBL | S | | | |
| 58544 | GAMBROSOL 10 M | sol 4x2500ml(sy10) | GBL | S | | | |
| 58516 | GAMBROSOL 10 H | sol 5x2000ml(ge10) | GBL | S | | | |
| 58515 | GAMBROSOL 10 H | sol 4x2500ml(ge10) | GBL | S | | | |
| 58514 | GAMBROSOL 10 H | sol 3x3000ml(ge10) | GBL | S | | | |
| 58502 | GAMBROSOL 10 H | sol 6x1500ml(sy10) | GBL | S | | | |
| 58503 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | GBL | S | | | |
| 58507 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | GBL | S | | | |
| 58504 | GAMBROSOL 10 H | sol 4x2500ml(sy10) | GBL | S | | | |
| 58505 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | GBL | S | | | |
| 6614 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2500ml(vak) | BXT | IRL | | | |
| 58548 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | GBL | S | | | |
| 58553 | GAMBROSOL 10 L | sol 6x1500ml(sy10) | GBL | S | | | |
| 52992 | PERITON.DIAL.+DEXT.1.5%+0.18CA | sol 4x2000ml | BFF | I | | | |
| 52993 | PERITON.DIAL.+DEXT.1.5%+0.18CA | sol 4x2500ml | BFF | I | | | |
| 52994 | PERITON.DIAL.+DEXT.2.5%+0.18CA | sol 4x2000ml(vak) | BFF | I | | | |
| 52995 | PERITON.DIAL.+DEXT.2.5%+0.18CA | sol 4x2500ml(vak) | BFF | I | | | |
| 58571 | GAMBROSOL 10 L | sol 3x3000ml(ge10) | GBL | S | | | |
| 58570 | GAMBROSOL 10 L | sol 4x2500ml(ge10) | GBL | S | | | |
| 55847 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2500ml(vak) | BFF | I | | | |
| 58542 | GAMBROSOL 10 M | sol 6x1500ml(sy10) | GBL | S | | | |
| 58569 | GAMBROSOL 10 L | sol 5x2000ml(ge10) | GBL | S | | | |
| 46927 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 58552 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | GBL | S | | | |
| 58551 | GAMBROSOL 10 L | sol 4x2500ml(sy10) | GBL | S | | | |
| 58550 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | GBL | S | | | |
| 58549 | GAMBROSOL 10 L | sol 2x4500ml(sy10) | GBL | S | | | |
| 58548 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | GBL | S | | | |
| 58547 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | GBL | S | | | |
| 58546 | GAMBROSOL 10 M | sol 2x4500ml(sy10) | GBL | S | | | |
| 58545 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | GBL | S | | | |
| 45704 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 68460 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | BJS | I | | | |
| 65950 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | BJS | I | | | |
| 65956 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | BJS | I | | | |
| 85923 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2000ml(vak) | BFF | I | | | |
| 85924 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x5000ml(vak) | BFF | I | | | |
| 85925 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2000ml(vak) | BFF | I | | | |
| 85926 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x5000ml(vak) | BFF | I | | | |
| 65946 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | BJS | I | | | |
| 45700 | GAMBROSOL 10 L SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 45640 | GAMBROSOL 10 H SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 45677 | GAMBROSOL 10 M GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 45674 | GAMBROSOL 10 M SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 45706 | GAMBROSOL 10 L SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 65959 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | BJS | I | | | |
| 65962 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | BJS | I | | | |
| 65963 | GAMBROSOL10 L | sol 5x2000ml(ge10) | BJS | I | | | |
| 65963 | GAMBROSOL 10 L | sol 5x2000ml(ge10) | BJS | I | | | |
| 65967 | GAMBROSOL 10 L | sol 3x3000ml(ge10) | BJS | I | | | |
| 45672 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 45704 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 65956 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | BJS | I | | | |
| 65950 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | BJS | I | | | |
| 65949 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | BJS | I | | | |
| 45632 | GAMBROSOL 10 H SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 45638 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 65946 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | BJS | I | | | |
| 45668 | GAMBROSOL 10 M SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 45645 | GAMBROSOL 10 H GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 65937 | GAMBROSOL 10 M | sol 5x2000ml(ge10) | BJS | I | | | |
| 45710 | GAMBROSOL 10 L GEMINI 10 | sol 4x2000ml(vak) | BJS | I | | | |
| 65949 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | BJS | I | | | |
| 68321 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | BJS | I | | | |
| 98253 | CAPD 2 | sol 1x2000ml | FRE | D | | | |
| 98277 | CAPD 4 | sol 1x5000ml | FRE | D | | | |
| 98275 | CAPD 4 | sol 1x2000ml | FRE | D | | | |
| 98267 | CAPD 3 | sol 1x5000ml | FRE | D | | | |
| 98265 | CAPD 3 | sol 1x2000ml | FRE | D | | | |
| 65936 | GAMBROSOL 10 M | sol 3x3000ml(ge10) | BJS | I | | | |
| 98254 | CAPD 2 | sol 1x2500ml | FRE | D | | | |
| 65967 | GAMBROSOL 10 L | sol 3x3000ml(ge10) | BJS | I | | | |
| 69318 | GAMBROSOL 10 H | sol 3x3000ml(ge10) | BJS | I | | | |
| 69304 | GAMBROSOL 10 H | sol 5x2000ml(ge10) | BJS | I | | | |
| 69183 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x5000ml(vak) | BFF | I | | | |
| 69182 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2000ml(vak) | BFF | I | | | |
| 68515 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | BJS | I | | | |
| 98255 | CAPD 2 | sol 1x5000ml | FRE | D | | | |
| 45711 | GAMBROSOL 10 L GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 102 | B05X | přídavky do nitrožilně podávaných roztoků (hydrogenuhličitan sodný) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 102.1 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100 | ML | 124,74 | O |
| 00524 | NATRIUM HYDROGENCARBONIC.LECIVA | inj 6x20ml 4.2% | LEX | CZ | | | |
| 55448 | NATRIUM HYDROGENCAR.LECIVA 4.2% | inj 10x10ml | LEX | CZ | | | |
| 102.2 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100 | ML | 11,00 | O |
| | | | | | | | |
| 102.2 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100 | ML | 10,65 | O |
| 31352 | ALKALIGEN INFUSION-HUMAN | inf 1x400ml | HUA | H | | | |
| 103 | B05X | přídavky do nitrožilně podávaných roztoků (ostatní) | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 103.1 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100 | ML | 17,40 | H |
| 70523 | INFUSIO KALII CHLORATI CONC.MVM | inf 1x250ml | MVM | CZ | | | |
| 103.2 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100 | ML | 22,88 | H |
| 44171 | CHLORID SODNY 5.85% BRAUN | inf 1x100ml | BME | D | | | |
| 69727 | ARDEAELYTOSOL NATRIUMCHLOR.5.85 | inf 1x200ml | ARD | CZ | | | |
| 103.3 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 24,93 | H |
| 12416 | INFUSIO NATR.CHLOR. CONCENTRATA | inf 1x3000ml(vak) | IMA | SK | | | |
| 87726 | ARDEAELYTOSOL NATRIUMCHLOR. 10% | inf 1x200ml | ARD | CZ | | | |
| 103.2 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100 | ML | 20,30 | H |
| 44171 | CHLORID SODNY 5.85% BRAUN | inf 1x100ml | | BME | D | | |
| 103.3 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 18,55 | H |
| 12416 | INFUSIO NATR.CHLOR.CONCENTRATA | inf 1x3000ml(vak) | IMA | SK | | | |
| 01695 | NATRII CHLORIDI 10% MEDVIR | inf 1x100ml | VYS | CZ | | | |
| 12408 | INFUSIO NATR.CHLOR. CONCENTRATA | inf 1x500ml(sklo) | IMA | SK | | | |
| 12413 | INFUSIO NATR.CHLOR. CONCENTRATA | inf 1x500ml(vak) | IMA | SK | | | |
| 12405 | INFUSIO NATR.CHLOR. CONCENTRATA | inf 1x200ml(sklo) | IMA | SK | | | |
| 12415 | INFUSIO NATR.CHLOR.CONCENTRATA | inf 1x2000ml(vak) | IMA | SK | | | |
| 12414 | INFUSIO NATR.CHLOR.CONCENTRATA | inf 1x1000ml(vak) | IMA | SK | | | |
| 12413 | INFUSIO NATR.CHLOR.CONCENTRATA | inf 1x500ml(vak) | IMA | SK | | | |
| 12405 | INFUSIO NATR.CHLOR.CONCENTRATA | inf 1x200ml(sklo) | IMA | SK | | | |
| 12408 | INFUSIO NATR.CHLOR.CONCENTRATA | inf 1x500ml(sklo) | IMA | SK | | | |
| 12407 | INFUSIO NATR.CHLOR.CONCENTRATA | inf 1x400ml(sklo) | IMA | SK | | | |
| 12415 | INFUSIO NATR.CHLOR. CONCENTRATA | inf 1x2000ml(vak) | IMA | SK | | | |
| 12414 | INFUSIO NATR.CHLOR. CONCENTRATA | inf 1x1000ml(vak) | IMA | SK | | | |
| 103.4 | B05XA04 | chlorid amonný | parent. | 100 | ML | 11,68 | H |
| | | | | | | | |
| 103.5 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100 | ML | 52,35 | H |
| | | | | | | | |
| 103.6 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10 | ML | 12,46 | H |
| | | | | | | | |
| 103.7 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 127,87 | H |
| 103.7 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 33,26 | H |
| 75101 | KALIUM-L-MALATLOSUNG | inf 10x20ml | LPD | A | | | |
| 103.8 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100 | ML | 257,49 | H |
| 103.8 | B05XB01 | chlorid argininu (koncentrace 21 %) | parent. | 100 | ML | 233,08 | H |
| 69596 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x300ml | ARD | CZ | | | |
| 86797 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x200ml | ARD | CZ | | | |
| 69597 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x500ml | ARD | CZ | | | |
| 69596 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x300ml | ARD | CZ | | | |
| 86798 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x250ml | ARD | CZ | | | |
| 86799 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x400ml | ARD | CZ | | | |
| 103.9 | B05XB02 | alanylglutamin | parent. | 1 | ML | 4,39 | H |
| | | | | | | | |
@@ -1747,29 +1759,30 @@
| 103.11 | B05XX | ostatní i.v. roztoky | parent. | 100 | ML | 7,63 | H |
| 104 | B05Z | roztoky k hemodialýze a hemofiltraci | lok. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 104.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1000 | ML | 166,19 | H |
| 104.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1000 | ML | 94,50 | H |
| | | | | | | | |
| 104.2 | B05ZA | hemodialytika, koncentráty | lok. | 1000 | ML | 125,72 | H |
| | | | | | | | |
| 104.3 | B05ZB | hemofiltráty | lok. | 1000 | ML | 166,19 | H |
| 54080 | MEDISOL K 3 | sol 2x5lt(vak) | MDT | CZ | | | |
| 104.3 | B05ZB | hemofiltráty | lok. | 1000 | ML | 94,50 | H |
| 54080 | MEDISOL K 3 | sol 2x5It(vak) | MDT | CZ | | | |
| 54114 | MEDISOL K 2 | sol 2x5lt(vak) | MDT | CZ | | | |
| 54113 | MEDISOL K 2 | sol 1x5lt(vak) | MDT | CZ | | | |
| 54079 | MEDISOL K 3 | sol 1x5lt(vak) | MDT | CZ | | | |
| 89174 | SOLUTION FOR HAEMOFILTRATION E2 | sol 1x5000ml | BFF | I | | | |
| 54113 | MEDISOL K 2 | sol 1x5lt(vak) | MDT | CZ | | | |
| 54114 | MEDISOL K 2 | sol 2x5lt(vak) | MDT | CZ | | | |
| 54079 | MEDISOL K 3 | sol 1x5lt(vak) | MDT | CZ | | | |
| 105 | C01AA | kardioglykosidy z náprstníku | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 105.1 | C01AA02 | acetyldigoxin | p.o. | 0.5 | MG | 1,03 | |
| | | | | | | | |
| 105.2 | C01AA04 | digitoxin | p.o. | 0.1 | MG | 1,03 | |
| | | | | | | | |
| 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,83 | |
| 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,25 | |
| 83318 | DIGOXIN 0.125 LECIVA | tbl 30x0.125mg | LEX | CZ | | | |
| 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | IVX | CZ | | | |
| 03542 | DIGOXIN 0.250 LECIVA | tbl 30x0.25mg | LEX | CZ | | | |
| 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | GNO | CZ | | | |
| 105.4 | C01AA08 | metildigoxin | p.o. | 0.2 | MG | 1,03 | |
| 106 | C01AA | kardioglykosidy z náprstníku | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 106.1 | C01AA05 | digoxin | parent. | 0.25 | MG | 6,99 | |
| 106.1 | C01AA05 | digoxin | parent. | 0.25 | MG | 7,32 | |
| 00435 | DIGOXIN SPOFA | inj 10x2ml/0.5mg | SPX | CZ | | | |
| 106.2 | C01AA08 | metildigoxin | parent. | 0.2 | MG | 6,99 | |
| | | | | | | | |
@@ -1778,17 +1791,18 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 107.1 | C01B | ipratropium | p.o. | 30 | MG | 53,77 | |
| 88433 | ITROP | tbl fc 20x10mg | BOE | F | | | |
| 107.2 | C01BA | detajmii bitartras | p.o. | 75 | MG | 14,39 | |
| 23113 | TACHMALCOR | drg 50x25mg | VAD | D | | | |
| 107.3 | C01BA01 | Chinidin | p.o. | 1.2 | GM | 19,36 | |
| 107.2 | C01BA | detajmii bitartras | p.o. | 75 | MG | 14,15 | |
| | | | | | | | |
| 107.3 | C01BA01 | chinidin | p.o. | 1.2 | GM | 15,19 | |
| 89773 | TBL.CHINIDINI SULFURICI 0.2 MVM | tbl 50x0.2gm | MVM | CZ | | | |
| 70549 | TBL.CHINIDINI SULFURICI 0.2 MVM | tbl 1000x0.2gm | MVM | CZ | | | |
| 107.4 | C01BA01 | Chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 27,27 | |
| 107.4 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 27,27 | |
| | | | | | | | |
| 107.5 | C01BA02 | prokainamid | p.o. | 3 | GM | 38,61 | |
| | | | | | | | |
| 107.6 | C01BA03 | disopyramid | p.o. | 0.4 | GM | 12,37 | |
| | | | | | | | |
| 107.7 | C01BA08 | prajmalin | p.o. | 30 | MG | 14,08 | |
| 107.7 IC01BA08 | prajmalin | p.o. | 30 | MG | 13,56 | | |
| 90992 | NEO-GILURYTMAL | tbl obd 50x20mg | SVP | D | | | |
| 108 | C01BA | antiarytmika, třída la | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1804,14 +1818,14 @@
| 109.1 | C01BB02 | mexiletin | p.o. | 0.8 | GM | 9,68 | |
| 93311 | KATEN RETARD | tbl 50x400mg | SLO | SK | | | |
| 109.2 | C01BB03 | tocainid | p.o. | 1.2 | GM | 10,22 | |
| 110 | C01BB | antiarytmika, třída lb | parent. | O/INT,KAR | | | |
| 110 | C31BB, | antiarytmika, třída Ib | parent. | O/INT,KAR | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,22 | O/INT,KAR |
| | | | | | | | |
| 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 351,64 | O/INT,KAR |
| | | | | | | | |
| 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 351,64 | O/INT,KAR |
| 111 | C01BC | antiarytmika, třída Ic | p.o. | | | | |
| 111 | C01BC | antiarytmika třída Ic | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 111.1 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 17,16 | |
| | | | | | | | |
@@ -1820,31 +1834,30 @@
| 53535 | PROPAFENON AL 150 | tbl obd 50x150mg | APA | D | | | |
| 59942 | PROPANORM 150MG | tbl obd 50x150mg | PMP | CZ | | | |
| 111.3 | C01BC03 | propafenon (nad 150 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,70 | |
| 112 | C01BC | antiarytmika, třída Ic | parent. | O/INT, KAR | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 112.1 | C01BC03 | Propafenon | parent. | 0.3 | GM | 176,65 | O/INT,KAR |
| 112 | C01BC | antiarytmika, třída Ic | parent. | O/INT,KAR | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 112.1 | C01BC03 | propafenon | parent. | 0.3 | GM | 174,00 | O/INT,KAR |
| 91275 | PROLEKOFEN | inj 10x10ml/35mg | LEK | SLO | | | |
| 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 139,01 | O/INT,KAR |
| 113 | C01BD | antiarytmika, třída III | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 4,20 | |
| 59286 | AMIOHEXAL 200 | tbl 100x200mg | SFS | D | | | |
| 59655 | AMIOKORDIN | tbl 60x200mg | KRK | SLO | | | |
| 59285 | AMIOHEXAL 200 | tbl 50x200mg | SFS | D | | | |
| 59286 | AMIOHEXAL 200 | tbl 100x200mg | SFS | D | | | |
| 59284 | AMIOHEXAL 200 | tbl 20x200mg | SFS | D | | | |
| 114 | C01BD | antiarytmika, třída III a adenosin | parent. | O/INT,KAR | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 19,94 | O/INT,KAR |
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 19,28 | O/INT,KAR |
| 96600 | SEDACORON | inj 5x3ml/150mg | EBW | A | | | |
| 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 139,01 | O/INT,KAR |
| | | | | | | | |
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 728,30 | O/INT,KAR |
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 695,63 | O/INT,KAR |
| 91615 | ADENOCOR | inj 6x2ml/6mg | SWI | F | | | |
| 115 | C01CA | adrenergní a dopaminergní léčiva (norepinefrin a dopamin) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 115.1 | C01CA03 | norepinefrin | parent. | 6 | MG | 76,00 | O |
| 115 | C01CA | adrenergní a dopaminergní léčiva (norepinofrin a dopamin) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 115.1 | C01CA03 | norepinefrin | parent. 6 | MG | 79,56 | O | |
| 00536 | NORADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | | | |
| 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 109,39 | O |
| 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 114,50 | O |
| 04380 | TENSAMIN | inj 10x5ml | LEX | CZ | | | |
| 116 | C01CA | adrenergní a dopaminergní léčiva (ostatní) | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1852,12 +1865,10 @@
| | | | | | | | |
| 116.2 | C01CA05 | norfenefrin | parent. | 25 | MG | 23,76 | H |
| | | | | | | | |
| 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 350,71 | H |
| 84361 | DOBUTAMIN GIULINI | inj sic 1x250mg | WAU | D | | | |
| 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 326,00 | O |
| 01639 | DOBUTAMIN GIULINI | inj sic 10x250mg | WAU | D | | | |
| 59267 | DOBUTAMIN LACHEMA 250 | inj sie 10x250mg | LCM | CZ | | | |
| 84361 | DOBUTAMIN GlULINI | inj sic 1x250mg | WAU | D | | | |
| 86762 | DOBUJECT | inf 5x5ml/250mg | LOY | SF | | | |
| 92483 | DOBUTAMIN LACHEMA 250 | inj sie 1x250mg | LCM | CZ | | | |
| 116.4 | C01CA09 | metaraminol | parent. | 50 | MG | 191,26 | H |
| | | | | | | | |
| 116.5 | C01CA10 | metoxamin | parent. | 30 | MG | 40,91 | H |
@@ -1868,14 +1879,14 @@
| | | | | | | | |
| 116.8 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1 | DF | 684,31 | P |
Léčivý přípravek obsahující epinefrin v lékových formách autoinjektoru předepisuje alergolog a klinický imunolog u pacientů s anamnézou anafylaktického šoku vyvolaného alergií na hmyz.
Léčivý přípravek obsahující epinefrin v lékových formách autoinjektoru předepisuje alergolog a klinický imunolog u pacientů s anamnézou anafylaktického šoku vyvolaného alergii na hmyz.
| 116.9 | C01CA24 | epinefrin | parent. | 0.5 | MG | 4,50 | O |
| 00362 | ADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | | | |
| | | | | | | | |
| 116.10 | C01CA14 | dopexamin | parent. | 500 | MG | 109,39 | H |
| 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4146,65 | X |
| 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4059,95 | X |
| 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F | | | |
| 117.2 | C01CE02 | milrinon | parent. | 50 | MG | 3980,00 | X |
| 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | | | | |
@@ -1883,7 +1894,6 @@
| 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,00 | |
| | | | | | | | |
| 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 3,00 | |
| | | | | | | | |
| 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,12 | |
| 31089 | NITROMINT 2.6MG | tbl ret 60x2.6mg | EGI | H | | | |
| 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 3,50 | |
@@ -1896,40 +1906,38 @@
| 118.7 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,20 | |
| 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D | | | |
| 118.8 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 2,75 | |
| 87184 | MONO MACK 20MG | tbl 30x20mg | ICS | CZ | | | |
| 59898 | ISMN AL 20 | tbl 30x20mg | APA | D | | | |
| 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D | | | |
| 76401 | SORBIMON 20MG | tbl 50x20mg | MCK | D | | | |
| 76402 | SORBIMON 20MG | tbl 100x20mg | MCK | D | | | |
| 96187 | MONOSAN 20MG | tbl 50x20mg | PMP | CZ | | | |
| 96190 | MONOSAN 20MG | tbl 30x20mg | PMP | CZ | | | |
| 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D | | | |
| 76402 | SORBIMON 20MG | tbl 100x20mg | MCK | D | | | |
| 92568 | ISMN AL 20 | tbl 60x20mg | APA | D | | | |
| 61467 | ISMN AL 20 | tbl 100x20mg | APA | D | | | |
| 76401 | SORBIMON 20MG | tbl 50x20mg | MCK | D | | | |
| 87184 | MONO MACK 20MG | tbl 30x20mg | ICS | CZ | | | |
| 92568 | ISMN AL 20 | tbl 60x20mg | APA | D | | | |
| 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 2,49 | |
| 96191 | MONOSAN 40MG | tbl 30x40mg | PMP | CZ | | | |
| 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D | | | |
| 96188 | MONOSAN 40MG | tbl 50x40mg | PMP | CZ | | | |
| 61469 | ISMN AL 40 | tbl 100x40mg | APA | D | | | |
| 59899 | ISMN AL 40 | tbl 30x40mg | APA | D | | | |
| 87185 | MONO MACK 40MG | tbl 30x40mg | ICS | CZ | | | |
| 92569 | ISMN AL 40 | tbl 60x40mg | APA | D | | | |
| 61469 | ISMN AL 40 | tbl 100x40mg | APA | D | | | |
| 76404 | SORBIMON 40MG | tbl 50x40mg | MCK | D | | | |
| 87185 | MONO MACK 40MG | tbl 30x40mg | ICS | CZ | | | |
| 96188 | MONOSAN 40MG | tbl 50x40mg | PMP | CZ | | | |
| 76403 | SORBIMON 40MG | tbl 20x40mg | MCK | D | | | |
| 59899 | ISMN AL 40 | tbl 30x40mg | APA | D | | | |
| 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D | | | |
| 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,59 | H |
| 119.1 | C01DA02 | glycerol trinitrát | parent. 2.5 | MG | 13,18 | H | |
| 02640 | NITRO MACK AMPULE | inj 10x5ml/5mg | PHH | D | | | |
| 04307 | NITRO POHL INFUS. | inf 10x10ml/10mg | PLB | D | | | |
| 83538 | NITRO POHL INFUS. | inf 1x50ml/50mg | PLB | D | | | |
| 83539 | NITRO POHL INFUS. | inf 10x50ml/50mg | PLB | D | | | |
| 83538 | NITRO POHL INFUS. | inf 1x50ml/50mg | PLB | D | | | |
| 04348 | NITRO-MACK | inj 10x5ml/5mg | MAC | D | | | |
| 04307 | NITRO POHL INFUS. | inf 10x10ml/10mg | PLB | D | | | |
| 02640 | NITRO MACK AMPULE | inj 10x5ml/5mg | PHH | D | | | |
| 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 123,96 | H |
| 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,59 | |
| 53139 | NITRILEX | aer 1x14gm/205davek | GNO | CZ | | | |
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,50 | |
| 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D | | | |
| 31407 | NITROMINT | aer dos 1x10gm | EGI | H | | | |
| 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D | | | |
| 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 8,80 | |
| 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1946,9 +1954,9 @@
| 49554 | MOLSIHEXAL 4MG | tbl 100x4mg | SFS | D | | | |
| 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,10 | |
| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | SFS | D | | | |
| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | SFS | D | | | |
| 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | SFS | D | | | |
| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | SFS | D | | | |
| 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 7,23 | L/INT, KAR |
| 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 6,50 | L/INT, KAR |
| 123 | C01DX | ostatní vazodilatancia | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 13,78 | H |
@@ -1956,14 +1964,15 @@
| 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 105,38 | H |
| 124 | C01EA | prostaglandiny | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3100,00 | X |
| 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3090,40 | X |
| 44169 | ALPROSTAPINT 500MCG/ML | inf 5x1ml/500rg | BGD | D | | | |
| 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ | | | |
| 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 647,95 | X |
| 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 638,23 | X |
| 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D | | | |
| 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 125.1 | C02AB01 | methyldopa (levotočiva) | p.o. | 1 | GM | 6,80 | |
| 01328 | DOPEGYT | tbl 50x250mg | EGI | H | | | |
| 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 6,80 | |
| | | | | | | | |
| 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 7,00 | |
| | | | | | | | |
| 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 7,00 | |
@@ -1974,7 +1983,7 @@
| | | | | | | | |
| 125.6 | C02AC06 | rilmenidin | p.o. | 1 | MG | 7,00 | |
| | | | | | | | |
| 125.7 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,56 | |
| 125.7 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,63 | |
| 02629 | CRYSTEPIN | drg 30 | LEX | CZ | | | |
| 125.8 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 4,94 | |
| | | | | | | | |
@@ -1982,8 +1991,8 @@
| 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 70,09 | H |
| 11823 | CATAPRESAN | inj 5x1ml/0.15mg | BOE | E | | | |
| 92074 | CATAPRESAN | inj 5x1ml/0.15mg | BGP | D | | | |
| 11823 | CATAPRESAN | inj 5x1 ml/0.15mg | BOE | E | | | |
| 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 127.1 | C02CA | metazosin | p.o. | 20 | MG | 5,96 | |
@@ -1991,20 +2000,20 @@
| 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 12,59 | |
| 58259 | DEPRAZOLIN MITE | tbl 15x1mg | LEX | CZ | | | |
| 94315 | DEPRAZOLIN MITE | tbl 10x1mg | LEX | CZ | | | |
| 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 3,18 | |
| 88173 | DEPRAZOLIN | | tbl 30x2mg | LEX | CZ | | |
| 127.4 | C02CA04 | doxazosin-retardované formy do 4 mg v jedné tabletě včetně | p.o. | 4 | MG | 20,33 | L/URN |
| | | | | | | | |
| 127.5 | C02CA04 | doxazosin-retardované formy nad 4 mg v jedné tabletě | p.o. | 4 | MG | 11,00 | L/URN |
| | | | | | | | |
| 127.6 | C02CA04 | doxazosin - neretardované formy | p.o. | 4 | MG | 18,10 | L/URN |
| 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 3,33 | |
| 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ | | | |
| 127.4 | C02CA04 | doxazosin-retardované formy do 4 mg v jedné tabletě včetně | p.o. | 4 | MG | 18,90 | L/URN |
| | | | | | | | |
| 127.5 | C02CA04 | doxazosin-retardované formy nad 4 mg v jedné tabletě | p.o. | 4 | MG | 10,20 | L/URN |
| | | | | | | | |
| 127.6 | C02CA04 | doxazosin - neretardované formy | p.o. | 4 | MG | 16,80 | L/URN |
| 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO | | | |
| 45215 | ZOXON 4 | tbl 30x4mg | LEX | CZ | | | |
| 64797 i | KAMIREN 4 | tbl 30x4mg | KRK | SLO | | | |
| 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO | | | |
| 64797 | KAMIREN 4 | tbl 30x4mg | KRK | SLO | | | |
| 127.7 | C02CA06 | urapidil | p.o. | 50 | MG | 6,89 | |
| 128 | 302CA | antihypertenziva působící na periferní alfa-1receptory | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 221,16 | O |
| 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 128.1 | C02CA06 | Urapidil | parent. | 50 | MG | 217,84 | O |
| 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D | | | |
| 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D | | | |
| 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | | | | |
@@ -2017,59 +2026,59 @@
| 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 283,99 | H |
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 30,40 | H |
| 90484 | NEPRESOL | inj 5x25mg+solv. | CGC | CH | | | |
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 273,97 | H |
| | | | | | | | |
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 30,20 | H |
| 90484 | NEPRESOL | I inj 5x25mg+solv. | CGC | CH | | | |
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 267,28 | H |
| 21221 | NIPRUSS | inf plv sol 5x60mg | SWP | D | | | |
| 131 | C03AA | thiazidová diuretika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 131.1 | C03AA03 | hydro-chlorothiazid | p.o. | 25 | MG | 0,90 | |
| 131.1 | C03AA03 | hydrochlorothiazid | p.o. | 25 | MG | 0,94 | |
| 00168 | HYDROCHLOROTHIAZID LECIVA | tbl 20x25mg | LEX | CZ | | | |
| 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 132.1 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,59 | |
| 83551 | URANDIL | tbl 30x50mg(blistr) | LEX | CZ | | | |
| 132.1 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,61 | |
| | | | | | | | |
| 132.2 | C03BA10 | xipamid | p.o. | 20 | MG | 1,03 | |
| | | | | | | | |
| 132.3 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,12 | |
| 46635 | INDAPAMID HF | tbl obd 30x2.5mg | HMF | YU | | | |
| 96696 | INDAP | cps 30x2.5mg | PMP | CZ | | | |
| 132.4 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,12 | |
| | | | | | | | |
| 132.5 | C03BA | metipamid | p.o. | 2.5 | MG | 1,03 | |
| 94810 | HYPOTYLIN | tbl 30x2.5mg | LEX | CZ | | | |
| | | | | | | | |
| 132.6 | C03B | cikletanin | p.o. | 50 | MG | 1,03 | |
| 133 | C03CA | kličková diuretika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,88 | |
| 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND | | | |
| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | | | |
| 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40mg | SLO | SK | | | |
| 56805 | FURORESE 40 | tbl 100x40mg | FST | D | | | |
| 76031 | FURSEMID | tbl 48x40mg | BLU | CHO | | | |
| 98219 | FURON 40MG | tbl 50x40mg | MCK | D | | | |
| 56802 | FURORESE 40 | tbl 20x40mg | FST | D | | | |
| 56804 | FURORESE 40 | tbl 50x40mg | FST | D | | | |
| 56802 | FURORESE 40 | tbl 20x40mg | FST | D | | | |
| 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40mg | SLO | SK | | | |
| 96328 | FURSEMID | tbl 12x40mg | BLU | CHO | | | |
| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | | | |
| 98219 | FURON 40MG | tbl 50x40mg | MCK | D | | | |
| 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND | | | |
| 97935 | FURSEMID | tbl 100x40mg | BLU | CHO | | | |
| 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,08 | |
| 56811 | FURORESE 250 | tbl 50x250mg | FST | D | | | |
| 56810 | FURORESE 250 | tbl 20x250mg | FST | D | | | |
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | | | |
| 68632 | FURORESE 500 | tbl 20x500mg | FST | D | | | |
| 56807 | FURORESE 125 | tbl 30x125mg | FST | D | | | |
| 56814 | FURORESE 500 | tbl 50x500mg | FST | D | | | |
| 56808 | FURORESE 125 | tbl 50x125mg | FST | D | | | |
| 56810 | FURORESE 250 | tbl 20x250mg | FST | D | | | |
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | | | |
| 56812 | FURORESE 250 | tbl 100x250mg | FST | D | | | |
| 56814 | FURORESE 500 | tbl 50x500mg | FST | D | | | |
| 56809 | FURORESE 125 | tbl 100x125mg | FST | D | | | |
| 56811 | FURORESE 250 | tbl 50x250mg | FST | D | | | |
| 56815 | FURORESE 500 | tbl 100x500mg | FST | D | | | |
| 56809 | FURORESE 125 | tbl 100x125mg | FST | D | | | |
| 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,88 | |
| | | | | | | | |
| 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,08 | |
| 134 | C03CA | kličková diuretika | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 15,04 | O |
| 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | HBS | SK | | | |
| 56817 | FURORESE 20 INJEKT | inj 5x2ml/20mg | PHH | D | | | |
| 56818 | FURORESE 20 INJEKT | inj 25x2ml/20mg | PHH | D | | | |
| 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | HBS | SK | | | |
| 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,36 | O |
| 56820 | FURORESE ROZTOK | inf 25x25ml/250mg | PHH | D | | | |
| 56819 | FURORESE ROZTOK | inf 5x25ml/250mg | PHH | D | | | |
@@ -2077,12 +2086,11 @@
| | | | | | | | |
| 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 7,72 | O |
| | | | | | | | |
| 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 543,63 | O |
| 134.5 | C03C | kyselina etakrynová | parent. 50 | MG | 543,63 | O | |
| 135 | C03D | kalium šetřící diuretika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 4,84 | |
| 96361 | XENALON-50 | tbl obd 20x50mg | MHA | CH | | | |
| 96362 | XENALON-100 | tbl obd 20x100mg | MHA | CH | | | |
| | | | | | | | |
| 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,56 | |
| 87662 | AMICLARAN | tbl 50x5mg | SLO | SK | | | |
| 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,22 | |
@@ -2091,15 +2099,16 @@
| 136.1 | C03EA | středně silná diuretika a kalium šetřící látky | p.o. | 1 | DF | 1,17 | |
| 88518 | AMICLOTON | tbl 30 | SLO | SK | | | |
| 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,54 | |
| 83718 | AMILORID HCT AL | tbl 100 | APA | D | | | |
| 89125 | LORADUR MITE | tbl 50x2.5mg/25mg | MCK | A | | | |
| 76380 | RHEFLUIN | tbl 30 | LEX | CZ | | | |
| 83717 | AMILORID HCT AL | tbl 50 | APA | D | | | |
| 83718 | AMILORID HCT AL | tbl 100 | APA | D | | | |
| 76380 | RHEFLUIN | tbl 30 | LEX | CZ | | | |
| 136.3 | C03EA14 | spironolakton/ butizid | p.o. | 1 | DF | 9,78 | |
| 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | O | | | |
| 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 9,78 | |
| 137 | C04AB | periferní varodilatancia ze skupiny derivátů imidazolu | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 20,82 | O |
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 83,14 | O |
| | | | | | | | |
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 87,00 | O |
| 00440 | DIVASCOL | inj 10x1ml/10mg | SPX | CZ | | | |
| 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2107,46 +2116,47 @@
| | | | | | | | |
| 138.2 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 4,57 | |
| | | | | | | | |
| 138.3 | C04AD03 | Pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 4,57 | |
| 138.3 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 4,57 | |
| | | | | | | | |
| 138.4 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 7,10 | |
| 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 100x400mg | APA | D | | | |
| 54247 | APO-PENTOXIFYLLINE SR | tbl ret 100x400mg | APT | CND | | | |
| 66513 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 30x400mg | APA | D | | | |
| 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 50x400mg | APA | D | | | |
| 53480 | TRENTAL 400 | por tblret100x400mg | HBS | SK | | | |
| 97698 | PENTOMER RETARD 400MG | tbl obd 20x400mg | MCK | D | | | |
| 47085 | PENTOMER RETARD 400MG | tbl obd 100x400mg | MCK | D | | | |
| 92353 | AGAPURIN RETARD | tbl obd 100x400mg | SLO | SK | | | |
| 87661 | AGAPURIN RETARD | tbl obd 20x400mg | SLO | SK | | | |
| 53479 | TRENTAL 400 | por tblret20x400mg | HBS | SK | | | |
| 92352 | AGAPURIN RETARD | tbl obd 50x400mg | SLO | SK | | | |
| 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 100x400mg | APA | D | | | |
| 97698 | PENTOMER RETARD 400MG | tbl obd 20x400mg | MCK | D | | | |
| 53479 | TRENTAL 400 | por tblret20x400mg | HBS | SK | | | |
| 54247 | APO-PENTOXIFYLLINE SR | tbl ret 100x400mg | APT | CND | | | |
| 87661 | AGAPURIN RETARD | tbl obd 20x400mg | SLO | SK | | | |
| 53480 | TRENTAL 400 | por tblret100x400mg | HBS | SK | | | |
| 47085 | PENTOMER RETARD 400MG | tbl obd 100x400mg | MCK | D | | | |
| 138.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 7,90 | |
| 97702 | PENTOMER RETARD 600MG | tbl obd 20x600mg | MCK | D | | | |
| 49600 | PENTOHEXAL 600 | tbl ret 30x600mg | SFS | D | | | |
| 49601 | PENTOHEXAL 600 | tbl ret 50x600mg | SFS | D | | | |
| 96180 | AGAPURIN 600 RETARD | tbl obd 20x600mg | SLO | SK | | | |
| 49601 | PENTOHEXAL 600 | tbl ret 50x600mg | SFS | D | | | |
| 49600 | PENTOHEXAL 600 | tbl ret 30x600mg | SFS | D | | | |
| 138.6 | C04AD04 | etophyllin nikotinát | p.o. | 0.3 | GM | 1,65 | |
| 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK | | | |
| 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 139.1 | C04AC | olamin nikotinát | parent. | 0.9 | GM | 20,04 | |
| | | | | | | | |
| 139.2 | C04AD | etophyllin/ theophyllin | parent. | 0.3 | GM | 11,05 | |
| 139.2 | C04AD | etophyllin/theophyllin | parent. | 0.3 | GM | 11,05 | |
| 57351 | OXANTIL | inj 5x2ml | HBS | SK | | | |
| 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,25 | |
| | | | | | | | |
| 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 28,40 | |
| 139.4 | C04AD03 | Pentoxifyllin | parent. | 0.3 | GM | 28,40 | |
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | | | |
| 69241 | PENTILIN 100 | inj 5x5ml/100mg | KRK | SLO | | | |
| 49603 | PENTOHEXAL 300 | inf 10x15ml/300mg | PHH | D | | | |
| 53200 | AGAPURIN | inj 5x5ml/100mg | SLO | SK | | | |
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | | | |
| 49603 | PENTOHEXAL 300 | inf 10x15ml/300mg | PHH | D | | | |
| 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,08 | |
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 MG | 2,11 | | |
| 91032 | SECATOXIN FORTE | gtt 1x25ml/62.5mg | GNO | CZ | | | |
| 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,50 | |
| 05742 | ERGOTOP 30 | tbl obd 28x30mg | GNO | CZ | | | |
| 140.3 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2 | ML | 1,79 | |
| 140.3 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2 | ML | 1,87 | |
| 88088 | ERSILAN | gtt 50ml | GNO | CZ | | | |
| 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2161,7 +2171,7 @@
| | | | | | | | |
| 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,72 | |
| | | | | | | | |
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,72 | |
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,96 | |
| 97026 | ENELBIN 100 RETARD | tbl ret 50x100mg | LEX | CZ | | | |
| 66015 | ENELBIN 100 RETARD | tbl ret 100x100mg | LEX | CZ | | | |
| 143 | C04AX | jiná periferní vasodilatancia | parent. | | | | |
@@ -2170,9 +2180,9 @@
| | | | | | | | |
| 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 51,52 | |
| | | | | | | | |
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 51,52 | |
| 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ | | | |
| 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | | | | |
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 53,95 | |
| 98049 | ENELBIN | inj 10x5mi/40mg | LEX | CZ | | | |
| 144 | C05AD antihemorhoidalia obsahující lokální anestetika | lok. | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| | | | | | | | |
@@ -2184,70 +2194,77 @@
| | | | | | | | |
| 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| | | | | | | | |
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 1,15 | |
| 00832 | AVIRIL H | ung 1x30gm | LEX | CZ | | | |
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,84 | |
| 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 145.1 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
| | | | | | | | |
| 145.2 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 145.1 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) lok. | 1 | GM | 0,78 | | |
| | | | | | | | |
| 145.2 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) lok. | 1 | DF | 0,98 | | |
| | | | | | | | |
| 145.3 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
| | | | | | | | |
| 145.4 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 146.1 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,83 | |
| 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použiti | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 146.1 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,87 | |
| 03575 | HEPAROID LECIVA | ung 1x30gm | LEX | CZ | | | |
| 146.2 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,83 | |
| 146.2 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,87 | |
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | | | |
| 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D | | | |
| 146.3 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1 | GM | 0,83 | |
| 146.3 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1 | GM | 0,87 | |
| 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 147.1 | C05CA04 | troxerutin | p.o. | 0.9 | GM | 4,50 | |
| 147.1 | C05CA04 | troxerutin | p.o. | 3 | DF | 4,50 | |
| | | | | | | | |
| 147.2 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,37 | |
| 96303 | ASCORUTIN | tbl obd 50 | SLO | SK | | | |
| 147.3 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,03 | |
| 02635 | ANAVENOL | gtt 1x25ml GNO | CZ | | | | |
| 147.4 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 6,52 | |
| | | | | | | | |
| 147.5 | C05CA54 | troxerutin, kombinace | p.o. | 2 | DF | 6,52 | |
| 02635 | ANAVENOL | gtt 1x25ml | GNO | CZ | | | |
| 147.4 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 4,50 | |
| | | | | | | | |
| 147.5 | C05CA54 | troxerutin, kombinace | p.o. | 2 | DF | 4,50 | |
| 148 | C05 | jiné kapiláry stabilizující látky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 148.1 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 6,52 | |
| 148.1 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 4,50 | |
| | | | | | | | |
| 148.2 | C05CX01 | tribenosid | p.o. | 0.6 | GM | 4,50 | |
| | | | | | | | |
| 148.3 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,52 | |
| 148.3 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,33 | |
| 94327 | YELLON | cps 30x20mg | SLO | SK | | | |
| 31000 | YELLON | cps 30x20mg-blistr | SLO | SK | | | |
| 94327 | YELLON | cps 30x20mg | SLO | SK | | | |
| 149 | C05 | jiné kapiláry stabilizující látky | parent. | H | | | |
| 149 | C05 | mé kapiláry stabilizující látky | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 54,26 | H |
| | | | | | | | |
| 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,38 | O |
| 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,16 | O |
| 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D | | | |
| 08510 | AETHOXYSKLEROL 0,5% | inj 5x2ml 0.5% | KRS | D | | | |
| 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D | | | |
| 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,55 | O |
| 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,30 | O |
| 20034 | AETHPOXYSKLEROL 1% | inj 1x30ml 1% | KRS | D | | | |
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml 1% | KRS | D | | | |
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml 1% | KRS | D | | | |
| 149.4 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1 | ML | 18,43 | O |
| 149.4 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1 | ML | 18,16 | O |
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml 2% | KRS | D | | | |
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml 3% | KRS | D | | | |
| 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 19,94 | O |
| 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 19,64 | O |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml 4% | KRS | D | | | |
| 149.6 | C05BB04 | natrium tetradecyl sulfat (koncentrace do 1% včetně) | parent. | 1 | ML | 14,16 | O |
| | | | | | | | |
| 149.7 | C05BB04 | natrium tetradecyl sulfat (koncentrace nad 1% ) | parent. | 1 | ML | 19,64 | O |
| 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | L/KAR,INT | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 150.1 | C07AA07 | sotalol | p.o. | 0.16 | GM | 5,12 | L/KAR,INT |
| 54132 | SOTALOL AL 160 | tbl 50x160mg | APA | D | | | |
| 46744 | SOTALOL 160-SL | tbl 30x160mg | SLO | SK | | | |
| 83669 | SOTAHEXAL 80 | tbl 100x80mg | HEX | D | | | |
| 83670 | SOTAHEXAL 160 | tbl 50x160mg | HEX | D | | | |
| 46608 | SOTALOL 80-SL | tbl 30x80mg | SLO | SK | | | |
| 83668 | SOTAHEXAL 80 | tbl 50x80mg | HEX | D | | | |
| 54131 | SOTALOL AL 160 | tbl 20x160mg | APA | D | | | |
| 83480 | SOTAHEXAL 80 | tbl 20x80mg | HEX | D | | | |
| 83671 | SOTAHEXAL 160 | tbl 100x160mg | HEX | D | | | |
| 54131 | SOTALOL AL 160 | tbl 20x160mg | APA | D | | | |
| 46744 | SOTALOL 160-SL | tbl 30x160mg | SLO | SK | | | |
| 54129 | SOTALOL AL 80 | tbl 50x80mg | APA | D | | | |
| 46608 | SOTALOL 80-SL | tbl 30x80mg | SLO | SK | | | |
| 54132 | SOTALOL AL 160 | tbl 50x160mg | APA | D | | | |
| 54129 | SOTALOL AL l80 | tbl 50x80mg | APA | D | | | |
| 54128 | SOTALOL AL 80 | tbl 20x80mg | APA | D | | | |
| 83481 | SOTAHEXAL 160 | tbl 20x160mg | HEX | D | | | |
| 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 151.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,78 | |
@@ -2268,7 +2285,7 @@
| | | | | | | | |
| 151.9 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,30 | |
| | | | | | | | |
| 151.10 | C07AA23 | Penbutolol | p.o. | 40 | MG | 2,74 | |
| 151.10 | C07AA23 | penbutolol | p.o. | 40 | MG | 2,74 | |
| | | | | | | | |
| 151.11 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,74 | |
| 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | O | | | |
@@ -2277,77 +2294,97 @@
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | | | |
| 152.2 | C07AA | talinolol | parent. | 50 | MG | 93,65 | O |
| | | | | | | | |
| 152.3 | C07AA02 | Oxprenolol | parent. | 0.1 | GM | 99,13 | O |
| 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 99,13 | O |
| | | | | | | | |
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99,13 | O |
| | | | | | | | |
| 152.5 | C07AA07 | Sotalol | parent. | 0.16 | GM | 900,64 | O |
| 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 900,64 | O |
| 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 153.1 | C07AB02 | metoprolol (do 0,05 g včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,93 | |
| 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H | | | |
| 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H | | | |
| 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND | | | |
| 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H | | | |
| 50080 | VASOCARDIN 50 | tbl 50x50mg | SLO | SK | | | |
| 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H | | | |
| 153.2 | C07AB02 | metoprolol (nad 0,05 g v jedné tabletě) | p.o. | 0.15 | GM | 2,74 | |
| 59894 | EGILOK 100MG | tbl 200x100mg | EGI | H | | | |
| 45555 | BETALOC 100MG | tbl 100x100mg | APN | S | | | |
| 32674 | METOPROLOL AL 100 | por tbl nob20x100mg | SDB | D | | | |
| 32675 | METOPROLOL AL 100 | por tblnob100x100mg | SDB | D | | | |
| 45592 | VASOCARDIN 100 | tbl 50x100mg-blistr | SLO | SK | | | |
| 62493 | METOPROLOL DH 100MG DIAG HUMAN | tbl 100x100mg | GRR | IRL | | | |
| 45592 | VASOCARDIN 100 | tbl 50x100mg-blistr | SLO | SK | | | |
| 59894 | EGILOK 100MG | tbl 200x100mg | EGI | H | | | |
| 96755 | APO-METOPROLOL 100 | tbl 100x100mg | APT | CND | | | |
| 59893 | EGILOK 100MG | tbl 60x100mg | EGI | H | | | |
| 153.3 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 3,52 | |
| | | | | | | | |
| 153.4 | C07AB02 | metoprolol (léková forma tablet y s řízeným uvolňováním) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 12,00 | P |
Metoprolol v lékové formě tablet s řízeným uvolňováním je ordinován k léčbě srdečního selhání; v dávce 25 mg je určen k zahájení léčby, pouze v případech kdy není pacinetem tolerována dávka vyšší, je možné podávat v dávce 25 mg dlouhodobě. Cílová dávka metoprololu v lékové formě tablet s řízeným uvolňováním v indikaci srdečního selhání je 200 mg denně, k této udržovací dávce je možné předepisovat tablety s obsahem 100 mg. V indikaci léčby hypertenze, arytmií a sekundární prevence nelze hradit ze zdravotního pojištění.
| 46980 | BETALOC SR 200MG | tbl ret 100x200mg | APN | S | | | |
| 32673 | METOPROLOL AL 200 RETARD | por tbl pro50x200mg | APA | D | | | |
| 46981 | BETALOC SR 200MG | tbl ret 30x200mg | APN | S | | | |
| 153.4 | C07AB02 | metoprolol (léková forma tablet y s řízeným uvolňováním) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 26,20 | P |
Metoprolol v lékové formě tablet s řízeným uvolňováním je ordinován k léčbě srdečního selhání; v dávce 25 mg je určen k zahájení léčby, pouze v případech kdy není pacinetem tolerována dávka vyšší, je možné podávat v dávce 25 mg dlouhodobě. Cílová dávka metoprololu v lékové formě tablet s řízeným uvolňováním v indikaci srdečního selhání je 200 mg denně, k této udržovací dávce je možné předepisovat tablety s obsahem 100 mg. V indikací léčby hypertenze, arytmií a sekundární prevence nelze hradit ze zdravotního pojištění.
| 31536 | BETALOC ZOK 25 MG | tbl ret 100x25mg | AZC | S | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 153.5 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 6,00 | P |
| | | | | | | | |
| 153.6 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně | p.o. | 75 | MG | 3,35 | |
| 83639 | ATEHEXAL 25 | tbl obd 50x25mg | HEX | D | | | |
| 62856 | ATENOBENE 50MG | tbl obd 20x50mg | MCK | D | | | |
| 62861 | ATENOBENE 25MG | tbl obd 30x25mg | MCK | D | | | |
| 89252 | ATENOLOL AL 25 | tbl obd 30x25mg | APA | D | | | |
| 83643 | ATEHEXAL 50 | tbl obd 50x50mg | HEX | D | | | |
| 83644 | ATEHEXAL 50 | tbl obd 100x50mg | HEX | D | | | |
| 83643 | ATEHEXAL 50 | tbl obd 50x50mg | HEX | D | | | |
| 8364? | ATEHEXAL 50 | tbl obd 30x50mg | HEX | D | | | |
| 83640 | ATEHEXAL 25 | tbl obd 100x25mg | HEX | D | | | |
| 89253 | ATENOLOL AL 25 | tbl obd 50x25mg | APA | D | | | |
| 62857 | ATENOBENE 50MG | tbl obd 50x50mg | MCK | D | | | |
| 83638 | ATEHEXAL 25 | tbl obd 30x25mg | HEX | D | | | |
| 62856 | ATENOBENE 50MG | tbl obd 20x50mg | MCK | D | | | |
| 62857 | ATENOBENE 50MG | tbl obd 50x50mg | MCK | D | | | |
| 62861 | ATENOBENE 25MG | tbl obd 30x25mg | MCK | D | | | |
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D | | | |
| 89255 | ATENOLOL AL 50 | tbl obd 30x50mg | APA | D | | | |
| 89256 | ATENOLOL AL 50 | tbl obd 50x50mg | APA | D | | | |
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D | | | |
| 42457 | ATEHEXAL 50 | por tbl flm 50x50mg | SFS | D | | | |
| 42456 | ATEHEXAL 50 | por tbl flm 30x50mg | SFS | D | | | |
| 42455 | ATEHEXAL 25 | por tbl flm100x25mg | SFS | D | | | |
| 42454 | ATEHEXAL 25 | por tbl flm 50x25mg | SFS | D | | | |
| 42453 | ATEHEXAL 25 | por tbl flm 30x25mg | SFS | D | | | |
| 42458 | ATEHEXAL 50 | por tbl flm100x50mg | SFS | D | | | |
| 83642 | ATEHEXAL 50 | tbl obd 30x50mg | HEX | D | | | |
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D | | | |
| 83639 | ATEHEXAL 25 | tbl obd 50x25mg | HEX | D | | | |
| 83640 | ATEHEXAL 25 | tbl obd 100x25mg | HEX | D | | | |
| 153.7 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75 | MG | 3,10 | |
| 96445 | COROTENOL 100 | tbl obd 30x100mg | MHA | CH | | | |
| 65389 | TENORMIN | tbl obd 28x100mg | ZNC | GB | | | |
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D | | | |
| 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D | | | |
| 54419 | ATEBLOCOR 100 | tbl obd 30x100mg | PMP | CZ | | | |
| 42459 | ATEHEXAL 100 | por tbl flm30x100mg | SFS | D | | | |
| 42460 | ATEHEXAL 100 | por tbl flm50x100mg | SFS | D | | | |
| 42461 | ATEHEXAL 100 | por tblflm100x100mg | SFS | D | | | |
| 83646 | ATEHEXAL 100 | tbl obd 30x100mg | HEX | D | | | |
| 83648 | ATEHEXAL 100 | tbl obd 100x100mg | HEX | D | | | |
| 83647 | ATEHEXAL 100 | tbl obd 50x100mg | HEX | D | | | |
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D | | | |
| 54419 | ATEBLOCOR 100 | tbl obd 30x100mg | PMP | CZ | | | |
| 83646 | ATEHEXAL 100 | tbl obd 30x100mg | HEX | D | | | |
| 96445 | COROTENOL 100 | tbl obd 30x100mg | MHA | CH | | | |
| 65389 | TENORMIN | tbl obd 28x100mg | ZNC | GB | | | |
| 153.8 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 5,12 | |
| | | | | | | | |
| 153.9 | C07AB05 | betaxolol | p.o. | 20 | MG | 5,12 | |
| | | | | | | | |
| 153.10 | C07AB07 | bisoprolol | p.o. | 10 | MG | 5,12 | |
| | | | | | | | |
| 153.11 | C07AB07 | bisoprolol do 2,5 mg v jedné tabletě včetně | p.o. | 10 | MG | 12,00 | P |
| 153.11 | C07AB07 | bisoprolol hemifumarát do 2,5 mg v jedné tabletě včetně | p.o. | 10 | MG | 13,37 | P |
| 03801 | CONCOR COR 2.5 MG | tbl obd 28x2.5mg | MEC | D | | | |
| 153.12 | C07AB07 | bisoprolol hemifumarát nad 2,5 mg v jedné tabletě | p.o. | 10 | MG | 6,00 | P |
Bisoprolol je ordinován k léčbě srdečního selhání; v dávce 2,5 mg je určen k zahájení léčby, pouze v případech, kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 2,5 mg dlouhodobě. Cílová dávka bisoprololu v této indikaci je 10 mg denně a k udržovací léčbě možno předpisovat bisoprolol v tabletách s obsahem 10 mg. V indikaci léčby hypertenze, arytmií a sekundární prevence nelze hrazeno ze zdravotního pojištění.
| 153.12 | C07AB08 | celiprolol | p.o. | 0.2 | GM | 5,12 | |
| 153.13 | C07AB08 | celiprolol | p.o. | 0.2 | GM | 5,12 | |
| 59761 | TENOLOC 200 | tbl obd 30x200mg | LEX | CZ | | | |
| 153.13 | C07AB12 | nebivolol | p.o. | 5 | MG | 5,12 | |
| 153.14 | C07AB12 | nebivolol | p.o. | 5 | MG | 5,12 | |
| 154 | C07AB | beta-blokátory, s beta-1 selektivitou | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1398,18 | O |
| | | | | | | | |
| 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 1878,19 | O |
| 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 1840,83 | O |
| 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB | | | |
| 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1398,18 | O |
| | | | | | | | |
| 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4836,19 | H |
| 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4673,10 | H |
| 58412 | BREVIBLOC 250MG/ML | inf cnc sol 1x10ml | BXT | GB | | | |
| 155 | C07AG | alfa, beta-blokátory | p.o. | L/KAR,INT | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2363,21 +2400,25 @@
| 45145 | TRANDATE | inj 5x20ml/100mg | MEH | GB | | | |
| 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 157.1 | C07CB03 | atenolol a jiná diuretika | p.o. | 1 | DF | 4,34 | |
| 157.1 | C07BB03 | atenolol a thiazidy | p.o. | 1 | DF | 4,34 | |
| 76715 | TENORETIC | tbl obd 28 | ZNC | GB | | | |
| 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,34 | |
| | | | | | | | |
| 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva | p.o. | 0.5 | DF | 0,73 | |
| 76981 | TRIMECRYTON | tbl 30(blistr) | LEX | CZ | | | |
| 157.4 | C07BB07 | bisoprolol a thiazidy | p.o. | 1 | DF | 3,71 | |
| 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva p.o. | 0.5 | DF | 0,73 | | |
| | | | | | | | |
| 157.4 | C07BB07 | bisoprolol a thiazidy p.o. | 1 | DF | 3,71 | | |
| 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 7,22 | |
| 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 6,08 | |
| 02945 | AGEN 5 | por tbl nob 30x5mg | LEX | CZ | | | |
| 03994 | NORMODIPINE 10 MG | por tbl nob 30x10mg | GED | H | | | |
| 58415 | ORCAL 5MG | tbl 30x5mg | LEK | SLO | | | |
| 58417 | ORCAL 10MG | tbl 30x10mg | LEK | SLO | | | |
| 02954 | AGEN 10 | por tbl nob 30x10mg | LEX | CZ | | | |
| 03993 | NORMODIPINE 5 MG | por tbl nob 30x5mg | GED | H | | | |
| 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 5,53 | |
| 02959 | PRESID 10 MG | tbl ret 30x10mg | IVX | CZ | | | |
| 02957 | PRESID 5 MG | tbl ret 30x5mg | IVX | CZ | | | |
| 02959 | PRESID 10 MG | tbl ret 30x10mg | IVX | CZ | | | |
| 02961 | PRESID 2.5 MG | tbl ret 30x2.5mg | IVX | CZ | | | |
| 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 5,28 | |
| | | | | | | | |
@@ -2386,16 +2427,11 @@
| 158.5 | C08CA05 | nifedipin | p.o. | 30 | MG | 1,56 | |
| | | | | | | | |
| 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,10 | |
| 65382 | NIFEHEXAL 20 RETARD | tbl obd 100x20mg | HEX | D | | | |
| 65381 | NIFEHEXAL 20 RETARD | tbl obd 50x20mg | HEX | D | | | |
| 98043 | CORINFAR 20 RETARD | drg ret 30x20mg | VAD | D | | | |
| 59937 | CORINFAR 20 RETARD | tbl ret 30x20mg | VAD | D | | | |
| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | | | |
| 158.7 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,37 | |
| 65384 | NIFEHEXAL 40 RETARD | tbl obd 50x40mg | HEX | D | | | |
| 65385 | NIFEHEXAL 40 RETARD | tbl obd 100x40mg | HEX | D | | | |
| 65383 | NIFEHEXAL 40 RETARD | tbl obd 30x40mg | HEX | D | | | |
| 158.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1 | DF | 5,53 | |
| 55910 | CORDIPIN XL | tbl ret 20x40mg | KRK | SLO | | | |
| | | | | | | | |
| 158.8 | C08CA05 | nifedipin (lékové formy s retardaci 24 hodin) | p.o. | 1 | DF | 5,53 | |
| 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO | | | |
| 53372 | NIFECARD XL 30MG | tbl obd 30x30mg | LEK | SLO | | | |
| 158.9 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 136,08 | X |
@@ -2403,11 +2439,15 @@
| 158.10 | C08CA07 | nisoldipin | p.o. | 20 | MG | 5,53 | |
| | | | | | | | |
| 158.11 | C08CA08 | nitrendipin | p.o. | 20 | MG | 5,53 | |
| 66498 | NITREPRESS 20 | tbl 50x20mg | HEX | D | | | |
| 66469 | NITREPRESS 10 | tbl 20x10mg | HEX | D | | | |
| 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO | | | |
| 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO | | | |
| 66495 | NITREPRESS 10 | tbl 50x10mg | HEX | D | | | |
| 66496 | NITREPRESS 10 | tbl 100x10mg | HEX | D | | | |
| 66497 | NITREPRESS 20 | tbl 100x20mg | HEX | D | | | |
| 66499 | NITREPRESS 20 | tbl 20x20mg | HEX | D | | | |
| 158.12 | C08CA09 | lacidipin | p.o. | 4 | MG | 7,22 | |
| 66498 | NITREPRESS 20 | tbl 50x20mg | HEX | D | | | |
| 158.12 | C08CA09 | lacidipin | p.o. | 4 | MG | 6,08 | |
| | | | | | | | |
| 158.13 | C08CA10 | nilvadipin | p.o. | 8 | MG | 5,53 | |
| | | | | | | | |
@@ -2420,160 +2460,170 @@
| | | | | | | | |
| 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3074,59 | H |
| | | | | | | | |
| 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3438,25 | X |
| 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3086,00 | X |
| 94535 | NIMOTOP S | inf 5x50ml/10mg | BAY | D | | | |
| 46475 | DILCEREN PRO INFUSIONE | inf 1x50ml/10mg | SLO | SK | | | |
| 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 160.1 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 5,00 | |
| 99306 | VERAPAMIL 80-SLOVAKOFARMA | tbl obd 30x80mg | SLO | SK | | | |
| 99305 | VERAPAMIL 40-SLOVAKOFARMA | tbl obd 30x40mg | SLO | SK | | | |
| 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D | | | |
| 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D | | | |
| 56162 | VERAHEXAL KHK RETARD | tbl ret 50x120mg | FST | D | | | |
| 56161 | VERAHEXAL KHK RETARD | tbl ret 30x120mg | FST | D | | | |
| 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D | | | |
| 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | | | |
| 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | | | |
| 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D | | | |
| 56153 | VERAHEXAL 40 | tbl obd 50x40mg | FST | D | | | |
| 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D | | | |
| 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D | | | |
| 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D | | | |
| 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D | | | |
| 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D | | | |
| 56154 | VERAHEXAL 40 | tbl obd 100x40mg | FST | D | | | |
| 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D | | | |
| 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D | | | |
| 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D | | | |
| 56154 | VERAHEXAL 40 | tbl obd 100x40mg | FST | D | | | |
| 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D | | | |
| 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D | | | |
| 56162 | VERAHEXAL KHK RETARD | tbl ret 50x120mg | FST | D | | | |
| 56153 | VERAHEXAL 40 | tbl obd 50x40mg | FST | D | | | |
| 56161 | VERAHEXAL KHK RETARD | tbl ret 30x120mg | FST | D | | | |
| 99306 | VERAPAMIL 80-SLOVAKOFARMA | tbl obd 30x80mg | SLO | SK | | | |
| 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D | | | |
| 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D | | | |
| 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | | | |
| 99305 | VERAPAMIL 40-SLOVAKOFARMA | tbl obd 30x40mg | SLO | SK | | | |
| 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | | | |
| 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D | | | |
| 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D | | | |
| 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D | | | |
| 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D | | | |
| 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 5,53 | |
| 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D | | | |
| 43879 | VEROGALID ER 240MG | tbl ret 100x240mg | GNO | CZ | | | |
| 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D | | | |
| 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D | | | |
| 93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO | | | |
| 43879 | VEROGALID ER 240MG | tbl ret 100x240mg | GNO | CZ | | | |
| 43877 | VEROGALID ER 240MG | tbl ret 30x240mg | GNO | CZ | | | |
| 56166 i | VERAHEXAL RR | tbl ret 100x240mg | FST | D | | | |
| 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,00 | |
| 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 360,71 | H |
| 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 355,24 | H |
| 09210 | LEKOPTIN | inj 50x2ml/5mg | LEK | SLO | | | |
| 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,28 | |
| 94314 | DIACORDIN 90 RETARD | tbl ret 30x90mg | LEX | CZ | | | |
| 93186 | BLOCALCIN | tbl 50x60mg | LCM | CZ | | | |
| 93711 | DIACORDIN 60 | tbl 50x60mg | LEX | CZ | | | |
| 94321 | BLOCALCIN 90 RETARD | tbl ret 30x90mg | LCM | CZ | | | |
| 93186 | BLOCALCIN 60 | por tbl nob 50x60mg | PVL | CZ | | | |
| 94321 | BLOCALCIN 90 RETARD | por tbl ret 30x90mg | PVL | CZ | | | |
| 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,53 | |
| 58752 | DIACORDIN 240 SR | cps ret 30x240mg | LEX | CZ | | | |
| 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H | | | |
| 163. | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 319,18 | H |
| 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 164.1 | C09 AA0 1 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,52 | |
| 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | | | |
| 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND | | | |
| 12150 | CAPTOPRIL AL 12.5 | tbl 100x12.5mg | APA | D | | | |
| 12149 | CAPTOPRIL AL 12.5 | tbl 50x12.5mg | APA | D | | | |
| 47282 | TENSIOMIN 12.5MG | tbl 200x12.5mg | EGI | H | | | |
| 31385 | TENSIOMIN 12.5MG | tbl 30x12.5mg | EGI | H | | | |
| 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | | | |
| 12150 | CAPTOPRIL AL 12.5 | tbl 100x12.5mg | APA | D | | | |
| 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND | | | |
| 12148 | CAPTOPRIL AL 12.5 | tbl 30x12.5mg | APA | D | | | |
| 49564 | TENSIOMIN 12.5MG | tbl 90x12.5mg | EGI | H | | | |
| 12149 | CAPTOPRIL AL 12.5 | tbl 50x12.5mg | APA | D | | | |
| 164.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,25 | |
| 68839 | APO-CAPTO 25MG | tbl 100x25mg | APT | CND | | | |
| 97873 | ALKADIL 25 MG | tbl 40x25mg | ALK | MAC | | | |
| 59379 | CAPTOPRIL 25 SVUS | tbl 30x25mg | SVS | CZ | | | |
| 59381 | CAPTOPRIL 25 SVUS | tbl 100x25mg | SVS | CZ | | | |
| 49562 | TENSIOMIN 25MG | tbl 90x25mg | EGI | H | | | |
| 47283 | TENSIOMIN 25MG | tbl 200x25mg | EGI | H | | | |
| 32251 | CAPTOPRIL AL 25 | tbl 30x25mg | APA | D | | | |
| 59380 | CAPTOPRIL 25 SVUS | tbl 50x25mg | SVS | CZ | | | |
| 59381 | CAPTOPRIL 25 SVUS | tbl 100x25mg | SVS | CZ | | | |
| 90975 | KATOPIL | tbl 40x25mg | GLN | YU | | | |
| 97873 | ALKADIL 25 MG | tbl 40x25mg | ALK | MAC | | | |
| 49562 | TENSIOMIN 25MG | tbl 90x25mg | EGI | H | | | |
| 32253 | CAPTOPRIL AL 25 | tbl 100x25mg | APA | D | | | |
| 32252 | CAPTOPRIL AL 25 | tbl 50x25mg | APA | D | | | |
| 32251 | CAPTOPRIL AL 25 | tbl 30x25mg | APA | D | | | |
| 31215 | TENSIOMIN 25MG | tbl 30x25mg | EGI | H | | | |
| 47283 | TENSIOMIN 25MG | tbl 200x25mg | EGI | H | | | |
| 68839 | APO-CAPTO 25MG | tbl 100x25mg | APT | CND | | | |
| 164.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 4,00 | |
| 31216 | TENSIOMIN 50MG | tbl 20x50mg | EGI | H | | | |
| 49563 | TENSIOMIN 50MG | tbl 90x50mg | EGI | H | | | |
| 59384 | CAPTOPRIL 50 SVUS | tbl 30x50mg | SVS | CZ | | | |
| 84143 | CAPTOPRIL AL 50 | tbl 100x50mg | APA | D | | | |
| 90976 | KATOPIL | tbl 40x50mg | GLN | YU | | | |
| 59386 | CAPTOPRIL 50 SVUS | tbl 100x50mg | SVS | CZ | | | |
| 59385 | CAPTOPRIL 50 SVUS | tbl 50x50mg | SVS | CZ | | | |
| 84142 | CAPTOPRIL AL 50 | tbl 50x50mg | APA | D | | | |
| 90976 | KATOPIL | tbl 40x50mg | GLN | YU | | | |
| 47284 | TENSIOMIN 50MG | tbl 200x50mg | EGI | H | | | |
| 59384 | CAPTOPRIL 50 SVUS | tbl 30x50mg | SVS | CZ | | | |
| 59386 | CAPTOPRIL 50 SVUS | tbl 100x50mg | SVS | CZ | | | |
| 49563 | TENSIOMIN 50MG | tbl 90x50mg | EGI | H | | | |
| 84141 | CAPTOPRIL AL 50 | tbl 30x50mg | APA | D | | | |
| 164.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 5,22 | |
| 83508 | EDNYT 5MG | tbl 100x5mg-lahv | GED | H | | | |
| 59916 | ENALAPRIL LACHEMA 5 | por tbl nob 60x5mg | PVL | CZ | | | |
| 32183 | E-COR 5 | por tbl nob 100x5mg | SLO | SK | | | |
| 32182 | E-COR 5 | por tbl nob 30x5mg | SLO | SK | | | |
| 32179 | E-COR 2.5 | por tbl nob30x2.5mg | SLO | SK | | | |
| 84514 | ACETENSIL 5MG | tbl 10x5mg | ANO | E | | | |
| 59877 | ENAPRIL 5 | tbl 30x5mg | SFS | d | | | |
| 59976 | ENAP 2.5MG | tbl 30x2.5mg | KRK | SLO | | | |
| 59878 | ENAPRIL 5 | tbl 50x5mg | SFS | D | | | |
| 30478 | ENAPIREX 5MG | tbl 28 | CHN | H | | | |
| 83507 | EDNYT 5MG | tbl 28x5mg-lahv | GED | H | | | |
| 84515 | ACETENSIL 5MG | tbl 60x5mg | ANO | E | | | |
| 59879 | ENAPRIL 5 | tbl 100x5mg | SFS | D | | | |
| 83503 | APO-ENALAPRIL 5MG | tbl 100x5mg | APQ | MEX | | | |
| 83505 | EDNYT 2.5MG | tbl 28x2.5mg | GED | H | | | |
| 45273 | ENAP 5MG | tbl 30x5mg | KRK | SLO | | | |
| 32277 | EDNYT 5 MG | tbl 100x5mg-blistr | GED | H | | | |
| 59108 | BERLIPRIL 5 | tbl 100x5mg | BCE | D | | | |
| 66067 | ENALAPRIL 2.5-sl | tbl 30x2.5mg(blis.) | SLO | SK | | | |
| 66115 | ENALAPRIL 2.5-SL | tbl 100x2.5mg(bli.) | SLO | SK | | | |
| 66148 | ENALAPRIL 5-SL | tbl 30x5mg(blistr) | SLO | SK | | | |
| 12087 | EDNYT 5 MG | tbl 30x5mg-blistr | GED | H | | | |
| 66197 | ENALAPRIL 5-SL | tbl 100x5mg(blis.) | SLO | SK | | | |
| 55637 | ENALAPRIL LACHEMA 5 | por tbl nob 100x5mg | PVL | CZ | | | |
| 59643 | ENAP 5MG | tbl 100x5mg | KRK | SLO | | | |
| 85927 | ENALAPRIL LACHEMA 5 | por tbl nob 20x5mg | PVL | CZ | | | |
| 42632 | ENAPIREX 5 MG | por tbl nob 70x5mg | CHN | H | | | |
| 06550 | ENAP 2.5MG | tbl 100x2.5mg | KRK | SLO | | | |
| 11991 | EDNYT 2.5 MG | tbl 30x2.5mg | GED | H | | | |
| 58363 | ENALAPRIL-RATIOPHARM 5 MG | tbl 30x5mg | MCK | D | | | |
| 84651 | BERLIPRIL 5 | tbl 30x5mg | BCE | D | | | |
| 66067 | ENALAPRIL 2.5-SL | tbl 30x2.5mg(blis.) | SLO | SK | | | |
| 30478 | ENAPIREX 5MG | tbl 28 | CHN | H | | | |
| 55637 | ENALAPRIL LACHEMA 5 | tbl 100x5mg | LCM | CZ | | | |
| 66115 | ENALAPRIL 2.5-SL | tbl 100x2.5mg(bli.) | SLO | SK | | | |
| 32183 | E-COR 5 | por tbl nob 100x5mg | SLO | SK | | | |
| 83503 | APO-ENALAPRIL 5MG | tbl 100x5mg | APQ | MEX | | | |
| 06550 | ENAP 2.5MG | tbl 100x2.5mg | KRK | SLO | | | |
| 66197 | ENALAPRIL 5-SL | tbl 100x5mg(blis.) | SLO | SK | | | |
| 66148 | ENALAPRIL 5-SL | tbl 30x5mg(blistr) | SLO | SK | | | |
| 84515 | ACETENSIL 5MG | tbl 60x5mg | ANO | E | | | |
| 32179 | E-COR 2.5 | por tbl nob30x2.5mg | SLO | SK | | | |
| 32182 | E-COR 5 | por tbl nob 30x5mg | SLO | SK | | | |
| 83508 | EDNYT 5MG | tbl 100x5mg-lahv | GED | H | | | |
| 32277 | EDNYT 5 MG | tbl 100x5mg-blistr | GED | H | | | |
| 59916 | ENALAPRIL LACHEMA 5 | tbl 60x5mg | LCM | CZ | | | |
| 59879 | ENAPRIL 5 | tbl 100x5mg | SFS | D | | | |
| 59108 | BERLIPRIL 5 | tbl 100x5mg | BCE | D | | | |
| 85927 | ENALAPRIL LACHEMA 5 | tbl 20x5mg | LCM | CZ | | | |
| 59643 | ENAP 5MG | tbl 100x5mg | KRK | SLO | | | |
| 59878 | ENAPRIL 5 | tbl 50x5mg | SFS | D | | | |
| 59877 | ENAPRIL 5 | tbl 30x5mg | SFS | D | | | |
| 59976 | ENAP 2.5MG | tbl 30x2.5mg | KRK | SLO | | | |
| 164.5 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 4,12 | |
| 30479 | ENAPIREX 10MG | tbl 28 | CHN | H | | | |
| 59880 | ENAPRIL 10 | tbl 30x10mg | SFS | D | | | |
| 92576 | ENALAPRIL LACHEMA 10 | tbl 20x10mg | LCM | CZ | | | |
| 59642 | ENAP 10MG | tbl 100x10mg | KRK | SLO | | | |
| 59882 | ENAPRIL 10 | tbl 100x10mg | SFS | D | | | |
| 59881 | ENAPRIL 10 | tbl 50x10mg | SFS | D | | | |
| 59917 | ENALAPRIL LACHEMA 10 | por tbl nob 60x10mg | PVL | CZ | | | |
| 83509 | EDNYT 10MG | tbl 28x10mg-lahv | GED | H | | | |
| 92576 | ENALAPRIL LACHEMA 10 | por tbl nob 20x10mg | PVL | CZ | | | |
| 58367 | ENALAPRIL-RATIOPHARM 10 MG | tbl 50x10mg | MCK | D | | | |
| 45274 | ENAP 10MG | tbl 30x10mg | KRK | SLO | | | |
| 42636 | ENAPIREX 10 MG | por tbl nob 70x10mg | CHN | H | | | |
| 64839 | APO-ENALAPRIL 10MG | tbl 100x10mg | APQ | MEX | | | |
| 59881 | ENAPRIL 10 | tbl 50x10mg | SFS | D | | | |
| 58052 | ENALAPRIL 10-SL | tbl 100x10mg(blis.) | SLO | SK | | | |
| 58366 | ENALAPRIL-RATIOPHARM 10 MG | tbl 30x10mg | MCK | D | | | |
| 83510 | EDNYT 10MG | tbl 100x10mg-lahv | GED | H | | | |
| 58055 | ENALAPRIL 10-SL | tbl 30x10mg(blistr) | SLO | SK | | | |
| 32276 | EDNYT 10 MG | tbl 100x10mg-blistr | GED | H | | | |
| 55638 | ENALAPRIL LACHEMA 10 | por tbl nob100x10mg | PVL | CZ | | | |
| 32186 | E-COR 10 | por tblnob100x10mg | SLO | SK | | | |
| 32185 | E-COR 10 | por tbl nob 30x10mg | SLO | SK | | | |
| 59642 | ENAP 10MG | tbl 100x10mg | KRK | SLO | | | |
| 32276 | EDNYT 10 MG | tbl 100x10mg-blistr | GED | H | | | |
| 58055 | ENALAPRIL 10-SL | tbl 30x10mg(blistr) | SLO | SK | | | |
| 58052 | ENALAPRIL 10-SL | tbl 100x10mg(blis.) | SLO | SK | | | |
| 83510 | EDNYT 10MG | tbl 100x10mg-lahv | GED | H | | | |
| 59882 | ENAPRIL 10 | tbl 100x10mg | SFS | D | | | |
| 59917 | ENALAPRIL LACHEMA 10 | tbl 60x10mg | LCM | CZ | | | |
| 45274 | ENAP 10MG | tbl 30x10mg | KRK | SLO | | | |
| 30479 | ENAPIREX 10MG | tbl 28 | CHN | H | | | |
| 55638 | ENALAPRIL LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | |
| 12156 | EDNYT 10 MG | tbl 30x10mg-blistr | GED | H | | | |
| 164.6 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 3,00 | |
| 59883 | ENAPRIL 20 | tbl 30x20mg | SFS | D | | | |
| 59884 | ENAPRIL 20 | tbl 50x20mg | SFS | D | | | |
| 59885 | ENAPRIL 20 | tbl 100x20mg | SFS | D | | | |
| 45275 | ENAP 20MG | tbl 30x20mg | KRK | SLO | | | |
| 58061 | ENALAPRIL 20-SL | tbl 30x20mg(blistr) | SLO | SK | | | |
| 59918 | ENALAPRIL LACHEMA 20 | por tbl nob 60x20mg | PVL | CZ | | | |
| 84516 | ACETENSIL 20MG | tbl 28x20mg | ANO | E | | | |
| 30480 | ENAPIREX 20MG | tbl 28 | CHN | H | | | |
| 83511 | EDNYT 20MG | tbl 28x20mg | GED | H | | | |
| 32188 | E-COR 20 | por tbl nob 30x20mg | SLO | SK | | | |
| 58369 | ENALAPRIL-RATIOPHARM 20 MG | tbl 30x20mg | MCK | D | | | |
| 32189 | E-COR 20 | por tblnob100x20mg | SLO | SK | | | |
| 85928 | ENALAPRIL LACHEMA 20 | por tbl nob 20x20mg | PVL | CZ | | | |
| 64840 | APO-ENALAPRIL 20MG | tbl 100x20mg | APQ | MEX | | | |
| 59641 | ENAP 20MG | tbl 100x20mg | KRK | SLO | | | |
| 12212 | EDNYT 20 MG | tbl 30x20mg | GED | H | | | |
| 64840 | APO-ENALAPRIL 20MG | tbl 100x20mg | APQ | MEX | | | |
| 83511 | EDNYT 20MG | tbl 28x20mg | GED | H | | | |
| 59641 | ENAP 20MG | tbl 100x20mg | KRK | SLO | | | |
| 85928 | ENALAPRIL LACHEMA 20 | tbl 20x20mg | LCM | CZ | | | |
| 84516 | ACETENSIL 20MG | tbl 28x20mg | ANO | E | | | |
| 58061 | ENALAPRIL 20-SL | tbl 30x20mg(blistr) | SLO | SK | | | |
| 30480 | ENAPIREX 20MG | tbl 28 | CHN | H | | | |
| 55639 | ENALAPRIL LACHEMA 20 | tbl 100x20mg | LCM | CZ | | | |
| 59885 | ENAPRIL 20 | tbl 100x20mg | SFS | D | | | |
| 59884 | ENAPRIL 20 | tbl 50x20mg | SFS | D | | | |
| 59883 | ENAPRIL 20 | tbl 30x20mg | SFS | D | | | |
| 164.7 | C09AA03 | lisinopril | p.o. | 10 | MG | 6,26 | |
| 32503 | DAPRIL 10 | por tbl nob100x10mg | MOE | CY | | | |
| 53641 | DIROTON 5MG | tbl 28x5mg | GED | H | | | |
| 53642 | DIROTON 10MG | tbl 28x10mg | GED | H | | | |
| 53643 | DIROTON 20MG | tbl 28x20mg | GED | H | | | |
| 32500 | DAPRIL 5 | por tbl nob 60x5mg | MOE | CY | | | |
| 32502 | DAPRIL 10 | por tbl nob 60x10mg | MOE | CY | | | |
| 02930 | DIROTON 2.5MG | por tbl nob28x2.5mg | GED | H | | | |
| 11006 | DIROTON 10 MG | tbl 100x10mg | GED | H | | | |
| 67562 | DAPRIL 10 | tbl 30x10mg | MOE | CY | | | |
| 67561 | DAPRIL 5 | tbl 30x5mg | MOE | CY | | | |
| 32504 | DAPRIL 20 | por tbl nob 30x20mg | MOE | CY | | | |
| 32505 | DAPRIL 20 | por tbl nob 60x20mg | MOE | CY | | | |
| 67563 | DAPRIL 20 | tbl 20x20mg | MOE | CY | | | |
| 67561 | DAPRIL 5 | tbl 30x5mg | MOE | CY | | | |
| 67562 | DAPRIL 10 | tbl 30x10mg | MOE | CY | | | |
| 53643 | DIROTON 20MG | tbl 28x20mg | GED | H | | | |
| 53642 | DIROTON 10MG | tbl 28x10mg | GED | H | | | |
| 02526 | LISTRIL 2.5 | tbl 30x2.5mg | TRT | IND | | | |
| 02561 | LISTRIL 10 | tbl 30x10mg | TRT | IND | | | |
| 84060 | LISTRIL 10 | tbl 100x10mg | TRT | IND | | | |
| 84058 | LISTRIL 2.5 | tbl 100x2.5mg | TRT | IND | | | |
| 84059 | LISTRIL 5 | tbl 100x5mg | TRT | IND | | | |
| 02560 | LISTRIL 5 | tbl 30x5mg | TRT | IND | | | |
| 11006 | DIROTON 10 MG | tbl 100x10mg | GED | H | | | |
| 32501 | DAPRIL 5 | por tbl nob100x5mg | MOE | CY | | | |
| 164.8 | C09AA04 | perindopril | p.o. | 4 | MG | 6,90 | |
| | | | | | | | |
| 164.9 | C09AA05 | ramipril do 2,5 mg v jedné tabletě včetně | p.o. | 2.5 | MG | 6,90 | |
@@ -2585,6 +2635,7 @@
| 164.12 | C09AA06 | quinapril nad 15 mg v jedné tabletě | p.o. | 15 | MG | 6,60 | |
| | | | | | | | |
| 164.13 | C09AA07 | benazepril | p.o. | 7.5 | MG | 6,90 | |
| | | | | | | | |
| 164.14 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 6,90 | |
| | | | | | | | |
| 164.15 | C09AA09 | fosinopril | p.o. | 1 | DF | 6,90 | |
@@ -2603,15 +2654,15 @@
| 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 4,78 | |
| 53248 | CAPTOHEXAL COMP.50/25 | tbl 50x50mg/25mg | SFS | D | | | |
| 53251 | CAPTOHEXAL COMP.25/12.5 | tbl 50x25mg/12.5mg | SFS | D | | | |
| 53252 | CAPTOHEXAL COMP.25/12.5 | tbl 100x25mg/12.5mg | SFS | D | | | |
| 53246 | CAPTOHEXAL COMP.50/25 | tbl 20x50mg/25mg | SFS | D | | | |
| 53243 | CAPTOHEXAL COMP.25/25 | tbl 50x25mg/25mg | SFS | D | | | |
| 53242 | CAPTOHEXAL COMP.25/25 | tbl 20x25mg/25mg | SFS | D | | | |
| 53243 | CAPTOHEXAL COMP.25/25 | tbl 50x25mg/25mg | SFS | D | | | |
| 53251 | CAPTOHEXAL COMP.25/12.5 | tbl 50x25mg/12.5mg | SFS | D | | | |
| 53245 | CAPTOHEXAL COMP.25/25 | tbl 100x25mg/25mg | SFS | D | | | |
| 53250 | CAPTOHEXAL COMP.25/12.5 | tbl 20x25mg/12.5mg | SFS | D | | | |
| 53249 | CAPTOHEXAL COMP.50/25 | tbl 100x50mg/25mg | SFS | D | | | |
| 53248 | CAPTOHEXAL COMP.50/25 | tbl 50x50mg/25mg | SFS | D | | | |
| 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 5,02 | |
| 66506 | ENAP-H | tbl 30 | KRK | SLO | | | |
| 55429 | ENAP-HL | tbl 30 | KRK | SLO | | | |
@@ -2628,20 +2679,27 @@
| | | | | | | | |
| 167.2 | C09CA02 | eprosartan | p.o. | 600 | MG | 21,24 | Z |
| | | | | | | | |
| 167.3 | C09CA03 | valsartan | p.o. | 80 | MG | 21,24 | Z |
| | | | | | | | |
| 167.4 | C09CA04 | irbesartan | p.o. | 150 | MG | 21,24 | Z |
| | | | | | | | |
| 167.5 | C09CA06 | kandesartan | p.o. | 8 | MG | 21,24 | Z |
| 53389 | ATACAND 16MG | tbl 28x16mg | APN | S | | | |
| 167.6 | C09CA07 | telmisartan | p.o. | 40 | MG | 21,24 | Z |
| | | | | | | | |
| 167.7 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 21,69 | Z |
| | | | | | | | |
| 167.8 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 8 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 21,69 | Z |
| | | | | | | | |
| 167.9 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 16 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 42,93 | Z |
| 58068 | ATACAND PLUS 16+12.5 MG | tbl 100 (lekovka) | AZC | S | | | |
| 167.3 | C09CA03 | valsartan do 80 mg v jedné tabletě včetně | p.o. | 80 | MG | 21,24 | Z |
| | | | | | | | |
| 167.4 | C09CA03 | valsartan nad 80 mg v jedné tabletě | p.o. | 80 | MG | 20,18 | Z |
| | | | | | | | |
| 167.5 | C09CA04 | irbesartan do 150 mg v jedné tabletě včetně | p.o. | 150 | MG | 21,24 | Z |
| | | | | | | | |
| 167.6 | C09CA04 | irbesartan nad 150 mg v jedné tabletě | p.o. | 150 | MG | 20,18 | Z |
| | | | | | | | |
| 167.7 | C09CA06 | kandesartan do 8 mg v jedné tabletě včetně | p.o. | 8 | MG | 21,24 | Z |
| | | | | | | | |
| 167.8 | C09CA06 | kandesartan nad 8 mg v jedné tabletě | p.o. | 8 | MG | 20,18 | Z |
| | | | | | | | |
| 167.9 | C09CA07 | telmisartan do 40 mg v jedné tabletě včetně | p.o. | 40 | MG | 21,24 | Z |
| | | | | | | | |
| 167.10 | C09CA07 | telmisartan nad 40 mg v jedné tabletě | p.o. | 40 | MG | 20,18 | Z |
| 64050 | MICARDIS 80MG | tbl 28x80mg | BGP | D | | | |
| 167.11 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 21,69 | Z |
| | | | | | | | |
| 167.12 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 8 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 21,69 | Z |
| | | | | | | | |
| 167.13 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 16 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 40,79 | Z |
| 168 | C10AA | hypolipidemika ze skupiny statinů | p.o. | P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2649,85 +2707,75 @@
Léčbu atorvastatinem, cerivastatinem, fluvastatinem a pravastatinem ordinuje kardiolog, internista, diabetolog nebo lékař pracující v poradnách pro poruchy metabolizmu lipidů:
- a) léčba nemocných s familiární hypercholesterolémií
- a) léčba nemocných s familiární hypercholesterolémií (atorvastatin v dávce 40mg denně je hrazen pouze v léčbě nemocných s isolovanou familiární hypercholesterolemi)
- b) léčba nemocných s manifestní aterosklerózou (sekundární prevence) s izolovanou hypercholesterolémií nebo s kombinovanou hyperlipidémií s převahou hypercholesterolémie
- c) léčba nemocných s kumulací rizikových faktorů (s vysokým rizikem kardiovaskulární příhody vyjádřeným absolutním desetiletým rizikem 20% a více ) s izolovanou hypercholesterolémií či s kombinovanou hyperlipidémií s převahou hypercholesterolémie
| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
| 10398 | SIMIREX 10 MG | por tbl flm 50x10mg | SYH | E | | | |
| 58773 | SIMVACARD 10 | tbl obd 28x10mg | LEX | CZ | | | |
| 58136 | VASILIP 10 | tbl obd 28x10mg | KRK | SLO | | | |
| 59727 | SIMGAL 10MG | tbl obd 28x10mg | GNO | CZ | | | |
| 59727 | SIMGAL 10MG | tbl obd 28x10mg | IVX | CZ | | | |
| 10390 | SIMIREX 10 MG | por tbl flm 30x10mg | SYH | E | | | |
| 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND | | | |
| 58773 | SI MVACARD 10 | tbl obd 28x10mg | LEX | CZ | | | |
| 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
| 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 16,80 | P |
| 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO | | | |
| 58775 | SIMVARD 20 | tbl obd 28x20mg | LEX | CZ | | | |
| 03248 | LIPART 20 MG | por tbl flm 30x20mg | LEK | SLO | | | |
| 10434 | SIMIREX 20 MG | por tbl flm 50x20mg | SYH | E | | | |
| 10422 | SIMIREX 20 MG | por tbl flm 30x20mg | SYH | E | | | |
| 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO | | | |
| 59728 | SIMGAL 20MG | tbl obd 28x20mg | IVX | CZ | | | |
| 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND | | | |
| 58775 | SI MVACARD 20 | tbl obd 28x20mg | LEX | CZ | | | |
| 168.3 | C10AA01 | simvastatin (nad 20 mg do 40mg v jedné tabletě včetně) | p.o. | 1 | DF | 32,56 | P |
| 58777 | SIMVACARD 40 | tbl obd 28x40mg | LEX | CZ | | | |
| 10466 | SIMIREX 40 MG | por tbl flm 50x40mg | SYH | E | | | |
| 10459 | SIMIREX 40 MG | por tbl flm 30x40mg | SYH | E | | | |
| 59729 | SIMGAL 40MG | tbl obd 28x40mg | IVX | CZ | | | |
| 03250 | LIPART 40 MG | por tbl flm 30x40mg | LEK | SLO | | | |
| 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | | | |
| 168.4 | C10AA01 | simvastatin (nad 40 mg v jedné tabletě) | p.o. | 1 | DF | 53,70 | P |
| | | | | | | | |
| 168.5 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
| 168.3 | C10AA01 | simvastatin (nad 20 mg do 40mg v jedné tabletě včetně) | p.o. | 1 | DF | 26,90 | P |
| 03250 | LIPART 40 MG | por tbl flm 30x40mg | lek | SLO | | | |
| 58777 | SIMVACARD 40 | tbl obd 28x40mg | lex | CZ | | | |
| 168.4 | C10AA01 | simvastatin (nad 40 mg v jedné tabletě) | p.o. | 1 | DF | 43,00 | P |
| | | | | | | | |
| 168.5 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 9,50 | P |
| 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND | | | |
| 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO | | | |
| 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND | | | |
| 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY | | | |
| 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY | | | |
| 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO | | | |
| 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND | | | |
| 168.6 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
| 168.6 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1 | DF | 15,20 | P |
| 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND | | | |
| 01254 | APO-LOVASTATIN 40 | tbl 30x40mg | APT | CND | | | |
| 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND | | | |
| 168.7 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
| | | | | | | | |
| 168.8 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
| | | | | | | | |
| 168.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě ) | p.o. | 1 | DF | 25,90 | P |
| 168.8 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 16,80 | P |
| | | | | | | | |
| 168.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě ) | p.o. | 1 | DF | 26,90 | P |
| | | | | | | | |
| 168.10 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P |
| | | | | | | | |
| 168.11 | C10AA04 | fluvastatin (nad 20 mg do 40 mgv jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P |
| | | | | | | | |
| 168.12 | C10AA04 | fluvastatin (nad 40 MGv jedné tabletě ) | p.o. | 1 | DF | 30,52 | P |
| | | | | | | | |
| 168.13 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 25,90 | P |
| | | | | | | | |
| 168.14 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1 | DF | 42,73 | P |
| | | | | | | | |
| 168.15 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1 | DF | 70,50 | P |
| | | | | | | | |
| 168.16 | C10AA06 | cerivastatin (do 0,10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 10,50 | P |
| | | | | | | | |
| 168.17 | C10AA06 | cerivastatin (nad 0,10 do 0,20 MG včetně v jedné tabletě) | p.o. | 1 | DF | 19,55 | P |
| | | | | | | | |
| 168.18 | C10AA06 | cerivastatin (nad 0,20 MG v jedné tabletědo 0,30 MG v jedné tabletě včetně) | p.o. | 1 | DF | 25,90 | P |
| | | | | | | | |
| 168.19 | C10AA06 | cerivastatin ( nad 0,30 MG v jedné tabletě ) | p.o. | 1 | DF | 31,60 | P |
| 168.11 | C10AA04 | fluvastatin (nad 20 mg do 40 mgv jedné tabletě včetně) | p.o. | 1 | DF | 16,80 | P |
| | | | | | | | |
| 168.12 | C10AA04 | fluvastatin (nad 40 MGv jedné tabletě ) | p.o. | 1 | DF | 32,17 | P |
| | | | | | | | |
| 168.13 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 22,50 | P |
| | | | | | | | |
| 168.14 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1 | DF | 36,00 | P |
| | | | | | | | |
| 168.15 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1 | DF | 57,60 | P |
| 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 169.1 | C10AB | etofylin klofibrát | p.o. | 0.5 | GM | 4,79 | |
| 49609 | DUOLIP FORTE | tbl obd 100x500mg | MCK | A | | | |
| 96357 | DUOLIP FORTE 500 | tbl 30x500mg | MCK | A | | | |
| 49608 | DUOLIP FORTE | tbl obd 30x500mg | MCK | A | | | |
| 96992 | DUOLIP FORTE 500 | tbl 100x500mg | MCK | A | | | |
| 49609 | DUOLIP FORTE | tbl obd 100x500mg | MCK | A | | | |
| 49608 | DUOLIP FORTE | tbl obd 30x500mg | MCK | A | | | |
| 96357 | DUOLIP FORTE 500 | tbl 30x500mg | MCK | A | | | |
| 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 6,80 | |
| | | | | | | | |
| 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 6,80 | |
| | | | | | | | |
| 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 6,80 | |
| | | | | | | | |
| 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1 | DF | 8,50 | |
| 169.6 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 8,50 | |
| | | | | | | | |
| 169.7 | C10AD06 | acipimox | p.o. | 500 | MG | 11,73 | |
| 41797 | LIPIREX 200MG | por cps dur60x200mg | SGY | B | | | |
| 04143 | APO-FENO | por cpsdur 30x200mg | APT | CND | | | |
| 56460 | LIPIREX 200MG | cps 30x200mg | SGY | B | | | |
| 04145 | APO-FENO | por cpsdur100x200mg | APT | CND | | | |
| 169.6 | C10AB05 | fenofibrát (supramikroniso- vané lékové formy) | p.o. | 1 | DF | 9,50 | |
| | | | | | | | |
| 169.7 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 8,50 | |
| | | | | | | | |
| 169.8 | C10AD06 | acipimox | p.o. | 500 | MG | 11,73 | |
| 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2738,59 +2786,57 @@
- b) léčba pacientů s pruritem při biliární cirhóze.
| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 31,09 | P |
| 94031 | VASOSAN P | plv 1x400gm | FOP | D | | | |
| 94033 | VASOSAN S | plv 1x400gm | FOP | D | | | |
| | | | | | | | |
| 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 59,39 | P |
| 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,54 | |
| 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | | | | |
| 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,66 | |
| 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ | | | |
| 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 1,96 | |
| 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 172.1 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1 | GM | 1,96 | |
| I 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D | | | |
| 86262 i | CANESTEN | crm 1x20gm | LEX | CZ | | | |
| 172.2 | D01AC01 | klotrimazol nad 20 g | lok. | 1 | GM | 1,65 | |
| 172.1 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1 | GM | 1,83 | |
| 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D | | | |
| 172.2 | D01AC01 | klotrimazol nad 20 g | lok. | 1 | GM | 1,57 | |
| 86397 | CLOTRIMAZOL AL 1% | crm 1x50gm 1% | APA | D | | | |
| 172.3 | D01AC01 | klotrimazol tekuté lékové formy | lok. | 1 | GM | 2,54 | |
| | | | | | | | |
| 172.4 | D01AC02 | mikonazol | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 172.5 | D01AC03 | ekonazol lékové formy krému | lok. | 1 | GM | 1,96 | |
| 172.4 | D01AC02 | mikonazol | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.5 | D01AC03 | ekonazol lékové formy krému | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.6 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1 | GM | 3,52 | |
| | | | | | | | |
| 172.7 | D01AC05 | isokonazol | lok. | 1 | ML | 1,96 | |
| | | | | | | | |
| 172.8 | D01AC08 | ketokonazol | lok. | 1 | GM | 1,96 | |
| 172.7 | D01AC05 | isokonazol | lok. | 1 | ML | 1,83 | |
| | | | | | | | |
| 172.8 | D01AC08 | ketokonazol | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.9 | D01AC10 | bifonazol | lok. | 1 | GM | 2,49 | |
| | | | | | | | |
| 172.10 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,49 | |
| 99248 | MYFUNGAR | crm 1x30gm | LEX | CZ | | | |
| 172.11 | D01AC12 | fenticonazol | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 172.11 | D01AC12 | feriticonazol | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.12 | D01AC16 | flutrimazol, lékové forma krém a spray | lok. | 1 | GM | 4,70 | |
| | | | | | | | |
| 172.13 | D01AC16 | flutrimazol, lékové forma gelu | lok. | 1 | GM | 3,06 | |
| 53904 | MICETAL | gel 1x100gm 1% | MCI | CZ | | | |
| | | | | | | | |
| 172.14 | D01AC14 | sertakonazol | lok. | 1 | GM | 2,49 | |
| | | | | | | | |
| 172.15 | D01AC20 | kombinace | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 172.16 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 1,96 | |
| 172.15 | D01AC20 | kombinace | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.16 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.17 | D01AC60 | bifonazol, kombinace | lok. | 1 | GM | 29,33 | P |
Léčbu ordinuje dermatolog u onychomykóz, doložených kultivačním vyšetřením a dokladovanou kontraindikací k použití systémové antimykotické terapie.
| 173 | D01AE | antimykotika pro lokální podáni ostatních skupin | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 173.1 | D01AE | jiná antimykotika k zevnímu použití (nitroethanoldodecylsulfonat) | lok. | 1 | ML | 0,83 | |
| 173 | D01AE | antimykotika pro lokální podání ostatních skupin | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 173.1 | D01AE | jiná antimykotika k zevnímu použití | lok. | 1 | ML | 0,78 | |
| 00799 | NITROFUNGIN | liq 1x25ml | GNO | CZ | | | |
| 173.2 | D01AE04 | kyselina undecylenová | lok. | 1 | GM | 0,93 | |
| 00871 | MYKOSEPTIN | ung 1x30gm | LEX | CZ | | | |
| | | | | | | | |
| 173.3 | D01AE14 | ciclopirox | lok. | 1 | GM | 3,91 | |
| 76152 | BATRAFEN | liq 1x20ml | HBS | SK | | | |
| 76150 | BATRAFEN | crm 1x20gm | HBS | SK | | | |
@@ -2798,11 +2844,11 @@
| | | | | | | | |
| 173.5 | D01AE16 | amorolfin | lok. | 1 | GM | 3,91 | |
| | | | | | | | |
| 173.6 | D01AE18 | tolnaftat | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 173.7 | D01AE19 | tolciklát | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1 | GM | 1,96 | |
| 173.6 | D01AE18 | tolnaftat | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 173.7 | D01AE19 | tolciklát | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 173.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1 | GM | 0,64 | |
| | | | | | | | |
@@ -2815,7 +2861,7 @@
Léčbu terbinafinem ordinuje dermatolog:
- a) těžké formy dermatomykóz vyvonalých dermatofyty na základě kultivačního nebo mikroskopického vyšetření
- a) těžké formy dermatomykóz vyvonalých dermatofyty na základě kultivačního nebo mikroskopického vyšetřeni
- b) těžké formy nehtových mykóz, platí-li alespoň jedna z následujících podmínek:
@@ -2827,11 +2873,14 @@
Podmínkou zahájení léčby ad b) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.
| 10144 | TERBISIL KID | por tblnob 14x125mg | GED | H | | | |
| 30769 | ONYCHON 250 | tbl 14x250mg lah | LEX | CZ | | | |
| 58430 | ONYCHON 250 | tbl 14x250mg bli | LEX | CZ | | | |
| 30769 | ONYCHON 250 | tbl 14x250mg lah | LEX | CZ | | | |
| 10147 | TERBISIL 250 MG | por tblnob 14x250mg | GED | H | | | |
| 10148 | TERBISIL 250 MG | por tblnob 28x250mg | GED | H | | | |
| 175 | D02AB | emolliencia obsahující oxid zinečnatý | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,78 | |
| 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,56 | |
| 54249 | SUSPENSIO ZINCI OXYDATI HERBAC. | sus 1x100gm | HEO | CZ | | | |
| 88780 | SUSPENSIO ZINCI OXYD.CSL4 PROF. | sus 1x100gm | PSR | CZ | | | |
| 176 | D02AC | emolliencia obsahující měkký parafin a tukové produkty | lok. | L/DER,PDD | | | |
@@ -2861,7 +2910,7 @@
| | | | | | | | |
| 177.5 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy gelu) | lok. | 1 | GM | 1,42 | |
| | | | | | | | |
| 177.6 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | 1 | ML | 3,91 | |
| 177.6 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | | ML | 3,91 | |
| | | | | | | | |
| 177.7 | D03AX02 | dextranomer | lok. | 1 | GM | 3,91 | |
| 178 | D03BA | proteolytické enzymy | lok. | P | | | |
@@ -2875,13 +2924,13 @@
- c) ošetřování nekrotických ran a dekubitů.
| 178.1 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1 | GM | 79,28 | P |
| 178.1 | D03BA proteolytické enzymy (chymotrypsin) | lok. | 1 | GM | 79,28 | P | |
| | | | | | | | |
| 178.2 | D03BA | proteolytické enzymy (kolagenáza - do 10 GM v jednom balení včetně) | lok. | 1 | GM | 18,57 | P |
| | | | | | | | |
| 178.3 | D03BA | proteolytické enzymy (plasmin/ deoxiribonukleáza) | lok. | 1 | GM | 13,69 | P |
| | | | | | | | |
| 178.4 | D03BA | proteolytické enzymy (trypsin/ chymotrypsin) | lok. | 1 | GM | 28,84 | P |
| 178.3 | D03BA | proteolytické enzymy (plasmin/deoxiribonukleáza) | lok. | 1 | GM | 13,46 | P |
| | | | | | | | |
| 178.4 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1 | GM | 28,84 | P |
| | | | | | | | |
| 178.5 | D03BA | proteolytické enzymy (kolagenáza - nad 10 GM v jednom balení) | lok. | 1 | GM | 16,62 | P |
| | | | | | | | |
@@ -2896,17 +2945,17 @@
- b) v ostatních případech pouze po schválení revizním lékařem zdravotní pojišťovny.
| 179.1 | D05AA | dehty | lok. | 1 | GM | 0,73 | |
| 66502 | ICHTOXYL | ung 1x30gm | HEO | CZ | | | |
| 55290 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1x100gm | MVM | CZ | | | |
| 85950 | SUSPENSIO VISNEVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ | | | |
| 66502 | ICHTOXYL | ung 1x30gm | HEO | CZ | | | |
| 66262 | SALOXYL | ung 1x30gm | HEO | CZ | | | |
| 55290 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1x100gm | MVM | CZ | | | |
| 179.2 | D05AA | dehty (odbarvený dehet) | lok. | 1 | GM | 1,17 | |
| | | | | | | | |
| 179.3 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1 | ML | 4,30 | |
| 179.3 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1 | ML | 4,15 | |
| 90618 | OXSORALEN | liq 1x50ml 0.15% | GER | A | | | |
| 179.4 | D05AC01 | dithranol | lok. | 1 | GM | 3,91 | |
| | | | | | | | |
| 179.5 | D05AX02 | kalcipothol | lok. | 1 | GM | 9,00 | P |
| 179.5 | D05AX02 | kalcipotriol | lok. | 1 | GM | 9,00 | P |
| | | | | | | | |
| 179.6 | D05AX04 | tacalcitol | lok. | 1 | GM | 18,00 | P |
| | | | | | | | |
@@ -2926,21 +2975,21 @@
| | | | | | | | |
| 180.2 | D05BB02 | acitretin | p.o. | 35 | MG | 81,14 | P |
| | | | | | | | |
| 180.3 | D05BA02 | methoxalen | p.o. | 10 | MG | 4,06 | L/DER |
| 180.3 | D05BA02 | methoxalen | p.o. | 10 | MG | 3,90 | L/DER |
| 03733 | OXSORALEN | cps 50x10mg | GER | A | | | |
| 181 | D06AX | antibiotika k zevnímu použiti | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 181.1 | D06AA | tetracyklin a deriváty | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 181.2 | D06AX | neomycin/bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,91 | |
| 55759 | PAMYCON NA PRIPRAVU KAPEK | plv 1x1lahv | BTA | SK | | | |
| 55762 | PAMYCON NA PRIPRAVU STER.ROZT. | plv 10x1lahv. | BTA | SK | | | |
| 181.2 | D06AX | neomycin/ bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,91 | |
| 55762 | PAMYCON NA PRIPRAVU STER.ROZT. | plv 10x1lahv. | | BTA | SK | | |
| 55759 | PAMYCON NA PRIPRAVU KAPEK | plv 1x1lahv | | BTA | SK | | |
| 181.3 | D06AX | neomycin/ bacitracin (zásyp do 2 g včetně) | lok. | 1 | GM | 13,69 | |
| | | | | | | | |
| 181.4 | D06AX | neomycin/ bacitracin (zásyp nad 2 do 5 g v jednom balení včetně) | lok. | 1 | GM | 7,63 | |
| | | | | | | | |
| 181.5 | D06AX | neomycin/ bacitracin (mast) | lok. | 1 | GM | 2,93 | |
| 01066 | FRAMYKOIN | ung 1x10gm | LEX | CZ | | | |
| | | | | | | | |
| 181.6 | D06AX | primycin | lok. | 1 | GM | 2,44 | |
| | | | | | | | |
| 181.7 | D06AX02 | chloramfenikol | lok. | 1 | GM | 2,88 | |
@@ -2964,60 +3013,61 @@
| 00899 | SULFATHIAZOL NEO-SLOVAKOFARMA | ung 1x20gm 5% | SLO | SK | | | |
| 182.6 | D06BA03 | mafenid | lok. | 1 | GM | 0,98 | L/DER,CHI |
| | | | | | | | |
| 182.7 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma náplasti) | lok. | 100 | CM2 | 13,49 | L/DER,CHI |
| 182.7 | D06BA51 | sulfadlazin stříbrný v kombinaci (léková forma náplasti) | lok. | 100 | CM2 | 13,49 | L/DER,CHI |
| | | | | | | | |
| 182.8 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma krému) | lok. | 1 | GM | 2,25 | L/DER,CHI |
| | | | | | | | |
| 182.9 | D06BX01 | metronidazol | lok. | 1 | GM | 2,25 | L/DER,CHI |
| 183 | D07AA | kortikosteroidy třídy I, slabě účinné | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 3,16 | |
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 3,31 | |
| 00858 | HYDROCORTISON LECIVA | ung 1x10gm 1% | LEX | CZ | | | |
| 183.2 | D07AA03 | Prednisolon | lok. | 1 | GM | 3,32 | |
| 184 | D07AB | kortokosteroidy třídy II, středně účinné | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,32 | |
| | | | | | | | |
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,32 | |
| 62047 | LOCOID LIPOCREAM | crm 1x30gm 0.1% | YEU | NL | | | |
| 09310 | LOCOID 0.1% | ung 1x30gm 0.1% | YEU | NL | | | |
| 09305 | LOCOID 0.1% | crm 1x30gm 0.1% | YEU | NL | | | |
| 09307 | LOCOID 0.1% LOTION | lot 1x30ml | YEU | NL | | | |
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,32 | |
| | | | | | | | |
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,32 | |
| | | | | | | | |
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,44 | |
| 183.2 | d07aa03 | prednisolon | lok. | 1 | GM | 3,18 | |
| 184 | D07AB | kortikosteroidy třídy II, středně účinné | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,18 | |
| | | | | | | | |
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,18 | |
| 09305 | LOCOID 0,1% | crm 1x30gm 0.1% | YEU | NL | | | |
| 09307 | LOCOID 0,1% LOTION | lot 1x30ml | YEU | NL | | | |
| 09310 | LOCOID 0,1% | ung 1x10gm 0.1% | YEU | NL | | | |
| 26047 | LOCOID LIPOCREAM | crm 1x30gm 0.1% | YEU | NL | | | |
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,18 | |
| | | | | | | | |
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,18 | |
| | | | | | | | |
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,55 | |
| 02828 | TRIAMCINOLON LECIVA | crm 1x10gm 0.1% | LEX | CZ | | | |
| 02829 | TRIAMCINOLON LECIVA | ung 1x10gm 0.1% | LEX | CZ | | | |
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1 | ML | 2,83 | |
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) lok. | 1 | ML | 2,83 | | |
| 02826 | TRIAMCINOLON-GALENA | lot 1x15gm | GNO | CZ | | | |
| 66167 | TRIAMCINOLON-GALENA | lot 1x30gm | GNO | CZ | | | |
| 184.7 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1 | GM | 0,73 | |
| | | | | | | | |
| 184.8 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1 | ML | 0,98 | |
| | | | | | | | |
| 184.9 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 3,09 | |
| 01965 | DEXAMETHAZON LECIVA | ung 1x10gm 0.025% | LEX | CZ | | | |
| 184.9 | D07AB10 | alclomethason | lok. | 1 | GM | 3,18 | |
| | | | | | | | |
| 184.10 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 3,09 | |
| 02415 | DEXAMETHAZON LECIVA | crm 10gm 0.01% | LEX | CZ | | | |
| 185 | D07AC | kortikosteroidy třídy III, účinné (fluorované) | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 185.1 | D07AC01 | betamethason dipropionát | lok. | 1 | GM | 2,49 | |
| 98034 | DIPROSONE | crm 1x30gm | SCH | B | | | |
| 80204 | BELODERM | ung 1x30gm 0.05% | BLU | CHO | | | |
| 98034 | DIPROSONE | crm 1 x30gm | SCH | B | | | |
| 88495 | KUTERID | ung 20gm | LEK | SLO | | | |
| 88489 | KUTERID | crm 20gm | LEK | SLO | | | |
| 98032 | DIPROSONE | ung 1x30gm | SCH | B | | | |
| 80206 | BELODERM | crm 1x30gm 0.05% | BLU | CHO | | | |
| 80204 | BELODERM | ung 1x30gm 0.05% | BLU | CHO | | | |
| 88495 | KUTERID | ung 20gm | LEK | SLO | | | |
| 98032 | DIPROSONE | ung 1x30gm | SCH | B | | | |
| 88489 | KUTERID | crm 20gm | LEK | SLO | | | |
| 185.2 | D07AC01 | betamethason valerát | lok. | 1 | GM | 3,32 | |
| | | | | | | | |
| 185.3 | D07AC02 | fluklorolon | lok. | 1 | GM | 3,32 | |
| | | | | | | | |
| 185.4 | D07AC04 | fluocinolon gel | lok. | 1 | GM | 2,44 | |
| 04156 | GELARGIN | gel 1x25gm | LEX | CZ | | | |
| | | | | | | | |
| 185.5 | D07AC04 | fluocinolon mast a krém (koncentrace do 0,025% včetně) | lok. | 1 | GM | 2,93 | |
| 55726 | SYNALAR | crm 1x30gm | ZNC | GB | | | |
| 55722 | SYNALAR | ung 1x30gm | ZNC | GB | | | |
| 55726 | SYNALAR | crm 1x30gm | ZNC | GB | | | |
| 92285 | GELARGIN UNG | ung 1x20gm/5mg | LEX | CZ | | | |
| 185.6 | D07AC04 | fluocinolon mast a krém (koncentrace nad 0,025%) | lok. | 1 | GM | 3,91 | |
| | | | | | | | |
@@ -3032,7 +3082,7 @@
| 185.11 | D07AC12 | halometason | lok. | 1 | GM | 3,27 | |
| | | | | | | | |
| 185.12 | D07AC17 | flutikason | lok. | 1 | GM | 3,42 | |
| 186 | D07AC | kortikosteroidy třídy III, účinné (nefluorované) | lok. | L/DER,ALG,PDD | | | |
| 186 | D07AC | kortikosteroidy třídy III. účinné (nefluorované) | lok. | L/DER,ALG,PDD | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 186.1 | D07AC09 | budesonid | lok. | 1 | GM | 3,18 | L/DER |
| | | | | | | | |
@@ -3050,7 +3100,7 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 187.1 | D07AD01 | klobetasol | lok. | 1 | GM | 4,40 | L/DER |
| | | | | | | | |
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,64 | L/DER |
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,52 | L/DER |
| 97020 | BETACORTON | liq 1x100ml | SEG | CH | | | |
| 97019 | BETACORTON | liq 1x25ml | SEG | CH | | | |
| 188 | D07BB | kortikosteroidy, středně účinné, kombinace s antiseptiky | lok. | | | | |
@@ -3063,70 +3113,69 @@
| | | | | | | | |
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 | GM | 0,59 | |
| | | | | | | | |
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,53 | |
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,60 | |
| 02827 | TRIAMCINOLON | tct 1x10ml | GNO | CZ | | | |
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,81 | |
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1.87 | |
| 04178 | TRIAMCINOLON E LECIVA | ung 1x20gm | LEX | CZ | | | |
| 188.7 | D07BA01 | prednisolon/ hexamidin diisothionát | lok. | 1 | GM | 1,96 | |
| 188.7 | D07BA01 | prednisolon/hexamidin diisothionát | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 188.8 | D07CC01 | betamethason a gentamycin | lok. | 1 | GM | 2,50 | L/DER |
| 189 | D07X | kortikosteroidy, jiné kombinace | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 1,96 | |
| | | | | | | | |
| 189.2 | D07XA02 | prednisolon/ kyselina salicylová | lok. | 1 | ML | 1,32 | |
| | | | | | | | |
| 189.3 | D07XB01 | flumetason/ dehet | lok. | 1 | GM | 4,40 | |
| 189.2 | D07XA02 | prednisolon/kyselina salicylová | lok. | 1 | ML | 1,32 | |
| | | | | | | | |
| 189.3 | D07XB01 | flumetason/dehet | lok. | 1 | GM | 4,40 | |
| | | | | | | | |
| 189.4 | D07XB01 | flumethason pivalat/kyselina salicylová | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 189.5 | D07XB02 | triamcinolon | lok. | 1 | GM | 1,81 | |
| 189.5 | D07XB02 | triamcinolon | lok. | 1 | GM | 1,87 | |
| 04160 | TRIAMCINOLON S LECIVA | ung 1x30gm | LEX | CZ | | | |
| 189.6 | D07XC | diflucortolon/ isoconasol | lok. | 1 | GM | 2,69 | |
| | | | | | | | |
| 189.7 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,69 | |
| 189.6 | D07XC | diflucortolon/ isoconasol | lok. | 1 | GM | 2,61 | |
| | | | | | | | |
| 189.7 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,61 | |
| 85864 | BELOSALIC | ung 1x30gm | BLU | CHO | | | |
| 189.8 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,69 | |
| | | | | | | | |
| 189.9 | D07XD | halcinonid/ kyselina salicylová | lok. | 1 | ML | 3,57 | |
| 189.8 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,61 | |
| | | | | | | | |
| 189.9 | D07XD | halcinonid/kyselina salicylová | lok. | 1 | ML | 3,57 | |
| | | | | | | | |
| 189.10 | D07XD | halcinonid/ močovina | lok. | 1 | GM | 3,57 | |
| | | | | | | | |
| 189.11 | D07CA01 | hydrocortison a antibiotika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,96 | |
| 189.11 | D07CA01 | hydrocortison a antibiotika (lékové formy mastí a krémů) | lok. | 1 GM | 1,96 | | |
| | | | | | | | |
| 189.12 | D07CA01 | hydrocortison a antibiotika (tekuté lékové formy) | lok. | 1 | ML | 1,96 | |
| 190 | D08A | antiseptika a desinficiencia | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 190.1 | D08AC02 | Chlorhexidin | lok. | 1000 | ML | 178,70 | |
| | | | | | | | |
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,68 | |
| 65997 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x500gm (dóza) | HEO | CZ | | | |
| 190.1 | D08AC02 | chlorhexidin | lok. | 1000 | ML | 178,70 | |
| | | | | | | | |
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,43 | |
| 65998 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x1000gm (dóza) | HEO | CZ | | | |
| 190.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10 | GM | 1,32 | |
| | | | | | | | |
| 190.4 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení) | lok. | 1 | ML | 0,98 | |
| 62318 | BETADINE (CHIRURG.) | liq 1x120ml | EGI | H | | | |
| 96605 | JODISOL SPRAY S MECH.ROZPRASOV. | spr 1x75gm | LDN | CZ | | | |
| 46054 | BRAUNOL | liq 1x100ml | BMB | CH | | | |
| 02981 | JODISOL ROZTOK | liq 1x80gm | LDN | CZ | | | |
| 46054 | BRAUNOL | liq 1x100ml | BMB | CH | | | |
| 96605 | JODISOL SPRAY S MECH.ROZPRASOV. | spr 1x75gm | LDN | CZ | | | |
| 190.5 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1 | ML | 0,49 | |
| 46056 | BRAUNOL | liq 1x500ml | BMB | CH | | | |
| 62317 | BETADINE | liq 1x1000ml | EGI | H | | | |
| 62319 | BETADINE (CHIRURG.) | liq 1x1000ml | EGI | H | | | |
| 46055 | BRAUNOL | liq 1x250ml | BMB | CH | | | |
| 02983 | JODISOL ROZTOK | liq 1x760gm | LDN | CZ | | | |
| 80553 | BRAUNOL | liq 1x1000ml | BMB | CH | | | |
| 62319 | BETADINE (CHIRURG.) | liq 1x1000ml | EGI | H | | | |
| 62317 | BETADINE | liq 1x1000ml | EGI | H | | | |
| 46056 | BRAUNOL | liq 1x500ml | BMB | CH | | | |
| 190.6 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1 | GM | 1,96 | |
| 84421 | BRAUNOVIDON MAST | ung 100gm (pe tuba) | BMB | CH | | | |
| 190.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení) | lok. | 1 | GM | 0,98 | |
| 46052 | BRAUNOVIDON MAST | ung 250gm (pe nad.) | BMB | CH | | | |
| 84422 | BRAUNOVIDON MAST | ung 250gm (pe tuba) | BMB | CH | | | |
| 46052 | BRAUNOVIDON MAST | ung 250gm (pe nad.) | BMB | CH | | | |
| 190.8 | D08AH | kloroxin | lok. | 1 | GM | 0,78 | |
| 190.8 | D08AH kloroxin | lok. | 1 | GM | 0,78 | | |
| | | | | | | | |
| 190.9 | D08AJ | bromid benzododecinia (tinktura a roztok do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| | | | | | | | |
| 190.10 | D08AJ | bromid benzododecinia (tinktura a roztok nad 50 ml v jednom balení) | lok. | 1 | ML | 0,29 | H |
| 58237 | AJATIN PROFARMA TINKTURA | tct 1x1000ml | PSR | CZ | | | |
| 190.11 | D08AJ | chlorid karbetopendecinia (tinktura 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 190.11 | D08AJ | chlorid karbetopende- cinia (tinktura 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 191 | D08AX | jiná antiseptika a desinficiencia | lok. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 191.1 | D08AX | hexamidin/ chlorhexidin | lok. | 1 | ML | 121,37 | H |
@@ -3138,33 +3187,35 @@
| 191.4 | D08AX | taurolidin | lok. | 1 | GM | 94,48 | H |
| 192 | D10A | lokálně podávaná léčiva k léčbě akne | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 3,96 | |
| 03740 | RETIN-A KREM 0.05% | crm 1x30gm | CIL | CH | | | |
| 98205 | LOCACID | crm 1x30gm 0.05% | PFB | F | | | |
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 3,75 | |
| 58237 | AJATIN PROFARMA TINKTURA | tct 1x1000ml | PSR | CZ | | | |
| 97573 | RETIN-A KREM 0.025% | crm 1x30gm | CIL | CH | | | |
| 66170 | LOCACID | crm 1x30gm 0.05% | PFH | F | | | |
| 192.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1 | GM | 4,40 | |
| | | | | | | | |
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,11 | |
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,00 | |
| | | | | | | | |
| 192.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1 | ML | 4,40 | |
| | | | | | | | |
| 192.5 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,42 | |
| | | | | | | | |
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0,39 | |
| 192.5 | D10AD03 | adapalen - léková forma krémů a gelů | lok. | 1 | GM | 4,00 | |
| | | | | | | | |
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,42 | |
| 47279 | ECLARAN 5 | gel 1x45gm | PFG | F | | | |
| 192.7 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0.39 | |
| 91816 | INOXITAN | lot 100ml 50mg/ml | GNO | CZ | | | |
| 192.7 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,54 | |
| | | | | | | | |
| 192.8 | D10AF01 | klindamycin | lok. | 1 | ML | 1,96 | |
| 192.9 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 192.10 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1 | ML | 2,17 | |
| | | | | | | | |
| 192.11 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,75 | |
| | | | | | | | |
| 192.12 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,93 | |
| | | | | | | | |
| 192.13 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 1,96 | |
| 192.8 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,54 | |
| | | | | | | | |
| 192.9 | D10AF01 | klindamycin | lok. | 1 | ML | 1,96 | |
| | | | | | | | |
| 192.10 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 192.11 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1 | ML | 2,13 | |
| 98204 | ERYFLUID | sol 1x30ml | PFB | F | | | |
| 192.12 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,72 | |
| 75285 | ERYFLUID | sol 1x100ml | PFB | F | | | |
| 192.13 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,93 | |
| | | | | | | | |
| 192.14 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 1,96 | |
| 193 | D10B | celkově podávaná léčiva k léčbě akné | p.o. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 193.1 | D10BA01 | isotretinoin (do 10 MG včetně v jedné kapsli ) | p.o. | 30 | MG | 83,53 | X |
@@ -3175,9 +3226,9 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 194.1 | D11AX | celulóza (lékové formy zásypů) | lok. | 1 | GM | 9,78 | L/DER |
| | | | | | | | |
| 194.2 | D11AX | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 16,86 | L/DER |
| 194.2 | D11AF | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 16,61 | L/DER |
| 60890 | VERRUMAL | liq 1x13ml | HEM | D | | | |
| 194.3 | D11AX | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,15 | L/DER,ONK |
| 194.3 | D11AF | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,15 | L/DER,ONK |
| 195 | G01AA | vaginálně podávaná antimykotika a antibiotika | vag. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3191,7 +3242,7 @@
| | | | | | | | |
| 195.2 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25 | MG | 4,11 | |
| | | | | | | | |
| 195.3 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25 | MG | 7,14 | |
| 195.3 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25 | MG | 6,88 | |
| 78213 | PIMAFUCIN | glo vag 3x100mg | YEU | NL | | | |
| 195.4 | G01AA10 | klindamycin (lékové formy krémů) | vag. | 1 | GM | 11,00 | P |
| | | | | | | | |
@@ -3202,25 +3253,20 @@
| 195.7 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. krémů) | vag. | 5 | GM | 35,19 | |
| 196 | G01AF | vaginálně podávané imidazolové deriváty | vag. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 196.1 | G01AF20 | kombinace imidazolových derivátů - mikonazol a metronidazol (lékové formy vag. tablet) | vag. | 1 | DF | 6,35 | |
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,71 | |
| 66787 | MEDAZOL | tbl vag 10 | BLU | CHO | | | |
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 8,70 | |
| 58254 | CLOTRIMAZOLUM GW | tbl vag 6x100mg | GWP | PL | | | |
| 196.1 | G01AF20 | kombinace imidazolových derivátů - mikonazol a metronidazol ( lékové formy vag. tablet) | vag. | 1 | DF | 6,35 | |
| | | | | | | | |
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,46 | |
| 02430 | ENTIZOL | tbl vag 10x500mg | POL | PL | | | |
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 8,25 | |
| 62862 | CANDIBENE 100MG | tbl vag 6x100mg | MCK | D | | | |
| 62863 | CANDIBENE 200MG | tbl vag 3x200mg | MCK | D | | | |
| 58654 | CLOTRIMAZOL AL 200 | tbl vag 3x200mg+apl | APA | D | | | |
| 66549 | CLOTRIMAZOL AL 200 | tbl vag 3x200mg+apl | HHC | D | | | |
| 65483 | CLOTRIMAZOL AL 100 | tbl vag 6x100mg+apl | HHC | D | | | |
| 93484 | CLOTRIMAZOLUM POLFA | tbl vag 6x100mg | POL | PL | | | |
| 58653 | CLOTRIMAZOL AL 100 | tbl vag 6x100mg+apl | APA | D | | | |
| 62862 | CANDIBENE 100MG | tbl vag 6x100mg | MCK | D | | | |
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,39 | |
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 12,88 | |
| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D | | | |
| 196.5 | G01AF04 | mikonazol | vag. | 0.1 | GM | 8,70 | |
| | | | | | | | |
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,39 | |
| | | | | | | | |
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globuli a čípků) | vag. | 0.1 | GM | 31,58 | |
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 12,88 | |
| | | | | | | | |
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globulí a čípků) | vag. | 0.1 | GM | 31,36 | |
| 06095 | GYNO-PEVARYL 50 | glo vag 15x50mg | CIL | CH | | | |
| 196.8 | G01AF11 | ketoconazol | vag. | 0.4 | GM | 13,44 | |
| | | | | | | | |
@@ -3228,12 +3274,12 @@
| | | | | | | | |
| 196.10 | G01AF17 | oxikonazol | vag. | 0.6 | GM | 109,90 | |
| 99250 | GYNO-MYFUNGAR | tbl vag 1x600mg | LEX | CZ | | | |
| 196.11 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80 | MG | 13,49 | |
| 196.11 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80 | MG | 12,88 | |
| | | | | | | | |
| 196.12 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80 | MG | 31,28 | |
| 197 | G01AX | vaginálně podávaná jiná antiinfektiva a antiseptika | vag. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 197.1 | G01AX | laktobacillus | vag. | 1 | DF | 10,26 | |
| 197.1 | G01AX | laktobacillus | vag. 1 | DF | 10,26 | | |
| | | | | | | | |
| 197.2 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1 | DF | 17,60 | |
| | | | | | | | |
@@ -3246,15 +3292,16 @@
| 197.6 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1 | DF | 6,40 | |
| | | | | | | | |
| 197.7 | G01AX03 | polykresulen | vag. | 90 | MG | 0,35 | |
| | | | | | | | |
| 197.8 | G01AX05 | nifuratel | p.o. | 0.6 | GM | 15,64 | L/GYN,URN |
| | | | | | | | |
| 197.9 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.2 | GM | 8,94 | |
| | | | | | | | |
| 197.10 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.2 | GM | 6,16 | |
| | | | | | | | |
| 197.11 | G01AX12 | ciklopirox (vaginální krém - do 40 GM včetně v jednom balení) | vag. | 1 | GM | 4,69 | |
| | | | | | | | |
| 197.12 | G01AX12 | ciklopirox (vaginální krém - nad 40 GM v jednom balení) | vag. | 1 | GM | 3,11 | |
| 197.11 | G01AX12 | ciklopirox (vaginální krém - do 40 gm včetně v jednom balení) | vag. | 1 | GM | 4,69 | |
| | | | | | | | |
| 197.12 | G01AX12 | ciklopirox (vaginální krém - nad 40 gm v jednom balení) | vag. | 1 | GM | 3,11 | |
| | | | | | | | |
| 197.13 | G01AX12 | ciclopirox (vaginální roztok) | vag. | 1 | DF | 17,60 | |
| | | | | | | | |
@@ -3270,19 +3317,19 @@
| 198.2 | G02AB03 | ergometrin | p.o. | 0.2 | MG | 1,12 | |
| 199 | G02AB | uterotonika ze skupiny námelových alkaloidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 199.1 | G02AB01 | methylergometrin | parent. | 0.2 | MG | 17,21 | |
| 00509 | METHYLERGOMETRIN SPOFA | inj 5x1ml/0.2mg | SPX | CZ | | | |
| 199.1 | G02AB01 | methylergometrin | parent. | 0.2 | MG | 18,00 | |
| 00509 | METHYLERGOMETRIN SPOFA | inj 5x1 ml/0.2mg | SPX | CZ | | | |
| 199.2 | G02AB03 | ergometrin | parent. | 0.2 | MG | 9,38 | |
| 200 | G02AD | uterotonika ze skupiny prostaglandinů | p.o. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 95,31 | H |
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 95,43 | H |
| 57150 | PROSTIN E2 | tbl 10x0.5mg | PAU | B | | | |
| 201 | G02AD | uterotonika ze skupiny prostaglandinů | vag. | K/P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje gynekolog:
- a) preindukce porodu při ukončení těhotenství,
- a) preindukce porodu při ukončeni těhotenství,
- b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
@@ -3290,11 +3337,11 @@
- d) v poporodním období při závažné metrorhagii.
| 201.1 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 770,00 | K/P |
| 201.1 | G02AD02 dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 770,00 | K/P | |
| | | | | | | | |
| 201.2 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1111,90 | K/P |
| | | | | | | | |
| 201.3 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 432,53 | K/P |
| 201.3 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 439,30 | K/P |
| 02289 | PROSTIN E2 | tbl vag 4x3mg | PAU | B | | | |
| 201.4 | G02AD02 | dinoproston (pesar) | vag. | 1 | DF | 2200,00 | K/P |
| 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | K/P | | | |
@@ -3302,13 +3349,13 @@
Léčbu ordinuje gynekolog:
- a) preindukce porodu při ukončení těhotenství,
- a) preindukce porodu při ukončeni těhotenství,
- b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
- c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,
- d) v poporodním období při závažné metrorhagii.
- d) v poporodním období pří závažné metrorhagii.
| 202.1 | G02AD01 | dinoprost | parent. | 25 | MG | 651,85 | K/P |
| | | | | | | | |
@@ -3324,11 +3371,11 @@
pouze jako pokračování parenterální aplikace tokolytik.
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 10,80 | P |
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 10,14 | P |
| 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A | | | |
| 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,66 | P |
| | | | | | | | |
| 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,66 | P |
| 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,14 | P |
| | | | | | | | |
| 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,14 | P |
| 21391 | PARTUSISTEN | tbl 50x5mg | BGP | D | | | |
| 204 | G02CA | tokolytika ze skupiny beta-sympatomimetik | parent. | U/P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3342,28 +3389,28 @@
- c) intrapartální akutní tokolýza.
| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 45,36 | U/P |
| 75464 | GYNIPRAL 25RG KONCENTR.ZUR INF. | inf 5x5ml/25rg | HNP | A | | | |
| 75463 | GYNIPRAL 10RG/2ML | inj 5x2ml/10rg | HNP | A | | | |
| 75464 | GYNIPRAL 25RG KONCENTR.ZUR INF. | inf 5x5ml/25rg | HNP | A | | | |
| 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 45,36 | U/P |
| | | | | | | | |
| 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 45,36 | U/P |
| 58242 | PARTUSISTEN | inf 25x10ml/0.5mg | BOE | E | | | |
| 03399 | PARTUSISTEN | inf 25x10ml/0.5mg | BGP | D | | | |
| 58242 | PARTUSISTEN | inf 25x10ml/0.5mg | BOE | E | | | |
| 204.4 | G02CX01 | atosiban infuse | parent. | 1 | DF | 3500,00 | H |
| | | | | | | | |
| 204.5 | G02CX01 | atosiban injekce | parent. | 1 | DF | 1.300,00 | H |
| 204.5 | G02CX01 | atosiban injekce | parent. | 1 | DF | 1300,00 | H |
| 205 | G02CB | inhibitory prolaktinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 205.1 | G02CB | tergurid | p.o. | 1 | MG | 5,46 | |
| 91979 | MYSALFON | tbl obd 30x0.5mg | LEK | CZ | | | |
| 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 14,22 | |
| 67512 | MEDOCRIPTINE | tbl 30x2.5mg | MOE | CY | | | |
| 67514 | MEDOCRIPTINE | tbl 500x2.5mg | MOE | CY | | | |
| 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ | | | |
| 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 13,59 | |
| 67514 | | MEDOCRIPTINE | tbl 500x2.5mg | MOE | CY | | |
| 67512 | | MEDOCRIPTINE | tbl 30x2.5mg | MOE | CY | | |
| 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,49 | |
| | | | | | | | |
| 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 27,08 | P |
Nesnášenlivost a nedostatečná účinnost jiných léků ze skupiny dopaminergních agonistů (terguridu a přípravků bromokriptinu) u nemocných s hyperprolaktinémií a prolaktin secernujícími adenomy a u nemocných s akromegalií, která je citlivá na tuto léčbu.
Nesnášenlivost a nedostatečná účinnost jiných léků ze skupiny dopaminergních agonistů (terguridu a přípravků bromokriptinu) u nemocných s hyperprolaktinémií a prolaktin secemujícími adenomy a u nemocných s akromegalií, která je citlivá na tuto léčbu.
| 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 27,08 | Z |
| 206 | G03B | androgeny | p.o. | L/END,ONK,GYN,SEX | | | |
@@ -3372,7 +3419,7 @@
| | | | | | | | |
| 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,04 | L/END,ONK, GYN, SEX,URN |
| 09591 | PROVI RON 25 | tbl 20x25mg | SAG | D | | | |
| 09592 | PROVIRON 25 | tbl 50x25mg | SAG | D | | | |
| 09592 | PROVI RON 25 | tbl 50x25mg | SAG | D | | | |
| 207 | G03B | androgeny | parent. | L/END,ONK,GYN,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 8,11 | L/END,ONK, GYN, SEX,URN |
@@ -3400,14 +3447,14 @@
| | | | | | | | |
| 208.5 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 4,40 | P |
| 47045 | ESTRAHEXAL 25 | tts emp 6x2mg | HEX | D | | | |
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 99 RG včetně /den, v rámci 28. denního cyklu) | transd. | 1 | DF | 6,00 | P |
| | | | | | | | |
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 9,00 | P |
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 99 rg včetně/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 6,00 | P |
| | | | | | | | |
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více rg /den, v rámci 28. denního cyklu) | transd. | 1 | DF | 9,00 | P |
| | | | | | | | |
| 208.8 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 5,87 | P |
| 76922 | OESTROGEL | gel 1x80gm | LBE | F | | | |
| 53753 | ESTREVA | gel 1x50gm/0.05gm | THL | MC | | | |
| 76922 | OESTROGEL | gel 1x80gm | LBE | F | | | |
| 208.9 | G03CA03 | estradiol | vag. | 25 | RG | 5,87 | P |
| 208.9 | G03CA03 | estradiol | vag. | 25 | RG | 9,79 | P |
| | | | | | | | |
| 208.10 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| | | | | | | | |
@@ -3417,20 +3464,19 @@
| | | | | | | | |
| 208.13 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 98182 | OVESTIN | crm vag 1x15gm+apl. | ORG | IRL | | | |
| 97170 | OVESTIN | crm 15gm+aplikator | ORG | NL | | | |
| 208.14 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 5,87 | P |
| | | | | | | | |
| 208.15 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,22 | P |
| 208.14 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 3,92 | P |
| | | | | | | | |
| 208.15 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,16 | P |
| 97590 | ORTHO-GYNEST D | sup vag 6 | CIL | CH | | | |
| 208.16 | G03CA57 | přírodní konj. estrogeny (do 625 RG včetně v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 6,00 | P |
| 208.16 | G03CA57 | přírodní konj. estrogeny (do 625 rg včetně v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 6,00 | P |
| 83387 | OESTROFEMINAL 0.6 | cps 21x0.6mg | MAC | D | | | |
| 208.17 | G03CA57 | přírodní konj. estrogeny (nad 625 RG v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 4,34 | P |
| 208.17 | G03CA57 | přírodní konj. estrogeny (nad 625 rg v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 4,34 | P |
| 09467 | OESTROFEMINAL 1.25 | cps 21x1.25mg | MAC | D | | | |
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 4,35 | |
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK | | | |
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK | | | |
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK | | | |
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,57 | |
| 00529 | NEOFOLLIN | inj 5x1ml/5mg | BTA | SK | | | |
| 209.3 | G03CA03 | estradiol implantát | parent. | 1 | DF | 1095,00 | |
@@ -3438,22 +3484,23 @@
| 209.4 | G03CA04 | estriol | parent. | 2 | MG | 4,30 | |
| 210 | G03D | progestiny | p.o. | L/GYN,URN,END,INT, SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 210.1 | G03DA02 | medroxyprogesteron | p.o. | 5 | MG | 3,62 | L/GYN,URN, END, INT,SEX |
| | | | | | | | |
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 17,40 | L/GYN,URN, END, INT,SEX |
| | | | | | | | |
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 3,81 | L/GYN,URN, END, INT,SEX |
| 210.1 | G03DA02 | medroxypro- gesteron | p.o. | 5 | MG | 3,62 | L/GYN,URN, END, INT,SEX |
| | | | | | | | |
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 15,60 | L/GYN,URN, END, INT,SEX |
| | | | | | | | |
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 5,20 | L/GYN,URN, END, INT,SEX |
| | | | | | | | |
| 210.4 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,88 | L/GYN,URN, END, INT,SEX |
| 01939 | NORETHISTERON SLOVAKOFARMA | tbl 30x5mg | SLO | SK | | | |
| 210.5 | G03DC03 | lynestrenol | p.o. | 5 | MG | 2,88 | L/GYN,URN, END, INT,SEX |
| | | | | | | | |
| 210.6 | G03DC05 | tibolon | p.o. | 2.5 | MG | 18,00 | P |
Léčbu tibolonem ordinuje gynekolog k léčbě estrogen deficitního syndromu tam, kde jsou jiné hormonální přípravky kontraindikovány nebo kde jiné hormonální přípravky pacientka objektivně nesnáší.
| 211 | G03D | progestiny | parent. | L/GYN,URN,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 211.1 | G03DA03 | hydroxy-progesteron | parent. | 10 | MG | 1,76 | L/GYN,URN, SEX |
| 211.1 | G03DA03 | hydroxypro- gesteron | parent. | 10 | MG | 1.76 | L/GYN,URN, SEX |
| 00531 | NEOLUTIN FORTE | inj 5x1ml/125mg | SPX | CZ | | | |
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 4,01 | L/GYN,URN, SEX |
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | SK | | | |
@@ -3471,85 +3518,89 @@
léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 213.1 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 2 MG estradiolu v jedné tabletě | p.o. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.2 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 1 MG estradiolu v jedné tabletě | p.o. | 1 | DF | 5,50 | P |
| | | | | | | | |
| 213.3 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1 | DF 6,84 | P | |
| | | | | | | | |
| 213.4 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace | p.o. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.5 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| | | | | | | | |
| 213.6 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.7 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.8 | G03FB06 | medroxyprogesteron a estrogen, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 213.1 | G03FA15 | dienogest a estradiol, fixní kombinace | p.o. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.2 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 2 mg estradiolu v jedné tabletě | p.o. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.3 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 1 mg estradiolu v jedné tabletě | p.o. | 1 | DF | 5,50 | P |
| | | | | | | | |
| 213.4 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.5 | G03FA12 | medroxypro- gesteron a estrogen, fixní kombinace | p.o. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.6 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| | | | | | | | |
| 213.7 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.8 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.9 | G03FB06 | medroxypro-gesteron a estrogen, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 54310 | DIVINA | tbl 3x21(=63) | ORN | DK | | | |
| 54309 | DIVINA | tbl 1x21 | ORN | DK | | | |
| 213.9 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 0.75 | DF | 5,08 | P |
| | | | | | | | |
| 213.10 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.11 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 0,75 | DF | 5,08 | P |
| 67425 | CYCLO-MENORETTE | tbl obd 3x21(=63) | WYE | D | | | |
| 213.10 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 0.75 | DF | 5,08 | P |
| | | | | | | | |
| 213.11 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| | | | | | | | |
| 213.12 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 0,75 | DF | 5,08 | P |
| 98135 | KLIMONORM | drg 1x21 | VJP | D | | | |
| 89782 | KLIMONORM | drg 3x21(=63) | VJP | D | | | |
| 98135 | KLIMONORM | drg 1x21 | VJP | D | | | |
| 213.12 | G03HB01 | cyproteron/ estradiol | p.o. | 0.75 | DF | 5,08 | P |
| 67424 | CYCLO-MENORETTE | tbl obd 21 | WYE | D | | | |
| 67425 | CYCLO-MENORETTE | tbl obd 3x21 (=63) | WYE | D | | | |
| 213.13 | G03HB01 | cyproteron/ estradiol | p.o. | 0.75 | DF | 5,08 | P |
| 214 | G03GA | gonadotrofin (choriový) | parent. | L/GYN,END,PDD,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 24,59 | L/GYN,END, PDD, SEX |
| 10809 | PREGNYL | inj 3x500ut+solv. | ORG | NL | | | |
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 15,45 | L/GYN,END, PDD, SEX |
| | | | | | | | |
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 14,98 | L/GYN,END, PDD, SEX |
| 11951 | PREGNYL | inj 3x1500ut+solv. | ORG | NL | | | |
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 11,05 | L/GYN,END, PDD, SEX |
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 10,71 | L/GYN,END, PDD, SEX |
| 96314 | PREGNYL | inj 3x5000ut+solv. | ORG | NL | | | |
| 215 | G03GA | gonadotrofin (lidský) | parent. | Z | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 329,64 | Z |
| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH | | | |
| 12979 | MENOGON | inj sic 10+10xsolv. | FEI | D | | | |
| 43728 | MERIONAL 75 M.J. | inj sic 10x75ut+sol | IBS | CH | | | |
| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH | | | |
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 400,81 | Z |
| 56473 | METRODIN 75 | inj sic 1x75ut+solv | SRO | I | | | |
| 56474 | METRODIN 75 | inj sic 10x75ut+sol | SRO | I | | | |
| 43724 | FOSTIMON 75 M.J | inj sic 10x75ut+sol | IBS | CH | | | |
| 43723 | FOSTIMON 75 M.J. | inj sic 1x75ut+solv | IBS | CH | | | |
| 43724 | FOSTIMON 75 M.J | inj sic 10x75ut+sol | IBS | CH | | | |
| 215.3 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75 | U | 488,79 | Z |
| | | | | | | | |
| 215.4 | G03GA05 | folitrofin alfa | parent. | 75 | U | 733,19 | Z |
| | | | | | | | |
| 215.5 | G03GA06 | folitrofin beta | parent. | 75 | U | 733,19 | Z |
| | | | | | | | |
| 215.6 | G03GA07 | lutropin alfa ( rekombinantní lidský luteinizační hormon) | parent. | 75 | U | 733,19 | Z |
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | L/GYN,END,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,32 | L/GYN,END, SEX, URN |
| | | | | | | | |
| 83672 | CLOMHEXAL 50 | tbl 10x50mg | HEX | D | | | |
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,24 | L/GYN,END, SEX,URN |
| 83672 | CLOMHEXAL | tbl 10x50mg | HEX | D | | | |
| 217 | G03HA | antiandrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 166,20 | |
| 77006 | ANDROCUR 10MG | tbl 15x10mg | SAG | D | | | |
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 61,80 | |
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D | | | |
| 59354 | ANDROCUR 100 | tbl obd 50x100mg | SUE | F | | | |
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D | | | |
| 59354 | ANDROCUR 100 | tbl obd 50x100mg | SUE | F | | | |
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D | | | |
| 218 | G03HA | antiandrogeny | parent. | L/PSY,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 128,06 | L/PSY,SEX, URN |
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 125,38 | L/PSY,SEX, URN |
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D | | | |
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | L/GYN,END,HEM,ALG, SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 83,68 | L/GYN,END, HEM, ALG,SEX |
| 67527 | ANARGIL 100MG | cps 500x100mg | MOE | CY | | | |
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY | | | |
| 67526 | ANARGIL 100MG | cps 200x100mg | MOE | CY | | | |
| 67528 | ANARGIL 200MG | cps 100x200mg | MOE | CY | | | |
| 67530 | ANARGIL 200MG | cps 500x200mg | MOE | CY | | | |
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY | | | |
| 67527 | ANARGIL 100MG | cps 500x100mg | MOE | CY | | | |
| 67525 | ANARGIL 100MG | cps 100x100mg | MOE | CY | | | |
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 47,36 | L/GYN,END, HEM, ALG,SEX |
| | | | | | | | |
| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 39,40 | P |
| 67526 | ANARGIL 100MG | cps 200x100mg | MOE | CY | | | |
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 46,42 | L/GYN,END, HEM, ALG,SEX |
| 83580 | NEMESTRAN | cps 8x2.5mg | ROU | GB | | | |
| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 37,40 | P |
Raloxifen: léčbu ordinuje internista, endokrinolog, revmatolog a ortoped: Postmenopauzální osteoporoza žen dokumentovaná denzitometricky (méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT) nebo z objektivních důvodů nelze použít HRT. Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
@@ -3561,21 +3612,19 @@
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 221.1 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,58 | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | | | | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | I | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 222.1 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10 | GM | 5,97 | |
| | | | | | | | |
| 222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 5,97 | |
| 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX, GER | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 13,24 | L/URN,GYN, SEX GER |
| | | | | | | | |
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 13,24 | L/URN,GYN, SEX GER |
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 12,96 | L/URN,GYN, SEX GER |
| | | | | | | | |
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 12,96 | L/URN,GYN, SEX GER |
| 66791 | DITROPAN | tbl 30x5mg | SSF | F | | | |
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 12,05 | L/URN,GYN, SEX PDD, GER |
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 11,87 | L/URN,GYN, SEX PDD, GER |
| 92255 | MICTONETTEN | drg 30x5mg | APG | D | | | |
| 66820 | MICTONETTEN | drg 100x5mg | APG | D | | | |
| 66819 | MICTONETTEN | drg 50x5mg | APG | D | | | |
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 5,40 | L/URN,GYN, SEX, GER |
| 66817 | MICTONORM | drg 50x15mg | APG | D | | | |
| 92254 | MICTONORM | drg 30x15mg | APG | D | | | |
@@ -3586,29 +3635,27 @@
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 21,50 | L/URN |
| | | | | | | | |
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 21,50 | L/URN |
| | | | | | | | |
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 21,50 | L/URN |
| | | | | | | | |
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 18,10 | L/URN |
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 20,00 | L/URN |
| | | | | | | | |
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 20,00 | L/URN |
| | | | | | | | |
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 20,00 | L/URN |
| | | | | | | | |
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 16,80 | L/URN |
| 44311 | KORNAM 2MG | tbl 30x2mg | LEK | SLO | | | |
| 44312 | KORNAM 5MG | tbl 30x5mg | LEK | SLO | | | |
| 44311 | KORNAM 2MG | tbl 30x2mg | LEK | SLO | | | |
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 21,50 | L/URN |
| 65988 | PENESTER | tbl obd 30x5mg | LEX | CZ | | | |
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 20,00 | L/URN |
| | | | | | | | |
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 16,00 | L/URN |
| 42212 | TADENAN 50MG | cps 30x50mg | FFF | F | | | |
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací | p.o. | 2 | DF | 16,00 | L/URN |
| 57895 | SPALDA SABAL 320MG | cps 200x320mg | KKA | D | | | |
| | | | | | | | |
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) | p.o. | 2 | DF | 16,00 | L/URN |
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D | | | |
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D | | | |
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D | | | |
| 224.8 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) | p.o. | 1 | DF | 16,00 | L/URN |
| 59710 | PROSTAMOL UNO | cps 30x320mg | BCE | D | | | |
| 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D | | | |
| 07428 | PROSTAKAN MONO | cps 120x160mg | SCE | D | | | |
| 57894 | SPALDA SABAL 320MG | cps 120x320mg | KKA | D | | | |
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D | | | |
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D | | | |
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D | | | |
| 59710 | PROSTAMOL UNO | cps 30x320mg | BCE | D | | | |
| 224.8 | G04CX03 | mepartricin | p.o. | 150 | KU | 21,50 | L/URN |
| 224.9 | G04CX03 | mepartricin | p.o. | 150 | KU | 20,00 | L/URN |
| 225 | H01A | hormony předního laloku hypofýzy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
@@ -3623,19 +3670,19 @@
| 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | FRL | CZ | | | |
| 226.3 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H |
| | | | | | | | |
| 226.4 | H01BA05 | ornipresin | parent. | 5 | U | 27,57 | H |
| 226.4 | H01BA05 | omipresin | parent. | 5 | U | 27,57 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 21,86 | |
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 22,89 | |
| 02634 | ADIURETIN | gtt nas 1x5ml/0.5mg | FRL | CZ | | | |
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 21,86 | |
| | | | | | | | |
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 21,86 | |
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 22,89 | |
| | | | | | | | |
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 22,89 | |
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 46,95 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | | | | |
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 21,00 | H |
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 49,20 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ | | | |
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 21,96 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ | | | |
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3646,50 +3693,48 @@
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 83795 | SYNAREL | spr nas 1x8ml | SEA | POR | | | |
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1600,00 | Z |
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL | | | |
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL | | | |
| 05981 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | IRL | | | |
| 05982 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | IRL | | | |
| 229.5 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0,25 | MG | 1600,00 | Z |
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL | | | |
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL | | | |
| 229.5 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0,25 MG | 1600,00 | Z | |
| | | | | | | | |
| 229.6 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0,25 | MG | 667,00 | Z |
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7941,40 | X |
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7754,00 | X |
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | | | |
| 92109 | SOMATOSTATIN | inj sic 1x250rg+1ml | UCB | B | | | |
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5022,50 | X |
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5016,00 | X |
| 93867 | SANDOSTATIN | inj 1x5ml/1mg-lahv. | SAN | CH | | | |
| 93866 | SANDOSTATIN | inj 5x1 ml/0.5mg | SAN | CH | | | |
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsičně s obsahem 10 MG | parent. | 0,357 | MG | 1378,40 | X |
| | | | | | | | |
| 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 MG | parent. | 0,714 | MG | 1840,570 | X |
| | | | | | | | |
| 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 MG | parent. | 1,072 | MG | 2297,30 | X |
| | | | | | | | |
| 230.6 | H01CB03 | lantreotid | parent. | 2,14 | MG | 1840,57 | X |
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 mg | parent. | 0,35 7 | MG | 1378,40 | X |
| | | | | | | | |
| 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 mg | parent. | 0,71 4 | MG | 1840,57 | X |
| | | | | | | | |
| 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 mg | parent. | 1,07 2 | MG | 2297,30 | X |
| | | | | | | | |
| 230.6 H01CB03 | lantreotid | parent. | 2,14 | MG | 1789,03 | X | |
| 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F | | | |
| 231 | H02AA | mineralokortikoidy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,79 | |
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,76 | |
| 232 | H02AB | glukokortikoidy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | |
| | | | | | | | |
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 10,22 | |
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 9,42 | |
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | | | |
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | |
| 46039 | DEXONA | tbl 100x0.5mg | CAI | IND | | | |
| 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ | | | |
| | | | | | | | |
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
| | | | | | | | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | |
| 86606 | MEDROL 16MG | tbl 50x16mg(blistr) | PAU | B | | | |
| 232.6 | H02AB07 | Prednison | p.o. | 10 | MG | 3,21 | |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | | | |
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | | | |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | | | |
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| 00332 | TRIAMCINOLON LECIVA | tbl 20x4mg | LEX | CZ | | | |
| | | | | | | | |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | | | |
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | |
@@ -3704,41 +3749,39 @@
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| | | | | | | | |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 3,69 | O |
| 89869 | DIPROPHOS | inj 5x1ml | SCH | B | | | |
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F | | | |
| 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,87 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D | | | |
| 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,54 | O |
| 46037 | DEXONA | inj 6x2ml 4mg/ml | CAI | IND | | | |
| 46038 | DEXONA | inj 8x6x2ml | CAI | IND | | | |
| 233.3 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,21 | O |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY | | | |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | | | |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY | | | |
| 233.4 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,50 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | | | | |
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 35,70 | O |
| 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B | | | |
| 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
| | | | | | | | |
| 233.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B | | | |
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,84 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | | | | |
| | | | | | | | |
| 233.6 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| | | | | | | | |
| 233.7 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
| | | | | | | | |
| 233.8 | H02AB06 | Prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,46 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | | | |
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | | | |
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| 08006 | KENALOG 10 | inj 1x5ml/50mg | LEX | CZ | | | |
| 02126 | KENALOG 40 | inj 1x5ml/200mg | LEX | CZ | | | |
| | | | | | | | |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 06199 | SOLU-CORTEF | inj sic 25x100mg | PAU | B | | | |
| 234 | H03AA | hormony štítné žlázy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | |
| 61160 | JODTHYROX | tbl 50 | MEC | D | | | |
| 61161 | JODTHYROX | tbl 100 | MEC | D | | | |
| 61160 | JODTHYROX | tbl 50 | MEC | D | | | |
| 234.2 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 234.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D | | | |
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D | | | |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D | | | |
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 RG do 100 RG včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D | | | |
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D | | | |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D | | | |
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 69191 | EUTHYROX 150 | tbl 100x150rg | MEC | D | | | |
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D | | | |
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 | |
@@ -3746,12 +3789,12 @@
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D | | | |
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 | |
| 61158 | JODID 100 | tbl 100 | MEC | D | | | |
| 61159 | JODID 200 | tbl 100 | MEC | D | | | |
| 61158 | JODID 100 | tbl 100 | MEC | D | | | |
| 235 | H03B | thyreostatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,76 | |
| 09577 | PROPYCIL 50 | tbl 100x50mg | SVP | D | | | |
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,04 | |
| 09557 | PROPYCIL | tbl 100x50mg | SVP | D | | | |
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 3,11 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | | | |
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | |
@@ -3763,30 +3806,30 @@
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
| | | | | | | | |
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK | | | |
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | L/INT,ORT, END |
| 30967 | OSTEODON 100 I.U. | sprnas 1x3.5ml/28dÁv | LEX | CZ | | | |
| 64662 | TONOCALCIN 100I.U.NOSNI SPREJ | spr nas 1x3.5ml | MCI | CZ | | | |
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 83,00 | L/INT,ORT, END |
| 30967 | OSTEODON 100 I.U. | sprnas1x3.5ml/28dÁv | LEX | CZ | | | |
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 U | 83,00 | L/INT,ORT,END | |
| 10146 | TONOCALCIN 200 I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | | | |
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT, END |
| 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B | | | |
| | | | | | | | |
| 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,ORT, END |
| | | | | | | | |
| 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | | | |
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | | | |
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | | | |
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | | | |
| 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ | | | |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | | | |
| 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D | | | |
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | |
| | | | | | | | |
@@ -3796,20 +3839,20 @@
| | | | | | | | |
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | |
| | | | | | | | |
| 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 7,00 | |
| 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 6,26 | |
| 241 | J01AA | tetracyklinová antibiotika | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 94,63 | K |
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 91,28 | K |
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | | | |
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | | | |
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 24,73 | |
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25,88 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | | | |
| 243 | J01BA | amfenikolová antibiotika | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 255,63 | K |
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 267,93 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | | | |
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | | | | |
@@ -3818,37 +3861,40 @@
| | | | | | | | |
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | |
| | | | | | | | |
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 GM v 1tabletě včetně | p.o. | 1 | GM | 10,12 | |
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1 tabletě včetně | p.o. | 1 | GM | 10,12 | |
| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D | | | |
| 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A | | | |
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | | | |
| 66364 | OSPAMOX 250MG | cps 12x250mg | BCA | A | | | |
| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D | | | |
| 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A | | | |
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | | | |
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | | | |
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | | | |
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | | | |
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | | | |
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 GM v 1tabletě | p.o. | 1 | GM | 9,06 | |
| 32557 | OSPAMOX 500 MG | por tbl obd14x500mg | BCA | A | | | |
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1tabletě | p.o. | 1 | GM | 9,06 | |
| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D | | | |
| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D | | | |
| 32558 | OSPAMOX 750 MG | por tbl obd14x750mg | BCA | A | | | |
| 32559 | OSPAMOX 1000 MG | por tblobd 14x1000mg | BCA | A | | | |
| 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A | | | |
| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D | | | |
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | | | |
| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D | | | |
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | | | |
| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D | | | |
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | | | |
| 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A | | | |
| 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D | | | |
| 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D | | | |
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 GM včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | | | |
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | | | |
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | | | |
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | | | |
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | | | |
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A | | | |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | | | |
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A | | | |
| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D | | | |
| 44347 | AMOXIHEXAL FORTE | plv sus 1x100ml | AAG | D | | | |
| 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 GM v 5 mililitrech) | p.o. | 1 | GM | 10,00 | |
| 44347 | AMOXIHEXAL FORTF | plv sus 1x100ml | AAG | D | | | |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | | | |
| 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1 | GM | 10,00 | |
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D | | | |
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | | | |
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D | | | |
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | | | |
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | | | |
| 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3860,40 +3906,38 @@
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB |
| | | | | | | | |
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB |
| | | | | | | | |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 247.1 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 247.1 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | |
| 92434 | V-PENICILIN 0.4MEGA BIOTIKA | tbl 30x400ku | BTA | SK | | | |
| 247.2 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 45996 | OSPEN 500 | tbl obd 30x500ku | BCA | A | | | |
| 56831 | OSPEN 500 | tbl obd 12x500ku | BCA | A | | | |
| 92435 | V-PENICILIN 0.8MEGA BIOTIKA | tbl 30x800ku | BTA | SK | | | |
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | | | |
| 247.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-blistr | SLO | SK | | | |
| 92436 | V-PENICILIN 1.2MEGA BIOTIKA | tbl 30x1.2mu | BTA | SK | | | |
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | | | |
| 30069 | PENCID 1000 | tbl obd 30x1mu | LEX | CZ | | | |
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | | | |
| 49513 | PENBENE | tbl obd 30x1mu | MCK | D | | | |
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | | | |
| 65356 | PENBENE | tbl obd 12x1mu | MCK | D | | | |
| 57778 | PENBENE 1500000 | tbl obd 21 | MCK | D | | | |
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | | | |
| 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | | | |
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | | | |
| 57778 | PENBENE 1500000 | tbl obd 21 | MCK | D | | | |
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | | | |
| 30069 | PENCID 1000 | tbl obd 30x1mu | LEX | CZ | | | |
| 49513 | PENBENE | tbl obd 30x1mu | MCK | D | | | |
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | | | |
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-blistr | SLO | SK | | | |
| 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A | | | |
| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-blistr | SLO | SK | | | |
| 92436 | V-PENICILIN 1.2MEGA BIOTIKA | tbl 30x1.2mu | BTA | SK | | | |
| 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A | | | |
| 45997 | OSPEN 1000 | tbl obd 30x1000ku | BCA | A | | | |
| 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 92434 | V-PENICILIN 0.4MEGA BIOTIKA | tbl 30x400ku | BTA | SK | | | |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | |
| 247.3 | J01CE02 | fenoxymethylpenicilin (od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 92435 | V-PENICILIN 0.8MEGA BIOTIKA | tbl 30x800ku | BTA | SK | | | |
| 56831 | OSPEN 500 | tbl obd 12x500ku | BCA | A | | | |
| 45996 | OSPEN 500 | tbl obd 30x500ku | BCA | A | | | |
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | | | |
| 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 15,05 | |
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | | | |
| 247.5 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | |
| 247.5 | J01CE10 | benzathin fenoxymethyl-penicilin | p.o. | 2 | GM | 29,43 | |
| 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO | | | |
| 49549 | OSPEN 400MG | sir 1x150ml | BCA | A | | | |
| 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
| | | | | | | | |
| 247.7 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| 247.6 | J01CE02 | fenoxymethyl-penicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
| 247.7 | J01CE02 | fenoxymethyl-penicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
@@ -3903,9 +3947,8 @@
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | | | |
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K |
| | | | | | | | |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 32,94 | K |
| 50160 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCW | A | | | |
| 01764 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCA | A | | | |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 27,83 | K |
| 01764 | RATARPEN 2.4 M.U.I. | inj sic 50x2,4mu | BCA | A | | | |
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
| | | | | | | | |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
@@ -3920,46 +3963,45 @@
| | | | | | | | |
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I | | | |
| 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ | | | |
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 98,74 | K |
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 95,80 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | | | |
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 251.1 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | |
| 251.1 | J01CR04 sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | | |
| | | | | | | | |
| 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
| | | | | | | | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
| 46093 | ENHANCIN 250/125MG | tbl obd 21x250mg | RXY | IND | | | |
| 97657 | AUGMENTIN 375MG | tbl obd 21x375mg | LEX | CZ | | | |
| 85524 | AMOKSIKLAV | tbl obd 21x375mg | LEK | SLO | | | |
| 97657 | AUGMENTIN 375MG | tbl obd 21x375mg | LEX | CZ | | | |
| 46093 | ENHANCIN 250/125MG | tbl obd 21x250mg | RXY | IND | | | |
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
| 83738 | AUGMENTIN 625MG | tbl obd 21x625mg | LEX | CZ | | | |
| 46094 | ENHANCIN 500/125MG | tbl obd 21x500mg | RXY | IND | | | |
| 85525 | AMOKSIKLAV | tbl obd 21x625mg | LEK | SLO | | | |
| 53577 | CURAM 625MG | tbl obd 21x625mg | BCA | A | | | |
| 83738 | AUGMENTIN 625MG | tbl obd 21x625mg | LEX | CZ | | | |
| 85525 | AMOKSIKLAV | tbl obd 21x625mg | LEK | SLO | | | |
| 46094 | ENHANCIN 500/125MG | tbl obd 21x500mg | RXY | IND | | | |
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 53959 | AUGMENTIN 1GM | tbl obd 14x1gm | LEX | CZ | | | |
| 12494 | AUGMENTIN 1GM | tbl 14x1gm | SKB | GB | | | |
| 05951 | AMOKSIKLAV 1G | tbl obd 14x1gm | LEA | SLO | | | |
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | | | |
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | |
| 97658 | AUGMENTIN 156MG/5ML | sir sic 1x100ml | LEX | CZ | | | |
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | | | |
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | |
| 83739 | AUGMENTIN 312MG/5ML | sir sic 1x100ml | LEX | CZ | | | |
| 53571 | CURAM 312.5MG/5ML | plv sus 1x100ml | BCA | A | | | |
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB |
| | | | | | | | |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB |
| 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO | | | |
| 32279 | AMOKSIKLAV 600 MG | inj sic 5x600mg | LEA | SLO | | | |
| 97660 | AUGMENTIN 1.2GM | inj sic 5x1.2gm | LEX | CZ | | | |
| 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO | | | |
| 32279 | AMOKSIKLAV 600 MG | inj sic 5x600mg | LEA | SLO | | | |
| 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO | | | |
| 32280 | AMOKSIKLAV 1.2 G | inj sic 5x1.2gm | LEA | SLO | | | |
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
| | | | | | | | |
@@ -3971,11 +4013,11 @@
| 253 | J01DA | cefalosporinová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | |
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | | | |
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | | | |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | | | |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | | | |
| 06158 | ORACEF | cps 16x500mg | KRK | SLO | | | |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | | | |
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | | | |
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | | | |
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | | | |
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | | | |
@@ -3984,23 +4026,26 @@
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| | | | | | | | |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 71,43 | |
| 53153 | VERCEF 250MG | cps 7x3(blistr) | RXY | IND | | | |
| 58765 | SERVICLOR 250 MG | cps 21x250mg | BCA | A | | | |
| 47210 | VERCEF MR 375 MG | por tblret 14x375mg | RXY | IND | | | |
| 53153 | VERCEF 250MG | cps 7x3(blistr) | RXY | IND | | | |
| 01665 | CEFACLOR 250-SL | cps 21x250mg | SLO | SK | | | |
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | |
| 32156 | SERVICLOR 500 MG | cps 21x500mg | BCA | A | | | |
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | | | |
| 01667 | CEFACLOR 500-SL | cps 21x500mg | SLO | SK | | | |
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | | | |
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D | | | |
| 53157 | VERCEF 500MG | cps 7x3(blistr) | RXY | IND | | | |
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | |
| | | | | | | | |
| 58763 | SERVICLOR 125 MG/5ML | por gra sus 1x100ml | BCA | A | | | |
| 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | |
| 53152 | VERCEF 250MG/5ML | plv sus 1x100ml | RXY | IND | | | |
| 58764 | SERVICLOR 250 MG/5ML | por gra sus 1x100ml | BCA | A | | | |
| 66282 | CEFACLOR AL SUSP. | gra sus 1x100ml/5gm | APA | D | | | |
| 53152 | VERCEF 250MG/5ML | plv sus 1x100ml | RXY | IND | | | |
| 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 40,00 | |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A | | | |
| 44799 | BIODROXIL | cps 12x500mg | BCA | A | | | |
| 253.10 | J01DA09 | Cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 63,30 | |
| 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 63,30 | |
| | | | | | | | |
| 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| | | | | | | | |
@@ -4025,26 +4070,28 @@
- c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK | | | |
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 149,40 | U/ATB |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | | | |
| 85510 | VULMIZOLIN 1.0 | inj sic 50x1gm | BTA | SK | | | |
| 91148 | VULMIZOLIN 1.0 | inj sic 10x1gm | BTA | SK | | | |
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F | | | |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | | | |
| 83111 | ORIZOLIN 1000 | inj sic 1x1000mg | CAI | IND | | | |
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB |
| | | | | | | | |
| 254.4 | J01DA06 | Cefuroxim | parent. | 4 | GM | 439,20 | U/ATB |
| 64837 | AXETINE 750MG | inj sic 100x750mg | MOE | CY | | | |
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 439,20 | U/ATB |
| 64835 | AXETINE 750MG | inj sic 10x750mg | MOE | CY | | | |
| 64832 | AXETINE 1.5GM | inj sic 50x1.5gm | MOE | CY | | | |
| 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY | | | |
| 64831 | AXETINE 1.5GM | inj sic 10x1.5gm | MOE | CY | | | |
| 64830 | AXETINE 1.5GM | inj sic 1x1.5gm | MOE | CY | | | |
| 64835 | AXETINE 750MG | inj sic 10x750mg | MOE | CY | | | |
| 64831 | AXETINE 1.5GM | inj sic 10x1.5gm | MOE | CY | | | |
| 64834 | AXETINE 750MG | inj sie 1x750mg | MOE | CY | | | |
| 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY | | | |
| 64832 | AXETINE 1.5GM | inj sic 50x1.5gm | MOE | CY | | | |
| 64836 | AXETINE 750MG | inj sie 50x750mg | MOE | CY | | | |
| 64837 | AXETINE 750MG | inj sic 100x750mg | i MOE | CY | | | |
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB |
| | | | | | | | |
| 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 524,01 | U/ATB |
| 05770 | TAXCEF | inj sic 1x1gm | RXY | IND | | | |
| 94176 I | CEFOTAXIME | inj 1x1gm | LEK | SLO | | | |
| 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO | | | |
| 254.7 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 459,00 | U/ATB |
| 05748 | TAXCEF 2G | inj sic 1x2gm | RXY | IND | | | |
| 254.8 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB |
@@ -4061,40 +4108,40 @@
| 254.13 | J01DA24 | cefepim | parent. | 4 | GM | 1605,91 | U/ATB |
| | | | | | | | |
| 254.14 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U/ATB |
| | | | | | | | |
| 254.15 | J01DA32 | cefoperazon | parent. | 6 | GM | 1526,24 | U/ATB |
| | | | | | | | |
| 254.16 | J01DA37 | cefpirom | parent. | 4 | GM | 1679,48 | U/ATB |
| 254.16 | J01DA37 | cefpirom | parent. | 4 | GM | 1638,40 | U/ATB |
| 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F | | | |
| 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1670,80 | U/ATB |
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1645,60 | U/ATB |
| 86412 | AZACTAM | inj sic 1x1gm | BMS | I | | | |
| 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2259,20 | U/ATB |
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2194,52 | U/ATB |
| 83487 | MERONEM 500MG I.V. | inj sic 10x500mg | ZNC | GB | | | |
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2258,99 | U/ATB |
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2238,99 | U/ATB |
| 12091 | TIENAM I.M. | inj sic 1x500/500mg | MSD | CH | | | |
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 12,32 | |
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 GM | 11,88 | | |
| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D | | | |
| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D | | | |
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 9,29 | |
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 8,94 | |
| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D | | | |
| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D | | | |
| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D | | | |
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | |
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | |
| | | | | | | | |
| 258.2 | J01EE01 | Sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | |
| 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | |
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D | | | |
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D | | | |
| 87758 | ORIPRIM | tbl 100x480mg | CAI | IND | | | |
| 12917 | BISMORAL 480 | tbl 20x480mg | SLO | SK | | | |
| 06264 | SUMETROLIM | tbl 20x480mg | EGI | H | | | |
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D | | | |
| 97868 | ORIPRIM | tbl 20x480mg | CAI | IND | | | |
| 87758 | ORIPRIM | tbl 100x480mg | CAI | IND | | | |
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D | | | |
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | |
| | | | | | | | |
| 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
@@ -4108,56 +4155,57 @@
| 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 259.1 | J01EE01 | Sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 129,00 | K |
| 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 127,04 | K |
| 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO | | | |
| 260 | J01FA | makrolidová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | |
| | | | | | | | |
| 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | |
| 260.1 | J01FA | telithromycin | p.o. | 800 | MG | 96,80 | U/ATB |
| | | | | | | | |
| 260.2 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | |
| | | | | | | | |
| 260.3 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 45,61 | |
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | | | |
| 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D | | | |
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | | | |
| 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D | | | |
| 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D | | | |
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | | | |
| 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 48,42 | |
| | | | | | | | |
| 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 15,36 | |
| | | | | | | | |
| 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 43,77 | |
| | | | | | | | |
| 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 37,84 | |
| | | | | | | | |
| 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 34,05 | |
| | | | | | | | |
| 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 42,58 | |
| | | | | | | | |
| 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 48,40 | |
| | | | | | | | |
| 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 70,00 | |
| | | | | | | | |
| 260.11 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 63,77 | |
| | | | | | | | |
| 260.12 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 63,27 | |
| | | | | | | | |
| 260.13 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 86,60 | |
| | | | | | | | |
| 260.14 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 48,42 | |
| | | | | | | | |
| 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,16 | |
| 260.4 | J01FA02 | spiramycin | p.o. | 3 | GM | 48,42 | |
| | | | | | | | |
| 260.5 | J01FA05 | oleandomycin | p.o. | 1 | GM | 15,36 | |
| | | | | | | | |
| 260.6 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 43,77 | |
| | | | | | | | |
| 260.7 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 37,84 | |
| | | | | | | | |
| 260.8 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 34,05 | |
| | | | | | | | |
| 260.9 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 42,58 | |
| | | | | | | | |
| 260.10 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 48,40 | |
| 53282 | FROMILID 250 | tbl obd 14x250mg | KRK | SLO | | | |
| 53283 | FROMILID 500 | tbl obd 14x500mg | KRK | SLO | | | |
| 260.11 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 70,00 | |
| | | | | | | | |
| 260.12 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 63,77 | |
| | | | | | | | |
| 260.13 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 63,27 | |
| | | | | | | | |
| 260.14 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 86,60 | |
| | | | | | | | |
| 260.15 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 48,42 | |
| | | | | | | | |
| 260.16 | J01RA | kombinace antibakteriálních léčiv (spiramycin/ metronidazol) | p.o. | 5 | DF | 32,16 | |
| 261 | J01FA | makrolidová antibiotika | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 717,50 | K |
| | | | | | | | |
| 261.2 | J01FA02 | spiramycin | parent. | 4,5 | MU | 663,67 | K |
| 78174 | ROVAMYCINE 1.5 M.I.U. | plv inf 1x1.5mu | RSL | F | | | |
| 261.3 | J01FA09 | klaritromycin | parent. | 1 | GM | 861,00 | K |
| 262 | J01FF | linkosamidová antibiotika | p.o. | ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 55,46 | |
| 56867 | KLIMICIN 300MG | cps 16x300mg | LEK | SLO | | | |
| 03365 | DALACIN C | cps 16x150mg | UPJ | B | | | |
| 94574 | KLIMICIN | cps 16x150mg | LEK | SLO | | | |
| 83458 | DALACIN C | cps 16x300mg | UPJ | B | | | |
| 94574 | KLIMICIN | cps 16x150mg | LEK | SLO | | | |
| 56867 | KLIMICIN 300MG | cps 16x300mg | LEK | SLO | | | |
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 136,53 | |
| | | | | | | | |
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB |
@@ -4165,14 +4213,16 @@
| 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB |
| 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 263.1 | J01FF01 | klindamycin (do 0,3 GM včetně v jedné ampuli) | parent. | 1.8 | GM | 598,67 | U/ATB |
| | | | | | | | |
| 263.2 | J01FF01 | klindamycin (nad 0,3 GM v jedné ampuli) | parent. | 1.8 | GM | 548,92 | U/ATB |
| 263.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.8 | GM | 598,67 | U/ATB |
| | | | | | | | |
| 263.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.8 | GM | 548,92 | U/ATB |
| | | | | | | | |
| 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB |
| | | | | | | | |
| 263.4 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1 | DF | 2492,00 | U/ATB |
| 264 | J01GA | streptomycin a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 119,10 | |
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 117,10 | |
| 59732 | STREPTOMYCIN GRUNENTHAL 1.0 G | inj sic 1x1gm+solv. | GRU | D | | | |
| 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4186,7 +4236,7 @@
| | | | | | | | |
| 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB |
| | | | | | | | |
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1 | DF | 152,06 | U/ATB |
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k impiantaci) | imp. | 1 | DF | 152,06 | U/ATB |
| | | | | | | | |
| 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB |
| | | | | | | | |
@@ -4198,9 +4248,9 @@
| | | | | | | | |
| 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB |
| | | | | | | | |
| 265.12 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB |
| | | | | | | | |
| 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB |
| 265.12 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB |
| | | | | | | | |
| 265.13 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB |
| 266 | J01MA | fluorované chinolony | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4208,25 +4258,27 @@
| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 24,50 | |
| 12349 | ZANOCIN 200MG | tbl obd 10x200mg | RXY | IND | | | |
| 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 24,50 | |
| 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND | | | |
| 266.2 | J01MA02 | Ciprofloxacin | p.o. | 1 | GM | 24,50 | |
| 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | | | |
| 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND | | | |
| 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ | | | |
| 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | | | |
| 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK | | | |
| 44986 | CIPLOX 500 | tbl obd 50x500mg CIA | IND | | | | |
| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | | | |
| 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND | | | |
| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | | | |
| 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK | | | |
| 69195 | CIPROBID 250 | tbl obd 10x250mg | CAI | IND | | | |
| 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO | | | |
| 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO | | | |
| 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND | | | |
| 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK | | | |
| 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK | | | |
| 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ | | | |
| 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | | | |
| 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | | | |
| 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO | | | |
| 69196 | CIPROBID 500 | tbl obd 10x500mg | CAI | IND | | | |
| 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 24,50 | |
| 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO | | | |
| 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 20,50 | |
| | | | | | | | |
| 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 20,50 | |
| 44091 | GYRABLOCK 400 | tbl obd 1000x400mg | MOE | CY | | | |
| 93465 | NOLICIN | tbl 20x400mg | KRK | SLO | | | |
| 44091 | GYRABLOCK 400 | tbl obd 1000x400mg | MOE | CY | | | |
| 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 24,50 | |
| | | | | | | | |
| 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 24,50 | |
@@ -4239,7 +4291,7 @@
| | | | | | | | |
| 266.11 | J01MA | trovafloxacin | p.o. | 0,2 | GM | 24,50 | P |
| | | | | | | | |
| 266.12 | J01MB05 | kyselina oxolinová | p.o. | 1 | GM | 8,55 | |
| 266.12 | J01MB05 | kyselina oxolinová | p.o. | 1 | GM | 8,91 | |
| 91101 | DESUROL | tbl 50x250mg | LEX | CZ | | | |
| 267 | J01MA | fluorované chinolony | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4248,9 +4300,9 @@
| 267.2 | J01MA02 | ciprofloxacin - infúze | parent. | 0.5 | GM | 212,23 | U/ATB |
| 59829 | CIPRINOL 100MG/50ML | inf 1x50ml/100mg | KRK | SLO | | | |
| 59830 | CIPRINOL 200MG/100ML | inf 1x100ml/200mg | KRK | SLO | | | |
| 267.3 | J01MA02 | Ciprofloxacin - injekce | parent. | 0.5 | GM | 190,00 | U/ATB |
| | | | | | | | |
| 267.4 | J01MA03 | Pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB |
| 267.3 | J01MA02 | ciprofloxacin - injekce | parent. | 0.5 | GM | 190,00 | U/ATB |
| | | | | | | | |
| 267.4 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB |
| 94155 | ABAKTAL | inj 10x5ml/400mg | LEK | SLO | | | |
| 267.5 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 212,23 | U/ATB |
| | | | | | | | |
@@ -4260,15 +4312,17 @@
| 268 | J01XA | ostatní antibiotika | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1265,30 | U/ATB |
| 92290 | EDICIN 1GM | inj.sicc.1x1gm | LEK | SLO | | | |
| 92289 | EDICIN 0.5GM | inj.sicc.1x500mg | LEK | SLO | | | |
| 92290 | EDICIN 1GM | inj.sicc.1x1gm | LEK | SLO | | | |
| 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 2492,83 | U/ATB |
| | | | | | | | |
| 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 116,92 | U/ATB |
| 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 109,34 | U/ATB |
| 61178 | COLIMYCINE | inj sic 50x1mu | RBE | F | | | |
| 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103,09 | U/ATB |
| | | | | | | | |
| 268.5 | J01XX | quinupristin v kombinaci s dalfopristinem | parent | 1 | DF | 2492,00 | U/ATB |
| 268.5 | J01XX08 | linezolid | p.o. | 1,2 | GM | 4958,00 | U/ATB |
| | | | | | | | |
| 268.6 | J01XX08 | linezolid | parent | 1,2 | GM | 4958,00 | U/ATB |
| 269 | J01XB | polymyxinová antibiotika | p.o. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 42,82 | U/ATB |
@@ -4277,13 +4331,13 @@
| 270.1 | J01XD01 | metronidazol | parent. | 1.5 | GM | 176,89 | U |
| | | | | | | | |
| 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 50,44 | U |
| 96404 | AVRAZOR | inj 5x3ml/500mg | LEX | CZ | | | |
| | | | | | | | |
| 270.3 | J01XE01 | nitrofurantoin | p.o. | 0.2 | GM | 3,65 | |
| 90510 | FURANTOIN LECIVA | tbl ent 20x100mg | LEX | CZ | | | |
| 271 | J02AA | antimykotická antibiotika | parent. | U | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 285,31 | U |
| 57548 | AMPHOTERICIN B SQUIBB | inj sic 1x50mg | BMJ | | | | |
| 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 279,36 | U |
| 57548 | AMPHOTERICIN B SQUIBB | inj sic 1x50mg | BMJ | F | | | |
| 271.2 | J02AA01 | amfotericin na tukových nosičích | parent. | 35 | MG | 1597,70 | U/ATB |
| 272 | J02AB | imidazolová antimykotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4324,30 +4378,37 @@
- e) itrakonazol tekuté lékové formy - léčba orální a oesophageální kandidózy a profylakticky u imunokompromitovaných pacientů
| 274.1 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě ) | p.o. | 0.15 | GM | 203,85 | P |
| 10743 | MYCOSYST 150 MG | cps 4x150mg | GED | H | | | |
| 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO | SK | | | |
| 66039 | MYCOMAX 150 | cps 1x150mg | LEX | CZ | | | |
| 59876 | MYCOSYST 150MG | cps 2x150mg | GED | H | | | |
| 59875 | MYCOSYST 150MG | cps 1x150mg | GED | H | | | |
| 5987b | MYCOSYST 150MG | cps 2x150mg | GED | H | | | |
| 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO | SK | | | |
| 10743 | MYCOSYST 150 MG | cps 4x150mg | GED | H | | | |
| 59788 | DIFLAZON 150 | cps 1x150mg | KRK | SLO | | | |
| 274.2 | J02AC01 | flukonazol - ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.2 | GM | 262,18 | P |
| 59786 | DIFLAZON 50 | cps 7x50mg | KRK | SLO | | | |
| 59874 | MYCOSYST 100MG | cps 28x100mg | GED | H | | | |
| 59873 | MYCOSYST 50MG | cps 7x50mg | GED | H | | | |
| 59874 | MYCOSYST 100MG | cps 28x100mg | GED | H | | | |
| 59790 | DIFLAZON 200 | cps 20x200mg | KRK | SLO | | | |
| 59789 | DIFLAZON 200 | cps 7x200mg | KRK | SLO | | | |
| 59787 | DIFLAZON 100 | cps 28x100mg | KRK | SLO | | | |
| 55396 | FLUCONAZOL 50-SLOVAKOFARMA | cps 7x50mg | SLO | SK | | | |
| 66033 | MYCOMAX 50 | cps 28x50mg | LEX | CZ | | | |
| 66036 | MYCOMAX 100 | cps 28x100mg | LEX | CZ | | | |
| 66032 | MYCOMAX 50 | cps 7x50mg | LEX | CZ | | | |
| 55396 | FLUCONAZOL 50-SLOVAKOFARMA | cps 7x50mg | SLO | SK | | | |
| 55397 | FLUCONAZOL 50-SLOVAKOFARMA | cps 14x50mg | SLO | SK | | | |
| 66037 | MYCOMAX 100 | cps 7x100mg | LEX | CZ | | | |
| 274.3 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 479,01 | P |
| 66032 | MYCOMAX 50 | cps 7x50mg | LEX | CZ | | | |
| 274.3 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.2 GM | 479,01 | P | |
| 66031 | MYCOMAX SIR | sir 1x100ml/500mg | LEX | CZ | | | |
| 64950 | DIFLUCAN 50MG/5ML | plv pro sus 1x35ml | PFC | F | | | |
| 274.4 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 436,59 | P |
| | | | | | | | |
| 274.5 | J02AC01 | flukonazol - tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.2 | GM | 349,25 | P |
| | | | | | | | |
| 274.6 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.2 | GM | 95,60 | P |
| 274.6 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom baleni) | p.o. | 0.2 | GM | 95,60 | P |
| | | | | | | | |
| 274.7 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 120,00 | P |
| | | | | | | | |
| 274.8 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 402,81 | P |
| 274.8 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 391,27 | P |
| 56067 | SPORANOX | sol 1x150ml/1.5gm | JAN | B | | | |
| 274.9 | J02AX01 | flucytosin | p.o. | 10 | GM | 858,22 | P |
| 275 | J02AC | triazolová antimykotika | parent. | U/P | | | |
@@ -4358,37 +4419,39 @@
Profylakticky: u imunokomprimovaných pacientů nebo pacientů připravovaných k transplantaci.
| 275.1 | J02AC01 | flukonazol | parent. | 0.2 | GM | 550,00 | U/P |
| 58431 | DIFLAZON | inf 1x100ml/200mg | KRK | SLO | | | |
| 46979 | FLUCONAZOL-SLOVAKOFARMA PRO INF | inf 1x100ml/200mg | SLO | SK | | | |
| 58431 | DIFLAZON | inf 1x100ml/200mg | KRK | SLO | | | |
| 275.2 | J02AX01 | flucytosin | parent. | 10 | GM | 2710,83 | U/P |
| | | | | | | | |
| 275.3 | J02AX04 | caspofungin s obsahem 50 mg v jedné ampulce | parent. | 1 | DF | 17259,00 | U/ATB |
| | | | | | | | |
| 275.4 | J02AX04 | caspofungin s obsahem 70 mg v jedné ampulce | parent. | 1 | DF | 24163,00 | U/ATB |
| 276 | J04AB | antibiotika k léčbě tuberkulózy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu rifabutinem ordinuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.
Léčbu rifabutinem ordinuje Pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.
| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 12,76 | |
| 96735 | ARFICIN | cps 100x150mg | BLU | CHO | | | |
| 96780 | ARFICIN | cps 100x300mg | BLU | CHO | | | |
| 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 125,72 | P |
| 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 244,40 | |
| | | | | | | | |
| 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 553,11 | |
| 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,00 | |
| 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,04 | |
| 03303 | NIDRAZID | tbl 250x100mg | LEX | CZ | | | |
| 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 14,85 | |
| | | | | | | | |
| 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,42 | |
| 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 14,63 | |
| 75508 | TISAMID | tbl 100x500mg | ORN | SF | | | |
| 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,22 | |
| 03023 | SURAL | tbl 100x400mg | CHN | H | | | |
| 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,37 | |
| 93821 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | SPC | F | | | |
| 91888 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | LVN | F | | | |
| 281 | J05A | antivirotika | p.o. | P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4396,7 +4459,7 @@
- a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,
- b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků).
- b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),
- c) léčba herpes zoster při lokalizaci v obličeji,
@@ -4408,7 +4471,7 @@
Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir, lamivudin a abacavir) indikuje infekcionista pracující v AIDS centrech.
Léčbu lamivudinem dále indikuje ošetřující lékař u chronické virové hepatitidy typu B.
Léčbu lamivudinem dále indikuje ošetřující lékař u chronické vírové hepatitidy typu B.
Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
@@ -4422,56 +4485,63 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 281.2 | J05AB01 | acyklovir do 200 mg včetně | p.o. | 4 | GM | 320,00 | P |
| 84127 | HERPESIN 200 | tbl 25x200mg | LCM | CZ | | | |
| 53608 | XOROX 200MG | tbl 25x200mg | KWI | A | | | |
| 57068 | ACICLOVIR AL 200 | tbl 25x200mg | APA | D | | | |
| 54213 | RANVIR 200 | tbl 25x200mg | RXG | IND | | | |
| 54031 | PROVIRSAN | tbl 30x200mg | PMP | CZ | | | |
| 281.3 | J05AB01 | acyklovir nad 200 mg | p.o. | 4 | GM | 265,00 | P |
| 84128 | HERPESIN 400 | tbl 25x400mg | LCM | CZ | | | |
| 53610 | XOROX 400MG | tbl 60x400mg | KWI | A | | | |
| 53611 | XOROX 800MG | tbl 35x800mg | KWI | A | | | |
| 56079 | ACICLOVIR AL 400 | tbl 35x400mg | APA | D | | | |
| 54216 | RANVIR 400 | tbl 25x400mg | RXG | IND | | | |
| 281.4 | J05AB04 | ribavirin | p.o. | 1200 | MG | 877,00 | X |
| | | | | | | | |
| 281.5 | J05AB06 | gancyklovir | p.o. | 3 | GM | 2002,96 | P |
| 54216 | RANVIR 400 | tbl 20x400mg | RXG | IND | | | |
| 281.4 | J05AB04 | ribavirin | p.o. | 1 | GM | 730,83 | X |
| | | | | | | | |
| 281.5 | J05AB06 | gancyklovir | p.o. | 3 | GM | 1960,07 | P |
| 59653 | CYMEVENE 250MG | cps 84x250mg | RPE | GB | | | |
| 281.6 | J05AB09 | famcyklovir | p.o. | 0.75 | GM | 458,88 | P |
| | | | | | | | |
| 281.7 | J05AB11 | valacyklovir | p.o. | 3 | GM | 440,00 | P |
| | | | | | | | |
| 281.8 | J05AE01 | saquinavir | p.o. | 1,8 | GM | 504,14 | P |
| | | | | | | | |
| 59463 | FORTOVASE 200 MG | cps 180x200mg | HLR | D | | | |
| 281.9 | J05AE02 | indinavir | p.o. | 2,4 | GM | 504,14 | P |
| | | | | | | | |
| 281.10 | J05AE03 | ritonavir | p.o. | 1,2 | GM | 504,14 | P |
| | | | | | | | |
| 281.11 | J05AE04 | nelfinavir | p.o. | 2,25 | GM | 504,14 | P |
| | | | | | | | |
| 281.12 | J05AF01 | zidovudin | p.o. | 1.5 | GM | 685,28 | P |
| | | | | | | | |
| 281.13 | J05AF02 | didanosin | p.o. | 0.4 | GM | 236,43 | P |
| | | | | | | | |
| 281.14 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 241,76 | P |
| 66734 | HIVID 0.75MG | tbl obd 100x0.75mg | HLR | CH | | | |
| 281.15 | J05AF04 | stavudin | p.o. | 80 | MG | 302,07 | P |
| 281.12 | J05AE06 | lopinavir,ritonavir v kombinaci | p.o. | 6 | DF | 564,00 | P |
| | | | | | | | |
| 281.13 | J05AF01 | zidovudin | p.o. | 1.5 | GM | 685,28 | P |
| | | | | | | | |
| 281.14 | J05AF02 | didanosin | p.o. | 0.4 | GM | 236,43 | P |
| | | | | | | | |
| 281.15 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 235,25 | P |
| 66734 | HMD 0.75MG | tbl obd 100x0.75mg | HLR | CH | | | |
| 281.16 | J05AF04 | stavudin | p.o. | 80 | MG | 302,07 | P |
| 53209 | ZERIT 40MG | cps 56x40mg | BMS | F | | | |
| 53210 | ZERIT 40MG | cps 60x40mg | BMS | F | | | |
| 281.16 | J05AF05 | lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně | p.o. | 0,3 | GM | 327,60 | P |
| 281.17 | J05AF05 | lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně | p.o. | 0,3 | GM | 292,03 | P |
| 02085 | ZEFFIX 100 MG | tbl obd 28x100mg | GOW | GB | | | |
| 02086 | ZEFFIX 100 MG | tbl obd 84x100mg | GOW | GB | | | |
| 02087 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GWL | GB | | | |
| 281.17 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru | p.o. | 0,3 | GM | 248,01 | P |
| | | | | | | | |
| 281.18 | J05AF06 | abacavir | p.o. | 600 | MG | 360,00 | P |
| | | | | | | | |
| 281.19 | J05AF30 | abacavir, lamivudin a zidovudin v kombinaci | p.o. | 2 | DF | 882,13 | P |
| 281.18 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru | p.o. | 0,3 | GM | 248,01 | P |
| | | | | | | | |
| 281.19 | J05AF06 | abacavir | p.o. | 600 | MG | 360,00 | P |
| | | | | | | | |
| 281.20 | J05AF30 | abacavir, lamivudin a zidovudin v kombinaci | p.o. | 2 | DF | 852,04 | P |
| 30158 | TRIZIVIR | por tbl flm 1x60 | GOW | GB | | | |
| 281.20 | J05AF30 | jiné kombinace antiretrovirových virostatik (lamivudin a zidovudin) | p.o. | 2 | DF | 522,13 | P |
| | | | | | | | |
| 281.21 | J05AG01 | nevirapin | p.o. | 0,4 | GM | 353,49 | P |
| 281.21 | J05AF30 | jiné kombinace antiretrovirových virostatik (lamivudin a zidovudin) | p.o. | 2 | DF | 522,13 | P |
| | | | | | | | |
| 281.22 | J05AG01 | nevirapin | p.o. | 0,4 GM | 343,34 | P | |
| 57777 | VIRAMUNE | tbl 60x200mg | UUI | P | | | |
| 281.22 | J05AG03 | efavirenz | p.o. | 0,6 | GM | 431,00 | P |
| | | | | | | | |
| 281.23 | J05AH01 | zanamivir | inhal. | 20 | MG | 130,00 | P |
Zanamivir je indikován pro léčbu influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam, kde očkovaní selhalo, u následujících skupin pacientů:
| 281.23 | J05AG03 | efavirenz | p.o. | 0,6 | GM | 431,00 | P |
| | | | | | | | |
| 281.24 | J05AH01 | zanamivir | inhal. | 20 | MG | 130,00 | P |
Zanamivir je indikován pro léčbu influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:
- 1. děti starší 12 let s cystickou fibrózou, děti s onkologickým onemocněním na imunosupresivní léčbě
@@ -4481,9 +4551,9 @@
Z veřejného zdravotního pojištění je pro jednu terapeutickou kůru hrazeno jedno balení určené k pětidenní léčbě. Zanamivir u výše uvedených skupin ordinuje ošetřující lékař pouze v době chřipkové epidemie vyhlášené hlavním hygienikem.
| 281.24 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 30,55 | P |
| 281.25 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 30,55 | P |
| 88174 | ISOPRINOSINE | tbl 5x10(=50)x500mg | EWO | CH | | | |
| 282 | J05AB | antivirotika ze skupiny nukloeosidů | parent. | U/P | | | |
| 282. | J05AB | antivirotika ze skupiny nukloeosidů | parent. | U/P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:
@@ -4509,7 +4579,8 @@
- c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
| 282.1 | J05AB01 | acyklovir | parent. | 4 | GM | 1551,47 | U/P |
| 93260 | HERPESIN 250 | inj sic 10x250mg | LCM | CZ | | | |
| 53607 | XOROX 250MG | inf sic 5x250mg | KWI | A | | | |
| 93260 | HERPESIN 250 | inf sic 10x250mg | PVL | CZ | | | |
| 282.2 | J05AB06 | gancyklovir | parent. | 0.5 | GM | 1568,70 | U/P |
| 02064 | CYMEVENE | inf sic 1x500mg | HLR | CH | | | |
| 282.3 | J05AB12 | cidofovir | parent. | 375 | MG | 33556,50 | U/P |
@@ -4532,38 +4603,35 @@
Sérum proti vzteklině ordinuje infekcionista k profylaxi nebo terapii vztekliny.
| 283.1 | J06AA | sérum proti stafylokokovým infekcím | parent. | | | plně | K/P | |
| | | | | | | | | |
| 283.2 | J06AA01 | sérum proti záškrtu | parent. | | | plně | K/P | |
| | | | | | | | | |
| 283.3 | J06AA03 | sérum proti hadímu jedu | parent. | | | plně | K/P | |
| 83330 | IPSER EUROPE PASTEUR(ANTIVEN.) | inj 1x5ml | PMX | F | | | | |
| 283.4 | J06AA04 | sérum proti botulinu | parent. | | | plně | K/P | |
| 01190 | BOSEA | inj 1x35ml | SVF | CZ | | | | |
| 283.5 | J06AA05 | sérum | proti plynaté sněti | parent. | | | plně | K/P |
| 01195 | GASEA | inj 1x20ml/25ku | SVF | CZ | | | | |
| 283.6 | J06AA06 | sérum proti vzteklině | parent. | | | plně | K/P | |
| 94015 | SERUM ANTIRAB.1000 U.I.PASTEUR | inj 1x5ml 200ut/ml | PMX | F | | | | |
| 284 | J06BA | imunoglobuliny, normální lidské | parent. | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 284.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci do velikosti méně než 5 ml v jedné ampuli | parent. | 1 | DF | 175,50 | O | |
| 57669 | PASTEUR.HUM. IMMUNOGL.GRIFOLS 16 | inj 1x2ml/320mg | GFO | E | | | | |
| 284.2 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci 5 ml a více v jedné ampuli | parent. | 1 | DF | 438,75 | O | |
| 57670 | PASTEUR.HUM. IMMUNOGL.GRIFOLS 16 | inj 1x5ml/800mg | GFO | E | | | | |
| 284.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (z tuzemské plazmy zakázkovou frakcionací) | parent. | 1 | GM | 991,90 | B | |
| | | | | | | | | |
| 284.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1 | GM | 991,90 | B | |
| 62555 | INTRAGLOBIN F PRO INFUS. | inf 1x200ml | BTP | D | | | | |
| 62554 | INTRAGLOBIN F PRO INFUS. | inf 1x100ml | BTP | D | | | | |
| 62553 | INTRAGLOBIN F PRO INFUS. | inf 1x50ml | BTP | D | | | | |
| 284.5 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1 | GM | 1955,16 | U | |
| | | | | | | | | |
| 284.6 | J06BA | imunoglobuliny, norm. lidské ( k extravasální aplikaci), kombinace s histaminem | parent. | 1 | DF | 89,53 | O | |
| 87736 | HISTAGLOBIN | inj sic 3x12mg+sol. | BBL | CH | | | | |
| 285 | J06BB | specifické imunoglobuliny | parent. | K | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu imunoglobuliny proti neštovicím a pásovému oparu ordinuje infekcionista, onkolog, hematolog a pediatr:
| 283.1 | J06AA | sérum proti stafylokokovým infekcím | parent. | | | plně | K/P |
| | | | | | | | |
| 283.2 | J06AA01 | sérum proti záškrtu | parent. | | | plně | K/P |
| 283.3 | J06AA03 | sérum proti hadímu jedu | parent. | | | plně | K/P |
| 83330 | IPSER EUROPE PASTEUR(ANTIVEN.) | inj 1x5ml | PMX | F | | | |
| 283.4 | J06AA04 | sérum proti botulinu | parent. | | | plně | K/P |
| 01190 | BOSEA | inj 1x35ml | SVF | CZ | | | |
| 283.5 | J06AA05 | sérum proti plynaté sněti | parent. | | | plně | K/P |
| 01195 | GASEA | inj 1x20ml/25ku | SVF | CZ | | | |
| 283.6 | J06AA06 | sérum proti vzteklině | parent. | | | plně | K/P |
| 94015 | SERUM ANTIRAB.1000 U.I.PASTEUR | inj 1x5ml 200ut/ml | PMX | F | | | |
| 284 | J06BA | imunoglobuliny, normální lidské | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 284.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci do velikosti méně než 5 ml v jedné ampuli | parent. | 1 | DF | 175,50 | O |
| 57669 | PASTEUR.HUM. IMMUNOGL.GRIFOLS 16 | inj 1x2ml/320mg | GFO | E | | | |
| 284.2 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci 5 ml a více v jedné ampuli | parent. | 1 | DF | 438,75 | O |
| 57670 | PASTEUR.HUM. IMMUNOGL.GRIFOLS 16 | inj 1x5ml/800mg | GFO | E | | | |
| 284.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1 GM | 956,88 | B | |
| 62553 | INTRAGLOBIN F PRO INFUS. | inf 1x50ml | BTP | D | | | |
| 62554 | INTRAGLOBIN F PRO INFUS. | inf 1x100ml | BTP | D | | | |
| 62555 | INTRAGLOBIN F PRO INFUS. | inf 1x200ml | BTP | D | | | |
| 284.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1 | GM | 1955,16 | U |
| | | | | | | | |
| 284.5 | J06BA | imunoglobuliny, norm. lidské ( k extravasální aplikaci), kombinace s histaminem | parent. | 1 | DF | 89,40 | O |
| 87736 | HISTAGLOBIN | inj sic 3x12mg+sol. | BBL | CH | | | |
| 285 | J06BB | specifické imunoglobuliny | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu imunoglobuliny proti nešťovicím a pásovému oparu ordinuje infekcionista, onkolog, hematolog a pediatr:
- a) neočkované těhotné ženy,
@@ -4583,34 +4651,36 @@
Imunoglobulin proti tetanu je hrazen dle symbolu B.
| 285.1 | J06BB | protiencefalický globulin | parent. | 1 | ML | 300,65 | K |
| 285.1 | J06BB12 | protiencefalický globulin | parent. | 1 | ML | 300,65 | K |
| 95084 | FSME-BULIN I.M. | inj 1x5ml | IMM | A | | | |
| 95082 | FSME-BULIN I.M. | inj 1x1ml | IMM | A | | | |
| 95083 | FSME-BULIN I.M. | inj 1x2ml | IMM | A | | | |
| 95084 | FSME-BULIN I.M. | inj 1x5ml | IMM | A | | | |
| 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 RG v jedné ampuli včetně) | parent. | 250 | RG | 1407,96 | K |
| | | | | | | | |
| 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 RG v jedné ampuli) | parent. | 250 | RG | 1320,40 | K |
| 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 rg v jedné ampuli včetně) | parent. | 250 | RG | 1407,96 | K |
| | | | | | | | |
| 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 rg v jedné ampuli) | parent. | 250 RG | 1320,40 | K | |
| 91307 | PARTOBULIN-INJECT I.M. | inj 1x1ml/250rg | OIH | A | | | |
| 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | | | plně | B |
| 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | | plně | B | |
| 44669 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x500ut+2ml | GFO | E | | | |
| 83607 | TETABULIN | inj 250ut/ml | IMM | A | | | |
| 57804 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x1ml/250ut-str | GFO | E | | | |
| 57805 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x2ml/500ut-str | GFO | E | | | |
| 44668 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x250ut+2ml | GFO | E | | | |
| 285.5 | J06BB03 | imunoglobulin proti neštovicím a pásovému oparu | parent. | 1 | KU | 33322,57 | K/P |
| 285.5 | J06BB03 | imunoglobulin proti neštovicím a pásovému oparu | parent. | 1 | KU | 32724,00 | K/P |
| 97896 | VARITECT(R) | inj 1x50ml | BTP | D | | | |
| 97894 | VARITECT(R) | inj 1x5ml | BTP | D | | | |
| 97895 | VARITECT(R) | inj 1x20ml | BTP | D | | | |
| 97896 | VARITECT(R) | inj 1x50ml | BTP | D | | | |
| 285.6 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | | | plně | K |
| 57419 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x3ml/600ut | GFO | E | | | |
| 57420 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x5ml/1000ut | GFO | E | | | |
| 97897 | HEPATECT(R) | inj 1x2ml | BTP | D | | | |
| 97898 | HEPATECT(R) | inj 1x10ml | BTP | D | | | |
| 285.7 | J06BB05 | imunoglobulin proti rabies | parent. | | | plně | K/P |
| 46731 | IMOGAM RABIES PASTEURIZED | inj 1x10ml/1500ut | AVS | F | | | |
| 53163 | IMOGAM RABIES PASTEURIZED | inj 1x2ml/300ut | AVS | F | | | |
| 46731 | IMOGAM RABIES PASTEURIZED | inj 1x10ml/1500ut | AVS | F | | | |
| 285.8 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 4956,87 | U/P |
| 285.8 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 4817,20 | U/P |
| 94864 | CYTOTECT | inf 1x50ml 100mg/ml | BTP | D | | | |
| 94862 | CYTOTECT | inj 1x10ml 100mg/ml | BTP | D | | | |
| 94863 | CYTOTECT | inj 1x20ml 100mg/ml | BTP | D | | | |
| 94862 | CYTOTECT | inj 1x10ml 100mg/ml | BTP | D | | | |
| 94864 | CYTOTECT | inf 1x50ml 100mg/ml | BTP | D | | | |
| 285.9 | J06BB16 | palivizumab do 50 mg v jedné ampuli včetně | parent | 1 | DF | 27.645 | X |
| 02106 | SYNAGIS 50MG | inj sic 1x50mg+sol | ABB | I | | | |
| 285.10 | J06BB16 | palivizumab nad 50 mg v jedné ampuli | parent. | 1 | DF | 45.568,00 | X |
@@ -4618,87 +4688,90 @@
| 286 | J07AM | očkovací látky proti tetanu | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 286.1 | J07AM01 | tetanový toxoid | parent. | | | plně | K |
| 83444 | TETAVAX | inj 20x0.5ml-strik. | PMX | F | | | |
| 83622 | ALTEANA | inj 10x0.5ml | SVF | CZ | | | |
| 83443 | TETAVAX | inj 1x0.5ml-strik. | PMX | F | | | |
| 83526 | TETAVAX | inj 10x10ml | PMX | F | | | |
| 83447 | TETAVAX | inj 10x20ml | PMX | F | | | |
| 83445 | TETAVAX | inj 1x10ml | PMX | F | | | |
| 83525 | TETAVAX | inj 20x0.5ml-ampule | PMX | F | | | |
| 83447 | TETAVAX | inj 10x20ml | PMX | F | | | |
| 83622 | ALTEANA | inj 10x0.5ml | SVF | CZ | | | |
| 83445 | TETAVAX | inj 1x10ml | PMX | F | | | |
| 83526 | TETAVAX | inj 10x10ml | PMX | F | | | |
| 83443 | TETAVAX | inj 1x0.5ml-strik. | PMX | F | | | |
| 83444 | TETAVAX | inj 20x0.5ml-strik. | PMX | F | | | |
| 287 | J07AN | očkovací látky proti tuberkulóze | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 254,86 | H |
| 66855 | BCG-VACCINE BEHRING | inj sic 1x0.1 ml+sol | CBG | D | | | |
| 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 229,40 | H |
| 76028 | LYOPHILIZED B.C.G.VACCINE | lyo 10x20davek+sol. | PMX | F | | | |
| 76027 | LYOPHILIZED B.C.G.VACCINE | lyo 10x10davek+sol. | PMX | F | | | |
| 58227 | BCG VACCINE SSI | inj sic 10x10dav+so | SST | DK | | | |
| 58228 | BCG VACCINE SSI | inj sic 10x20dav+so | SST | DK | | | |
| 76189 | BCG-VACCINE 500 BEHRING | inj sic 50x0.1ml+so | CBG | D | | | |
| 66855 | BCG-VACCINE BEHRING | inj sic 1x0.1ml+sol | CBG | D | | | |
| 288 | J07AX | jiné bakteriální očkovací látky | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 288.1 | J07AX | jiné bakteriální vakcíny (proti-stafylokoková vakcína) | parent. | | | plně | K |
| | | | | | | | |
| 288.2 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,15 | K |
| | | | | | | | |
| 288.3 | J07AX | jiné bakteriální vakcíny (proti-pseudomonádová vakcína) | parent. | 1 | DF | 206,02 | 0 |
| | | | | | | | |
| 288.4 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1 | DF | 280,47 | 0 |
| 288.1 | J07AX | jiné bakteriální vakcíny (protistafyloko- ková vakcína) | parent. | | | plně | K |
| 94269 | POLYSTAFANA | inj 10x0.5ml | SVF | CZ | | | |
| 288.2 | J07AX jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,15 | K | |
| | | | | | | | |
| 288.3 | J07AX | jiné bakteriální vakcíny (protipseudo-monádová vakcína) | parent. | 1 | DF | 206,02 | O |
| | | | | | | | |
| 288.4 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1 | DF | 280,47 | O |
Vybrané vakcíny se podávají u splenektomovaných pacientů po nebo před výkonem a u pacientů po transplantaci krvetvorných buněk.
Meningokokus, bivalentni polysacharidový antigen se podává po nebo před výkonem u splenektomovaných pacientů.
| 288.5 | J07AG51 | vakcína proti hemofilu influenze B | parent. | 1 | DF | 212,30 | O/P |
| | | | | | | | |
| 288.6 | J07AL01 | pneumokoková vakcína | parent. | 1 | DF | 208,70 | O/P |
| | | | | | | | |
| 288.7 | J07AM51 | tetanový anatoxin, kombinace s anatoxinem záškrtu | parent. | 1 | DF | 11,67 | O/P |
Meningokokus, bivalentni polysacharídový antigen se podává po nebo před výkonem u splenektomovaných pacientů.
| 288.5 | J07AG01 | hemofilus influenze B, čistěný purifikovaný antigen | parent. | 1 DF | 212,30 | O/P | |
| | | | | | | | |
| 288.6 | J07AG51 | hemofilus influenze B, kombinace s toxoidy | parent. | 1 | DF | 212,30 | O/P |
| | | | | | | | |
| 288.7 | J07AL01 | pneumokoková vakcína | parent. | 1 | DF | 208,70 | O/P |
| | | | | | | | |
| 288.8 | J07AM51 | tetanový anatoxin, kombinace s anatoxinem záškrtu | parent. | 1 | DF | 11,67 | O/P |
| 01221 | ALDITEANA SEVAC | inj 10x0.5ml | SEV | CZ | | | |
| 288.8 | J07BB02 | chřipka, čištěný antigen | parent. | 1 | DF | 188,90 | O/P |
| 49482 | INFLUVAC | inj 1x0.5ml/dav+str | SOO | NL | | | |
| 12877 | INFLUVAC | inj 10x0.5ml/1dÁvka | SOO | NL | | | |
| 288.9 | J07BB02 | chřipka, čištěný antigen | parent. | 1 | DF | 188,90 | O/P |
| 12877 | INFLUVAC | injsus10x0.5ml/1dáv | SOO | NL | | | |
| 83429 | VAXIGRIP | inj 1x0.5ml | PMX | F | | | |
| 288.9 | J07BF03 | dětská obrna, trivalentní, inaktivovaný celý virus | parent. | 1 | DF | 95,30 | O/P |
| 288.10 | J07BJ01 | zarděnky, živý oslabený virus | parent. | 1 | DF | 74,00 | O/P |
| 49482 | INFLUVAC | injsus1xÖ.5ml/dav. | SOO | NL | | | |
| 288.10 | J07BF03 | dětská obrna, trivalentní, inaktivovaný celý virus | parent. | 1 | DF | 95,30 | O/P |
| | | | | | | | |
| 288.11 | J07BJ01 | zarděnky, živý oslabený virus | parent. | 1 | DF | 74,00 | O/P |
| 88548 | ERVEVAX RUBELLA VACCINE S.C. | inj sic 10dav.+solv | SKX | B | | | |
| 88550 | ERVEVAX RUBELLA VACCINE S.C. | inj sic 1dav.+solv. | SKX | B | | | |
| 288.11 | J07AH03 | meningokokus, bivalentní čištěný polysacharidový antigen | parent. | 1 | DF | 115,10 | O/P |
| 56191 | MENPOVAX A+C | inj sic 1x1dav+solv | CNC | I | | | |
| 88549 | ERVEVAX RUBELLA VACCINE | inj pso Iqf 50dÁv. | SKX | B | | | |
| 288.12 | J07AH03 | meningokokus, bivalentní čištěný polysacharidový antigen | parent. | 1 | DF | 115,10 | O/P |
| 76063 | MENINGOCOCCAL POLYS.A+C VACCINE | inj 1x1dav.+strik. | PMX | F | | | |
| 289 | J07BG | očkovací látky proti vzteklině | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 289.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | | | plně | K |
| 75379 | RABIPUR | inj sic 1x2.5ut | CBG | D | | | |
| 90996 | RABIPUR | inj sic 5x2.5ut | CBG | D | | | |
| 93706 | VERORAB | inj sic 1dav.+0.5ml | PMX | F | | | |
| 75379 | RABIPUR | inj sic 1x2.5ut | CBG | D | | | |
| 290 | L01AA | alkylační cytostatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 5,72 | |
| 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 5,52 | |
| 94174 | CYCLOPHOSPHAMIDE ORION | tbl obd 50x50mg | ONA | SF | | | |
| 290.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,50 | |
| 01842 | LEUKERAN 2MG | tbl obd 25x2mg | BWE | GB | | | |
| 11244 | LEUKERAN | tbl obd 25x2mg | GWE | GB | | | |
| 290.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 3,72 | |
| | | | | | | | |
| 290.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,30 | |
| 58104 | ALKERAN 2MG | tbl obd 25x2mg | GWE | GB | | | |
| 02050 | ALKERAN | tbl obd 25x2mg | BWE | GB | | | |
| 32213 | ALKERAN 2 MG | por tbl obd 25x2mg | GOK | GB | | | |
| 290.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 2,88 | |
| 58105 | ALKERAN 5MG | tbl obd 25x5mg | GWE | GB | | | |
| 02051 | ALKERAN | tbl obd 25x5mg | BWE | GB | | | |
| | | | | | | | |
| 290.6 | L01AA08 | prednimustin | p.o. | 1 | MG | 3,62 | |
| | | | | | | | |
| 290.7 | L01AX03 | temozolomid | p. o. | 370 | MG | 15998,00 | X |
| 66109 | TEMODAL 20MG | cps 5x20mg | SCH | B | | | |
| 66106 | TEMODAL 250MG | cps 5x250mg | SCH | B | | | |
| 66109 | TEMODAL 20MG | cps 5x20mg | SCH | B | | | |
| 66104 | TEMODAL 100MG | cps 5x100mg | SCH | B | | | |
| 291 | L01AA | alkylační cytostatika | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 291.1 | L01AA01 | cyklofosfamid | parent. | 10 | MG | 3,52 | B |
| 10777 | CYTOXAN 1 G | inj sic 6x1gm | BMS | POR | | | |
| 10776 | CYTOXAN 500 MG | inj sic 12x500mg | BMS | POR | | | |
| 10777 | CYTOXAN 1 G | inj sic 6x1gm | BMS | POR | | | |
| 70442 | CYTOXAN | inj sic 12x500mg | BMS | USA | | | |
| 70441 | CYTOXAN | inj sic 12x200mg | BMS | USA | | | |
| 70443 | CYTOXAN | inj sic 6x1gm | BMS | USA | | | |
| 70442 | CYTOXAN | inj sic 12x500mg | BMS | USA | | | |
| 291.2 | L01AA03 | melfalan | parent. | 1 | MG | 12,61 | B/ONK,HEM |
| 75182 | ALKERAN | inj 1x50mg+10mlsolv | BWE | GB | | | |
| 32508 | ALKERAN | inj pso Iqf 50mg | GOK | GB | | | |
| 32507 | ALKERAN | inj pso Iqf 50mg | GXW | I | | | |
| 291.3 | L01AA05 | chlormethin | parent. | 1 | MG | 34,22 | B/ONK,HEM |
| | | | | | | | |
| 291.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,42 | B/ONK,HEM |
@@ -4707,28 +4780,25 @@
| 70469 | HOLOXAN 2GM | inj sic 1x2gm | ASD | D | | | |
| 291.6 | L01AC01 | thiotepa | parent. | 1 | MG | 21,31 | B/ONK,HEM |
| | | | | | | | |
| 291.7 | L01AX04 | dakarbazin | parent. | 10 | MG | 7,92 | B/ONK,HEM |
| 88560 | DACARBAZIN LACHEMA 500 | inj sic 1x500mg | LCM | CZ | | | |
| 90000 | DACARBAZIN LACHEMA 1000 | inj sic 5x1000mg | LCM | CZ | | | |
| 291.7 | L01AX04 | dakarbazin | parent. | 10 | MG | 7,90 | B/ONK,HEM |
| 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | | | |
| 88561 | DACARBAZIN LACHEMA 500 | inj sic 5x500mg | LCM | CZ | | | |
| 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ | | | |
| 88560 | DACARBAZIN LACHEMA 500 | inj sic 1x500mg | LCM | CZ | | | |
| 89999 | DACARBAZIN LACHEMA 1000 | inj sic 1x1000mg | LCM | CZ | | | |
| 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | | | |
| 90000 | DACARBAZIN LACHEMA 1000 | inj sic 5x1000mg | LCM | CZ | | | |
| 292 | L01AB | alkylsulfaty | p.o. | L/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 292.1 | L01AB01 | busulfán (do 0,5 mg v jedné tabletě včetně) | p.o. | 1 | MG | 14,86 | L/ONK,HEM |
| | | | | | | | |
| 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 | MG | 4,89 | L/ONK,HEM |
| 21157 | MYLERAN | tbl 100x2mg | BWE | GB | | | |
| 293 | L01AD | nitrosomočoviny | p.o. | L/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,72 | L/ONK,HEM |
| 60270 | CEENU LOMUSTINE (CCNU) 10MG | cps 20x10mg | BMS | USA | | | |
| 293.2 | L01AD02 | lomustin (nad 10 do 40 mg v jedné tabletě včetně) | p.o. | 1 | MG | 6,01 | L/ONK,HEM |
| 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 MG | 5,72 | L/ONK,HEM | |
| | | | | | | | |
| 293.2 | L01AD02 | lomustin (nad 10 do 40 mg v jedné tabletě včetně) | p.o. | 1 MG | 5,63 | L/ONK,HEM | |
| 03735 | CEENU LOMUSTINE(CCNU) COMBI | cps 6 | BMS | USA | | | |
| 64653 | CEENU LOMUSTINE (CCNU) 100MG | cps 20x100mg | BMS | I | | | |
| 60271 | CEENU LOMUSTINE (CCNU) 40MG | cps 20x40mg | BMS | USA | | | |
| 293.3 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,45 | L/ONK,HEM |
| 293.3 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,39 | L/ONK,HEM |
| 60272 | CEENU LOMUSTINE (CCNU) 100MG | cps 20x100mg | BMS | USA | | | |
| 294 | L01AD | nitrosomočoviny | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4736,6 +4806,7 @@
| 53666 | BICNU(STERILE CARMUSTINE/BCNU/) | inj sic 1x100mg+sol | BMS | I | | | |
| 83482 | BICNU(CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | USA | | | |
| 294.2 | L01AD04 | streptozocin | parent. | 10 | MG | 14,81 | B/ONK,HEM |
| | | | | | | | |
| 294.3 | L01AD05 | fotemustin | parent. | 1 | MG | 94,48 | B/P |
Fotemustin - léčba generalizovaného maligního melanomu. Léčbu ordinuje onkolog pouze na pracovištích se speciálním smluvním vztahem se zdravotními pojišťovnami.
@@ -4750,22 +4821,27 @@
| 296.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1 | MG | 9,09 | B |
| 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | LCM | CZ | | | |
| 12787 | METHOTREXATE-TEVA 2.5MG/ML | inj 5x2ml/5mg | AIC | IL | | | |
| 296.2 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,89 | B |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ | | | |
| 296.3 | L01BA01 | metotrexát (nad 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,23 | B |
| 10827 | METHOTREXATE-TEVA 2.5MG/ML | inj 5x2ml/5mg | PHM | NL | | | |
| 296.2 | L01BA01 | metotrexát (nad 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,23 | B |
| 12788 | METHOTREXATE-TEVA 25MG/ML | inj 1x2ml/50mg | AIC | IL | | | |
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | | | |
| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | LCM | CZ | | | |
| 11193 | METHOTREXATE-TEVA 25MG/ML | inj 1x4ml/100mg-lah | PHM | NL | | | |
| 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ | | | |
| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | LCM | CZ | | | |
| 12788 | METHOTREXATE-TEVA 25MG/ML | inj 1x2ml/50mg | AIC | IL | | | |
| 12789 | METHOTREXATE-TEVA 25MG/ML | inj 1x4ml/100mg | AIC | IL | | | |
| 12790 | METHOTREXATE-TEVA 25MG/ML | inj 1x8ml/200mg | AIC | IL | | | |
| 11192 | METHOTREXATE-TEVA 25MG/ML | i inj 5x2ml/50mg-amp. | PHM | NL | | | |
| 12791 | METHOTREXATE-TEVA 25MG/ML | inj 1x20ml/500mg | AIC | IL | | | |
| 12792 | METHOTREXATE-TEVA 25MG/ML | inj 5x2ml/50mg | AIC | IL | | | |
| 11191 | METHOTREXATE-TEVA 25MG/ML | inj 1x2ml/50mg-lahv | PHM | NL | | | |
| 64784 | METHOTREXAT EBEWE | inf 1x5ml/500mg | EBW | A | | | |
| 11194 | METHOTREXATE-TEVA 25MG/ML | inj 1x8ml/200mg-lah | PHM | NL | | | |
| 83484 | METHOTREXAT LEDERLE | inf 1x20ml/500mg | LED | D | | | |
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | | | |
| 64784 | METHOTREXAT EBEWE | inf 1x5ml/500mg | EBW | A | | | |
| 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ | | | |
| 296.4 | L01BA03 | raltitrexed | parent. | 1 | DF | 7498,00 | X |
| 65351 | TOMUDEX | inj sic 1x2mg | AZC | GB | | | |
| 11195 | METHOTREXATE-TEVA 25MG/ML | inj 1x20ml/500mg-la | PHM | NL | | | |
| 296.3 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,89 | B |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ | | | |
| 296.4 | L01BA03 | raltitrexed | parent. | 1 | DF | 7498,20 | X |
| 297 | L01BB | antimetabolity ze skupiny analog purinů | p.o. | L/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 297.1 | L01BB02 | merkaptopurin | p.o. | 10 | MG | 6,21 | L/ONK,HEM |
@@ -4773,24 +4849,26 @@
| 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9,34 | L/ONK,HEM |
| | | | | | | | |
| 297.3 | L01BB05 | fludarabin | p.o. | 1 | MG | 87,20 | L/ONK,HEM |
| 58898 | FLUDARA | tbl obd 20x10mg | SAG | D | | | |
| 58897 | FLUDARA | tbl obd 15x10mg | SAG | D | | | |
| 298 | L01BB | antimetabolity ze skupiny analog purinů | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 298.1 | L01BB04 | cladribin | parent. | 1 | MG | 884,61 | B/ONK,HEM |
| | | | | | | | |
| 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 130,26 | B/ONK,HEM |
| 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 126,51 | B/ONK,HEM |
| 59058 | FLUDARA | inj sic 5x50mg | SHI | I | | | |
| 77008 | FLUDARA I.V. | inj sic 5x50mg | SAG | D | | | |
| 59058 | FLUDARA | inj sic 5x50mg | SHI | I | | | |
| 299 | L01BC | antimetabolity ze skupiny analog pyrimidinu | p.o. | L/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 299.1 | L01BC | azaribin | p.o. | 1 | MG | 8,50 | L/ONK,HEM |
| | | | | | | | |
| 299.2 | L01BC02 | fluorouracil | p.o. | 10 | MG | 1,47 | L/ONK,HEM |
| | | | | | | | |
| 299.3 | L01BC03 | tegafur | p.o. | 10 | MG | 1,48 | L/ONK,HEM |
| 10407 | FTORAFUR | cps 100x400mg | GRX | LV | | | |
| 299.4 | L01BC06 | capecitabin do 150 mg v jedné tabletě včetně | p.o. | 1 | DF | 38,05 | X |
| | | | | | | | |
| 30397 | XELODA 150 MG | por tbl flm 60x150mg | HLR | | | | |
| 299.5 | L01BC06 | capecitabin nad 150 mg v jedné tabletě | p.o. | 1 | DF | 126,19 | X |
| 30402 | XELODA 500 MG | por tbl flm 120x500mg | HLR | D | | | |
| 300 | L01BC | antimetabolity ze skupiny analog pyrimidinu | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 300.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,27 | B/ONK,HEM |
@@ -4799,15 +4877,25 @@
| 300.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1 | MG | 1,03 | B/ONK,HEM |
| 96990 | ALEXAN (LAHVICKY) | inj 1x20ml/1000mg | MAC | D | | | |
| 300.3 | L01BC02 | fluorouracil | parent. | 10 | MG | 2,72 | B/ONK,HEM |
| 11101 | LA-FU 50 MG/ML | inj 5x20ml/1000mg | PVL | CZ | | | |
| 11100 | LA-FU 50 MG/ML | inj 10x5ml/250mg | PVL | CZ | | | |
| 11117 | LA-FU 50 MG/ML | inj 1x20ml/1000mg | PVL | CZ | | | |
| 12667 | 5-FLUOROURACIL EBEWE | inj 1x100ml/5000mg | EBW | A | | | |
| 11171 | FLUOROURACIL-TEVA | inj 1x5ml/250mg | PHM | NL | | | |
| 56055 | 5-FLUOROURACIL EBEWE | inj 1x5ml/250mg | EBW | A | | | |
| 32752 | FLUORO-URACIL ICN | injsoi 5x20ml/1gm | SOC | CH | | | |
| 58240 | FLUORO-URACIL ICN | inj sol 5x5ml/250mg | SOC | CH | | | |
| 11393 | LA-FU 50 MG/ML | inj 1x10ml/500mg | PVL | CZ | | | |
| 12666 | 5-FLUOROURACIL EBEWE | inj 1x20ml/1000mg | EBW | A | | | |
| 11101 | LA-FU 50 MG/ML | inj 5x20ml/1000mg | PVL | CZ | | | |
| 32751 | FLUORO-URACIL ICN | injsol 5x10ml/500mg | SOC | CH | | | |
| 11117 | LA-FU 50 MG/ML | inj 1x20ml/1000mg | PVL | CZ | | | |
| 11100 | LA-FU 50 MG/ML | inj 10x5ml/250mg | PVL | CZ | | | |
| 11175 | FLUOROURACIL-TEVA | inj 1x20ml/1000mg | PHM | NL | | | |
| 57650 | LA-FU 500 | inj 1x10ml/500mg | LCM | CZ | | | |
| 32761 | FLUOROURACIL-TEVA | inj sol 1x100ml/5gm | PHM | NL | | | |
| 12665 | 5-FLUOROURACIL EBEWE | inj 1x10ml/500mg | EBW | A | | | |
| 32750 | FLUORO-URACIL ICN | injsol 10x5ml/250mg | SOC | CH | | | |
| 32753 | FLUORO-URACIL ICN | injsol 1x100ml/5gm | SOC | CH | | | |
| 11173 | FLUOROURACIL-TEVA | inj 1x10ml/500mg | PHM | NL | | | |
| 12667 | 5-FLUOROURACIL EBEWE | inj 1x100ml/5000mg | EBW | A | | | |
| 11394 | LA-FU 50 MG/ML | inj 10x10ml/500mg | PVL | CZ | | | |
| 57650 | LA-FU 500 | inj 1x10ml/500mg | LCM | CZ | | | |
| 300.4 | L01BC03 | tegafur | parent. | 10 | MG | 2,83 | B/ONK,HEM |
| | | | | | | | |
| 300.5 | L01BC05 | gemcitabin | parent. | 1 | MG | 5,87 | X |
@@ -4815,38 +4903,39 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 301.1 | L01CA01 | vinblastin | parent. | 1 | MG | 26,54 | B/ONK,HEM |
| | | | | | | | |
| 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 219,20 | B/ONK,HEM |
| 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 182,10 | B/ONK,HEM |
| 12772 | VINCRISTINE-TEVA | inj sic 1x1mg+solv. | AIC | IL | | | |
| 11421 | VINCRISTINE-TEVA | inj 1x2ml/2mg | PHM | NL | | | |
| 12773 | VINCRISTINE TEVA | inj 1x1ml/1mg | AIC | IL | | | |
| 47220 | VINCRISTINE TEVA | inj 1x2ml/2mg | AIC | IL | | | |
| 10707 | VINCRISTINE-TEVA | inj sic 1x1mg+solv. | PHM | NL | | | |
| 11421 | VINCRISTINE-TEVA | inj 1x2ml/2mg | PHM | NL | | | |
| 47221 | VINCRISTINE TEVA | inj 1x5ml/5mg | AIC | IL | | | |
| 11422 | VINCRISTINE-TEVA | inj 1x5ml/5mg | PHM | NL | | | |
| 12772 | VINCRISTINE-TEVA | inj sic 1x1mg+solv. | AIC | IL | | | |
| 12773 | VINCRISTINE TEVA | inj 1x1ml/1mg | AIC | IL | | | |
| 47220 | VINCRISTINE TEVA | inj 1x2ml/2mg | AIC | IL | | | |
| 11420 | VINCRISTINE-TEVA | inj 1x1ml/1mg | PHM | NL | | | |
| 301.3 | L01CA04 | vinorelbin | parent. | 1 | MG | 108,27 | X |
| 302 | L01CB | podofylotoxinové deriváty | p.o. | L/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 302.1 | L01CB01 | etoposid | p.o. | 1 | MG | 3,39 | L/ONK,HEM |
| 302.1 | L01CB01 | etoposid | p.o. | 1 | MG | 3,05 | L/ONK,HEM |
| 86417 | VEPESID | cps 10x100mg | BMS | D | | | |
| 86416 | VEPESID | cps 20x50mg | BMS | D | | | |
| 86710 | VEPESID | cps 10x100mg | BMS | I | | | |
| 97401 | VEPESID | cps 20x50mg | BMS | I | | | |
| 86416 | VEPESID | cps 20x50mg | BMS | D | | | |
| 93696 | LASTET | cps 40x25mg | NKU | J | | | |
| 93698 | LASTET | cps 10x100mg | NKU | J | | | |
| 93697 | LASTET | cps 20x50mg | NKU | J | | | |
| 303 | L01CB | podofylotoxinové deriváty | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 3,36 | B/ONK,HEM |
| 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 3,02 | B/ONK,HEM |
| 86709 | VEPESID | inf cnc10x5ml/100mg | BMS | I | | | |
| 86418 | VEPESID | inj 10x5ml/100mg | BMS | D | | | |
| 86709 | VEPESID | inf cnc 0x5ml/100mg | BMS | I | | | |
| 01635 | ETOPOSIDE PHARMACIA & UPJOHN | inj 1x5ml/100mg | PAU | AUS | | | |
| 12671 | ETOPOSID EBEWE | inf 1x20ml/400mg | EBW | A | | | |
| 303.2 | L01CB02 | teniposid | parent. | 1 | MG | 6,06 | B/ONK,HEM |
| 304 | L01CD | taxany | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 304.1 | L01CD01 | paclitaxel | parent. | 1 | MG | 140,25 | X |
| 45155 | PAXENE | inf cnc 25ml/150mg | GNO | CZ | | | |
| 45154 | PAXENE | inf cnc 1x5ml/30mg | GNO | CZ | | | |
| 05952 | PAXENE | inf cnc16.7ml/100mg | GNO | CZ | | | |
| 05953 | PAXENE | inf cnc 50ml/300mg | GNO | CZ | | | |
| 05952 | PAXENE | inf cnc16.7ml/100mg | IVX | CZ | | | |
| 05953 | PAXENE | inf cnc 50ml/300mg | IVX | CZ | | | |
| 45154 | PAXENE | inf cnc 1x5ml/30mg | IVX | CZ | | | |
| 45155 | PAXENE | inf cnc 25ml/150mg | IVX | CZ | | | |
| 304.2 | L01CD02 | docetaxel | parent. | 1 | MG | 245,83 | X |
| 305 | L01DA | aktinomyciny | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4854,21 +4943,21 @@
| 306 | L01DB | antracykliny a jejich deriváty | p.o. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 274,70 | X |
| 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I | | | |
| 78813 | ZAVEDOS 10MG | cps 1x10mg | FAR | I | | | |
| 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I | | | |
| 78814 | ZAVEDOS 25MG | cps 1x25mg | FAR | I | | | |
| 307 | L01DB | antracykliny a jejich deriváty | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 307.1 | L01DB01 | doxorubicin (do 40 mg včetně v jedné ampuli) | parent. | 1 | MG | 34,22 | B/ONK,HEM |
| 307.1 | L01DB01 | doxorubicin (do 40 mg včetně v jedné ampuli) | parent. 1 MG | 33,58 | B/ONK,HEM | | |
| 30949 | DOXORUBICIN LACHEMA 10 | inj plv sol 1x10mg | PVL | CZ | | | |
| 12663 | DOXORUBICIN EBEWE 10MG | inj 1x5ml/10mg | EBW | A | | | |
| 307.2 | L01DB01 | doxorubicin (nad 40 mg v jedné ampuli) | parent. | 1 | MG | 32,80 | B/ONK,HEM |
| 307.2 | L01DB01 | doxorubicin (nad 40 mg v jedné ampuli) | parent. | 1 | MG | 32,18 | B/ONK,HEM |
| 30950 | DOXORUBICIN LACHEMA 50 | inj plv sol 1x50mg | PVL | CZ | | | |
| 12664 | DOXORUBICIN EBEWE 50MG | inj 1x25ml/50mg | EBW | A | | | |
| 307.3 | L01DB02 | daunorubicin | parent. | 1 | MG | 19,21 | B/ONK,HEM |
| | | | | | | | |
| 307.4 | L01DB03 | epirubicin | parent. | 1 | MG | 40,08 | B/ONK,HEM |
| 58289 | FARMORUBICIN PFS | inj 1x25ml/50mg | PUH | I | | | |
| | | | | | | | |
| 307.5 | L01DB04 | aklarubicin | parent. | 1 | MG | 19,21 | B/ONK,HEM |
| | | | | | | | |
| 307.6 | L01DB05 | zorubicin | parent. | 1 | MG | 19,21 | B/ONK,HEM |
@@ -4876,68 +4965,68 @@
| 307.7 | L01DB06 | idarubicin | parent. | 1 | MG | 753,57 | B/ONK,HEM |
| | | | | | | | |
| 307.8 | L01DB07 | mitoxantron | parent. | 1 | MG | 53,96 | B/ONK,HEM |
| 54033 | REFADOR | inj 1x15ml/30mg | LCM | CZ | | | |
| 54033 | REFADOR | inj cnc 1x15ml/30mg | PVL | CZ | | | |
| 308 | L01DC | ostatní cytotoxická antibiotika | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 67,31 | B/ONK,HEM |
| 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 66,36 | B/ONK,HEM |
| 03404 | BLEOCIN | inj 1x15mg | NKU | J | | | |
| 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 76,25 | B/ONK,HEM |
| | | | | | | | |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 71,37 | B/ONK,HEM |
| 83440 | MITOMYCIN C KYOWA | inj sic 5x20mg | KYA | J | | | |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 70,36 | B/ONK,HEM |
| 309 | L01XA | platinová cytostatika | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 309.1 | L01XA01 | cisplatina | parent. | 1 | MG | 8,21 | B/ONK,HEM |
| 96453 | PLATIDIAM | inj 10x10mg/20ml | LCM | CZ | | | |
| 92302 | CISPLATIN EBEWE | inf 1x100ml/50mg | EBW | A | | | |
| 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ | | | |
| 96455 | PLATIDIAM | inj 1x50mg/100ml | LCM | CZ | | | |
| 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ | | | |
| 92302 | CISPLATIN EBEWE | inf 1x100ml/50mg | EBW | A | | | |
| 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1 | mg | 6,70 | B/ONK,HEM |
| 75010 | CYCLOPLATIN | inj 1x5ml/50mg | LCM | CZ | | | |
| 90777 | CYCLOPLATIN 50 | inj sic 10x50mg | LCM | CZ | | | |
| 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | mg | 3,86 | B/ONK,HEM |
| 60924 | CYCLOPLATIN | inj 1x60ml/600mg | LCM | CZ | | | |
| 93665 | CYCLOPLATIN 200 | inj sic 5x200mg | LCM | CZ | | | |
| 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. 1 | MG | 6,70 | B/ONK,HEM | |
| 75010 | CYCLOPLATIN 50 | inf cnc sol 1x5ml | PVL | CZ | | | |
| 90777 | CYCLOPLATIN 50 | inf plv sol 10x50mg | PVL | CZ | | | |
| 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | MG | 3,86 B/ONK,HEM | |
| 10830 | CARBOPLATIN-TEVA | inj 1x45ml/450mg | PHM | NL | | | |
| 93665 | CYCLOPLATIN 200 | inf plv sol 5x200mg | PVL | CZ | | | |
| 310 | L01XB | methylhydrazinová cytostatika | p.o. | L/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2,44 | L/ONK,HEM |
| 311 | L01XX | ostatní cytostatika | p.o. | L/ONK,HEM,URN | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 | GM | 2,30 | L/ONK,HEM, URN |
| 95122 | LITALIR | cps 100x500mg | BMS | D | | | |
| 57345 | LITALIR | cps 100x500mg | BMS | I | | | |
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 GM | 2,23 | L/ONK,HEM,URN | |
| 57345 | LITARIL | CPS 100x500mg | BMS | I | | | |
| 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 3,91 | L/ONK,HEM, URN |
| 58742 | ESTRACYT | cps 100x140mg | PUA | I | | | |
| 08921 | ESTRACYT | cps 100x140mg | PHA | S | | | |
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 104,85 | L/ONK,HEM, URN |
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 101,68 | L/ONK,HEM, URN |
| 84009 | VESANOID | cps 100x10mg | HLR | CH | | | |
| 311.4 | L01XX28 | imatinib | p.o. | 400 | MG | 3766,60 | H |
| 311.4 | L01XX28 | imatinib | p.o. | 400 | MG | 2672,95 | X |
| 40199 | GLIVEC 100MG | cps 120x100mg | NPF | CH | | | |
| 312 | L01XX | ostatní cytostatika | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 312.1 | L01XC02 | rituximab | parent. | 10 | MG | 1360,43 | Z |
| 312.1 | L01XC02 | rituximab | parent. | 10 | MG | 1336,46 | Z |
| 59839 | MABTHERA 100MG | inf 2x10ml/100mg | HLR | D | | | |
| 46130 | MABTHERA 500MG | inf 1x50ml/500mg | HLR | D | | | |
| 312.2 | L01XC03 | trastuzumab | parent. | 1 | DF | 26200,00 | X |
| | | | | | | | |
| 312.3 | L01XX01 | amsakrin | parent. | 1 | MG | 26,15 | B/ONK,HEM |
| | | | | | | | |
| 312.4 | L01XX02 | asparagináza | parent. | 1 | MG | 2784,54 | B/P |
| 312.3 | L01XD02 | verteporfin | parent. | 15 | MG | 44000,00 | X |
| | | | | | | | |
| 312.4 | L01XX01 | amsakrin | parent. | 1 | MG | 25,80 | B/ONK,HEM |
| | | | | | | | |
| 312.5 | L01XX02 | asparagináza | parent. | 1 | MG | 2784,54 | B/P |
Léčbu L-asparaginázou ordinuje onkolog nebo hematolog. Revizní lékař pojišťovny může na základě žádosti lékaře povolit plnou úhradu ekonomicky náročnějších přípravků obsahujících L-asparaginázu v případě, že se jedná o podání dětem do 18 let věku, nebo že se jedná o opakované podání starším osobám, případně u pacientů s alergickou anamnézou.
| 58319 | KIDROLASE | inj sic 10x10ku | THN | B | | | |
| 92117 | KIDROLASE | inj sic 10x10ku | RBE | F | | | |
| 312.5 | L01XX11 | estramustin | parent. | 1 | MG | 1,03 | B/ONK,HEM, UR N |
| | | | | | | | |
| 312.6 | L01XX17 | topotekan | parent. | 1 | MG | 3066,38 | X |
| | | | | | | | |
| 312.7 | L01XX19 | irinotekan | parent. | 1 | MG | 77,33 | X |
| | | | | | | | |
| 312.8 | L01XX09 | miltefosin | lok. | 60 | MG | 9,78 | |
| 94058 | ERWINASE | inj sic 20x10ku | POT | GB | | | |
| 312.6 | L01XX11 | estramustin | parent. | 1 | MG | 1,03 | B/ONK,HEM, URN |
| | | | | | | | |
| 312.7 | L01XX17 | topotekan | parent. | 1 | MG | 3066,38 | X |
| | | | | | | | |
| 312.8 | L01XX19 | irinotekan | parent. | 1 | MG | 76,68 | X |
| 56005 | CAMPTO 40MG/2ML | sol inf 1x2ml/40mg | RDG | GB | | | |
| 312.9 | L01XX09 | miltefosin | lok. | 60 | MG | 9,78 | |
| 313 | L02AA | estrogeny | p.o. | L/ONK,HEM,URN,GYN, SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,32 | L/ONK,HEM, URN GYN,SEX |
| | | | | | | | |
| 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,06 | L/ONK,HEM, URN GYN,SEX |
| | | | | | | | |
| 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,32 | L/ONK,HEM, URN GYN,SEX |
@@ -4946,38 +5035,37 @@
| 314.1 | L02AA01 | diethylstilbestrol | parent. | 10 | MG | 6,55 | B/ONK,HEM, URN,SEX |
| | | | | | | | |
| 314.2 | L02AA02 | polyestradiol fosfát | parent. | 1 | MG | 3,18 | B/ONK,HEM, URN,SEX |
| | | | | | | | |
| 314.3 | L02AA04 | fosfestrol | parent. | 0.1 | GM | 4,79 | B/ONK,HEM, URN,SEX |
| 315 | L02AB | progestiny | p.o. | L/ONK,HEM,URN,GYN, SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 315.1 | L02AB01 | megestrol (pevné lékové formy) | p.o. | 160 | MG | 52,13 | L/ONK,HEM, URN GYN,SEX |
| 58936 | MEGACE 160MG | tbl 100x160mg | BSG | D | | | |
| 58935 | MEGACE 40MG | tbl 100x40mg | BSG | D | | | |
| 315 | L02AB | progestiny | p.o. | L/ONK,HEM,URN GYN,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 315.1 | L02AB01 | megestrol (pevné lékové formy) | p.o. | 160 | MG | 46,90 | L/ONK,HEM, URN GYN,SEX |
| 86059 | MEGACE | tbl 100x160mg | BMS | D | | | |
| 86211 | MEGACE | tbl 100x40mg | BMS | D | | | |
| 86059 | MEGACE | tbl 100x160mg | BMS | D | | | |
| 315.2 | L02AB01 | megestrol (tekuté lékové formy) | p.o. | 160 | MG | 73,07 | Z |
| 53146 | MEGACE 40MG/ML | sus por 1x240ml | BMS | POR | | | |
| 53145 | MEGACE 40MG/ML | sus por 1x240ml | BMS | USA | | | |
| 315.3 | L02AB02 | medroxyprogesteron | p.o. | 1 | GM | 175,96 | L/ONK,HEM, URN GYN,SEX |
| 315.2 | L02AB01 | megestrol (tekuté lékové formy) | p.o. | 160 | MG | 70,97 | P |
| 53145 | MEGACE 40 MG/ML | sus por 1x240ml | | BMS | USA | | |
Indikováno v případech kachexie u manifestního AIDS a v případech, kdy nádorová kachexie je kontraindikací kurativní protinádorové terapie.
| 315.3 | L02AB02 | medroxypro-gesteron | p.o. | 1 | GM | 175,96 | L/ONK,HEM, URN GYN,SEX |
| 58390 | PROVERA 500MG | tbl 20x500mg | PUA | I | | | |
| 58392 | PROVERA 100MG | tbl 100x100mg | PUA | I | | | |
| 316 | L02AB | progestiny | parent. | L/ONK,GYN,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 316.1 | L02AB02 | medroxyprogesteron | parent. | 1 | GM | 784,67 | L/ONK,GYN, SEX |
| 316.1 | L02AB02 | medroxypro-gesteron | parent. | 1 | GM | 786,00 | L/ONK,GYN, SEX |
| 87805 | DEPO-PROVERA 150MG/ML | inj 1x1ml/150mg | UPJ | B | | | |
| 316.2 | L02AB03 | gestonoron | parent. | 1 | MG | 1,12 | L/ONK,GYN, SEX |
| 317 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | inhal. | Z | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 317.1 | L02AE01 | buserelin | inhal. | 1 | MG | 236,87 | Z |
| 58107 | SUPRECUR | sol 2x10gm/15mg+apl | HMR | D | | | |
| 58106 | SUPRECUR | sol 1x10gm/15mg+apl | HMR | D | | | |
| 317.1 | L02AE01 | buserelin | inhal. | 1 | MG | 233,29 | Z |
| 58106 | SUPRECUR | sol 1x10gm/15mg+apl | AVT | D | | | |
| 58107 | SUPRECUR | sol 2x10gm/15mg+apl | AVT | D | | | |
| 318 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | parent. | K/P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje onkolog, urolog, endokrinolog, dětský endokrinolog nebo gynekolog:
- a) léčba karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen,
jen po dobu adjuvantní chemo- nebo radioterapie.
- a) léčba karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen, jen po dobu adjuvantní chemo- nebo radioterapie.
- b) léčba karcinomu prostaty,
@@ -4987,7 +5075,7 @@
- e) pubertas precox,
- f) indukce ovulace při in vitro fertilizad pouze na základě předchozího schválení revizním lékařem.
- f) indukce ovulace při in vitro fertilizaci pouze na základě předchozího schválení revizním lékařem.
| 318.1 | L02AE01 | buserelin | parent. | 1 | MG | 253,00 | K/P |
| | | | | | | | |
@@ -4995,102 +5083,98 @@
| 75018 | SUPREFACT DEPOT | imp 1ks=2x3.15mg+ap | AVT | D | | | |
| 66042 | SUPREFACT DEPOT 3 MĚSÍCE | imp 1x9.45mg=3xstl | AVT | D | | | |
| 318.3 | L02AE02 | leuprorelin | parent. | 1 | MG | 253,00 | K/P |
| | | | | | | | |
| 318.4 | L02AE02 | leuprorelin (depotní lékové formy) | parent. | 1 | MG | 1522,80 | K/P |
| | | | | | | | |
| 318.5 | L02AE03 | goserelin (depotní lékové formy) | parent. | 1 | MG | 1576,50 | K/P |
| | | | | | | | |
| 318.6 | L02AE04 | triptorelin | parent. | 1 | DF | 253,00 | K/P |
| 318.6 | L02AE04 | triptorelin | parent. | 1 | DF | 251,89 | K/P |
| 58623 | DIPHERELINE 0.1 MG | inj sic 7x0.1mg+sol | PBE | F | | | |
| 318.7 | L02AE04 | triptorelin (depotní lékové formy) | parent. | 1 | MG | 1522,80 | K/P |
| 318.7 | L02AE04 | triptorelin (depotní lékové formy) | parent. | 1 | MG | 1516,13 | K/P |
| 01656 | DIPHERELINE S.R. 3 MG | inj psulqf1x3mg+sol | PBE | F | | | |
| 319 | L02BA | antiestrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 319.1 | L02BA01 | tamoxifen (do 20 mg v 1 tabletě včetně) | p.o. | 20 | MG | 6,00 | |
| 44057 | TAMOXIFEN EBEWE 20 | tbl 30x20mg | EBW | A | | | |
| 12446 | TAMOXIFEN-RATIOPHARM 10 | tbl 100x10mg | MCK | D | | | |
| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | |
| 10703 | TAMIFEN 10 | tbl 100x10mg | MOE | CY | | | |
| 44057 | TAMOXIFEN EBEWE 20 | tbl 30x20mg | EBW | A | | | |
| 58701 | TAMOXIFEN EBEWE 10MG | tbl 100x10mg | EBW | A | | | |
| 44056 | TAMOXIFEN EBEWE 10 | tbl 30x10mg | EBW | A | | | |
| 67039 | TAMIFEN 10 | tbl 30x10mg | MOE | CY | | | |
| 58702 | TAMOXIFEN EBEWE 20MG | tbl 100x20mg | EBW | A | | | |
| 64810 | NOLVADEX D | tbl obd 30x20mg | AZC | GB | | | |
| 44056 | TAMOXIFEN EBEWE 10 | tbl 30x10mg | EBW | A | | | |
| 58702 | TAMOXIFEN EBEWE 20MG | tbl 100x20mg | EBW | A | | | |
| 58701 | TAMOXIFEN EBEWE 10MG | tbl 100x10mg | EBW | A | | | |
| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | |
| 67039 | TAMIFEN 10 | tbl 30x10mg | MOE | CY | | | |
| 12446 | TAMOXIFEN-RATIOPHARM 10 | tbl 100x10mg | MCK | D | | | |
| 319.2 | L02BA01 | tamoxifen (nad 20 mg v 1 tabletě) | p.o. | 20 | MG | 4,40 | |
| 44059 | TAMOXIFEN EBEWE 40 | tbl 30x40mg | EBW | A | | | |
| 44058 | TAMOXIFEN EBEWE 30 | tbl 30x30mg | EBW | A | | | |
| 44059 | TAMOXIFEN EBEWE 40 | tbl 30x40mg | EBW | A | | | |
| 320 | L02BB | antiandrogeny | p.o. | L/ONK,URN,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 320.1 | L02BB01 | flutamid | p.o. | 0,75 | GM | 82,50 | L/ONK,URN, SEX |
| 54521 | ANDRAXAN | tbl obd 100x250mg | MCI | CZ | | | |
| 83392 | FLUCINOM | tbl 100x250mg | SCH | B | | | |
| 58741 | APO-FLUTAMIDE | tbl obd 100x250mg | APT | CND | | | |
| 320 | L02BB | antiandrogeny | P.O. | L/ONK,URN,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 320.1 | L02BB01 | flutamid | p.o. | 0,75 | GM | 81,21 | L/ONK,URN, SEX, END |
| | | | | | | | |
| 320.2 | L02BB02 | nilutamid | p.o. | 0,3 | GM | 165,00 | L/ONK,URN, SEX |
| 93259 | ANANDRON 150MG | tbl 30x150mg | CSS | F | | | |
| 320.3 | L02BB03 | bicalutamid | p.o. | 50 | MG | 107,14 | L/ONK,URN, SEX |
| 321 | L02BG | inhibitory tvorby steroidních hormonů | p.o. | L/ONK,END | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 321.1 | L02BG01 | aminogluthetimid | p.o. | 1 | GM | 63,54 | L/ONK,END |
| 321.1 | L02BG01 | aminogluthetimid | p.o. | 1 | GM | 63,11 | L/ONK,END |
| 07510 | ORIMETEN | tbl 100x250mg | CGC | CH | | | |
| 321.2 | L02BG03 | anastrozol | p.o. | 1 | MG | 162,14 | X |
| 32.2 | L02BG03 | anastrozol | p.o. | 1 | MG | 162,14 | X |
| | | | | | | | |
| 321.3 | L02BG04 | letrozol | p.o. | 2,5 | MG | 162,14 | X |
| | | | | | | | |
| 56509 | FEMARA | tbl obd 30x2.5mg | NPA | CH | | | |
| 321.4 | L02BG06 | exemestan | p.o. | 25 | MG | 162,14 | X |
| 322 | L02BG | inhibitory tvorby steroidních hormonů | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 322.1 | L02BG02 | formestan | parent. | 18 | MG | 233,77 | X |
| 322.1 | IL02BG02 | formestan | parent. | 18 | MG | 233,77 | X I |
| 92361 | LENTARON DEPOT 250MG I.M. | inj sic 1x250mg+2ml | CGC | CH | | | |
| 323 | L03AA | cytokiny | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 323.1 | L03AA02 | filgrastim | parent. | 1 | MG | 10936,60 | X |
| 57863 | NEUPOGEN | inj 5x1 ml | AMG | POR | | | |
| 69026 | NEUPOGEN | inj 5x1ml | HLR | CH | | | |
| 57863 | NEUPOGEN | inj 5x1ml | AMG | POR | | | |
| 57864 | NEUPOGEN | inj 5x1.6ml | AMG | POR | | | |
| 69026 | NEUPOGEN | inj 5x1ml | HLR | CH | | | |
| 98297 | NEUPOGEN | inj 5x1.6ml | HLR | CH | | | |
| 323.2 | L03AA03 | molgramostim (do 0,3 MG včetně v jedné ampuli) | parent. | 1 | MG | 13613,27 | X |
| | | | | | | | |
| 323.3 | L03AA03 | molgramostim (nad 0,3 MG v jedné ampuli) | parent. | 1 | MG | 11843,67 | X |
| 323.2 | L03AA03 | molgramostim (do 0,3 mgG včetně v jedné amplili) | parent. | 1 | MG | 13613,27 | X |
| | | | | | | | |
| 323.3 | L03AA03 | molgramostim (nad 0,3 mg v jedné ampuli) | parent. | 1 | MG | 11843,67 | X |
| | | | | | | | |
| 323.4 | L03AA10 | lenograstim | parent. | 1 | MG | 12477,40 | X |
| | | | | | | | |
| 323.5 | L03AB01 | interferon alfa natural | parent. | 1 | MU | 239,51 | X |
| 323.5 | L03AB01 | interferon alfa natural | parent. | 1 | MU | 233,45 | X |
| | | | | | | | |
| 323.6 | L03AB03 | interferon gamma | parent. | 1 | MU | 1531,33 | X |
| | | | | | | | |
| 323.7 | L03AB04 | interferon alfa-2a - aplikční forma „pera“ | parent. | 1 | MU | 239,51 | X |
| | | | | | | | |
| 323.8 | L03AB04 | interferon alfa-2a do 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1 | MU | 239,51 | X |
| 89224 | ROFERON A | inj 1x1ml/3mu | HLR | CH | | | |
| 323.9 | L03AB04 | interferon alfa-2a nad 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1 | MU | 220,35 | X |
| | | | | | | | |
| 323.10 | L03AB05 | interferon alfa-2b - aplikční forma „pera“ | parent. | 1 | MU | 239,51 | X |
| 32574 | INTRONA 60 MIU REDIPEN | inj soll.2ml/6x10mu | SCH | IRL | | | |
| 54473 | INTRON A REDIPEN 5 MIL.M.J. | inj 1x1.2ml/30mu | SCH | IRL | | | |
| 54472 | INTRON A REDIPEN 3MIL.M.J. | inj 1x1.2ml/18mu | SCH | IRL | | | |
| 323.7 | L03AB04 | interferon alfa-2a - aplikční forma „pera“ | parent. | 1 | MU | 233,45 | X |
| | | | | | | | |
| 323.8 | L03AB04 | interferon alfa-2a do 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1 | MU | 233,45 | X |
| | | | | | | | |
| 323.9 | L03AB04 | interferon alfa-2a nad 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1 | MU | 213,15 | X |
| | | | | | | | |
| 323.10 | L03AB05 | interferon alfa-2b - aplikční forma „pera“ | parent. | 1 | MU | 233,45 | X |
| 32574 | INTRONA 60 MIU REDIPEN | inj sol1.2ml/6x10mu | SCH | IRL | | | |
| 32573 | INTRONA 18 MIU REDIPEN | inj sol 1.2ml/6x3mu | SCH | IRL | | | |
| 32572 | INTRONA 30 MIU REDIPEN | inj sol 1.2ml/6x5mu | SCH | IRL | | | |
| 54474 | INTRON A REDIPEN 10MIL.M.J. | inj 1x1.2ml/60mu | SCH | IRL | | | |
| 323.11 | L03AB05 | interferon alfa-2b do 10 MU v 1 ampuli včetně - jiné aplikační formy | parent. | 1 | MU | 239,51 | X |
| 323.11 | L03AB05 | interferon alfa-2b do 10 MU v 1 ampuli včetně - jiné aplikační formy | parent. | 1 | MU | 233,45 | X |
| 32576 | INTRONA 3 MIU | inj sol 0.5ml/3mu | SCH | IRL | | | |
| 32575 | INTRONA 10 MIU | inj sol 1ml/10mu | SCH | IRL | | | |
| 32577 | INTRONA 5 MIU | inj sol 0.5ml/5mu | SCH | IRL | | | |
| 54560 | INTRON A 5 MIL.M.J./0.5 ML | inj 1x0.5ml+soupr. | SCH | IRL | | | |
| 54561 | INTRON A 5 MIL.M.J./0.5 ML | inj 1x1ml+soupr. | SCH | IRL | | | |
| 323.12 | L03AB05 | interferon alfa-2b nad 10 MU v 1 ampuli - jiné aplikační formy | parent. | 1 | MU | 220,35 | X |
| | | | | | | | |
| 323.13 | L03AB06 | interferon alfa-n 1 do 9MU v 1 ampuli včetně | parent. | 1 | MU | 239,51 | X |
| | | | | | | | |
| 323.14 | L03AB06 | interferon alfa-n 1 více než 9MU v 1 ampuli | parent. | 1 | MU | 220,35 | X |
| 323.12 | L03AB05 | interferon alfa-2b nad 10 MU v 1 ampuli - jiné aplikační formy | parent. | 1 | MU | 213,15 | X |
| 323.13 | L03AB06 | interferon alfa-n 1 do 9MU v 1 ampuli včetně | parent. | 1 | MU | 233,45 | X |
| | | | | | | | |
| 323.14 | L03AB06 | interferon alfa-n1 více než 9MU v 1 ampuli | parent. | 1 | MU | 213,15 | X |
| | | | | | | | |
| 323.15 | L03AB07 | interferon beta - 1a | parent. | 1 | MU | 430,33 | X |
| | | | | | | | |
| 323.16 | L03AB07 | interferon beta - 1a výhradně pro intramuskulární podání | parent. | 1 | DF | 7745,95 | X |
| 06241 | AVONEX | inj sic 4x30rg+solv | BHF | NL | | | |
| 57913 | AVONEX | inj sic 4x30rg+solv | BGI | NL | | | |
| 323.17 | L03AB08 | interferon beta - 1 b | parent. | 1 | MU | 276,80 | X |
| | | | | | | | |
| 323.18 | L03AB09 | interferon alfacon - 1 | parent. | 1 | MU | 239,51 | X |
| | | | | | | | |
| 323.19 | L03AB10 | peginterferon | parent. | 7,5 | RG | 239,51 | X |
| | | | | | | | |
| 323.20 | L03AC | interleukin 2 | parent. | 1 | MG | 7739,31 | X |
| 323.17 | L03AB08 interferon beta - 1 b | parent. | 1 | MU | 276,80 | X | |
| | | | | | | | |
| 323.18 | L03AB09 | interferon alfacon - 1 | parent. | 1 | MU | 233,45 | X |
| | | | | | | | |
| 323.19 | L03AB10 | peginterferon | parent. | 7,5 | RG | 233,45 | X |
| | | | | | | | |
| 323.20 | L03AC01 | aldesleukin | parent. | 1 | MG | 7517,20 | X |
| 86786 | PROLEUKIN | inj sic 1x1mg | CNC | NL | | | |
| 324 | L03AX | ostatní imunostimulační léčiva | lok., p.o. | L/ALG | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5103,7 +5187,7 @@
| 324.4 | L03AX | vaccin. staphyl. phagolys. | lok. | 1 | ML | 36,51 | L/ALG,ORL |
| 325 | L03AX | ostatní imunostimulační léčiva | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 325.1 | L03AX03 | BCG vakcína | parent. | 1 | MG | 43,36 | O/ONK,URN |
| 325.1 | L03AX03 | BCG vakcína | parent. | 1 | MG | 38,21 | O/ONK,URN |
| 68908 | IMMUCYST BCG IMMUNOTHERAPEUT. | inj sic 3x27mg+1ml | CNG | CND | | | |
| 325.2 | L03AX | dialyzát lidských leukocytů | parent. | 1 | DF | 988,38 | O/ALG,IMU |
| 56930 | IMMODIN SEVAC | inj sic 1x2ml+solv. | SEV | CZ | | | |
@@ -5117,10 +5201,12 @@
| 325.6 | L03AX | laktobacillus acidophilus | parent. | 3 | DF | 612,65 | O/GYN |
| 86711 | SOLCOTRICHOVAC | inj 3x0.5ml | SOC | CH | | | |
| 325.7 | L03AX | vaccin. staphyl. phagolys. | parent. | 1 | DF | 72,98 | O |
| | | | | | | | |
| 325.8 | L03AX13 | glatirameracetat kopolymer | parent. | 20 | MG | 1106,56 | X |
| 326 | L04AA | selektivní imunosupresivní léčiva | p.o. | P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu cyklosporinem ordinuje lékař pracující v transplantačních centrech, onkolog, hematolog, dermatolog, urolog revmatolog a alergolog, klinický imunolog a pediatr:
Léčbu cyklosporinem ordinuje lékař pracující v transplantačních centrech, onkolog, hematolog, dermatolog, nefrolog, revmatolog, alergolog, klinický imunolog, pediatr a gastroenterolog:
- a) prevence reakce štěpu proti hostiteli po transplantacích,
@@ -5140,13 +5226,11 @@
- i) těžké formy polymyositidy/dermatomyositidy nereagující na standardní léčbu,
- j) v indikaci plicní fibrózy ordinuje též lékař s nástavbovou specializací v oboru tuberkulózy a respiračních nemocí
Léčba se zahajuje obvykle v rámci hospitalizace pacienta s odpovídajícím odstupem od jiné terapie (např. PUVA, retinoidy, cytostatika), léčbu provádí pouze pracoviště s dostupností příslušných laboratorních vyšetření (včetně stanovení hladiny cyklosporinu).
- j) v indikaci plicní fibrózy ordinuje též lékař s nástavbovou specializací v oboru tuberkulózy a respiračních nemocí Léčba se zahajuje obvykle v rámci hospitalizace pacienta s odpovídajícím odstupem od jiné terapie (např. PUVA, retinoidy, cytostatika), léčbu provádí pouze pracoviště s dostupností příslušných laboratorních vyšetření (včetně stanovení hladiny cyklosporinu).
- k) u myasthenia gravis předepisuje neurolog.
Léčbu mophetil mycophenolatem ordinuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů u kterých byla provedena alogenní transplantace ledvin. Podává se v kombinaci s cyklosporinem a kortikosteroidy.
Léčbu mophetil mycophenolatem ordinuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů u kterých byla provedena alogenní transplantace ledvin. Podává se v kombinací s cyklosporinem a kortikosteroidy.
- l) těžké generalizované formy atopické dermatitidy se syndromem hyper-lgE.
@@ -5158,77 +5242,77 @@
- 3. Transplantace jater
Léčbu sirolimem ordinuje lékař transplantačního centra se zajištěnou dostupností monitorování hladin sirolimu u pacientů po transpantaci ledvin v případě klinických (zhoršení funkce štěpu o 30 umol/l nebo o 30% po vyloučení jiných příčin zhoršení ledviné funkce s výjimkou chronické rejekce) nebo bioptických projevů nefrotoxicity kalcineurinových inhibitorů a pouze v případech, kdy jiné postupy pro zmírnění nebo odstranění nefrotoxicity nebyly úspěšné.
Léčbu leflunomidem ordinuje revmatolog.
Léčba je indikována u pacientů s revmatoidní artritídou (RA),která je stále aktivní a progreduje vzdor léčbě minimálně 2 léky ze skupiny tzv.léků druhé řady (jedním z nich musí být metotrexat).Tyto léky musí být podávány prokazatelně dostatečně dlouhou dobu (nejméně 6 měsíců) a v dostatečné dávce (sulfasalazin 3 g/denně,metotrexát 25 mg/týdně).
Aktivita RA musí být hodnocena jako vysoká (DAS 5,1 metodikou formuláře DAS 28) nebo kombinace 5 oteklých kloubů a CRP > 10 mg/l.
Aktivita RA musí být hodnocena jako vysoká (DAS ≥5,1 metodikou formuláře DAS 28) nebo kombinace 5 oteklých kloubů a CRP > 10 mg/l.
Efekt léčby musí být průkazný do 6 měsíců po začátku léčby,kvantifikován jako pokles DAS > 1,2.
Průběh léčby leflunomidem bude dokumentován v dotazníku České revmatologické společnosti,které budou kontrolovány a vyhodnocovány.
| 326.1 | L04AA01 | cyklosporin | p.o. | 250 | MG | 275,00 | P |
| 94052 | CONSUPREN | sol 1x50ml 100mg/ml | GNO | CZ | | | |
| 92572 | CONSUPREN S 25MG | cps 50x25mg | GNO | CZ | | | |
| 92573 | CONSUPREN S 50MG | cps 50x50mg | GNO | CZ | | | |
| 326.2 | L04AA01 | cyklosporin (mikroemul-gované formy) | p.o. | 250 | MG | 275,00 | P |
| 92574 | CONSUPREN S 100MG | cps 50x100mg | GNO | CZ | | | |
| 92573 | CONSUPREN S 50MG | cps 50x50mg | GNO | CZ | | | |
| 92572 | CONSUPREN S 25MG | cps 50x25mg | GNO | CZ | | | |
| 326.2 | L04AA01 | cyklosporin (mikroemulgo vané formy) | p.o. | 250 | MG | 275,00 | P |
| 94052 | CONSUPREN | sol 1x50ml 100mg/ml | IVX | CZ | | | |
| 84044 | SANDIMMUN NEORAL 25MG | cps 50x25mg | SAN | CH | | | |
| 84046 | SANDIMMUN NEORAL 100MG | cps 50x100mg | SAN | CH | | | |
| 84045 | SANDIMMUN NEORAL 50MG | cps 50x50mg | SAN | CH | | | |
| 84047 | SANDIMMUN NEORAL 100MG/ML | sol 1x50ml 100mg/ml | SAN | CH | | | |
| 84046 | SANDIMMUN NEORAL 100MG | cps 50x100mg | SAN | CH | | | |
| 326.3 | L04AA05 | tacrolimus | p.o. | 5 | MG | 376,26 | P |
| 57630 | PROGRAF 5MG | cps 60x5mg | FUJ | IRL | | | |
| 57628 | PROGRAM MG | cps 60x1mg | FUJ | IRL | | | |
| 57629 | PROGRAF 5MG | cps 30x5mg | FUJ | IRL | | | |
| 57628 | PROGRAF 1MG | cps 60x1 mg | FUJ | IRL | | | |
| 57627 | PROGRAF 1MG | cps 30x1mg | FUJ | IRL | | | |
| 326.4 | L04AA06 | mophetil mycophenolát | p.o. | 10 | MG | 2,32 | P |
| 44077 | CELLCEPT 500MG | tbl obd 50x500mg | HLR | CH | | | |
| 326.5 | L04AA13 | leflunomid | p.o. | 15 | MG | 67,40 | P |
| 32892 | CELLCEPT 500 MG | por tbl flm50x500mg | HLR | D | | | |
| 326.5 | L04AA10 | sirolimus | p.o. | 6 | MG | 684,00 | P |
| | | | | | | | |
| 326.6 | L04AA13 | leflunomid | p.o. | 15 | MG | 67,40 | P |
| 327 | L04AA | selektivní imunosupresivní léčiva | parent. | U/J10 | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 327.1 | L04AA09 | basiliximab | parent. | 20 | MG | 53004,39 | H |
| | | | | | | | |
| 327.2 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,64 | U/J10 |
| 88514 | SANDIMMUN KONZENTRAT | inf 10x5ml 50mg/1ml | SAN | CH | | | |
| 327.2 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,60 | U/J10 |
| 88514 | SANDIMMUN KONZENTRAT | inf 60x5ml/1ml | SAN | CH | | | |
| 327.3 | L04AA02 | muromonab-CD3 | parent. | 5 | MG | 11129,25 | U/J10 |
| | | | | | | | |
| 327.4 | L04AA03 | antilymfocytární IG | parent. | 10 | MG | 103,87 | U/J10 |
| 327.4 | L04AA03 | antilymfocytár ní IG | parent. | 10 | MG | 103,87 | U/J10 |
| | | | | | | | |
| 327.5 | L04AA04 | antithymocytární IG | parent. | 1 | MG | 121,46 | U/J10 |
| 44491 | ATG-FRESENIUS S | inj 1x5ml/100mg | FRE | D | | | |
| 44492 | ATG-FRESENIUS S | inj 10x5ml/100mg | FRE | D | | | |
| 327.6 | L04AA05 | tacrolimus | parent. | 5 | MG | 1661,15 | H |
| 57631 | PROGRAF 5MG/ML | inf cnc 10x1ml/5mg | FUJ | IRL | | | |
| 327.7 | L04AA07 | glatirameracetat kopolymer | parent. | 20 | MG | 1106,56 | X |
| | | | | | | | |
| 327.8 | L04AA12 | infliximab | parent. | 400 | MG | 75200,00 | X |
| 327.7 | L04AA11 | etanerceptum | parent. | 7 | MG | 1538,35 | Z |
| | | | | | | | |
| 327.8 | L04AA12 | infliximab | parent. | 375 | MG | 70500,00 | X |
| 328 | L04AX | ostatní imunosupresiva | p.o. | L/J10,REV,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,56 | |
| 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,87 | |
| 58498 | IMURAN 25MG | tbl obd 100x25mg | GOK | GB | | | |
| 31396 | IMURAN | tbl obd 100x25mg | BWE | GB | | | |
| 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,12 | |
| 58499 | IMURAN 50MG | tbl obd 100x50mg | GOK | GB | | | |
| 02418 | IMURAN | tbl obd 100x50mg | BWE | GB | | | |
| 329 | L04AX | ostatní imunosupresiva | parent. | U/J10 | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 9,82 | U/J10 |
| 02016 | IMURAN | inj sic 1x50mg+2ml | BWE | GB | | | |
| 32819 | IMURAN | inj sic 1x50mg | GXW | I | | | |
| 58678 | IMURAN | inj sic 1x50mg | GOK | GB | | | |
| 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 330.1 | M01AA | butylpyrazolidi ny | p.o. | 3 | DF | 3,32 | |
| 330.1 | M01AA | butylpyrazolidiny | p.o. | 3 | DF | 3,32 | |
| | | | | | | | |
| 330.2 | M01AA05 | klofezon | p.o. | 0.6 | GM | 3,32 | |
| 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 331.1 | M01AA | butylpyrazolidi ny | parent. | 1 | DF | 6,89 | |
| 331.1 | M01AA | butylpyrazolidiny | parent. | 1 | DF | 6,89 | |
| 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,76 | |
| | | | | | | | |
| 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 3,18 | |
| 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 2,65 | |
| 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | | | |
| 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | | | |
| 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 4,69 | |
@@ -5236,32 +5320,33 @@
| 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 4,69 | |
| | | | | | | | |
| 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 4,29 | |
| 89026 | DICLOFENAC AL 50 | tbl obd 100x50mg | APA | D | | | |
| 45519 | DICLOFEN 25 SVUS | tbl obd 20x25mg | SVS | CZ | | | |
| 45521 | DICLOFEN 25 SVUS | tbl obd 50x25mg | SVS | CZ | | | |
| 59137 | MYOGIT 50 | tbl ent 20x50mg | PFL | D | | | |
| 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | | | |
| 89025 | DICLOFENAC AL 50 | tbl obd 50x50mg | APA | D | | | |
| 89024 | DICLOFENAC AL 50 | tbl obd 20x50mg | APA | D | | | |
| 98144 | VERAL 25MG | tbl 30x25mg | SLO | SK | | | |
| 89025 | DICLOFENAC AL 50 | tbl obd 50x50mg | APA | D | | | |
| 98108 | NAKLOFEN | tbl ent 20x50mg | KRK | SLO | | | |
| 83518 | VERAL 50MG | tbl ent 20x50mg | SLO | SK | | | |
| 75632 | DICLOFENAC AL RETARD | tbl obd 50x100mg | APA | D | | | |
| 75633 | DICLOFENAC AL RETARD | tbl obd 100x100mg | APA | D | | | |
| 59134 | MYOGIT 25 | tbl ent 20x25mg | PFL | D | | | |
| 59137 | MYOGIT 50 | tbl ent 20x50mg | PFL | D | | | |
| 75632 | DICLOFENAC AL RETARD | tbl obd 50x100mg | APA | D | | | |
| 66049 | VERAL 100 RETARD | tbl ret 30x100mg | SLO | SK | | | |
| 89026 | DICLOFENAC AL 50 | tbl obd 100x50mg | APA | D | | | |
| 98144 | VERAL 25MG | tbl 30x25mg | SLO | SK | | | |
| 53640 | APO-DICLO SR 100 | tbl ret 100x100mg | APT | CND | | | |
| 58880 | DOLMINA 100 SR | tbl ret 20x100mg | LEX | CZ | | | |
| 75631 | DICLOFENAC AL RETARD | tbl obd 20x100mg | APA | D | | | |
| 66050 | VERAL 75 RETARD | tbl ret 20x75mg | SLO | SK | | | |
| 05714 | DICLOFEN 25 SVUS | tbl obd 30x25mg | SVS | CZ | | | |
| 83519 | VERAL 50MG | tbl ent 50x50mg | SLO | SK | | | |
| 96742 | APO-DICLO 50MG | tbl ent 100x50mg | APT | CND | | | |
| 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D | | | |
| 58880 | DOLMINA 100 SR | tbl ret 20x100mg | LEX | CZ | | | |
| 75604 | DICLOFENAC AL 25 | tbl obd 50x25mg | APA | D | | | |
| 59396 | APO-DICLO SR 100 | tbl ret 30x100mg | APT | CND | | | |
| 96742 | APO-DICLO 50MG | tbl ent 100x50mg | APT | CND | | | |
| 53640 | APO-DICLO SR 100 | tbl ret 100x100mg | APT | CND | | | |
| 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | | | |
| 332.6 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (do 100 MG v jedné tabletě včetně) | p.o. | 0.1 | GM | 4,52 | |
| | | | | | | | |
| 332.7 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (nad 100 MG v jedné tabletě) | p.o. | 0.1 | GM | 4,20 | |
| 05714 | DICLOFEN 25 SVUS | tbl obd 30x25mg | SVS | CZ | | | |
| 98108 | NAKLOFEN | tbl ent 20x50mg | KRK | SLO | | | |
| 45521 | DICLOFEN 25 SVUS | tbl obd 50x25mg | SVS | CZ | | | |
| 83519 | VERAL 50MG | tbl ent 50x50mg | SLO | SK | | | |
| 45519 | DICLOFEN 25 SVUS | tbl obd 20x25mg | SVS | CZ | | | |
| 66050 | VERAL 75 RETARD | tbl ret 20x75mg | SLO | SK | | | |
| 83518 | VERAL 50MG | tbl ent 20x50mg | SLO | SK | | | |
| 332.6 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (do 100 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 4,52 | |
| | | | | | | | |
| 332.7 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (nad 100 mg v jedné tabletě) | p.o. | 0.1 | GM | 4,20 | |
| 46621 | UNO | tbl obd 20x150mg | MCK | D | | | |
| 46620 | UNO | tbl obd 10x150mg | MCK | D | | | |
| 332.8 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 4,29 | |
@@ -5274,38 +5359,33 @@
| 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,27 | |
| 96329 | INDOMETACIN | sup 10x100mg | BLU | CHO | | | |
| 93724 | INDOMETACIN 100 BERLIN-CHEMIE | sup 10x100mg | BCE | D | | | |
| 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 10,56 | |
| | | | | | | | |
| 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 10,56 | |
| 98110 | NAKLOFEN | sup 10x50mg | KRK | SLO | | | |
| 87206 | VERAL 100MG | sup 10x100mg | SLO | SK | | | |
| 66957 | MONOFLAM 100MG | sup 10x100mg | LIC | D | | | |
| 66956 | MONOFLAM 50MG | sup 10x50mg | LIC | D | | | |
| 87206 | VERAL 100MG | sup 10x100mg | SLO | SK | | | |
| 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 10,56 | |
| 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | |
| 334 | M01AB | prolizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 12,66 | |
| | | | | | | | |
| 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 12,90 | |
| 54539 | DOLMINA INJ. | inj 5x3ml/75mg | LEX | CZ | | | |
| 67548 | ALMIRAL | inj 100x3ml/75mg | MOE | CY | | | |
| 67547 | ALMIRAL | inj 10x3ml/75mg | MOE | CY | | | |
| 67548 | ALMIRAL | inj 100x3ml/75mg | MOE | CY | | | |
| 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,49 | |
| 68581 | PIROX 10 | tbl 50x10mg | CTA | D | | | |
| 91721 | ARTHREMIN 10 | cps 30x10mg | LEX | CZ | | | |
| 31245 | HOTEMIN 10MG | cps 20x10mg | EGI | H | | | |
| 47112 | PIROX 20 | tbl 20x20mg | MCK | D | | | |
| 68582 | PIROX 20 | tbl 50x20mg | CTA | D | | | |
| 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | | | |
| 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | | | |
| 97711 | APO-PIROXICAM 10 | cps 100x10mg | APT | CND | | | |
| 84717 | HOTEMIN 20MG | cps 20x20mg | EGI | H | | | |
| 53744 | PRO-ROXIKAM 10MG | tbl 20x10mg | PMP | CZ | | | |
| 11068 | PIROXICAM AL 20 | tbl 20x20mg | APA | D | | | |
| 53744 | PRO-ROXIKAM 10MG | tbl 20x10mg | PMP | CZ | | | |
| 47112 | PIROX 20 | tbl 20x20mg | MCK | D | | | |
| 53745 | PRO-ROXIKAM 20MG | tbl 20x20mg | PMP | CZ | | | |
| 335.2 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20 | MG | 4,52 | |
| | | | | | | | |
@@ -5322,22 +5402,18 @@
| 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 337.1 | M01AC01 | piroxikam | parent. | 20 | MG | 11,73 | |
| 68649 | HOTEMIN | inj 5x1ml/20mg | EGI | H | | | |
| | | | | | | | |
| 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 11,73 | |
| 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,79 | |
| 11063 | IBALGIN 600 | tbl obd 30x600mg | LEX | CZ | | | |
| 02857 | PABIPROFEN | tbl obd 20x200mg | PBA | PL | | | |
| 32020 | IBUPROFEN AL 400 | tbl obd 100x400mg | APA | D | | | |
| 46983 | IBUPROFEN 400 LECIVA | tbl obd 100x400mg | LEX | CZ | | | |
| 66990 | DOLGIT 800 | tbl obd 20x800mg | DLR | D | | | |
| 32018 | IBUPROFEN AL 400 | tbl obd 30x400mg | APA | D | | | |
| 32020 | IBUPROFEN AL 400 | tbl obd 100x400mg | APA | D | | | |
| 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | |
| 02857 | PABIPROFEN | tbl obd 20x200mg | PBA | PL | | | |
| 32019 | IBUPROFEN AL 400 | tbl obd 50x400mg | APA | D | | | |
| 11064 | IBALGIN 600 | tbl obd 100x600mg | LEX | CZ | | | |
| 32081 | IBALGIN 400 | tbl obd 30x400mg | LEX | CZ | | | |
| 32082 | IBALGIN 400 | tbl obd 100x400mg | LEX | CZ | | | |
| 46983 | IBUPROFEN 400 LECIVA | tbl obd 100x400mg | LEX | CZ | | | |
| 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | |
| 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 19,55 | |
| | | | | | | | |
| 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 4,29 | |
@@ -5356,14 +5432,16 @@
| | | | | | | | |
| 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 6,00 | |
| | | | | | | | |
| 338.11 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 4,29 | |
| 338.11 | M01AE17 | dexketoprofen | p.o. | 75 | MG | 15,60 | |
| | | | | | | | |
| 338.12 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 4,29 | |
| 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 339.1 | M01AE01 | ibuprofen | p.rect. | 1.2 | GM | 9,38 | |
| | | | | | | | |
| 339.2 | M01AE02 | naproxen | p.rect. | 0.5 | GM | 10,75 | |
| | | | | | | | |
| 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 8,75 | |
| 84358 | NAPROBENE 500MG | sup 10x500mg | MCK | D | | | |
| 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 8,37 | |
| 06171 | PROFENID 100MG | sup 12 | RPC | F | | | |
| 67639 | KETOPROFEN VON CT | sup 10x100mg | CTA | D | | | |
| 339.4 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.6 | GM | 10,75 | |
@@ -5373,9 +5451,9 @@
| | | | | | | | |
| 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 13,73 | |
| | | | | | | | |
| 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 15,69 | |
| 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 15,45 | |
| 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | | | |
| 59443 | KETONAL | inj 5x2ml/100mg | LEK | SLO | | | |
| 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | | | |
| 340.4 | M01AG | etofenamat | parent. | 1 | GM | 13,73 | |
| 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | L/REV | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5387,15 +5465,13 @@
| | | | | | | | |
| 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 11,78 | |
| | | | | | | | |
| 341.5 | M01AX17 | nimesulid (pevné lékové formy) | p.o. | 0.2 | GM | 14,32 | L/REV,ORT, NEU |
| | | | | | | | |
| 341.6 | M01AX17 | nimesulid (tekuté lékové formy) | p.o. | 0.2 | GM | 19,55 | L/REV,PDD, NEU |
| | | | | | | | |
| 341.7 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,32 | L/REV,ORT, NEU |
| | | | | | | | |
| 341.8 | M01AX21 | diacerein | p.o. | 100 | MG | 10,50 | L/REV, ORT |
| | | | | | | | |
| 341.9 | M01AH01 | celecoxib | p.o. | 0.2 | GM | 30,00 | P |
| 341.5 | M01AX17 | nimesulid | p.o. | 0.2 | GM | 14,32 | L/REV,ORT, NEU |
| | | | | | | | |
| 341.6 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,32 | L/REV,ORT, NEU |
| | | | | | | | |
| 341.7 | M01AX21 | diacerein | p.o. | 100 | MG | 10,50 | L/REV, ORT |
| | | | | | | | |
| 341.8 | M01AH01 | celecoxib | p.o. | 0.2 | GM | 30,00 | P |
Léčiva skupiny specifických COX 2 inhibitorů jsou předepisována revmatologem nebo ortopedem osobám s níže uvedeným rizikem:
@@ -5413,12 +5489,14 @@
Z prostředků veřejného zdravotního pojištění je hrazena v indikaci osteoartróza denní dávka celecoxibu do 200 mg včetně nebo denní dávka rofecoxibu do 25 mg včetně; v indikaci revmatoidní artriris denní dávka celecoxibu do 400 mg včetně nebo denní dávka rofecoxibu do 25 mg včetně.
| 341.10 | M01AH02 | rofecoxib (pevné i tekuté lékové formy) | p.o. | 1 | DF | 45,00 | P |
| 341.9 | M01AH02 | rofecoxib (pevné lékové formy) | p.o. | 1 | DF | 45,00 | P |
| | | | | | | | |
| 341.10 | M01AH02 | rofecoxib (tekuté lékové formy) | p.o. | 1 | DF | 45,00 | P |
| 342 | M01CB | léčiva obsahující zlato | parent. | L/REV | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,60 | L/REV |
| 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,35 | L/REV |
| 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | |
| 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | | | |
| 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | |
| 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5426,8 +5504,10 @@
součást léčby primární osteoarthrózy kolenních klobů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.
| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 32,50 | |
| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 31,34 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | | | |
| 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 22,88 | |
| | | | | | | | |
| 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 195,52 | P |
@@ -5436,6 +5516,7 @@
| 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| | | | | | | | |
| 344.2 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.3 | M02AA | kombinace ibuprofenu a heparinoidu do 50 g včetně v jednom balení | lok. | 1 | GM | 0,85 | |
@@ -5449,7 +5530,7 @@
| 344.7 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.8 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| 01780 | REUMADOR | gel 1x100gm | SLO | SK | | | |
| 01780 | REUMADOR | gel 1x100gm | | SK | | | |
| 344.9 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.10 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
@@ -5460,11 +5541,11 @@
| | | | | | | | |
| 344.13 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| | | | | | | | |
| 344.14 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| 344.14 | M02AA15 | diklofenak do 50 g masti včetně v jednom baleni | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.15 | M02AA15 | diklofenak nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| 67550 | ALMIRAL GEL | gel 1x250gm | MOE | CY | | | |
| 65985 | VERAL GEL | gel 1x100gm 1% | SLO | SK | | | |
| 67550 | ALMIRAL GEL | gel 1x250gm | MOE | CY | | | |
| 344.16 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,08 | |
| | | | | | | | |
| 344.17 | M02AA17 | kyselina niflumová nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
@@ -5498,39 +5579,39 @@
| | | | | | | | |
| 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 63,84 | H |
| | | | | | | | |
| 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 38,72 | H |
| 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 40,52 | H |
| 97387 | SUCCINYLCHOLINJODID VUAB | inj 1x250mg | VUA | CZ | | | |
| 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | H | | | |
| 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniovych derivátů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 113,59 | H |
| | | | | | | | |
| 57540 | PAVULON 4MG=2ML | inj 50x2ml/4mg | ORG | F | | | |
| 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 43,11 | H |
| | | | | | | | |
| 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 113,59 | H |
| | | | | | | | |
| 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 110,61 | H |
| 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 98,58 | H |
| 53615 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x25ml/250mg | GNN | D | | | |
| 53618 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x5ml/50mg | GNN | D | | | |
| 53620 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x25ml/250mg | GNN | D | | | |
| 53613 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x5ml/50mg | GNN | D | | | |
| 53619 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x10ml/100mg | GNN | D | | | |
| 53617 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x2.5ml/25mg | GNN | D | | | |
| 53616 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 2x25ml/250mg | GNN | D | | | |
| 53612 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x2.5ml/25mg | GNN | D | | | |
| 53613 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x5ml/50mg | GNN | D | | | |
| 53614 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x10ml/100mg | GNN | D | | | |
| 53615 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x25ml/250mg | GNN | D | | | |
| 53620 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x25ml/250mg | GNN | D | | | |
| 53617 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x2.5ml/25mg | GNN | D | | | |
| 53618 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x5ml/50mg | GNN | D | | | |
| 53619 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x10ml/100mg | GNN | D | | | |
| 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 103,48 | H |
| | | | | | | | |
| 349.6 | M03AC09 | rokuroniumbromid | parent. | 50 | MG | 200,00 | H |
| | | | | | | | |
| 349.7 | M03AC10 | mivacuronium | parent. | 10 | MG | 129,58 | H |
| | | | | | | | |
| 349.8 | M03AC11 | cisatracurium | parent. | 10 | MG | 208,40 | H |
| 56517 | NIMBEX FORTE | inj 1x30ml/150mg | GWE | GB | | | |
| 350 | M03AX | ostatní svalová relaxancia | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 9580,28 | X |
| 75241 | BOTOX | inj sic 1x100ut | ABL | IRL | | | |
| 75241 | BOTOX | inj sic 1x100ut | ALL | IRL | | | |
| 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2443,95 | X |
| 32074 | DYSPORT | inj sic 1x500ut | IPW | GB | | | |
| 97456 | DYSPORT | inj sic 2x500ut | SPY | GB | | | |
| 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | L/NEU,ORT,REV | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5558,12 +5639,11 @@
| 351.11 | M03BA52 | carisoprodol a paracetamol v kombinaci | parent. | 3 | DF | 2,50 | |
| 352 | M03CA | přímo působící svalová relaxancia | parent. | T | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7156,08 | T |
| 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7008,60 | T |
| 91583 | DANTROLEN | inj sic3x12x20mg+so | RHA | D | | | |
| 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,28 | |
| 96332 | ALOPURINOL BELUPO | tbl 100x100mg | BLU | CHO | | | |
| 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,08 | |
@@ -5571,7 +5651,7 @@
| 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,86 | |
| 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 5,91 | |
| 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 5,69 | |
| 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | SVP | D | | | |
| 356 | M05BA | bisfosfonáty | p.o. | P | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5586,7 +5666,11 @@
Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog:
Postmenopauzální osteoporoza žen dokumentovaná denzitometricky (méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT) nebo z objektivních důvodů nelze použít HRT. Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
- a) Denzitometricky dokumentovaná osteoporóza (méně než -2,5 SD) nebo osteoporotická patologická zlomenina.
- b) Ženy s osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii nebo ženy s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT)
Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
M05BA03 - kyselina pamidronová:
@@ -5597,10 +5681,10 @@
- b) Manifestní Pagetova choroba.
| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 225,58 | P |
| 93985 | LODRONAT | cps 60x400mg | ROC | D | | | |
| 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | |
| 56638 | BONEFOS 800MG | tbl obd 60x800mg | LOY | SF | | | |
| 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | |
| 93985 | LODRONAT | cps 60x400mg | ROC | D | | | |
| 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 41,30 | P |
| 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 39,40 | P |
| | | | | | | | |
| 356.3 | M05BA07 | kyselina risedronová | p.o. | 1 | DF | 39,40 | P |
| 357 | M05BA | bisfosfonáty | parent. | O/P | | | |
@@ -5616,11 +5700,11 @@
Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog:
- a) Denzitometricky dokumentovaná osteoporóza nebo osteoporotická patologická zlomenina.
- b) Ženy o osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapií.
Výše uvedená léčba kyselinou alendronovou je dlouhodobá, minimálně po dobu jednoho roku. Terapie delší než jeden rok je indikována pouze pokud u pacienta prokazatelně zastavila úbytek kostní hmoty.
- a) Denzitometricky dokumentovaná osteoporóza ( méně než -2,5 SD ) nebo osteoporotická patologická zlomenina.
- b) Ženy s osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii nebo ženy s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT)
Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
M05BA03 - kyselina pamidronová:
@@ -5642,42 +5726,43 @@
| 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 304,96 | H |
| 75284 | NARCOTAN | liq 1x250ml | LEX | CZ | | | |
| 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 2290,62 | H |
| 55404 | AERRANE | inh sol 1x100ml | BXI | B | | | |
| | | | | | | | |
| 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 1852,76 | H |
| 10722 | ISOFLURAN RHODIA | inh 1x250ml | ROD | GB | | | |
| 55405 | AERRANE | inh sol 1x250ml | BXI | B | | | |
| 359.3 | N01AB07 | desfluran | inhal. | 100 | ML | 1407,00 | H |
| | | | | | | | |
| 359.4 | N01AB08 | sevofluoran | inhal. | 100 | ML | 2290,62 | H |
| 360 | N01AF | injkeční anestetika ze skupiny barbiturátů | parent. | H | | | |
| 360 | N01AF | injekční anestetika ze skupiny barbiturátů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 142,63 | H |
| | | | | | | | |
| 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 60,41 | H |
| | | | | | | | |
| 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 37,10 | H |
| 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 38,85 | H |
| 97389 | THIOPENTAL VUAB | inj sic 1x1gm | VUA | CZ | | | |
| 361 | N01AH | opioidní anestetika (fentanyl) | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 361.1 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 145,00 | O |
| 361.1 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. 1 | MG | 137,80 | O | |
| 30101 | FENTANYL TORREX 50MCG/ML | inj 5x2ml/100rg | TRX | A | | | |
| 361.2 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 106,84 | O |
| 361.2 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 101,48 | O |
| 30102 | FENTANYL TORREX 50MCG/ML | inj 5x10ml/500rg | TRX | A | | | |
| 362 | N01AH | opioidní anestetika (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 48,29 | H |
| 362 | N01AH | opioidní anestetika (ostatní) | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 46,89 | H |
| 87721 | RAPIFEN | inj 5x2ml | JAN | B | | | |
| 362.2 | N01AH03 | sufentanyl (do 10 RG v ampuli včetně) | parent. | 0.6 | MG | 1383,67 | H |
| 362.2 | N01AH03 | sufentanyl (do 10 rg v ampuli včetně) | parent. | 0.6 | MG | 1344,54 | H |
| 93701 | SUFENTA I.V. | inj 5x2ml/10rg | JAN | B | | | |
| 362.3 | N01AH03 | sufentanyl (nad 50 RG v ampuli) | parent. | 0.6 | MG | 740,22 | H |
| 362.3 | N01AH03 | sufentanyl (nad 10 do 50 rg v ampuli včetně) | parent. | 0.6 | MG | 644,02 | H |
| 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B | | | |
| 362.4 | N01AH03 | sufentanyl (nad 50 rg v ampuli) | parent. | 0.6 | MG | 718,96 | H |
| 93702 | SUFENTA FORTE I.V. | inj 5x5ml/250rg | JAN | B | | | |
| 362.4 | N01AH03 | sufentanyl (nad 10 do 50 RG v ampuli včetně) | parent. | 0.6 | MG | 1210,83 | H |
| 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B | | | |
| 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 38,22 | H |
| | | | | | | | |
| 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 264,29 | H |
| 363 | N01AX | ostatní celková anestetika | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 363.1 | N01AX03 | ketamin (koncetrace do 1 % včetně) | parent. | 1 | GM | 240,19 | O |
| 363.1 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 1 | GM | 240,19 | O |
| 64824 | NARKAMON SPOFA 1% | inj 10x10ml/100mg | SPX | CZ | | | |
| 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 1 | GM | 234,04 | O |
| | | | | | | | |
@@ -5685,73 +5770,61 @@
| | | | | | | | |
| 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 162,72 | O |
| | | | | | | | |
| 363.5 | N01AX10 | propofol | parent. | 10 | ML | 96,14 | O |
| 363.5 | N01AX10 | propofol | parent. | 10 | ML | 87,00 | O |
| 56664 | PROPOFOL GENTHON 10MG/ML | inj 5x20ml/200mg | GNN | D | | | |
| 56663 | PROPOFOL GENTHON 10MG/ML | inj 1x20ml/200mg | GNN | D | | | |
| 56665 | PROPOFOL GENTHON 10MG/ML | inj 10x20ml/200mg | GNN | D | | | |
| 56670 | PROPOFOL GENTHON 10MG/ML | inj 5x100ml/1gm | GNN | D | | | |
| 56671 | PROPOFOL GENTHON 10MG/ML | inj 10x100ml/1gm | GNN | D | | | |
| 56669 | PROPOFOL GENTHON 10MG/ML | inj 1x100ml/1gm | GNN | D | | | |
| 56668 | PROPOFOL GENTHON 10MG/ML | inj 10x50ml/500mg | GNN | D | | | |
| 56667 | PROPOFOL GENTHON 10MG/ML | inj 5x50ml/500mg | GNN | D | | | |
| 56666 | PROPOFOL GENTHON 10MG/ML | inj 1x50ml/500mg | GNN | D | | | |
| 56663 | PROPOFOL GENTHON 10MG/ML | inj 1x20ml/200mg | GNN | D | | | |
| 56665 | PROPOFOL GENTHON 10MG/ML | inj 10x20ml/200mg | GNN | ID | | | |
| 56664 | PROPOFOL GENTHON 10MG/ML | inj 5x20ml/200mg | GNN | D | | | |
| 56667 | PROPOFOL GENTHON 10MG/ML | inj 5x50ml/500mg | GNN | D | | | |
| 56670 | PROPOFOL GENTHON 10MG/ML | inj 5x100ml/1gm | GNN | D | | | |
| 56669 | PROPOFOL GENTHON 10MG/ML | inj 1x 100ml/1gm | GNN | D | | | |
| 56668 | PROPOFOL GENTHON 10MG/ML | inj 10x50ml/500mg | GNN | D | | | |
| 53441 | PROPOFOL ABBOTT | inj 5x20ml/200mg-am | ABN | USA | | | |
| 53442 | PROPOFOL ABBOTT | inj 5x20ml/200mg-la | ABN | USA | | | |
| 53444 | PROPOFOL ABBOTT | inj 1x100ml/1gm | ABN | USA | | | |
| 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 19,55 | O |
| | | | | | | | |
| 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O |
| 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ | | | |
| 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,54 | O |
| 86447 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | | |
| | | | | | | | |
| 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,49 | O |
| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | |
| 86437 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 40x80ml 0.2% | ARD | CZ | | | |
| 86448 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | | |
| 86450 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 20x250ml 1% | ARD | CZ | | | |
| 86451 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 12x500ml 1% | ARD | CZ | | | |
| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x200ml 1% | ARD | CZ | | | |
| 86444 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x250ml 0.2% | ARD | CZ | | | |
| 89215 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x200ml 0.5% | ARD | CZ | | | |
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | |
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | | | |
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | |
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | | | |
| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml 0.5% | ARD | CZ | | | |
| 89213 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x200ml 0.2% | ARD | CZ | | | |
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | | | |
| 89217 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 20x200ml 1% | ARD | CZ | | | |
| 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ | | | |
| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | |
| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml 0.2% | ARD | CZ | | | |
| 69669 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x80ml 0.2% | ARD | CZ | | | |
| 86445 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 12x500ml 0.2% | ARD | CZ | | | |
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | | | |
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | |
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | |
| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | |
| 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,40 | O |
| 02684 | MESOCAIN | gel 1x20gm | SLO | SK | | | |
| 365.2 | N01BB02 | lidokain | lok. | 1 | ML | 7,68 | O |
| 62392 | INSTILLAGEL | gel 10x6ml(strik.) | FAP | D | | | |
| 62393 | INSTILLAGEL | gel 10x11 ml(strik.) | FAP | D | | | |
Autokatetrizace močových cest prováděná pacientem v domácí péči.
| 365.2 | N01BB02 | lidokain (obsah 6 ml) | lok. | 1 | ML | 5,60 | P |
| | | | | | | | |
| 365.3 | N01BB02 | lidokain (obsah 11 ml) | lok. | 1 | ML | 3,90 | P |
| 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O |
| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | |
| 69704 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | | | |
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | |
| 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O |
| 00502 | MESOCAIN | inj 10x10ml 1% | LEX | CZ | | | |
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O |
| 69707 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x80ml 1% | ARD | CZ | | | |
| 366.2 | N01BB | trimekain (konœntrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,43 | O |
| 00502 | MESOCAIN | inj 10x10ml | LEX | CZ | | | |
| | | | | | | | |
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. 1 | ML | 0,78 | O | |
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | |
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | |
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | |
| 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O |
| | | | | | | | |
| 366.5 | N01BB | trimekain/ adrenalin | parent. | 1 | ML | 2,35 | O |
| | | | | | | | |
| 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O |
| | | | | | | | |
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 49,66 | O |
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 48,84 | O |
| 92836 | MARCAINE SPINAL 0.5% HEAVY | inj 5x4ml/20mg | AST | S | | | |
| 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O |
| | | | | | | | |
@@ -5759,44 +5832,50 @@
| | | | | | | | |
| 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,15 | O |
| 87571 | ULTRACAIN 2% | inj 5x5ml | HMR | D | | | |
| 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 10,22 | O |
| 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 9,86 | O |
| 91234 | ULTRACAIN HYPERBAR 5% | inj 10x2ml/100mg | HMR | D | | | |
| 366.12 | N01BB51 | bupivakain/ adrenalin | parent. | 1 | ML | 3,81 | O |
| | | | | | | | |
| 366.13 | N01BB52 | lidokain/ adrenalin | parent. | 1 | ML | 2,35 | O |
| | | | | | | | |
| 366.14 | N01BB58 | artikain/ adrenalin | parent. | 1 | ML | 4,15 | O |
| 93109 | SUPRACAIN 4% | inj 10x2ml | LEX | CZ | | | |
| 366.15 | N01BB09 | ropivacain | parent. | 1 | ML | 15,64 | O |
| | | | | | | | |
| 366.15 | N01BB10 | ropivacain | parent. | 1 | ML | 14,00 | O |
| 46610 | NAROPIN 2MG/ML | inf 5x100ml/200mg | APN | S | | | |
| 56038 | NAROPIN 2MG/ML | inj 5x10ml/20mg | APN | S | | | |
| 46610 | NAROPIN 2MG/ML | inf 5x100ml/200mg | APN | S | | | |
| 366.16 | N01BB09 | levobupivacain | parent. | 1 | ML | 14,00 | O |
| 03761 | CHIROCAINE 5 MG | inj cnc sol 10x10ml | ABB | I | | | |
| 03755 | CHIROCAINE 2.5 MG | inj cnc sol 10x10ml | ABB | I | | | |
| 367 | N01BX | ostatní lokální anestetika | lok. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O |
| 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 | |
| 94309 | MST CONTINUS | tbl 60x10mg | NPP | GB | | | |
| 88834 | M-ESLON SR 10 | cps ret 20x10mg | ETP | F | | | |
| 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D | | | |
| 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F | | | |
| 94309 | MST CONTINUS | tbl 60x10mg | NPP | GB | | | |
| 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 | |
| 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK | | | |
| 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK | | | |
| 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 GM | 53,20 | | |
| 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F | | | |
| 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB | | | |
| 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D | | | |
| 368.3 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | |
| 80406 | VENDAL RETARD | tbl fc 30x30mg | lar | D | | | |
| 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK | | | |
| 55941 | M-ESLON SR 30 | cps ret 50x30mg | ETP | F | | | |
| 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK | | | |
| 368.3 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | |
| 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK | | | |
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | | | |
| 88839 | M-ESLON SR 60 | cps ret 20x60mg | ETP | F | | | |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | | | |
| 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | | | |
| 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D | | | |
| 368.4 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | |
| 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | | | |
| 80408 | VENDAL RETARD | tbl fc 30x100mg | LAR | D | | | |
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | | | |
| 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK | | | |
| 80409 | VENDAL RETARD | tbl fc 30x200mg | LAR | D | | | |
| 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK | | | |
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | | | |
| 368.4 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | |
| 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D | | | |
| 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | | | |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | | | |
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | | | |
| 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK | | | |
| 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | |
| | | | | | | | |
| 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | |
@@ -5811,21 +5890,18 @@
| | | | | | | | |
| 368.11 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 30 | MG | 52,64 | |
| | | | | | | | |
| 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 48,74 | |
| | | | | | | | |
| 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 52,34 | |
| 56874 | DHC CONTINUS 90MG | tbl ret 20x90mg | NPP | GB | | | |
| 56873 | DHC CONTINUS 60MG | tbl ret 20x60mg | NPP | GB | | | |
| 368.12 N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 48,74 | | |
| 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.15 | GM | 32,71 | |
| 80451 | DHC CONTINUS 60MG | tbl 56x60mg | NPP | GB | | | |
| 80452 | DHC CONTINUS 90MG | tbl 56x90mg | NPP | GB | | | |
| 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.24 | GM | 44,58 | |
| 80453 | DHC CONTINUS 120MG | tbl 56x120mg | NPP | GB | | | |
| 56873 | DHC CONTINUS 60MG | tbl ret 20x60mg | NPP | GB | | | |
| 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.15 | GM | 27,86 | |
| 56875 | DHC CONTINUS 120MG | tbl ret 20x120mg | NPP | GB | | | |
| 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 15,42 | O |
| 369 | N02AA | analgetika ze stupiny přírodních opioidů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 15,45 | O |
| 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | | | |
| 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,32 | O |
| 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 MG | 9,33 | O | |
| 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | | | |
| 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5835,7 +5911,7 @@
| | | | | | | | |
| 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 458,80 | P |
| | | | | | | | |
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 667,20 | P |
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 667,24 | P |
| | | | | | | | |
| 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 807,50 | P |
@@ -5843,9 +5919,9 @@
| 371 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 371.1 | N02AB02 | pethidin (do 50 mg v jedné ampuli včetně) | parent. | 0.4 | GM | 55,52 | O |
| 371.1 | N02AB02 | pethidin (do 50 mg v jedné ampuli včetně) | parent. | 0.4 | GM | 55,68 | O |
| 02715 | DOLSIN | inj 10x1ml 5% | HBS | SK | | | |
| 371.2 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.4 | GM | 34,36 | O |
| 371.2 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.4 | GM | 34,44 | O |
| 02716 | DOLSIN | inj 10x2ml 5% | HBS | SK | | | |
| 371.3 | N02AC03 | piritramid | parent. | 300 | MG | 94,43 | O |
| 372 | N02AC | analgetika ze skupupiny difenylpropylaminových derivátů | p.o. | | | | |
@@ -5853,81 +5929,77 @@
| 372.1 | N02AC05 | benzitramid | p.o. | 10 | MG | 12,71 | |
| 373 | N02AD | analgetika ze skupiny benzomorfanových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 373.1 | N02AD01 | pentazocin | p.o. | 0.2 | GM | 28,93 | |
| 08968 | FORTRAL | tbl 100x50mg | KRK | SLO | | | |
| 373.1 | N02AD01 | pentazocin | p.o. | 0.2 | GM | 27,26 | |
| 08968 | FORTRAL | tbl 100x50mg | KRK | SK | | | |
| 374 | N02AD | analgetika ze skupiny benzomorfanových derivátů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 374.1 | N02AD01 | pentazocin | parent. | 0.2 | GM | 112,87 | O |
| 374.1 | N02AD01 | pentazocin | parent. | 0.2 | GM | 106,40 | O |
| 08966 | FORTRAL | inj 10x1ml/30mg | KRK | SLO | | | |
| 375 | N02AX | analgetika ze skupiny ostatních opioidů | p.o., subling. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 375.1 | N02AE01 | buprenorfin | subling. | 1.2 | MG | 80,00 | |
| | | | | | | | |
| 375.2 | N02AX01 | tilidin | p.o. | 0.2 | GM | 19,78 | |
| 03558 | VALORON | gtt 10ml 10% | GNO | CZ | | | |
| 03558 VALORON | gtt 10ml 10% | IVX | CZ | | | | |
| 375.3 | N02AX02 | tramadol hydrochlorid (pevné lékové formy neretardované) | p.o. | 0.3 | GM | 23,00 | |
| 12826 | TRAMADOL LANNACHER 50MG | tbl flm 30x50mg | LAR | A | | | |
| 12825 | TRAMADOL LANNACHER 50MG | tbl flm 20x50mg | LAR | A | | | |
| 83094 | TRAMAL | cps 20x50mg | LEX | CZ | | | |
| 53716 | PROTRADON | cps 500x50mg | PMP | CZ | | | |
| 84747 | TRAMADOL 50 SLOVAKOFARMA | cps 10x50mg | SLO | SK | | | |
| 54082 | TRAMADOL 50 HF | cps 20x50mg | HMF | YU | | | |
| 12474 | TRAMABENE 50 TOBOLKY | cps 10x50mg | MCK | D | | | |
| 84748 | TRAMADOL 50 SLOVAKOFARMA | cps 20x50mg | SLO | SK | | | |
| 12475 | TRAMABENE 50 TOBOLKY | cps 30x50mg | MCK | D | | | |
| 84375 | PROTRADON | cps 10x50mg | PMP | CZ | | | |
| 12824 | TRAMADOL LANNACHER 50MG | tbl flm 10x50mg | LAR | A | | | |
| 84376 | PROTRADON | cps 20x50mg | PMP | CZ | | | |
| 84375 | PROTRADON | cps 10x50mg | PMP | CZ | | | |
| 84747 | TRAMADOL 50 SLOVAKOFARMA | cps 10x50mg | SLO | SK | | | |
| 84748 | TRAMADOL 50 SLOVAKOFARMA | cps 20x50mg | SLO | SK | | | |
| 12825 | TRAMADOL LANNACHER 50MG | tbl flm 20x50mg | LAR | A | | | |
| 12826 | TRAMADOL LANNACHER 50MG | tbl flm 30x50mg | LAR | A | | | |
| 53716 | PROTRADON | cps 500x50mg | PMP | CZ | | | |
| 12474 | TRAMABENE 50 TOBOLKY | cps 10x50mg | MCK | D | | | |
| 83094 | TRAMAL | cps 20x50mg | LEX | CZ | | | |
| 84631 | TRAMADOL-K | cps 20x50mg | KRK | SLO | | | |
| 375.4 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.3 | GM | 32,75 | |
| 375.4 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.3 | GM | 29,40 | |
| 32197 | TRAMADOL-K RETARD | por tbl ret30x100mg | KRK | SLO | | | |
| 59671 | TRALGIT SR 100 | por tbl ret10x100mg | SLO | SK | | | |
| 43712 | TRAMAL RETARD 100 | tbl obd 30x100mg | LEX | CZ | | | |
| 59673 | TRALGIT SR 100 | por tbl ret50x100mg | SLO | SK | | | |
| 59672 | TRALGIT SR 100 | por tbl ret30x100mg | SLO | SK | | | |
| 53366 | TRAMAL RETARD 150 | tbl ret 10x150mg | LEX | CZ | | | |
| 43712 | TRAMAL RETARD 100 | tbl obd 30x100mg | LEX | CZ | | | |
| 53369 | TRAMAL RETARD 200 | tbl ret 30x200mg | LEX | CZ | | | |
| 43711 | TRAMAL RETARD 100 | tbl obd 10x100mg | LEX | CZ | | | |
| 53368 | TRAMAL RETARD 200 | tbl ret 10x200mg | LEX | CZ | | | |
| 53367 | TRAMAL RETARD 150 | tbl ret 30x150mg | LEX | CZ | | | |
| 375.5 | N02AX02 | tramadol hydrochlorid ( tekuté lékové formy) | p.o. | 0.3 | GM | 34,26 | |
| 375.5 | N02AX02 | tramadol hydrochlorid ( tekuté lékové formy) | p.o. | 0.3 | GM | 30,84 | |
| 56036 | TRAMAL | gtt 1x96ml/9.6gm | LEX | CZ | | | |
| 83095 | TRAMAL | gtt 1x10ml/1gm | LEX | CZ | | | |
| 12473 | TRAMABENE KAPKY | gtt 1x100ml/10gm | MCK | D | | | |
| 12918 | TRAMADOL-SLOVAKOFARMA | sol 1x10ml | SLO | SK | | | |
| 31922 | TRAMAGIT | gtt 1x10ml/1gm | KWM | D | | | |
| 59076 | TRAMADOL AL | gtt 1x20ml/2gm | SDB | D | | | |
| 12472 | TRAMABENE KAPKY | gtt 1x30ml/3gm | MCK | D | | | |
| 84630 | TRAMADOL-K | gtt 1x10ml/1gm | KRK | SLO | | | |
| 12473 | TRAMABENE KAPKY | gtt 1x100ml/10gm | MCK | D | | | |
| 12503 | TRAMAGIT | gtt 2x10ml/1gm | KWM | D | | | |
| 57622 | TRAMADOL SVUS KAPKY | gtt 1x100ml/10gm | SVS | CZ | | | |
| 59077 | TRAMADOL AL | gtt 1x50ml/5gm | SDB | D | | | |
| 59076 | TRAMADOL AL | gtt 1x20ml/2gm | SDB | D | | | |
| 12471 | TRAMABENE KAPKY | gtt 1x10ml/1gm | MCK | D | | | |
| 12472 | TRAMABENE KAPKY | gtt 1x30ml/3gm | MCK | D | | | |
| 53555 | PROTRADON KAPKY | gtt 1x10ml/1gm | PMP | CZ | | | |
| 57620 | TRAMADOL SVUS KAPKY | gtt 1x10ml/1gm | SVS | CZ | | | |
| 57621 | TRAMADOL SVUS KAPKY | gtt 1x30ml/3gm | SVS | CZ | | | |
| 57622 | TRAMADOL SVUS KAPKY | gtt 1x100ml/10gm | SVS | CZ | | | |
| 376 | N02AX | analgetika ze skupiny ostatních opioidů | p.rect., parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 376.1 | N02AE01 | buprenorfin | parent. | 1.2 | MG | 200,40 | O |
| | | | | | | | |
| 376.2 | N02AF01 | butorfanol | parent. | 12 | MG | 83,10 | O |
| 88739 | BEFORAL | inj 5x1ml/2mg | LEX | CZ | | | |
| | | | | | | | |
| 376.3 | N02AF02 | nalbufin | parent. | 80 | MG | 69,21 | O |
| | | | | | | | |
| 376.4 | N02AX01 | tilidin | parent. | 0.2 | GM | 16,37 | O |
| | | | | | | | |
| 376.5 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.3 | GM | 56,79 | |
| 376.5 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.3 | GM | 54,78 | |
| 84632 | TRAMADOL-K | sup 5x100mg | KRK | SLO | | | |
| 12822 | TRAMADOL LANNACHER 100MG | sup 5x100mg | LAR | A | | | |
| 44713 | TRAMADOL 100-SLOVAKOFARMA | sup 10x100mg | SLO | SK | | | |
| 376.6 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 109,44 | O |
| 376.6 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 102,84 | O |
| 12477 | TRAMABENE 50 INJEKCE | inj 5x1ml/50mg | MCK | D | | | |
| 83097 | TRAMAL 50 | inj 5x1ml/50mg | LEX | CZ | | | |
| 84628 | TRAMADOL-K 50MG/1ML | inj 5x1ml/50mg | KRK | SLO | | | |
| 92363 | TRAMADOL LANNACHER 50MG/1ML | inj 5x1ml/50mg | LAR | A | | | |
| 53675 | TRAMADOL-SLOVAKOFARMA 50MG/1ML | inj 5x1ml/50mg | SLO | SK | | | |
| 12477 | TRAMABENE 50 INJEKCE | inj 5x1ml/50mg | MCK | D | | | |
| 376.7 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 55,71 | O |
| 53678 | TRAMADOL-SLOVAKOFARMA 100MG/2ML | inj 5x2ml/100mg | SLO | SK | | | |
| 376.7 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 53,76 | O |
| 84629 | TRAMADOL-K 100MG/2ML | inj 5x2ml/100mg | KRK | SLO | | | |
| 92364 | TRAMADOL LANNACHER 100MG/2ML | inj 5x2ml/100mg | LAR | A | | | |
| 76389 | TRAMADOL AL | inj 5x2ml/100mg | SDB | D | | | |
| 58993 | TRAMADOL AL | inj 10x2ml/100mg | SDB | D | | | |
| 67559 | MABRON | inj 10x2ml/100mg | MOE | CY | | | |
| i 58994 | TRAMADOL AL | inj 20x2ml/100mg | SDB | D | | | |
| 83098 | TRAMAL 100 | inj 5x2ml/100mg | LEX | CZ | | | |
| 12478 | TRAMABENE 100 INJEKCE | inj 5x2ml/100mg | MCK | D | | | |
| 67558 | MABRON | inj 5x2ml/100mg | MOE | CY | | | |
| 58994 | TRAMADOL AL | inj 20x2ml/100mg | SDB | D | | | |
| 58993 | TRAMADOL AL | inj 10x2ml/100mg | SDB | D | | | |
| 67560 | MABRON | inj 100x2ml/100mg | MOE | CY | | | |
| 53678 | TRAMADOL-SLOVAKOFARMA 100MG/2ML | inj 5x2ml/100mg | SLO | SK | | | |
| 377 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 377.1 | N02BA01 | kyselina acetylsalicylová | p.o. | 3 | GM | 6,45 | |
@@ -5946,64 +6018,56 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 378.1 | N02BA | lysin salicylát | parent. | 3 | GM | 41,79 | |
| | | | | | | | |
| 378.2 | N02BA04 | salicylát sodný | parent. | 3 | GM | 38,49 | |
| 378.2 | N02BA04 | salicylát sodný | parent. | 3 | GM | 38,58 | |
| 00527 | NATRIUM SALICYLICUM BIOTIKA | inj 10x10ml 10% | HBS | SK | | | |
| 378.3 | N02BA | lysin acetylsalicylát | parent. | 3 | GM | 40,37 | |
| 379 | N02BE | analgetika ze skupiny anilidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 379.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,26 | |
| 379.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,67 | |
| 97656 | PARALEN 125 | tbl 20x125mg | LEX | CZ | | | |
| 379.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3 | GM | 4,94 | |
| 83608 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | APT | CND | | | |
| 84749 | MEDIPYRIN 500 | tbl 10x500mg | SLO | SK | | | |
| 71997 | PARACETAMOL K | tbl 10x500mg | KRK | SLO | | | |
| 98078 | PARACETAMOL K | tbl 1000x500mg | KRK | SLO | | | |
| 379.3 | N02BE01 | paracetamol (tekuté lékové formy) | p.o. | 3 | GM | 8,65 | |
| 380 | N02BE | analgetika ze skupiny anilidů | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 380.1 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3 | GM | 90,96 | |
| 67230 | EFFERALGAN NOURRISSON 80MG | sup 10x80mg | UPS | F | | | |
| 67226 | EFFERALGAN JEUNE ENFANT 150MG | sup 10x150mg | UPS | F | | | |
| 91249 | PARALEN 100 | sup 5x100mg | LEX | CZ | | | |
| 86009 | BEN-U-RON 125MG | sup 5x125mg | BNC | D | | | |
| 86010 | BEN-U-RON 125MG | sup 10x125mg | BNC | D | | | |
| 86009 | BEN-U-RON 125MG | sup 5x125mg | BNC | D | | | |
| 380.2 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3 | GM | 26,98 | |
| 04343 | PARALEN 500 | sup 5x500mg | LEX | CZ | | | |
| 59869 | MEDIPYRIN 250 | sup 10x250mg | SLO | SK | | | |
| 67227 | EFFERALGAN GRAND ENFANT 300MG | sup 10x300mg | UPS | F | | | |
| 53169 | EFFERALGAN ADULTE 600MG | sup 10x600mg | UPS | F | | | |
| 86015 | BEN-U-RON 1000MG | sup 10x1000mg | BNC | D | | | |
| 86014 | BEN-U-RON 500MG | sup 10x500mg | BNC | D | | | |
| 86013 | BEN-U-RON 500MG | sup 5x500mg | BNC | D | | | |
| 94982 | MEXALEN | sup 6x1000mg | MCK | D | | | |
| 53169 | EFFERALGAN ADULTE 600MG | sup 10x600mg | UPS | F | | | |
| 381 | N02B | ostatní analgetika | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 381.1 | N02BB02 | metamizol sodný (nad 1 g v 1 ampuli) | parent. | 3 | GM | 18,48 | O |
| 381.1 | N02BB02 | metamizol sodný (do 1 g v 1 ampuli včetně) | parent. | 3 | GM | 44,53 | O |
| 62437 | NOVALGIN | inj 10x2ml/1000mg | HMR | D | | | |
| 07981 | NOVALGIN | inj 10x2ml/1000mg | HBS | SK | | | |
| 381.2 | N02BB02 | metamizol sodný (nad 1 g v 1 ampuli) | parent. | 3 | GM | 18,48 | O |
| 62813 | NOVALGIN | inj 5x5ml/2500mg | HMR | D | | | |
| 55824 | NOVALGIN | inj 5x5ml/2500mg | HBS | SK | | | |
| 62813 | NOVALGIN | inj 5x5ml/2500mg | HMR | D | | | |
| 381.2 | N02BB02 | metamizol sodný (do 1 g v 1 ampuli včetně) | parent. | 3 | GM | 44,53 | O |
| 07981 | NOVALGIN | inj 10x2ml/1000mg | HBS | SK | | | |
| 62437 | NOVALGIN | inj 10x2ml/1000mg | HMR | D | | | |
| 381.3 | N02BB73 | aminophenazon v kombinaci s psycholeptiky | parent. | 1 | DF | 13,98 | O |
| 00457 | EUNALGIT | inj 5x2ml | LEX | CZ | | | |
| 381.4 | N02BE05 | propacetamol | parent. | 1 | GM | 41,84 | O |
| 382 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 382.1 | N02CA01 | dihydroergotamin | p.o. | 4 | MG | 1,22 | |
| | | | | | | | |
| 382.2 | N02CA07 | lisurid | p.o. | 75 | RG | 0,73 | |
| | | | | | | | |
| 382.3 | N02CA52 | ergotamin, kombinace | p.o. | 4 | DF | 9,38 | |
| 383 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 383.1 | N02CA01 | dihydroergotamin | parent. | 4 | MG | 113,50 | |
| 383.1 | N02CA01 | dihydroergotamin | parent. | 4 | MG | 112,72 | |
| 90795 | DIHYDERGOT | inj 5x1ml 1mg/ml | SAN | CH | | | |
| 383.2 | N02CA01 | dihydroergotamin nosní spray | inhal. | 1 | MG | 50,00 | |
| 384 | N02C | jiná antimigrenika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 384.1 | N02CC01 | sumatriptan (do 0,05 GM včetně v jedné tabletě) | p.o. | 0.1 | GM | 166,66 | |
| | | | | | | | |
| 384.2 | N02CC01 | sumatriptan (nad 0,05 GM v jedné tabletě) | p.o. | 0.1 | GM | 125,00 | |
| 384.1 | N02CC01 | sumatriptan (do 50 mg včetně v jedné tabletě) | p.o. | 50 | MG | 105,00 | |
| | | | | | | | |
| 384.2 | N02CC01 | sumatriptan (nad 50 mg v jedné tabletě) | p.o. | 50 | MG | 78,75 | |
| | | | | | | | |
| 384.3 | N02CC01 | sumatriptan | parent. | 1 | DF | 899,35 | X |
| | | | | | | | |
@@ -6011,13 +6075,13 @@
Léčbu indikuje neurolog k tereapii těžkého migrenozního záchvatu s časným zvracením, nejvíce v počtu 2 balení (4 dávky) za měsíc.
| 384.5 | N02CC02 | naratriptan | p.o. | 2,5 | MG | 125,00 | |
| | | | | | | | |
| 384.6 | N02CC03 | zolmitriptan | p.o. | 2,5 | MG | 125,00 | |
| | | | | | | | |
| 384.7 | N02CC04 | rizatriptan | p.o. | 10 | MG | 125,00 | |
| | | | | | | | |
| 384.8 | N02CC | eletriptan | p.o. | 40 | MG | 125,00 | |
| 384.5 | N02CC02 | naratriptan | p.o. | 2,5 | MG | 105,00 | |
| | | | | | | | |
| 384.6 | N02CC03 | zolmitriptan | p.o. | 2,5 | MG | 105,00 | |
| | | | | | | | |
| 384.7 | N02CC04 | rizatriptan | p.o. | 10 | MG | 105,00 | |
| | | | | | | | |
| 384.8 | N02CC | eletriptan | p.o. | 40 | MG | 105,00 | |
| | | | | | | | |
| 384.9 | N02CX01 | pizotifen | p.o. | 1.5 | MG | 5,87 | |
| | | | | | | | |
@@ -6030,19 +6094,19 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 385.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.1 | GM | 2,05 | |
| | | | | | | | |
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,31 | |
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,08 | |
| 68578 | PHENAEMALETTEN | tbl 50x15mg | DET | D | | | |
| 385.3 | N03AA02 | Ifenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,40 | |
| 68579 | PHENAEMAL 0.1 | tbl 50x100mg | DET | D | | | |
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 4,89 | |
| 385.3 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,27 | |
| | | | | | | | |
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 4,72 | |
| 01365 | MYSOLINE | tbl 100x250mg | ZNC | GB | | | |
| 385.5 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 45,51 | |
| 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 386.1 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.1 | GM | 132,22 | O |
| 386.1 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.1 | GM | 126,25 | O |
| 66845 | GARDENAL | inj sic 1x40mg+solv | RPC | F | | | |
| 386.2 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.1 | GM | 13,98 | O |
| 84449 | LUMINAL | inj 5x1 ml/219mg | DET | D | | | |
| 386.2 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.1 | GM | 13,46 | O |
| 84449 | LIMINAL | inj 5x1ml/219mg | DET | D | | | |
| 387 | N03AB | antiepileptika ze skupiny hydantoinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 387.1 | N03AB02 | fenytoin | p.o. | 0.3 | GM | 2,81 | |
@@ -6051,71 +6115,71 @@
| 387.2 | N03AB04 | mefenytoin | p.o. | 0.4 | GM | 2,44 | |
| | | | | | | | |
| 387.3 | N03AB52 | fenytoin, kombinace | p.o. | 3 | DF | 2,40 | |
| 02625 | SANEPIL | tbl 20 (blistr) | SLO | SK | | | |
| 388 | N03AB | antiepileptika ze skupiny hydantoinů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 388.1 | N03AB02 | fenytoin | parent. | 0.3 | GM | 122,25 | O |
| 03300 | EPANUTIN | inj 5x5ml/250mg | PDA | GB | | | |
| 388.1 | N03AB02 | fenytoin | parent. | 0.3 | GM | 116,04 | O |
| 59080 | EPANUTIN PARENTERAL | inj 5x5ml/250mg | GOD | D | | | |
| 389 | N03AD | antiepileptika ze skupiny sukcinimidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 17,06 | |
| 93710 | SUXILEP | cps 120x250mg | VJP | D | | | |
| 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 16,78 | |
| 92041 | PETINIMID | cps 100x250mg | GER | A | | | |
| 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 23,07 | |
| 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 22,69 | |
| 02035 | SUXILEP | gtt 50gm 50% | GMD | D | | | |
| 02110 | PETINIMID | sir 250ml 12.5gm | GER | A | | | |
| 389.3 | N03AD03 | mesuximid | p.o. | 0.9 | GM | 24,78 | |
| 390 | N03AE | antiepileptika ze skupiny benzodiazepinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 34,17 | |
| 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 33,60 | |
| 59908 | RIVOTRIL 2.5MG/ML | gtt 1x10ml/25mg | ROX | I | | | |
| 390.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8 | MG | 24,15 | |
| 03031 | RIVOTRIL | tbl 50x0.5mg | HLR | CH | | | |
| 390.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8 | MG | 12,71 | |
| 391 | N03AE | antiepileptika ze skupiny benzodiazepinů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 238,53 | O |
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 230,32 | O |
| 03030 | RIVOTRIL | inj 5x1ml/1mg+solv. | HLR | CH | | | |
| 392 | N03AF | antiepileptika ze skupiny derivátů karboxamidu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,37 | |
| 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,16 | |
| 98080 | NEUROTOP | tbl 50x200mg | GER | A | | | |
| 62309 | APO-CARBAMAZEPINE 200MG | tbl 100x200mg | APT | CND | | | |
| 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 17,21 | |
| 96305 | NEUROTOP RETARD 300 | tbl 50x300mg | GER | A | | | |
| 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 16,94 | |
| 71954 | TIMONIL RETARD | tbl 50x150mg | DET | D | | | |
| 60164 | TIMONIL RETARD | tbl 50x300mg | DET | D | | | |
| 60165 | TIMONIL RETARD | tbl 100x300mg | DET | D | | | |
| 96306 | NEUROTOP RETARD 600 | tbl 50x600mg | GER | A | | | |
| 60166 | TIMONIL RETARD | tbl 50x600mg | DET | D | | | |
| 75293 | TIMONIL RETARD | tbl 100x150mg | DET | D | | | |
| 60165 | TIMONIL RETARD | tbl 100x300mg | DET | D | | | |
| 71954 | TIMONIL RETARD | tbl 50x150mg | DET | D | | | |
| 96305 | NEUROTOP RETARD 300 | tbl 50x300mg | GER | A | | | |
| 392.3 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1 | GM | 42,52 | |
| | | | | | | | |
| 392.4 | N03AF02 | oxcarbazepin | p.o. | 1 | GM | 11,10 | |
| 393 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (natrium valproát) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 393.1 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 19,40 | |
| 393.1 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 19,06 | |
| 08768 | CONVULEX | cps 100x150mg | GER | A | | | |
| 61183 | ORFIRIL 150 | drg 50x150mg | DET | D | | | |
| 393.2 | N03AG01 | natrium valproát (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 15,64 | |
| 08769 | CONVULEX | cps 100x300mg | GER | A | | | |
| 75296 | CONVULEX | cps 100x500mg | GER | A | | | |
| 08769 | CONVULEX | cps 100x300mg | GER | A | | | |
| 61184 i | ORFIRIL 300 | drg 50x300mg | DET | D | | | |
| 61184 | ORFIRIL 300 | drg 50x300mg | DET | D | | | |
| 93334 | EVERIDEN | tbl 100x300mg | SLO | SK | | | |
| 61185 | ORFIRIL 600 | drg 50x600mg | DET | D | | | |
| 61187 | ORFIRIL 300 | drg 100x300mg | DET | D | | | |
| 93334 | EVERIDEN | tbl 100x300mg | SLO | SK | | | |
| 393.3 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 MG v jedné tabletě včetně) | p.o. | 1.5 | GM | 26,88 | |
| 393.3 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 mg v jedné tabletě včetně) | p.o. | 1.5 | GM | 26,88 | |
| 57712 | ORFIRIL LONG 300MG | cps ret 50x300mg | DET | D | | | |
| 62705 | ORFIRIL 300 RETARD | drg ret 100x300mg | DET | D | | | |
| 58785 | CONVULEX CR 300 MG | tbl ret 50x300mg | GER | A | | | |
| 393.4 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 MG v jedné tabletě) | p.o. | 1.5 | GM | 28,46 | |
| 57713 | ORFIRIL LONG 300MG | cps ret 100x300mg | DET | D | | | |
| 393.4 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 28,46 | |
| 57715 | ORFIRIL LONG 500MG | tbl ret 50x500mg | DET | D | | | |
| 57716 | ORFIRIL LONG 500MG | tbl ret 100x500mg | DET | D | | | |
| 58787 | CONVULEX CR 500 MG | tbl ret 50x500mg | GER | A | | | |
| 57718 | ORFIRIL LONG 1000MG | tbl ret 50x1000mg | DET | D | | | |
| 393.5 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 MG v jedné tabletě) | p.o. | 1.5 | GM | 31,90 | |
| | | | | | | | |
| 393.6 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 MG v jedné tabletě) | p.o. | 1.5 | GM | 30,32 | |
| 57719 | ORFIRIL LONG 1000MG | tbl ret 100x1000mg | DET | D | | | |
| 393.5 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 31,90 | |
| 393.6 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 30,32 | |
| 92587 | DEPAKINE CHRONO 500MG SECABLE | tbl ret 30x500mg | SWI | F | | | |
| 44997 | DEPAKINE CHRONO 500MG SECABLE | tbl ret 100x500mg | SWI | F | | | |
| 92587 | DEPAKINE CHRONO 500MG SECABLE | tbl ret 30x500mg | SWI | F | | | |
| 393.7 | N03AG01 | natrium valproát (tekuté lékové formy) | p.o. | 1.5 | GM | 26,54 | |
| 08770 | CONVULEX | gtt 100ml 300mg/ml | GER | A | | | |
| 394 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (ostatní) | p.o. | L/NEU,PSY | | | |
@@ -6131,107 +6195,111 @@
| 54238 | ORFIRIL INJEKTIONSLOSUNG | inj 5x3ml/300mg | DET | D | | | |
| 396 | N03AX | ostatní antiepileptika | p.o. | L/PSY,NEU | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 16,72 | L/PSY,NEU |
| 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 16,11 | L/PSY,NEU |
| 55852 | OSPOLOT | tbl obd 50x200mg | DET | D | | | |
Lamotrigin, disperzní léková forma: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být, z jakýchkoliv důvodů léčeny tabletovou formou.
| 396.2 | N03AX09 | lamotrigin (disperzní forma do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 300,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 84511 | LAMICTAL 5MG DISPERSIBLE/CHEW. | ctb 30x5mg | BWE | GB | | | |
| 396.3 | N03AX09 | lamotrigin ( disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 185,00 | P |
| 84512 | LAMICTAL 25MG DISPERSIBLE/CHEW. | ctb 30x25mg | BWE | GB | | | |
| 396.4 | N03AX09 | lamotrigin (disperzní forma nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 144,00 | P |
| 84513 | LAMICTAL 100MG DISPERSIBLE/CHEW | ctb 30x100mg | BWE | GB | | | |
| 396.5 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| | | | | | | | |
| 396.6 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| 396.7 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| | | | | | | | |
| 396.8 | N03AX10 | felbamat | p.o. | 2.4 | GM | 283,03 | L/PSY,NEU |
Lamotrigin, disperzní léková forma: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být léčeny tabletovou formou.
| 396.2 | N03AX09 | lamotrigin (disperzní forma do 2 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 500,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 396.3 | N03AX09 | lamotrigin (disperzní forma nad 2 mg do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 300,00 | P |
| 42584 | LAMICTAL 5 MG | por tbl mnd 30x5mg | GOW | GB | | | |
| 396.4 | N03AX09 | lamotrigin (disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 185,00 | P |
| 42585 | LAMICTAL 25 MG | por tbl mnd 30x25mg | GOW | GB | | | |
| 396.5 | N03AX09 | lamotrigin ( disperzní forma nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 144,00 | P |
| 42586 | LAMICTAL 100 MG | por tbl mnd30x100mg | GOW | GB | | | |
| 396.6 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| | | | | | | | |
| 396.7 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| | | | | | | | |
| 396.8 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| | | | | | | | |
| 396.9 | N03AX10 | felbamat | p.o. | 2.4 | GM | 283,03 | L/PSY,NEU |
| 77005 | TALOXA 600MG | tbl 100x600mg | SCH | B | | | |
| 77003 | TALOXA | sus 230ml 120mg/ml | SCH | B | | | |
| 77004 | TALOXA 400MG | tbl 100x400mg | SCH | B | | | |
| 77003 | TALOXA | sus 230ml 120mg/ml | SCH | B | | | |
Topiramat - léková forma tobolky: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být, z jakýchkoliv důvodů, léčeny tabletovou formou.
| 396.9 | N03AX11 | topiramat tobolky (do 15 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 300,00 | P |
| | | | | | | | |
| 396.10 | N03AX11 | topiramat tobolky (nad 15 mg do 25 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 185,00 | P |
| | | | | | | | |
| 396.11 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| 396.10 | N03AX11 | topiramat tobolky (do 15 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 300,00 | P |
| | | | | | | | |
| 396.11 | N03AX11 | topiramat tobolky (nad 15 mg do 25 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 185,00 | P |
| | | | | | | | |
| 396.12 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| 44671 | TOPAMAX 25MG | tbl obd 28x25mg-bl. | CIL | CH | | | |
| 396.12 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| 396.13 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| 44675 | TOPAMAX 50MG | tbl obd 28x50mg-bl. | CIL | CH | | | |
| 396.13 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| | | | | | | | |
| 396.14 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 135,36 | L/PSY,NEU |
| 396.14 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| | | | | | | | |
| 396.15 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 135,36 | L/PSY,NEU |
| 84401 | NEURONTIN 400MG | cps 50x400mg | PDA | D | | | |
| 84400 | NEURONTIN 300MG | cps 100x300mg | PDA | D | | | |
| 84399 | NEURONTIN 300MG | cps 50x300mg | PDA | D | | | |
| 84398 | NEURONTIN 100MG | cps 100x100mg | PDA | D | | | |
| 84400 | NEURONTIN 300MG | cps 100x300mg | PDA | D | | | |
| 84396 | NEURONTIN 100MG | cps 20x100mg | PDA | D | | | |
| 396.15 | N03AX14 | levetiracetam | p.o. | 2 | GM | 135,36 | L/PSY, NEU |
| 396.16 | N03AX14 | levetiracetam | p.o. | 2 | GM | 135,36 | L/PSY, NEU |
| 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 6,83 | |
| 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 7,15 | |
| 00102 | DEPARKIN | drg 50x50mg | LEX | CZ | | | |
| 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 12,22 | |
| | | | | | | | |
| 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,09 | |
| | | | | | | | |
| 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 8,80 | |
| 57783 | KEMADRIN | tbl 100x5mg | ACA | GB | | | |
| 01337 | KEMADRIN | tbl 100x5mg | BWE | GB | | | |
| 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 58,52 | O |
| 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | | | |
| 01973 | AKINETON | inj 5x1ml/5mg | EBW | A | | | |
| 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | | | |
| 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,71 | O |
| 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,16 | |
| 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejich derivátů | p.o. | | | | |
| 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,12 | |
| 96751 | APO-BENZTROPINE 2MG | tbl 100x2mg | APT | CND | | | |
| 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 24,64 | |
| | | | | | | | |
| 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 29,62 | |
| 400.2 | N04BA02 | levodopa/ karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 GM | 29,62 | | |
| 45241 | ISICOM 100MG | tbl 100x125mg | DET | D | | | |
| 400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | |
| 400.3 | N04BA02 | levodopa/ karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | |
| 03591 | NAKOM | tbl 100x275mg | LEK | SLO | | | |
| 45244 | ISICOM 250MG | tbl 100x275mg | DET | D | | | |
| 400.4 | N04BA02 | levodopa/ benserazid | p.o. | 0.6 | GM | 22,00 | |
| | | | | | | | |
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy do 0,125 GM včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | |
| | | | | | | | |
| 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy nad 0,125 GM v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | |
| 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | L/NEU,PSY,GER | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 5,28 | L/NEU,PSY, GER |
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 gm včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | |
| 12073 | MADOPAR HBS | cps 30x125mg | HLR | CH | | | |
| 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 gm v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | |
| 401 | N04BB- | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | L/NEU,PSY,GER | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 5,52 | L/NEU,PSY, GER |
| 02871 | VIREGYT-K | cps 50x100mg | EGI | H | | | |
| 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,33 | L/NEU,PSY, GER |
| | | | | | | | |
| 401.3 | N04BB01 | amantadin | parent. | 0,2 | GM | 4,25 | H |
| 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | L/NEU,PSY,GER | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 402.1 | N04BD01 | selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 6,21 | L/NEU,PSY, GER |
| 402.1 | N04BD01 | selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 6,12 | L/NEU,PSY, GER |
| 59279 | SELEGILIN-RATIOPHARM 5 MG | tbl 50x5mg | MCK | D | | | |
| 03073 | APO-SELEG | por tbl nob100x5mg | APT | CND | | | |
| 03074 | APO-SELEG | por tbl nob 50x5mg | APT | CND | | | |
| 31036 | JUMEX 5MG | tbl 50x5mg | CHN | H | | | |
| 55764 | COGNITIV 5MG | tbl obd 100x5mg | EBW | A | | | |
| 402.2 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,85 | L/NEU,PSY, GER |
| | | | | | | | |
| 402.2 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,79 | L/NEU,PSY, GER |
| 55766 | COGNITIV 10MG | tbl obd 100x10mg | EBW | A | | | |
| 402.3 | N04BX01 | tolkapon | p.o. | 0,3 | GM | 116,72 | X |
| | | | | | | | |
| 402.4 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 176,94 | X |
| | | | | | | | |
| 402.5 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 16,11 | X |
| 402.5 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 145,66 | X |
| | | | | | | | |
| 402.6 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 132,95 | X |
| | | | | | | | |
| 402.7 | N04BC03 | dihydro-ergokriptin | p.o. | 10 | MG | 16,11 | X |
| 64928 | ALMIRID | tbl 20x20mg | MON | I | | | |
| 402.6 | N04BC05 | pramipexol | p.o. | 2,5 | MG | 110,79 | X |
| | | | | | | | |
| 402.7 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 145,66 | X |
| | | | | | | | |
| 402.8 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 132,95 | X |
| 402.8 | N04BC05 | pramipexol | p.o. | 2,5 | MG | 110,79 | X |
| | | | | | | | |
| 402.9 | N04BX02 | entacapon | p.o. | 1 | GM | 175,00 | X |
| 54466 | COMTAN | tbl obd 30x200mg | NPA | D | | | |
@@ -6240,25 +6308,25 @@
| 402.11 | N04BC04 | ropinirol nad 2 mg v jedné tabletě | p.o. | 6 | MG | 60,00 | X |
| 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,00 | |
| 02114 | PLEGOMAZIN 25MG | tbl obd 50x25mg | EGI | H | | | |
| 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 6,43 | |
| 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,19 | |
| 02114 | PLEGOMAZIN 25MG | por tbl obd 50x25mg | EGI | H | | | |
| 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 6,53 | |
| 62313 | PLEGOMAZIN 100MG | tbl obd 30x100mg | EGI | H | | | |
| 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 62,76 | |
| | | | | | | | |
| 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 16,68 | |
| 02429 | TISERCIN | tbl obd 50x25mg | EGI | H | | | |
| 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 16,94 | |
| 02429 | TISERCIN | por tbl flm 50x25mg | EGI | H | | | |
| 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,49 | |
| 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | O | | | |
| 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothlazinů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 25,37 | O |
| 00561 | PLEGOMAZIN 2.5% | inj 10x2ml/50mg | EGI | H | | | |
| 00560 | PLEGOMAZIN 0.5% | inj 10x5ml/25mg | EGI | H | | | |
| 00561 | PLEGOMAZIN 2.5% | inj 10x2ml/50mg | EGI | H | | | |
| 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 30,89 | O |
| 01845 | TISERCIN | inj 10x1ml/25mg | EGI | H | | | |
| 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,76 | |
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,83 | |
| 00262 | PERFENAZIN LECIVA | tbl obd 50x8mg | LEX | CZ | | | |
| 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 12,42 | |
| | | | | | | | |
@@ -6271,15 +6339,16 @@
| 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | | | |
| 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | L/NEU,PSY,GER | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,30 | L/NEU,PSY, GER |
| | | | | | | | |
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,19 | L/NEU,PSY, GER |
| 01559 | NEULEPTIL | gtt 1x25ml | RRO | F | | | |
| 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,72 | L/NEU,PSY, GER |
| | | | | | | | |
| 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 14,18 | |
| 00324 | THIORIDAZIN 25 LECIVA | drg 50x25mg | LEX | CZ | | | |
| 00325 | THIORIDAZIN 100 LECIVA | drg 20x100mg | LEX | CZ | | | |
| 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,06 | |
| 408 | N35AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. 8 | MG | 6,06 | | |
| 98291 | APO-HALOPERIDOL | tbl 100x1mg | APT | CND | | | |
| 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 10,12 | |
| 58378 | APO-HALOPERIDOL 2MG/ML | gtt 1x100ml/200mg | APT | CND | | | |
@@ -6299,7 +6368,6 @@
| 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 50,10 | O |
| | | | | | | | |
| 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 50,10 | O |
| 01443 | DEHYDROBENZPERIDOL | inj 50x10ml/25mg | JAN | B | | | |
| 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,28 | |
@@ -6308,18 +6376,18 @@
| | | | | | | | |
| 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 26,39 | |
| | | | | | | | |
| 410.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 7,82 | |
| 410.4 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 13,27 | |
| 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | | | |
| 410.5 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 8,18 | |
| 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30x50mg | LEX | CZ | | | |
| 410.5 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,71 | |
| 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | | | |
| 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 13,83 | |
| 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 13,27 | |
| 57827 | CISORDINOL 25MG | tbl obd 50x25mg-pp | LUN | DK | | | |
| 57823 | CISORDINOL 10MG | tbl obd 50x10mg-pp | LUN | DK | | | |
| 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,44 | O |
| 88379 | MECLOPIN | inj 5x1ml/25mg | SPX | CZ | | | |
| 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 15,16 | O |
| 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,55 | O |
| 88379 | MECLOPIN | inj 5x1ml | SPX | CZ | | | |
| 411.2 | N05AF01 | flupentixol | parent. | 4 MG | 15,16 | O | |
| | | | | | | | |
| 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,03 | O |
| | | | | | | | |
@@ -6328,16 +6396,16 @@
| 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 11,78 | O |
| 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 10,80 | |
| 98120 | ORAP | tbl 75x1mg | JAN | B | | | |
| 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 10,76 | |
| 10735 | ORAP FORTE | tbl 20x4mg | JAG | P | | | |
| 02757 | ORAP FORTE | tbl 20x4mg | JAN | B | | | |
| 10733 | ORAP | tbl 75x1mg | JAG | P | | | |
| 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,11 | |
| 98120 | ORAP | tbl 75x1mg | JAN | B | | | |
| 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,01 | |
| 01637 | SEMAP | tbl 12x20mg | JAN | P | | | |
| 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 12,71 | O |
| 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 12,39 | O |
| 09164 | IMAP | inj 1x6ml/12mg | JAN | B | | | |
| 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | L/PSY | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6345,71 +6413,81 @@
| | | | | | | | |
| 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 75,03 | L/PSY,NEU |
| 03617 | LEPONEX | tbl 50x25mg | SAN | CH | | | |
| 42824 | CLOZAPIN DESITIN 25 MG | por tbl nob 30x25mg | SBV | NL | | | |
| 414.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 66,18 | L/PSY,NEU |
| | | | | | | | |
| 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 60,37 | L/PSY |
| 42825 | CLOZAPIN DESITIN 100 MG | por tbl nob30x100mg | SBV | NL | | | |
| 02970 | LEPONEX | tbl 50x100mg | SAN | CH | | | |
| 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 143,00 | L/PSY |
| 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 138,70 | L/PSY |
| | | | | | | | |
| 414.6 | N05AH04 | quetiapin do 25 mg včetně v jedné tabletě | p.o. | 0,4 | GM | 260,00 | P |
Indikuje neurolog u pacienetů s psychotickými komplikacemi dopaminergní léčby Parkinsonovy nemoci.
| 414.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0,4 | GM | 143,00 | L/PSY,NEU |
Indikuje neurolog u pacientů s psychotickými komplikacemi dopaminergní léčby Parkinsonovy nemoci.
| 414.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0,4 | GM | 138,70 | L/PSY,NEU |
| | | | | | | | |
| 414.8 | N05AX11 | zotepin | p.o. | 0,2 | GM | 76,90 | L/PSY |
| 415 | N05AH | Neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | H | | | |
| 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 86,22 | H |
| 416 | N05AL | Neuroleptika ze skupiny benzamidů | p.o. | L/PSY,NEU | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 416.1 | N05AL01 | Sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 42,03 | |
| 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | L/PSY,NEU | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 42,03 | |
| 54432 | PROSULPIN 50MG | tbl 30x50mg | PMP | CZ | | | |
| 46751 | SULPIROL 50 | por cps dur100x50mg | SFS | D | | | |
| 46750 | SULPIROL 50 | por cps dur 50x50mg | SFS | D | | | |
| 11468 | PROSULPIN 50MG | tbl 60x50mg | PMP | CZ | | | |
| 54432 | PROSULPIN 50MG | tbl 30x50mg | PMP | CZ | | | |
| 416.2 | N05AL01 | Sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 24,59 | L/PSY,NEU |
| 46749 | SULPIROL 50 | por cps dur 20x50mg | SFS | D | | | |
| 416.2 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 24,59 | L/PSY,NEU |
| 11149 | PROSULPIN 200MG | tbl 60x200mg | PMP | CZ | | | |
| 46746 | SULPIROL 200 | por tblnob100x200mg | SFS | D | | | |
| 46747 | SULPIROL 200 | por tbl nob50x200mg | SFS | D | | | |
| 64590 | DOGMATIL 200MG TBL. | tbl 120x200mg | SSJ | F | | | |
| 07387 | PROSULPIN | tbl 30x200mg | PMP | CZ | | | |
| 64590 | DOGMATIL 200MG TBL. | tbl 120x200mg | SSJ | F | | | |
| 46743 | SULPIROL 200 | por tblnob100x200mg | HEX | D | | | |
| 46742 | SULPIROL 200 | por tbl nob50x200mg | HEX | D | | | |
| 46741 | SULPIROL 200 | por tbl nob20x200mg | HEX | D | | | |
| 46748 | SULPIROL 200 | por tbl nob20x200mg | SFS | D | | | |
| 416.3 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.4 | GM | 29,99 | |
| | | | | | | | |
| 416.4 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.4 | GM | 46,53 | |
| | | | | | | | |
| 416.5 | N05AL05 | amisulprid (pevné lékové formy)do 50 mg v jedné tabletě včetně | p.o. | 1 | DF | 18,50 | L/PSY |
| | | | | | | | |
| 416.6 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 600 | MG | 143,00 | L/PSY |
| 417 | N05AL | Neuroleptika ze skupiny benzamidů | parent. | O/PSY,NEU | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 417.1 | N05AL01 | Sulpirid | parent. | 0.8 | GM | 74,69 | 0/PSY,NEU |
| 416.6 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 600 | MG | 138,70 | L/PSY |
| 417 | N05AL | neuroleptika ze skupiny benzamidů | parent. | O/PSY,NEU | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 417.1 | N05AL01 | sulpirid | parent. | 0.8 | GM | 71,33 | O/PSY,NEU |
| 89922 | DOGMATIL 100 | inj 6x2ml/100mg | SSJ | F | | | |
| 417.2 | N05AL03 | tiaprid | parent. | 0.4 | GM | 55,43 | O |
| 91117 | TIAPRIDAL | inj 12x2ml/100mg | LSY | F | | | |
| 418 | N05AN | Lithium | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 418.1 | N05AN01 | lithium do 0,3 GM včetně v jedné tabletě | p.o. | 1 | GM | 6,95 | |
| 418 | N05AN | lithium | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 418.1 | N05AN01 | lithium do 0,3 g včetně v jedné tabletě | p.o. | 1 | GM | 6,95 | |
| 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | | | |
| 418.2 | N05AN01 | lithium nad 0,3 GM v jedné tabletě | p.o. | 1 | GM | 4,67 | |
| 418.2 | N05AN01 | lithium nad 0,3 g v jedné tabletě | p.o. | 1 | GM | 4,67 | |
| 04385 | CONTEMNOL | tbl 100x500mg | SLO | SK | | | |
| 419 | N05AX | Ostatní antipsychotika | p.o. | L/PSY | | | |
| 419 | N05AX | ostatní antipsychotika | p.o. | L/PSY | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 419.1 | N05AX08 | risperidon (pevné lékové formy do 1 mg včetně) | p.o. | 5 | MG | 112,50 | L/PSY, NEU, GER, INT |
| | | | | | | | |
| 419.2 | N05AX08 | risperidon (pevné lékové formy nad 1 mg ) | p.o. | 5 | MG | 119,26 | L/PSY, NEU, |
| 419.2 | N05AX08 | risperidon (pevné lékové formy nad 1 mg ) | p.o. | 5 | MG | 115,73 | L/PSY, NEU, GER, INT |
| 46966 | RISPERDAL 2MG | tbl obd 20x2mg | JAG | I | | | |
| 46970 | RISPERDAL 4MG | tbl obd 20x4mg | JAG | I | | | |
| 46969 | RISPERDAL 3MG | tbl obd 60x3mg | JAG | I | | | |
| 46968 | RISPERDAL 3MG | tbl obd 20x3mg | JAG | I | | | |
| 46969 | RISPERDAL 3MG | tbl obd 60x3mg | JAG | I | | | |
| 46966 | RISPERDAL 2MG | tbl obd 20x2mg | JAG | I | | | |
| 46967 | RISPERDAL 2MG | tbl obd 60x2mg | JAG | I | | | |
| 46970 | RISPERDAL 4MG | tbl obd 20x4mg | JAG | I | | | |
| 419.3 | N05AX08 | risperidon (tekuté lékové formy) | p.o. | 5 | MG | 112,50 | L/PSY, NEU, GER, INT |
| | | | | | | | |
| 419.4 | N05AE03 | sertindol | p.o. | 1 | DF | 143,12 | L/PSY |
| 419.4 | N05AE03 | sertindol | p.o. | 1 | DF | 138,70 | L/PSY |
| 13039 | SERDOLECT 4MG | tbl obd 30x4mg | LUN | DK | | | |
| 419.5 | N05AE04 | ziprasidon | p.o. | 80 | MG | 143,00 | L/PSY |
| 420 | N05BA | Anxiolytika ze skupiny derivátů benzodiazepinu | p.o. | | | | |
| 419.5 | N05AE04 | ziprasidon | p.o. | 80 | MG | 138,70 | L/PSY |
| 420 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 420.1 | N05BA23 | tofisopam | p.o. | 0.15 | GM | 0,68 | |
| | | | | | | | |
| 420.2 | N05BA01 | diazepam | p.o. | 10 | MG | 0,68 | |
| | | | | | | | |
| 02478 | DIAZEPAM SLOVAKOFARMA | tbl 20x10mg | SLO | SK | | | |
| 420.3 | N05BA02 | chlordiazepoxid | p.o. | 30 | MG | 0,68 | |
| | | | | | | | |
| 420.4 | N05BA03 | medazepam | p.o. | 20 | MG | 0,68 | |
@@ -6423,7 +6501,6 @@
| 420.8 | N05BA08 | bromazepam | p.o. | 10 | MG | 0,68 | |
| | | | | | | | |
| 420.9 | N05BA09 | klobazam | p.o. | 20 | MG | 0,68 | |
| | | | | | | | |
| 420.10 | N05BA11 | prazepam | p.o. | 30 | MG | 0,68 | |
| | | | | | | | |
| 420.11 | N05BA12 | alprazolam (do 1 mg v jedné tabletě) | p.o. | 1 | MG | 0,68 | |
@@ -6432,21 +6509,22 @@
Léčbu alprazolamem ordinuje psychiatr, neurolog nebo internista: léčba panické úzkosti.
| 59758 | FRONTIN 1.0MG | | tbl 30x1mg | EGI | H | | |
| 59759 | FRONTIN 1.0MG | tbl 100x1mg | EGI | H | | | |
| 59758 | FRONTIN 1.0MG | tbl 30x1mg | EGI | H | | | |
| 86656 | NEUROL 1.0 | tbl 30x1mg | LEX | CZ | | | |
| 421 | N05BA | Anxiolytika ze skupiny derivátů benzodiazepinu | p.rect. | L/NEU,PSY,PDD | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 421.1 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10 | MG | 116,16 | L/NEU,PSY, PDD |
| 421 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.rect. | L/NEU,PSY,PDD | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 421.1 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. 10 | MG | 108,16 | L/NEU,PSY,PDD | |
| 04326 | STESOLID 5MG | enm 5x2.5ml/5mg | ALO | N | | | |
| 69417 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/5mg | DET | D | | | |
| 421.2 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10 | MG | 71,64 | L/NEU,PSY, PDD |
| 421.2 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10 | MG | 67,14 | L/NEU,PSY, PDD |
| 04327 | STESOLID 10MG | enm 5x2.5ml/10mg | ALO | N | | | |
| 69418 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/10mg | DET | D | | | |
| 422 | N05BA | Anxiolytika ze skupiny derivátů benzodiazepinu | parent. | | | | |
| 422 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 422.1 | N05BA01 | diazepam | parent. | 10 | MG | 7,53 | |
| 96610 | APAURIN | inj 10x2ml/10mg | KRK | SLO | | | |
| 422.2 | N05BA05 | klorazepát draselný | parent. | 20 | MG | 14,66 | |
| 423 | N05BX | Ostatní anxiolytika | p.o. | | | | |
| 422.2 | n05ba05 | klorazepát draselný | parent. | 20 | MG | 14,66 | |
| 423 | N05BX | ostatní anxiolytika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 423.1 | N05BB01 | hydroxyzin | p.o. | 75 | MG | 0,68 | |
| | | | | | | | |
@@ -6454,77 +6532,78 @@
| | | | | | | | |
| 423.3 | N05BX01 | mefenoxalon | p.o. | 1.2 | GM | 16,42 | |
| 85656 | DORSIFLEX | tbl 30x200mg | LEK | SLO | | | |
| 03645 | DIMEXOL | tbl 30x200mg | LEX | CZ | | | |
| 423.4 | N05BE01 | buspiron | p.o. | 30 | MG | 2,49 | |
| 424 | N05CA | Hypnotika ze skupiny barbiturátů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 424.1 | N05CA01 | pentobarbital | parent. | 0.1 | GM | 23,32 | H |
| 425 | N05CD | Hypnotika ze skupiny benzodiazepinů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 425.1 | N05CD03 | flunitrazepam | parent. | 1 | MG | 6,35 | O |
| 424 | N05CA | hypnotika ze skupiny barbiturátů | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 424.1 | IN05CA01 | pentobarbital | parent. | 0.1 | GM | 23,32 | H |
| 425 | N05CD | hypnotika ze skupiny benzodiazepinů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 425.1 | N05CD03 | flunitrazepam | parent. | 1 | MG | 6,61 | O |
| 90559 | ROHYPNOL INJ | inj 5x1ml+5x1ml sol | LEX | CZ | | | |
| 425.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15 | MG | 107,37 | O |
| 00903 | MIDAZOLAM SYNTHON 1MG/ML | inj 10x5ml/5mg | SOO | NL | | | |
| 425.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15 | MG | 105,75 | O |
| 00903 | MIDAZOLAM SYNTHON 1 MG/ML | inj 10x5ml/5mg | SOO | NL | | | |
| 53631 | MIDAZOLAM SYNTHON 1MG/ML | inj 10x5ml/5mg | ANN | IRL | | | |
| 53633 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x1ml/5mg | ANN | IRL | | | |
| 02922 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x1ml/5mg | SOO | NL | | | |
| 425.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15 | MG | 74,02 | O |
| 425.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15 | MG | 72,90 | O |
| 53635 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x3ml/15mg | ANN | IRL | | | |
| 02924 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x3ml/15mg | SOO | NL | | | |
| 53635 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x3ml/15mg | ANN | IRL | | | |
| 426 | N06AA | Antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | p.o. | | | | |
| 426 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 426.1 | N06AA01 | desipramin | p.o. | 0.1 | GM | 17,11 | |
| | | | | | | | |
| 426.2 | N06AA02 | imipramin | p.o. | 0.1 | GM | 9,90 | |
| 00200 | MELIPRAMIN | tbl obd 50x25mg | EGI | H | | | |
| | | | | | | | |
| 426.3 | N06AA04 | klomipramin | p.o. | 0.1 | GM | 14,66 | |
| 93828 | ANAFRANIL SR GEIGY 75 | tbl obd 20x75mg | CGC | CH | | | |
| 426.4 | N06AA05 | opipramol | p.o. | 0.15 | GM | 12,02 | |
| | | | | | | | |
| 426.5 | N06AA07 | lofepramin | p.o. | 105 | MG | 14,66 | |
| | | | | | | | |
| 426.6 | N06AA08 | dibenzepin | p.o. | 0.3 | GM | 15,50 | |
| 426.4 | n06aa05 | opipramol | p.o. | 0.15 | GM | 12,02 | |
| | | | | | | | |
| 426.5 | n06aa07 | lofepramin | p.o. | 105 | MG | 14,66 | |
| | | | | | | | |
| 426.6 | n06aa08 | dibenzepin | p.o. | 0.3 | GM | 15,41 | |
| 02641 | NOVERIL 240 | tbl 20x240mg | WAN | CH | | | |
| 426.7 | N06AA09 | amitriptylin | p.o. | 75 | MG | 2,85 | |
| 87167 | AMITRIPTYLIN SLOVAKOFARMA | tbl obd 50x28.3mg | SLO | SK | | | |
| 426.8 | N06AA10 | nortriptylin | p.o. | 75 | MG | 9,78 | |
| 426.8 | N06AA10 | nortriptylin | p.o. | 75 | MG | 9,10 | |
| 12343 | NORTRILEN | tbl obd 50x25mg | LUN | DK | | | |
| 426.9 | N06AA16 | dosulepin | p.o. | 150 | MG | 9,78 | |
| 03851 | PROTHIADEN 10 | tbl obd 50x10mg | LEX | CZ | | | |
| 04207 | PROTHIADEN 25 | drg 30x25mg | LEX | CZ | | | |
| 77047 | PROTHIADEN 75 | tbl obd 30x75mg | LEX | CZ | | | |
| 04207 | PROTHIADEN 25 | drg 30x25mg | LEX | CZ | | | |
| 426.10 | N06AA21 | maprotilin (do 50 mg včetně v jedné tabletě) | p.o. | 100 | MG | 13,64 | |
| 03792 | LUDIOMIL | drg 30x25mg | CGC | CH | | | |
| 426.10 | N06AA21 | maprotilin | p.o. | 100 | MG | 12,28 | |
| 45757 | MAPROTIBENE 25MG | tbl obd 20x25mg | MCK | D | | | |
| 45759 | MAPROTIBENE 50MG | tbl obd 20x50mg | MCK | D | | | |
| 45757 | MAPROTIBENE 25MG | tbl obd 20x25mg | MCK | D | | | |
| 426.11 | N06AA21 | maprotilin (nad 50 mg v jedné tabletě) | p.o. | 100 | MG | 12,71 | |
| 04257 | LUDIOMIL 75 | drg 20x75mg | CGC | CH | | | |
| 427 | N06AA | Antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | parent. | O | | | |
| 427 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 427.1 | N06AA01 | desipramin | parent. | 0.1 | GM | 96,44 | O |
| | | | | | | | |
| 427.2 | N06AA02 | imipramin | parent. | 0.1 | GM | 48,39 | O |
| | | | | | | | |
| 427.3 | N06AA04 | klomipramin | parent. | 0.1 | GM | 96,44 | O |
| 427.3 | N06AA04 | klomipramin | parent. | 0.1 | GM | 95,76 | O |
| 02884 | ANAFRANIL | inj 10x2ml 25mg | CGC | CH | | | |
| 427.4 | N06AA08 | dibenzepin | parent. | 0.3 | GM | 96,44 | O |
| | | | | | | | |
| 427.5 | N06AA09 | amitriptylin | parent. | 75 | MG | 30,79 | O |
| 04079 | AMITRIPTYLIN LECIVA | inj 10x2ml/20mg | LI X | CZ | | | |
| 427.6 | N06AA21 | maprotilin | parent. | 100 | MG | 109,29 | O |
| | | | | | | | |
| 427.6 | N06AA21 | maprotilin | parent. | 100 | MG | 108,64 | O |
| 94560 | LUDIOMIL | inj 10x5ml/25mg | CGC | CH | | | |
| 428 | N06AB | Antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | p.o. | L/PSY,SEX | | | |
| 428 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | p.o. | L/PSY,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 428.1 | N06AB03 | fluoxetin | p.o. | 20 | MG | 14,70 | |
| 44397 | APO-FLUOXETINE | cps 30x20mg | APT | CND | | | |
| 13022 | PORTAL | cps 14x20mg | LEK | SLO | | | |
| 64657 | FLUOXIN | por cps dur 50x20mg | SFS | D | | | |
| 64656 | FLUOXIN | por cps dur 20x20mg | SFS | D | | | |
| 54423 | MAGRILAN | cps 30x20mg | MOE | CY | | | |
| 54422 | MAGRILAN | cps 10x20mg | MOE | CY | | | |
| 54073 | FLOXET 20MG | cps 14x20mg | EGI | H | | | |
| 56471 | FLUVAL | cps 14x20mg | KRK | SLO | | | |
| 56472 | FLUVAL | cps 28x20mg | KRK | SLO | | | |
| 54074 | FLOXET 20MG | cps 28x20mg | EGI | H | | | |
| 13023 | PORTAL | cps 28x20mg | LEK | SLO | | | |
| 92346 | DEPREX | cps 30x20mg | LEX | CZ | | | |
| 44398 | APO-FLUOXETINE | cps 100x20mg | APT | CND | | | |
| 59274 | FLUMIREX | cps 30x20mg | CHN | H | | | |
| 56984 | DEPRENON | cps 20x20mg | SLO | SK | | | |
| 54074 | FLOXET 20MG | cps 28x20mg | EGI | H | | | |
| 92346 | DEPREX | cps 30x20mg | LEX | CZ | | | |
| 54073 | FLOXET 20MG | cps 14x20mg | EGI | H | | | |
| 44397 | APO-FLUOXETINE | cps 30x20mg | APT | CND | | | |
| 13022 | PORTAL | cps 14x20mg | LEK | SLO | | | |
| 428.2 | N06AB04 | citalopram do 10 mg v jedné tabletě včetně | p.o. | 20 | MG | 20,00 | L/PSY,SEX, NEU, INT |
| 03976 | CITALEC 10 | tbl obd30x10mg-bli | LEX | CZ | | | |
| 428.3 | N06AB04 | citalopram nad 10 mg v jedné tabletě | p.o. | 20 | MG | 18,50 | L/PSY,SEX, NEU, INT |
@@ -6535,14 +6614,14 @@
| | | | | | | | |
| 428.6 | N06AB06 | sertralin | p.o. | 50 | MG | 18,50 | L/PSY,SEX, NEU, INT |
| | | | | | | | |
| 428.7 | N06AB08 | fluvoxamin (do 50 mg v jedné tabletě včetně) | p.o. | 100 | MG | 20,00 | L/PSY,SEX, NEU, INT |
| 428.7 | N06AB08 | fluvoxamin ( do 50 mg v jedné tabletě včetně) | p.o. | 100 | MG | 20,00 | L/PSY,SEX, NEU, INT |
| | | | | | | | |
| 428.8 | N06AB08 | fluvoxamin (nad 50 mg v jedné tabletě) | p.o. | 100 | MG | 18,50 | L/PSY,SEX, NEU, INT |
| 429 | N06AB | Antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | parent. | O/PSY,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 429.1 | N06AB04 | citalopram | parent. | 20 | MG | 231,15 | O/PSY,SEX |
| 429 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | parent. | O/PSY,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 429.1 | N06AB04 | citalopram | parent. | 20 | MG | 228,29 | O/PSY,SEX |
| 60113 | SEROPRAM | inf 10x1ml/40mg | LUN | DK | | | |
| 430 | N06A | Ostatní antidepresiva | p.o. | L/PSY,SEX,NEU | | | |
| 430 | N06A | ostatní antidepresiva | p.o. | L/PSY,SEX,NEU | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 430.1 | N06AF01 | isocarbaxazid | p.o. | 15 | MG | 4,30 | L/PSY,SEX, NEU, |
| | | | | | | | |
@@ -6552,82 +6631,99 @@
| | | | | | | | |
| 430.4 | N06AG02 | moklobemid nad 150 mg v jedné tabletě | p.o. | 0.3 | GM | 18,50 | L/PSY,SEX, NEU, INT |
| | | | | | | | |
| 430.5 | N06AX03 | mianserin (do 10 mg v jedné tabletě včetně) | p.o. | 60 | MG | 18,77 | L/PSY,SEX, NEU |
| 67353 | MIANSERIN 10 VON CT | tbl obd 20x10mg | CTA | D | | | |
| 430.5 | N06AX03 | mianserin do 10 mg v jedné tabletě včetně | p.o. | 60 | MG | 16,95 | L/PSY,SEX, NEU |
| 45769 | MIABENE 10MG | tbl obd 20x10mg | MCK | D | | | |
| 430.6 | N06AX03 | mianserin (nad 10 mg v jedné tabletě) | p.o. | 60 | MG | 17,60 | L/PSY,SEX, NEU |
| 430.6 | N06AX03 | mianserin nad 10 mg v jedné tabletě | p.o. | 60 | MG | 17,60 | L/PSY,SEX, NEU |
| 67355 | MIANSERIN 30 VON CT | tbl obd 20x30mg | CTA | D | | | |
| 45771 | MIABENE 30MG | tbl obd 20x30mg | MCK | D | | | |
| 430.7 | N06AX05 | trazodon | p.o. | 0.3 | GM | 14,22 | L/PSY,SEX, NEU |
| 430.8 | N06AX06 | nefazodon hydrochlorid | p.o. | 400 | MG | 22,95 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.9 | N06AX09 | viloxazin | p.o. | 0.2 | GM | 14,22 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.10 | N06AX11 | mirtazapin | p.o. | 30 | MG | 24,65 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.11 | N06AX12 | bupropion | p.o. | 200 | MG | 20,00 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.12 | N06AX14 | tianeptin | p.o. | 37.5 | MG | 18,50 | L/PSY,SEX, NEU, INT |
| | | | | | | | |
| 430.13 | N06AX16 | venlafaxin | p.o. | 100 | MG | 24,65 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.14 | N06AX17 | milnacipran | p.o. | 100 | MG | 24,65 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.15 | N06AX18 | reboxetin | p.o. | 8 | MG | 22,95 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.16 | V11 | hyperici extractum siccum normatum (LI 160) | p.o. | 900 | MG | 10,80 | |
| 431 | N06BA | Centrálně působící stimulancia | p.o. | L/NEU,PSY,PDD,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 431.1 | N06BA04 | methylphenidat | p.o. | 30 | MG | 9,14 | L/NEU,PSY, PDD, SEX |
| | | | | | | | |
| 430.8 | N06AX05 | trazodon, tablety s řízeným uvolňováním | p.o. | 0.3 | GM | 17,60 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.9 | N06AX06 | nefazodon hydrochlorid | p.o. | 400 | MG | 22,95 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.10 | N06AX09 | viloxazin | p.o. | 0.2 | GM | 14,22 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.11 | N06AX11 | mirtazapin | p.o. | 30 | MG | 24,65 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.12 | N06AX12 | bupropion | p.o. | 200 | MG | 20,00 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.13 | N06AX14 | tianeptin | p.o. | 37.5 | MG | 18,50 | L/PSY,SEX, NEU, INT |
| | | | | | | | |
| 430.14 | N06AX16 | venlafaxin | p.o. | 100 | MG | 24,65 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.15 | N06AX17 | milnacipran | p.o. | 100 | MG | 24,65 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.16 | N06AX18 | reboxetin | p.o. | 8 | MG | 22,95 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.17 | V11 | hyperici extractum siccum normatum (LI 160) | p.o. | 900 | MG | 10,80 | |
| 431 | N06BA | centrálně působící stimulancia | p.o. | L/NEU,PSY,PDD,SEX | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 431.1 | N06BA04 | methylphenidat | p.o. | 30 | MG | 9,00 | L/NEU,PSY, PDD, SEX |
| 83328 | RITALIN | tbl 30x10mg | CGC | CH | | | |
| 431.2 | N06BA07 | modafinil | p.o. | 300 | MG | 9,14 | L/NEU,PSY, PDD, SEX |
| 432 | N06BX | Ostatní psychostimulancia a nootropika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 432.1 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.3 | GM | 6,50 | L/PSY, NEU,PDD |
| | | | | | | | |
| 432.2 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.3 | GM | 18,87 | L/PSY, NEU,PDD |
| | | | | | | | |
| 432.3 | N06BX03 | Piracetam (pevné lékové formy) | p.o. | 2.4 | GM | 6,50 | L/PSY, NEU,PDD |
| 46128 | PIRACETAM-EGIS 400MG | tbl obd 60x400mg | EGI | H | | | |
| 431.2 | N06BA07 | modafinil | p.o. | 300 | MG | 9,00 | L/NEU,PSY, PDD, SEX |
| 432 | N06BX | ostatní psychostimulancia a nootropika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Pyritinol, piracetam a vinpocetin indikuje neurolog a psychiatr pacientům s nejméně jedou z následujících diagnóz:
1) afasie cévního původu a poruchy kognitivních funkcí po prodělané CPM,
2) stav po kraniocerebrálních traumatech - poúrazové kognitivní a psychické dysfunkce,
3) vaskulární demence,
4) kortikální myoklonus,
5) DMO.
Dále je psychiatrem, neurologem a othorynolaryngologem vinpocetin indikován pacientům s vertigem a tinitem.
Tekuté lékové formy jsou indikovány pacientům ve výše uvedených indikacích, postižených současné poruchou polykání.
| 432.1 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.3 | GM | 6,50 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 432.2 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.3 | GM | 18,12 | P |
| | | | | | | | |
| 432.3 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.4 | GM | 6,50 | P |
| 66648 | PIRACETAM AL 800 | tbl obd 100x800mg | APA | D | | | |
| 10032 | PIRACETAM AL 800 | tbl obd 60x800mg | APA | D | | | |
| 81598 | PIRABENE 800MG | tbl obd 100x800mg | MCK | D | | | |
| 81600 | PIRABENE 1200MG | tbl obd 60x1200mg | MCK | D | | | |
| 46126 | PIRACETAM-EGIS 800MG | tbl obd 30x800mg | EGI | H | | | |
| 10032 | PIRACETAM AL 800 | tbl obd 60x800mg | APA | D | | | |
| 66648 | PIRACETAM AL 800 | tbl obd 100x800mg | APA | D | | | |
| 432.4 | N06BX03 | Piracetam (tekuté lékové formy) | p.o. | 2.4 | GM | 18,87 | L/PSY, NEU,PDD |
| 66647 | PIRACETAM AL 800 | tbl obd 50x800mg | APA | D | | | |
| 46126 | PIRACETAM EGIS | tbl obd 30x800mg | EGI | H | | | |
| 46128 | PIRACETAM EGIS | tbl obd 60x400mg | EGI | H | | | |
| 66646 | PIRACETAM AL 800 | tbl obd 30x800mg | APA | D | | | |
| 81660 | PIRABENE 1200MG | tbl obd 60x1200mg | MCK | D | | | |
| 432.4 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.4 | GM | 18,12 | P |
| 04289 | NOOTROPIL 33% ORAL | sol 1x125ml 33% | UCB | B | | | |
| 88156 | NOOTROPIL 20% ORAL | sol 1x125ml 20% | UCB | B | | | |
| 432.5 | N06BX18 | vinpocetin | p.o. | 15 | MG | 6,50 | L/PSY, NEU,PDD |
| 432.5 | N06BX18 | vinpocetin | p.o. | 15 | MG | 6,50 | P |
Léčbu inhibitory acetylcholinesterázy (lAchE) ordinuje neurolog nebo psychiatr pacientům, u kterých je diagnosticky vyloučena demence jiného typu než Alzheimerova a potvrzena diagnóza Alzheimerovy demence (ACH) se stupněm postižení vyjádřeným dle škály MMSE (Mini-Mental State Examination) v rozmezí dosaženého skóre 20 – 13 bodů včetně.
Po 12.týdnech (3 měsíce) od zahájení podávání lAchE je provedeno další vyšetření pacienta škálou MMSE. Léčba lAchE je hrazena z prostředků zdravotního pojištění při setrvání skóre, nebo jeho poklesu o nejvíce 2 body ve srovnání s hodnotou MMSE dosahovanou pacientem před zahájením léčby lAchE). Další kontroly MMSE jsou prováděny nejméně po každých 3 měsících léčby.
Léčba lAchE není hrazena u pacientů, u nichž po 6/9 atd. měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku (tj. zastavení progrese anebo pokles menší než 2 body dle škály MMSE oproti původnímu stavu) a dále při zjištěném skóre škály MMSE 12 bodů. Tato kritéria se vztahují i na léčbu pacientů trvající v rámci stanovených kritérií déle než 9 měsíců.
Po 12.týdnech (3 měsíce) od zahájení podáváni lAchE je provedeno další vyšetření pacienta škálou MMSE. Léčba lAchE je hrazena z prostředků zdravotního pojištění při setrvání skóre, nebo jeho poklesu o nejvíce 2 body ve srovnání s hodnotou MMSE dosahovanou pacientem před zahájením léčby lAchE). Další kontroly MMSE jsou prováděny nejméně po každých 3 měsících léčby. Léčba lAchE není hrazena u pacientů, u nichž po 6/9 atd. měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku (tj. zastavení progrese anebo pokles menší než 2 body dle škály MMSE oproti původnímu stavu) a dále při zjištěném skóre škály MMSE 12 bodů. Tato kritéria se vztahují i na léčbu pacientů trvající v rámci stanovených kritérií déle než 9 měsíců.
| 432.6 | N06DA02 | donepezil do 5mg v jedné tabletě včetně | p.o. | 1 | DF | 60,00 | P |
| | | | | | | | |
| 432.7 | N06DA02 | donepezil nad 5 mg v jedné tabletě | p.o. | 1 | DF | 117,50 | P |
| | | | | | | | |
| 432.8 | N06DA03 | rivastigmin do 3mg v jedné tabletě včetně | p.o. | 2 | DF | 60,00 | P |
| | | | | | | | |
| 432.9 | N06DA03 | rivastigmin nad 3mg v jedné tabletě | p.o. | 2 | DF | 117,50 | P |
| 432.7 | N06DA02 | donepezil nad 5 mg v jedné tabletě | p.o. | 1 | DF | 117,00 | P |
| | | | | | | | |
| 432.8 | N06DA03 | rivastigmin do 1,5 mg v jedné tabletě včetně | p.o. | 2 | DF | 60,00 | P |
| | | | | | | | |
| 432.9 | N06DA03 | rivastigmin nad 1,5 mg v jedné tabletě | p.o. | 2 | DF | 117,00 | P |
| | | | | | | | |
| 432.10 | N06DA04 | galantamin do 4 mg v jedné tabletě včetně | p.o. | 2 | DF | 60,00 | P |
| | | | | | | | |
| 432.11 | N06DA04 | galantamin nad 4 mg v jedné tabletě | p.o. | 2 | DF | 117,50 | P |
| | | | | | | | |
| 432.12 | N06DX02 | extrakty z Ginkgo biloba (pevné lékové formy) | p.o. | 120 | MG | 9,00 | |
| | | | | | | | |
| 432.13 | N06DX02 | extrakty z Ginkgo biloba (tekuté lékové formy) | p.o. | 120 | MG | 10,75 | |
| 432.11 | N06DA04 | galantamin nad 4 mg v jedné tabletě | p.o. | 2 | DF | 117,00 | P |
| | | | | | | | |
| 432.12 | N06DX02 | extrakty z Ginkgo biloba (pevné i tekuté lékové formy) | p.o. | 120 | MG | 9,00 | L/PSY, NEU, INT, OPH, ORL |
| 433 | N06BX | ostatní psychostimulancia a nootropika | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 433.1 | N06BX01 | meklofenoxat | parent. | 0.5 | GM | 83,53 | H |
| | | | | | | | |
| 433.2 | N06BX02 | pyritinol | parent. | 0.3 | GM | 60,27 | H |
| | | | | | | | |
| 433.3 | N06BX03 | Piracetam | parent. | 6 | GM | 60,27 | H |
| 96719 | OIKAMID | inj 10x5ml/1gm | PLI | CHO | | | |
| 433.2 | N06BX02 | pyritinol | parent. | 0.3 | GM | 57,25 | H |
| | | | | | | | |
| 433.3 | N06BX03 | piracetam | parent. | 6 | GM | 57,25 | H |
| 11337 | GERATAM 3G | inj 4x15ml/3gm | UCB | B | | | |
| 433.4 | N06BX18 | vinpocetin | parent. | 15 | MG | 24,98 | H |
| 434 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6638,10 +6734,10 @@
| 434.3 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180 | MG | 16,81 | |
| | | | | | | | |
| 434.4 | N07AA03 | distigmin | p.o. | 5 | MG | 5,82 | |
| 02360 | UBRETID | tbl 20x5mg | HNP | A | | | |
| 02130 | UBRETID | tbl 50x5mg | HNP | A | | | |
| 02360 | UBRETID | tbl 20x5mg | HNP | A | | | |
| 434.5 | N07AA30 | ambenonium | p.o. | 60 | MG | 18,04 | |
| 435 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | parent. | | | | |
| 435 | N07AA | parasympatomimetika zeskupiny inhibitorů cholinesterázy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 435.1 | N07AA01 | neostigmin | parent. | 2 | MG | 18,04 | |
| 00612 | SYNTOSTIGMIN | inj 10x1ml/0.5mg | HBS | SK | | | |
@@ -6652,11 +6748,11 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 436.1 | N07CA52 | cinarizin, kombinace (s dimenhydrinátem) | p.o. | 3 | DF | 4,79 | |
| | | | | | | | |
| 436.2 | N07CA01 | betahistin | p.o. | 24 | MG | 9,74 | |
| 436.2 | N07CA01 | betahistin | p.o. | 24 | MG | 8,76 | |
| 87218 | MICROSER | tbl 50x8mg | FOM | I | | | |
| 436.3 | N07CA02 | cinarizin (do 25 MG včetně v jedné tabletě) | p.o. | 90 | MG | 1,86 | |
| | | | | | | | |
| 436.4 | N07CA02 | cinarizin (nad 25 MG v jedné tabletě) | p.o. | 90 | MG | 1,56 | |
| 436.3 | N07CA02 | cinarizin (do 25 mg včetně v jedné tabletě) | p.o. | 90 | MG | 1,86 | |
| | | | | | | | |
| 436.4 | N07CA02 | cinarizin (nad 25 mg v jedné tabletě) | p.o. | 90 | MG | 1,56 | |
| 07390 | CINEDIL | tbl 50x75mg | ALK | MAC | | | |
| 436.5 | N07CA03 | flunarizin | p.o. | 10 | MG | 4,79 | |
| 437 | N07XX | ostatní léčiva nervové soustavy | parent. | X | | | |
@@ -6671,7 +6767,6 @@
| 438.3 | P01AB02 | tinidazol | p.o. | 2 | GM | 13,30 | |
| | | | | | | | |
| 438.4 | P01AB03 | ornidazol | p.o. | 1.5 | GM | 22,00 | |
| 91132 | AVRAZOR | tbl 6x500mg | LEX | CZ | | | |
| 439 | P01BA | antimalarika ze skupiny aminochinolonových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6687,23 +6782,23 @@
Léčbu meflochinem ordinuje infekcionista: léčba tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).
| 439.1 | P01BA01 | Chlorochin | p.o. | 0.5 | GM | 2,75 | |
| 439.1 | P01BA01 | chlorochin | p.o. | 0.5 | GM | 2,79 | |
| 00098 | DELAGIL | tbl 30x250mg | IDA | H | | | |
| 439.2 | P01BA02 | hydroxychlorochin | p.o. | 0.4 | GM | 18,04 | P |
| 54424 | PLAQUENIL | tbl obd 60x200mg | SFW | GB | | | |
| 54425 | PLAQUENIL NEO | tbl obd 60x200mg | SFW | GB | | | |
| 439.2 | P01BA02 | hydroxychloro- chin | p.o. | 0.4 | GM | 17,66 | P |
| 54424 | PLAQUENIL | tbl obd 60x20mg | MHA | CH | | | |
| 439.3 | P01BC02 | meflochin | p.o. | 1 | GM | 366,98 | P |
| 92441 | MEPHAQUIN | tbl obd 6x250mg | MHA | CH | | | |
| 440 | P01BD | antimalarika ze skupiny diaminopyrimidinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 440.1 | P01BD01 | pyrimethamin | p.o. | 75 | MG | 15,93 | |
| | | | | | | | |
| 440.2 | P01BD51 | pyrimethamin, kombinace | p.o. | 75 | MG | 50,83 | |
| 441 | P01CX | ostatní léčiva k léčbě protozoóz | parent. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 441.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1047,13 | X |
| 442 | P02CA | anthelmintika ze skupiny benzimidazolových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 442.1 | P02CA01 | mebendazol | p.o. | 0.2 | GM | 14,03 | |
| 442.1 | P02CA01 | mebendazol | p.o. | 0.2 | GM | 13,60 | |
| 59238 | VERMOX | tbl 6x100mg | JAG | I | | | |
| 442.2 | P02CA02 | tiabendazol | p.o. | 3 | GM | 125,42 | |
| | | | | | | | |
@@ -6713,12 +6808,13 @@
| 443.1 | P02CB01 | piperazin | p.o. | 2 | GM | 3,96 | |
| 444 | P02CE | anthelmintika ze skupiny imidazothiazolových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 444.1 | P02CE01 | levamizol | p.o. | 0.15 | GM | 29,10 | |
| 444.1 | P02CE01 | levamizol | p.o. | 0.15 | GM | 29,55 | |
| 04030 | DECARIS | tbl 2x50mg | GED | H | | | |
| 445 | P02CX | ostatní anthelmintika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 445.1 | P02CX01 | pyrvinium | p.o. | 0.3 | GM | 17,69 | |
| 02139 | PYRVINIUM | sus 1x100ml | GNO | CZ | | | |
| 446 | P02DA | anticestodika ze skupiny derivátů kyseliny salicylové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 446.1 | P02DA01 | niklosamid | p.o. | 2 | GM | 131,19 | |
@@ -6728,19 +6824,21 @@
| | | | | | | | |
| 447.2 | P03AB02 | lindan (lékové formy lotia) | lok. | 1 | ML | 1,08 | |
| 97547 | JACUTIN | lot 1x200ml | HEM | D | | | |
| 447.3 | P03AB02 | lindan (lékové formy spreje) | lok. | 1 | ML | 1,17 | |
| 92765 | SKABICID | drm eml 1x100gm/gm | AVE | CZ | | | |
| 62364 | JACUTIN | lot 1x100ml | HEM | D | | | |
| 447.3 | P03AB02 | lindan (lékové formy spreje) | lok. | 1 | ML | 1.17 | |
| 448 | P03AC | ektoparazitika ze skupiny pyrethrinů | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 448.1 | P03AC | esdepallethrin | lok. | 1 | ML | 1,17 | |
| | | | | | | | |
| 448.2 | P03AC04 | permerthrin | lok. | 1 | ML | 1,17 | |
| 449 | R01AC | protialergická léčiva k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | |
| 449 | R01AC | protialergická léčiva k lokálnímu podáni | lok. | L/ALG,TRN,ORL | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 449.1 | R01AC01 | natrium kromoglykát (do 15 mililitrů včetně v jednom balení) | lok. | 40 | MG | 13,88 | L/ALG,TRN, ORL |
| 12582 | ALLERGOCROM | spr nas 1x15ml | URS | D | | | |
| 83652 | CROMOHEXAL | spr nas 1x15ml | HEX | D | | | |
| 76418 | CROMOBENE | spr nas 1x15ml | MCK | D | | | |
| 449.2 | R01AC01 | natrium kromoglykát (nad 15 mililitrů v jednom balení) | lok. | 40 | MG | 13,59 | L/ALG,TRN, ORL |
| 12582 | ALLERGOCROM | spr nas 1x15ml | URS | D | | | |
| 449.2 | R01AC01 | natrium kromoglykát (nad 15 mililitrů v jednom baleni) | lok. | 40 | MG | 13,09 | L/ALG,TRN, ORL |
| 86429 | CROMOHEXAL | spr nas 1x30ml | HEX | D | | | |
| 449.3 | R01AC02 | levokabastin | lok. | 0.6 | MG | 10,80 | |
| | | | | | | | |
@@ -6748,17 +6846,16 @@
| 450 | R01AD | kortikosteroidy k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 450.1 | R01AD01 | beclomethason dipropionát | lok. | 0.4 | MG | 4,30 | |
| 58408 | NASOBEC | spr nas 200x50rg | GNO | CZ | | | |
| 99860 | BECLOMET NASAL AQUA 100 | aer 23ml 200df | ORN | SF | | | |
| 58408 | NASOBEC | spr nas 200x50rg | GNO | CZ | | | |
| 66006 | BECLOMET NASAL AQUA | spr nas 23ml/200dav | OKU | SF | | | |
| 450.2 | R01AD04 | flunisolid | lok. | 0.15 | MG | 7,00 | L/ALG,TRN, ORL |
| | | | | | | | |
| 450.3 | R01AD05 | budesonid lokálně do 50 RG v jedné dávce včetně | lok. | 0.3 | MG | 7,50 | L/ALG,TRN, ORL |
| 450.3 | R01AD05 | budesonid lokálně do 50 rg v jedné dávce včetně | lok. | 0.3 | MG | 7,50 | L/ALG,TRN, ORL |
| 55427 | TAFEN NASAL 50MCG | spr nas 1x10ml/200d | LEK | SLO | | | |
| 450.4 | R01AD05 | budesonid lokálně nad 50 RG v jedné dávce | lok. | 0.3 | MG | 6,75 | L/ALG,TRN, ORL |
| 450.4 | R01AD05 | budesonid lokálně nad 50 rg v jedné dávce | lok. | 0.3 | MG | 6,75 | L/ALG,TRN, ORL |
| | | | | | | | |
| 450.5 | R01AD08 | flutikason | lok. | 0.2 | MG | 9,50 | L/ALG,TRN, ORL |
| | | | | | | | |
| 450.6 | R01AD11 | triamcinolon acetonid | lok. | 220 | RG | 7,50 | L/ALG,TRN, ORL |
| | | | | | | | |
| 450.7 | R01AD09 | momethason | lok. | 200 | RG | 10,56 | L/ALG,TRN, ORL |
@@ -6767,7 +6864,7 @@
| 451 | R03AC | inhalační selektivní beta-2 sympatomimetika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu inhalačního salmeterolu a formoterolu indikuje alergolog a pneumolog u perzistujícího astmatu tam, kde astma není zcela pod kontrolou při podávání kortikosteroidu inhalační cestou a při dobré spolupráci pacienta.
Léčbu inhalačního salmeterolu a formoterolu indikuje alergolog a pneumolog u perzistujícího astmatu tam, kde astma není zcela pod kontrolou při podávání kortikosteroidu inhalační cestou a při dobré spoluprácí pacienta.
| 451.1 | R03AC02 | freonový salbutamol (lékové formy aerosolu) | inhal. | 0.8 | MG | 3,37 | |
| | | | | | | | |
@@ -6784,30 +6881,32 @@
| 451.7 | R03AC03 | terbutalin (lékové formy aerosolu) | inhal. | 2 | MG | 3,52 | |
| | | | | | | | |
| 451.8 | R03AC03 | terbutalin (lékové formy prášku k inhalaci) | inhal. | 2 | MG | 7,23 | |
| | | | | | | | |
| 451.9 | R03AC04 | fenoterol (lékové formy aerosolu) | inhal. | 0.6 | MG | 2,74 | |
| 02863 | BEROTEC 0.2MG | aer 1x15ml/300d | BGP | D | | | |
| 92588 | BEROTEC 0.2MG | aer 1x10ml/200d | BGP | D | | | |
| 02863 | BEROTEC 0.2MG | aer 1x15ml/300d | BGP | D | | | |
| 451.10 | R03AC04 | fenoterol (lékové formy roztoku) | inhal. | 4 | MG | 24,64 | |
| 46830 | BEROTEC 0.1% | inh sol 1x20ml 0.1% | BOE | I | | | |
| 12070 | BEROTEC 0.1% | inh sol 1x20ml 0.1% | BOE | D | | | |
| 451.11 | R03AC04 | fenoterol (lékové formy prášku k inhalaci) | inhal. | 0.6 | MG | 7,23 | |
| | | | | | | | |
| 451.12 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.5 | MG | 2,74 | |
| | | | | | | | |
| 451.13 | R03AC12 | salmeterol (lékové formy aerosolu) | inhal. | 0.1 | MG | 20,63 | P |
| | | | | | | | |
| 451.14 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) do 0,025 miligramů včetně v jedné dávce | inhal. | 0.1 | MG | 31,87 | P |
| | | | | | | | |
| 451.15 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) nad 0,025 miligramů v jedné dávce | inhal. | 0.1 | MG | 29,12 | P |
| | | | | | | | |
| 451.16 | R03AC13 | formoterol (lékové formy prášku k inhalaci) do 4,5 RG včetně v jedné dávce | inhal. | 24 | RG | 31,87 | P |
| | | | | | | | |
| 451.17 | R03AC13 | formoterol (lékové formy prášku k inhalaci) nad 4,5 RG v jedné dávce | inhal. | 24 | RG | 29,12 | P |
| 451.10 | R03AC04 | fenoterol (lékové formy aerosolu bezfreonové) | inhal. | 0.6 | MG | 4,93 | |
| | | | | | | | |
| 451.11 | R03AC04 | fenoterol (lékové formy roztoku) | inhal. | 4 | MG | 24,64 | |
| | | | | | | | |
| 451.12 | R03AC04 | fenoterol (lékové formy prášku k inhalaci) | inhal. | 0.6 | MG | 7,23 | |
| | | | | | | | |
| 451.13 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.5 | MG | 2,74 | |
| | | | | | | | |
| 451.14 | R03AC12 | salmeterol (lékové formy aerosolu) | inhal. | 0.1 | MG | 20,63 | P |
| | | | | | | | |
| 451.15 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) do 0,025 mg včetně v jedné dávce | inhal. | 0.1 | MG | 31,87 | P |
| | | | | | | | |
| 451.16 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) nad 0,025 mg v jedné dávce | inhal. | 0.1 | MG | 29,12 | P |
| | | | | | | | |
| 451.17 | R03AC13 | formoterol (lékové formy prášku k inhalaci) do 4,5 rg včetně v jedné dávce | inhal. | 24 | RG | 31,87 | P |
| | | | | | | | |
| 451.18 | R03AC13 | formoterol (lékové formy prášku k inhalaci) nad 4,5 rg v jedné dávce | inhal. | 24 | RG | 29,12 | P |
| 452 | R03AK | inhalační sympatomimetika a jiná antiastmatika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 452.1 | R03AK03 | fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6 | DF | 5,03 | |
| 452.1 | R03AK03 | fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6 | DF | 4,83 | |
| 87899 | BERODUAL | aer dos 15ml/300df | BGP | D | | | |
| 452.2 | R03AK03 | fenoterol kombinace s kromoglykátem (lékové formy aerosolu) | inhal. | 1 | DF | 1,25 | L/ALG,TRN |
| 452.2 | R03AK03 | fenoterol kombinace s kromoglykátem (lékové formy aerosolu) | inhal. | 1 | DF | 1.25 | L/ALG,TRN |
| | | | | | | | |
| 452.3 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy roztoku) | inhal. | 4 | ML | 20,63 | |
| | | | | | | | |
@@ -6815,7 +6914,7 @@
| | | | | | | | |
| 452.5 | R03AK04 | salbutamol v kombinaci s bromidem ipratropia | inhal. | 6 | DF | 7,33 | L/ALG,TRN |
| | | | | | | | |
| 452.6 | R03AK04 | salbutamol v kombinaci s kromoglykátem | inhal. | 8 | DF | 11,73 | L/ALG,TRN |
| 452.6 | R03AK04 | salbutamol v kombinaci s kromoglykátem | inhal. | 8 | DF | 11,73 | L/ALG, TRN |
| | | | | | | | |
| 452.7 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/100 | inhal. | 2 | DF | 45,40 | L/ALG,TRN |
| | | | | | | | |
@@ -6828,43 +6927,43 @@
| 452.11 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 200/6 | inhal. | 2 | DF | 27,50 | L/ALG,TRN |
| 453 | R03BA | inhalační kortikosteroidy | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 453.1 | R03BA01 | beklomethason (lékové formy aerosolu freonové) do 100 RG včetně v jedné dávce | inhal. | 0.8 | MG | 6,35 | |
| | | | | | | | |
| 453.2 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) do 100 RG včetně v jedné dávce | inhal. | 0.8 | MG | 10,80 | |
| 58792 | ECOBEC 100 MCG | aer dos 1x200dávek | GNO | CZ | | | |
| 453.3 | R03BA01 | beklomethason (lékové formy aerosolu freonové) nad 100 RG v jedné dávce | inhal. | 0.8 | MG | 5,20 | |
| | | | | | | | |
| 453.4 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) nad 100 RG v jedné dávce | inhal. | 0.8 | MG | 8,90 | |
| 58793 | ECOBEC 250 MCG | aer dos 1x200dávek | GNO | CZ | | | |
| 453.1 | R03BA01 | beklomethason (lékové formy aerosolu freonové) do 100 rg včetně v jedné dávce | inhal. | 0.8 | MG | 6,35 | |
| | | | | | | | |
| 453.2 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) do 100 rg včetně v jedné dávce | inhal. | 0.8 | MG | 10,80 | |
| 58792 | ECOBEC 100 MCG | aer dos 1x200dávek | IVX | CZ | | | |
| 453.3 | R03BA01 | beklomethason (lékové formy aerosolu freonové) nad 100 rg v jedné dávce | inhal. | 0.8 | MG | 5,20 | |
| 64664 | BECLOMET FORTE | aer dos 12.5ml/200d | OKU | SF | | | |
| 453.4 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) nad 100 rq v jedné dávce | inhal. | 0.8 | MG | 8,90 | |
| 58793 | ECOBEC 250 MCG | aer dos 1x200dávek | IVX | CZ | | | |
| 453.5 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) do 0,1 mg včetně v jedné dávce | inhal. | 0.8 | MG | 20,77 | |
| 83044 | BECODISKS | plv inh 15x8x100rg | GLA | F | | | |
| 453.6 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) více než 0,1 mg do 0,2 mg včetně v jedné dávce | inhal. | 0.8 | MG | 17,60 | |
| 83044 | BECODISKS 100 | inhplvdos 15x8dávek | GWE | F | | | |
| 453.6 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) více než 0.1 mg do 0,2 mg včetně v jedné dávce | inhal. | 0.8 | MG | 17,60 | |
| | | | | | | | |
| 453.7 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) nad 0,2 mg v jedné dávce | inhal. | 0.8 | MG | 14,40 | |
| | | | | | | | |
| 453.8 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 RG včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 15,80 | |
| | | | | | | | |
| 453.9 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 RG včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 26,80 | |
| | | | | | | | |
| 453.10 | R03BA01 | beklomethason (lékové formy aerosolu vdechem freonové aktivované nad 200 RG v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 12,80 | |
| | | | | | | | |
| 453.11 | R03BA01 | beklomethason (lékové formy aerosolu vdechem bezfreonové aktivované nad 200 RG v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 21,80 | |
| | | | | | | | |
| 453.12 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 RG včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 14,95 | |
| | | | | | | | |
| 453.13 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 RG včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 25,40 | |
| | | | | | | | |
| 453.14 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové nad 200 RG v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 12,10 | |
| | | | | | | | |
| 453.15 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové nad 200 RG v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 20,60 | |
| | | | | | | | |
| 453.16 | R03BA02 | budesonid (lékové formy aerosolu) | inhal. | 0.8 | MG | 11,70 | |
| | | | | | | | |
| 453.17 | R03BA02 | budesonid (lékové formy prášku k inhalaci, do 100 RG v 1 dávce včetně) | inhal. | 0.8 | MG | 20,77 | |
| | | | | | | | |
| 453.18 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 100 RG do 200 RG v 1 dávce včetně) | inhal. | 0.8 | MG | 17,60 | |
| | | | | | | | |
| 453.19 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 200 RG v 1 dávce) | inhal. | 0.8 | MG | 14,40 | |
| 453.8 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 rgG včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 15,80 | |
| | | | | | | | |
| 453.9 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 rg včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 26,80 | |
| | | | | | | | |
| 453.10 | R03BA01 | beklomethason (lékové formy aerosolu vdechem freonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 12,80 | |
| | | | | | | | |
| 453.11 | R03BA01 | beklomethason (lékové formy aerosolu vdechem bezfreonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 21,80 | |
| | | | | | | | |
| 453.12 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 rg včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 14,95 | |
| | | | | | | | |
| 453.13 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 rg včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 25,40 | |
| | | | | | | | |
| 453.14 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové nad 200 rg v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 12,10 | |
| | | | | | | | |
| 453.15 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové nad 200 rg v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 20,60 | |
| | | | | | | | |
| 453.16 R03BA02 budesonid (lékové formy aerosolu) | inhal. | 0.8 | MG | 11,70 | | | |
| | | | | | | | |
| 453.17 | R03BA02 | budesonid (lékové formy prášku k inhalaci, do 100 rg v 1 dávce včetně) | inhal. | 0.8 | MG | 20,77 | |
| | | | | | | | |
| 453.18 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 100 rg do 200 rg v 1 dávce včetně) | inhal. | 0.8 | MG | 17,60 | |
| | | | | | | | |
| 453.19 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 200 rg v 1 dávce) | inhal. | 0.8 | MG | 14,40 | |
| | | | | | | | |
| 453.20 | R03BA02 | budesonid (lékové formy suspense k inhalaci) do 0,25 mg včetně v 1 ml | inhal. | 0.8 | MG | 20,77 | |
| | | | | | | | |
@@ -6876,22 +6975,22 @@
| | | | | | | | |
| 453.24 | R03BA05 | flutikason (lékové formy aerosolu) | inhal. | 0.6 | MG | 11,70 | |
| | | | | | | | |
| 453.25 | R03BA05 | flutikason (lékové formy prášku k inhalaci do 100 RG včetně v jedné dávce) | inhal. | 0.6 | MG | 30,00 | |
| | | | | | | | |
| 453.26 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 100 RG do 250 RG včetně v jedné dávce) | inhal. | 0.6 | MG | 26,75 | |
| | | | | | | | |
| 453.27 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 250 RG v jedné dávce) | inhal. | 0.6 | MG | 22,30 | |
| 453.25 | R03BA05 | flutikason (lékové formy prášku k inhalaci do 100 rg včetně v jedné dávce) | inhal. | 0.6 | MG | 30,00 | |
| | | | | | | | |
| 453.26 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 100 rg do 250 rg včetně v jedné dávce) | inhal. | 0.6 | MG | 26,75 | |
| | | | | | | | |
| 453.27 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 250 rg v jedné dávce) | inhal. | 0.6 | MG | 22,30 | |
| 454 | R03BB | inhalační anticholinergika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 454.1 | R03BB01 | bromid ipratropia (lékové formy aerosolu) | inhal. | 0.12 | MG | 5,38 | |
| 80103 | ATROVENT | aer dos 15ml/300dav | BGP | D | | | |
| 454.2 | R03BB01 | bromid ipratropia (lékové formy prášku k inhalaci) | inhal. | 0.12 | MG | 2,25 | |
| 454.2 | R03BB01 | bromid ipratropia (lékové formy prášku k inhalaci) | inhal. | 0.12 | MG | 2,16 | |
| 75847 | ATROVENT INHALETTEN | cps inh 100x0.2mg | BGP | D | | | |
| 454.3 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. | 4 | ML | 34,31 | L/ALG,TRN, ORL |
| 454.3 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. 4 | ML | 33,34 | L/ALG,TRN,ORL | |
| 92351 | ATROVENT 0.025% | inh sol 1x20ml | BOE | I | | | |
| 455 | R03BC | inhalační protialergická léčiva | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 455.1 | R03BC01 | natrium kromoglykát (lékové formy aerosolu) | inhal. | 40 | MG | 17,50 | |
| 455.1 | R03BC01 | natrium kromoglykát (lékové formy aerosolu) inhal. 40 MG | 17,50 | | | | |
| | | | | | | | |
| 455.2 | R03BC01 | natrium kromoglykát (lékové formy prášku k inhalaci) | inhal. | 80 | MG | 21,65 | |
| 68835 | CROMOLYN | inh cps 50 | ORN | SF | | | |
@@ -6916,7 +7015,7 @@
| 458 | R03CC | celkově podávaná selektivní sympatomimetika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 458.1 | R03CC02 | salbutamol (pevné lékové formy) | p.o. | 12 | MG | 6,19 | |
| | | | | | | | |
| 91085 | SALBUTAMOL POLFA | tbl 30x4mg | POL | PL | | | |
| 458.2 | R03CC02 | salbutamol (tekuté lékové formy) | p.o. | 12 | MG | 13,10 | |
| | | | | | | | |
| 458.3 | R03CC03 | terbutalin | p.o. | 15 | MG | 6,19 | |
@@ -6939,12 +7038,12 @@
| 460 | R03D | ostatní antiastmatika k celkovému podání | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 460.1 | R03DA04 | teofylin (retardované lékové formy první skupiny) | p.o. | 0.4 | GM | 2,88 | |
| 99137 | SPOPHYLLIN RETARD 100MG | tbl ret 50x100mg | SLO | SK | | | |
| 98064 | SPOPHYLLIN RETARD 250MG | tbl ret 50x250mg | SLO | SK | | | |
| 99137 | SPOPHYLLIN RETARD 100MG | tbl ret 50x100mg | SLO | SK | | | |
| 460.2 | R03DA04 | teofylin (retardované lékové formy druhé skupiny do 250 mg včetně v jedné tabletě) | p.o. | 0.4 | GM | 4,79 | |
| | | | | | | | |
| 460.3 | R03DA04 | teofylin (retardované lékové formy druhé skupiny nad 250 mg v jedné tabletě) | p.o. | 0.4 | GM | 4,50 | |
| 61238 | THEOPLUS | tbl ret 30x300mg | PFB | F | | | |
| 94192 | TEOTARD | cps ret 40x200mg | KRK | SLO | | | |
| 460.3 | R03DA04 | teofylin (retardované lékové formy druhé skupiny nad 250 mg v jedné tabletě) | p.o. | 0.4 | GM | 4,27 | |
| 94191 | TEOTARD | cps ret 40x350mg | KRK | SLO | | | |
| 460.4 | R03DA05 | aminofylin | p.o. | 0.6 | GM | 4,89 | |
| | | | | | | | |
| 460.5 | R03DA05 | aminofylin (retardované lékové formy do 150 mg včetně) | p.o. | 0.6 | GM | 9,92 | |
@@ -6965,7 +7064,7 @@
- c) aspirinové astma
Nedojde-li během 3 měsíců léčby ke stabilizaci a kontrole perzistující formy astmatu, není další terapie montelukastem indikován
Nedojde-li během 3 měsíců léčby ke stabilizaci a kontrole perzistující formy astmatu, není další terapie montelukastem indikována.
| 460.10 | R03DC03 | montelukast (s obsahem 5 mg v jedné tabletě) | p.o. | 10 | MG | 114,52 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6987,53 +7086,46 @@
| 460.11 | R03DC03 | montelukast (s obsahem 10 mg v jedné tabletě) | p.o. | 10 | MG | 46,16 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčba antileukotrieny u dospělých je předepisována alergologem nebo pneumologem u perzistujících forem bronchiálního astmatu v následujících indikacích: a) aspirin - senzitivní (nesteroidními antiflogistiky indukované astma), b) astma v kombinaci s nosní polypózou, c) námahou indukované astma, d) astma s prokázanou dobrou odpovídavostí na léčbu antileukotrieny v dětském věku, e) astma, kde nedostačuje dlouhodobá léčba inhalačními kortikosteroidy, beta2-mimetiky s prodlouženým účinkem, teofyliny s prodlouženým účinkem, nebo nelze tyto léky podávat pro prokázanou intoleranci. V případě neúspěchu kombinované terapie s antileukotrieny do třech měsíců po jejím zahájení, není další preskripce antileukotrienů indikována.
| 461 | R03DA | Ostatní antiastmatika k celkovému podání ze skupiny xantinů | p.rect. | | | | |
Léčba antileukotrieny u dospělých je předepisována alergologem nebo pneumologem u perzistujících forem bronchiálního astmatu v následujících indikacích: a) aspirin – senzitivní (nesteroidnímí antiflogistiky indukované astma), b) astma v kombinaci s nosní polypózou, c) námahou indukované astma, d) astma s prokázanou dobrou odpovídavostí na léčbu antileukotrieny v dětském věku, e) astma, kde nedostačuje dlouhodobá léčba inhalačními kortikosteroidy, beta2-mimetiky s prodlouženým účinkem, teofyliny s prodlouženým účinkem, nebo nelze tyto léky podávat pro prokázanou intoleranci. V případě neúspěchu kombinované terapie s antileukotrieny do třech měsíců po jejím zahájení, není další preskripce antileukotrienů indikována.
| 461 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 461.1 | R03DA05 | aminofylin | p.rect. | 0.6 | GM | 6,35 | |
| 462 | R03DA | Ostatní antiastmatika k celkovému podání ze skupiny xantinů | parent. | O | | | |
| 462 | R03DA | ostatní antiastmatika k cekovému podání ze skupiny xantinů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 462.1 | R03DA05 | aminofylin | parent. | 0.6 | GM | 29,23 | O |
| 96371 | AMINOPHYLLINUM I.V. | inj 50x10ml/250mg | LEK | SLO | | | |
| 93129 | AMINOPHYLLINUM LEK | inj 10x10ml/250mg | LEK | SLO | | | |
| 96371 | AMINOPHYLLINUM I.V. | inj 50x10ml/250mg | LEK | SLO | | | |
| 463 | R05CB | Mukolytika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 463.1 | R05CB01 | acetylcystein - pevné lékové formy | p.o. | 0.5 | GM | 6,00 | |
| 463 | R05CB | mukolytika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 463.1 | R05CB01 | acetylcystein - pevné lékové formy | p.o. | 0.5 | GM | 2,25 | |
| | | | | | | | |
| 463.2 | R05CB01 | acetylcystein (tekuté lékové formy -sirup) | p.o. | 0.5 | GM | 5,75 | |
| | | | | | | | |
| 463.3 | R05CB02 | bromhexin (pevné lékové formy) | p.o. | 24 | MG | 1,96 | |
| | | | | | | | |
| 463.4 | R05CB02 | bromhexin (tekuté lékové formy) | p.o. | 24 | MG | 3,23 | |
| | | | | | | | |
| 463.5 | R05CB03 | karbocystein (pevné lékové formy) | p.o. | 1.5 | GM | 8,10 | |
| 463.3 | R05CB02 | bromhexin (pevné lékové formy) | p.o. | 24 | MG | 2,08 | |
| 42263 | FLEGAMINA | tbl 20x8mg | POL | PL | | | |
| 463.4 | R05CB02 | bromhexin (tekuté lékové formy) | p.o. | 24 | MG | 2,08 | |
| | | | | | | | |
| 463.5 | R05CB03 | karbocystein (pevné lékové formy) | p.o. | 1.5 | GM | 1,80 | |
| | | | | | | | |
| 463.6 | R05CB03 | karbocystein (tekuté lékové formy - sirup) | p.o. | 1.5 | GM | 6,90 | |
| 463.7 | R05CB06 | ambroxol (pevné lékové formy) | p.o. | 0.15 | GM | 8,10 | |
| 67010 | AMBROSAN RETARD 75MG | cps ret 10x75mg | ETS | F | | | |
| 03103 | AMBROSAN RETARD 75MG | cps ret 20x75mg | ETS | F | | | |
| 43947 | AMBROXOL AL 75 RETARD | cps ret 20x75mg | APA | D | | | |
| 78278 | AMBROSAN | tbl 20x30mg | PMP | CZ | | | |
| 96192 | AMBROSAN | tbl 30x30mg | PMP | CZ | | | |
| 59483 | AMBROSAN | tbl 500x30mg | PMP | CZ | | | |
| 97453 | SOLVOLAN | tbl 20x30mg | KRK | SLO | | | |
| 43950 | AMBROXOL AL 30 TABLETTEN | tbl 20x30mg | APA | D | | | |
| 463.8 | R05CB06 | ambroxol (tekuté lékové formy - kapky) | p.o. | 0.15 | GM | 11,48 | |
| 58373 | AMBROXOL AL KAPKY | gtt 1x50ml/375mg | APA | D | | | |
| 58374 | AMBROXOL AL KAPKY | gtt 1x100ml/750mg | APA | D | | | |
| | | | | | | | |
| 463.7 | R05CB06 | ambroxol (pevné lékové formy) | p.o. | 0.15 | GM | 4,50 | |
| 94918 | AMBROBENE | tbl 20x30mg | MCK | D | | | |
| 463.8 | R05CB06 | ambroxol (tekuté lékové formy - kapky) | p.o. | 0.15 | GM | 4,50 | |
| | | | | | | | |
| 463.9 | R05CB06 | ambroxol (tekuté lékové formy - sirup) | p.o. | 0.15 | GM | 11,72 | |
| | | | | | | | |
| 463.10 | R05CB15 | erdostein (pevné lékové formy) | p.o. | 600 | MG | 8,10 | |
| 463.10 | R05CB15 | erdostein (pevné lékové formy) | p.o. | 600 | MG | 4,50 | |
| | | | | | | | |
| 463.11 | R05CB15 | erdostein (tekuté lékové formy-sirup) | p.o. | 600 | MG | 3,94 | |
| 464 | R05CB | Mukolytika | inhal. | | | | |
| 464 | R05CB | mukolytika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 464.1 | R05CB01 | acetylcystein | inhal. | 1.6 | GM | 12,07 | |
| | | | | | | | |
| 464.2 | R05CB02 | bromhexin | inhal. | 24 | MG | 3,47 | |
| | | | | | | | |
| 464.3 | R05CB05 | mesna | inhal. | 600 | MG | 40,67 | |
| 464.3 | R05CB05 | mesna | inhal. | 600 | MG | 39,13 | |
| 03614 | MISTABRON | sol 6x3ml/600mg | UCB | B | | | |
| 464.4 | R05CB13 | alfadornáza | inhal. | 2.5 | MG | 1137,70 | P |
@@ -7044,34 +7136,32 @@
- b) při častých respiračních infekcích vyžadujících antibiotickou léčbu.
| 77521 | PULMOZYME | inh sol 6x2.5ml | GCH | USA | | | |
| | | | | | | | |
| 464.5 | R05CB15 | erdostein | inhal. | 450 | MG | 8,31 | |
| 465 | R05CB | Mukolytika | parent. | | | | |
| 465 | R05CB | mukolytika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 465.1 | R05CB01 | acetylcystein | parent. | 0.5 | GM | 16,76 | |
| 88939 | ACC INJEKT | inj 5x3ml/300mg | HEX | D | | | |
| 88941 | ACC INJEKT | inj 100x3ml/300mg | HEX | D | | | |
| 58889 | BRONCHOLYSIN SPOFA | inj 5x5ml/1gm | SPX | CZ | | | |
| 88939 | ACC INJEKT | inj 5x3ml/300mg | HEX | D | | | |
| 465.2 | R05CB02 | bromhexin | parent. | 24 | MG | 40,37 | |
| | | | | | | | |
| 465.3 | R05CB06 | ambroxol | parent. | 0.15 | GM | 226,02 | |
| | | | | | | | |
| 465.4 | R05CB06 | ambroxol (koncentrat k infuzi) | parent. | 1 | DF | 343,81 | H |
| 465.4 | R05CB06 | ambroxol (koncentrat k infuzi) | parent. | 1 | DF | 336,70 | H |
| 12839 | MUCOSOLVAN | inf 1x50ml/1000mg | BKG | D | | | |
| 465.5 | R05CA03 | guaifenesin | parent. | 0.9 | GM | 16,57 | |
| 58249 | GUAJACURAN 5% | inj 10x10ml/0.5gm | LEX | CZ | | | |
| 92347 | GUAJACURAN 5% | inj 6x20ml/1gm | LEX | CZ | | | |
| 466 | R05DA | antitusika ze skupiny derivátů opioidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 466.1 | R05DA01 | ethylmorfin do 15 MG včetně | p.o. | 50 | MG | 6,39 | |
| 466.1 | R05DA01 | ethylmorfin do 15 mgG včetně | p.o. | 50 | MG | 6,39 | |
| 44590 | DIOLAN 15MG | tbl 10x15mg(blistr) | SLO | SK | | | |
| 466.2 | R05DA01 | ethylmorfin nad 15 MG | p.o. | 50 | MG | 5,95 | |
| 466.2 | R05DA01 | ethylmorfin nad 15 mg | p.o. | 50 | MG | 5,95 | |
| 44589 | DIOLAN 30MG | tbl 10x30mg(blistr) | SLO | SK | | | |
| 466.3 | R05DA04 | kodein | p.o. | 0.1 | GM | 12,80 | |
| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10x30mg-blistr | SLO | SK | | | |
| 56992 | CODEIN SLOVAKOFARMA 15MG | tbl 10x15mg-blistr | SLO | SK | | | |
| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10x30mg-blistr | SLO | SK | | | |
| 466.4 | R05DA08 | folkodin | p.o. | 50 | MG | 3,67 | |
| | | | | | | | |
| 466.5 | R05DA09 | dextromethorphan | p.o. | 90 | MG | 3,67 | |
| 466.5 | R05DA09 | dextromethor- phan | p.o. | 90 | MG | 3,67 | |
| | | | | | | | |
| 466.6 | R05DA20 | kombinace antitusik | p.o. | 3 | DF | 3,67 | |
| 467 | R05DB | antitusika chemicky blízká lokálním anestetikům | p.o., p.rect., parent. | | | | |
@@ -7084,19 +7174,19 @@
| 92252 | SEDOTUSSIN 8MG BABIES | sup 6x8mg | UCB | B | | | |
| 467.4 | R05DB05 | pentoxyverin (nad 8 mg v jednom čípku) | p.rect. | 100 | MG | 63,40 | L/PDD |
| | | | | | | | |
| 467.5 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25 | MG | 3,00 | |
| 467.5 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25 | MG | 1,04 | |
| | | | | | | | |
| 467.6 | R05DB13 | butamirát (tekuté lékové formy-kapky) | p.o. | 25 | MG | 10,56 | |
| 94859 | TUSSIN | gtt 1x10ml | GNO | CZ | | | |
| 94859 | TUSSIN | gtt 1x10ml | IVX | CZ | | | |
| 467.7 | R05DB13 | butamirát (tekuté lékové formy-sirup) | p.o. | 25 | MG | 3,83 | |
| | | | | | | | |
| 467.8 | R05DB18 | prednoxdiazin | p.o. | 300 | MG | 1,96 | |
| | | | | | | | |
| 467.9 | R05DB19 | dropropizin | p.o. | 25 | MG | 2,44 | |
| | | | | | | | |
| 467.10 | R05DB27 | levodropropizin (tekuté lékové formy - kapky) | p.o. | 25 | MG | 2,44 | |
| | | | | | | | |
| 467.11 | R05DB27 | levodropropizin (tekuté lékové formy - sirup) | p.o. | 25 | MG | 0,96 | |
| 467.9 | R05DB19 | dropropizin | p.o. | 25 | MG | 0,88 | |
| | | | | | | | |
| 467.10 | R05DB27 | levodropropizin (tekuté lékové formy - kapky) | p.o. | 120 | MG | 4,13 | |
| | | | | | | | |
| 467.11 | R05DB27 | levodropropizin (tekuté lékové formy - sirup) | p.o. | 120 | MG | 4,60 | |
| | | | | | | | |
| 467.12 | R05FB02 | butamirát a guaifenesin v kombinaci (tekuté lékové formy) | p.o. | 25 | MG | 10,56 | |
| 468 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | p.o. | | | | |
@@ -7109,7 +7199,7 @@
| 09789 | TAVEGYL | tbl 20x1mg | KRK | SLO | | | |
| 468.4 | R06AA07 | difenylpyralin | p.o. | 10 | MG | 7,72 | |
| | | | | | | | |
| 468.5 | R06AA02 | difenhydramin (tekuté lékové formy) | p.o. | 0.2 | GM | 8,99 | |
| 468.5 | R06AA02 | difenhydramin (tekuté lékové formy) | p.o. | 0.2 | GM | 8,54 | |
| 469 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 469.1 | R06AA04 | klemastin | parent. | 2 | MG | 32,44 | O |
@@ -7119,17 +7209,17 @@
| 470.1 | R06AB03 | dimetinden (pevné lékové formy) | p.o. | 4 | MG | 10,71 | |
| 12515 | FENISTIL 24 | cps ret 20x4mg | NCH | CH | | | |
| 12514 | FENISTIL 24 | cps ret 10x4mg | NCH | CH | | | |
| 470.2 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4 | MG | 8,99 | |
| 470.2 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4 | MG | 8,54 | |
| | | | | | | | |
| 470.3 | R06AB56 | dexbromfeniramin, kombinace | p.o. | 2 | DF | 8,50 | |
| 471 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 471.1 | R06AD02 | prometazin (pevné lékové formy) | p.o. | 25 | MG | 4,49 | |
| | | | | | | | |
| 471.2 | R06AD02 | prometazin (tekuté lékové formy) | p.o. | 25 | MG | 8,99 | |
| | | | | | | | |
| 471.3 | R06AD03 | thiethylperazin | p.o. | 13 | MG | 4,50 | |
| 09844 | TORECAN | drg 50x6.5mg | KRK | SLO | | | |
| 471.2 | R06AD02 | prometazin (tekuté lékové formy) | p.o. | 25 | MG | 8,54 | |
| | | | | | | | |
| 471.3 | R06AD03 | thiethylperazin | p.o. | 13 | MG | 3,31 | |
| | | | | | | | |
| 471.4 | R06AD03 | thiethylperazin | p.rect. | 13 | MG | 21,65 | |
| 09847 | TORECAN | sup 6x6.5mg | KRK | SLO | | | |
| 472 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | parent. | O | | | |
@@ -7141,82 +7231,93 @@
| 473 | R06AX | jiná antihistaminika k systémovému použití | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 473.1 | R06AE06 | oxatomid | p.o. | 60 | MG | 7,04 | |
| 473.2 | R06AE07 | cetirizin (pevné lékové formy) | p.o. | 10 | MG | 7,25 | |
| 02926 | LETIZEN | tbl obd 20x10mg | KRK | SLO | | | |
| 64867 | ALERID | tbl obd 20x10mg | CIA | IND | | | |
| | | | | | | | |
| 473.2 | R06AE07 | cetirizin (pevné lékové formy) | p.o. | 10 | MG | 6,90 | |
| 03900 | CEREX | por tbl flm100x10mg | SFS | D | | | |
| 03898 | CEREX | por tbl flm 20x10mg | SFS | D | | | |
| 03899 | CEREX | por tbl flm 50x10mg | SFS | D | | | |
| 66029 | ZODAC | tbl obd 10x10mg | LEX | CZ | | | |
| 66030 | ZODAC | tbl obd 30x10mg | LEX | CZ | | | |
| 59539 | CETIRIZIN-SL | por tbl flm 20x10mg | SLO | SK | | | |
| 05496 | ZODAC | tbl obd 60x10mg | LEX | CZ | | | |
| 64868 | ALERID | tbl obd 50x10mg | CIA | IND | | | |
| 64867 | ALERID | tbl obd 20x10mg | CIA | IND | | | |
| 59538 | CETIRIZIN-SL | por tbl flm 10x10mg | SLO | SK | | | |
| 59540 | CETIRIZIN-SL | por tbl flm 30x10mg | SLO | SK | | | |
| 59541 | CETIRIZIN-SL | por tbl flm 50x10mg | SLO | SK | | | |
| 02927 | LETIZEN | tbl obd 50x10mg | KRK | SLO | | | |
| 42481 | CETIRIZIN-SL | por tbl flm 7x10mg | SLO | SK | | | |
| 43872 | ALERID | tbl obd 10x10mg | CIA | IND | | | |
| 02927 | LETIZEN | tbl obd 50x10mg | KRK | SLO | | | |
| 66030 | ZODAC | tbl obd 30x10mg | LEX | CZ | | | |
| 66029 | ZODAC | tbl obd 10x10mg | LEX | CZ | | | |
| 473.3 | R06AE07 | Cetirizin (tekuté lékové formy) | p.o. | 10 | MG | 8,99 | |
| 66830 | ZYRTEC | gtt 1x20ml 10mg/ml | UCB | B | | | |
| 55178 | ZYRTEC | gtt 1x20ml 10mg/ml | UCB | I | | | |
| 02926 | LETIZEN | tbl obd 20x10mg | KRK | SLO | | | |
| 473.3 | R06AE07 | cetirizin (tekuté lékové formy) | p.o. | 10 | MG | 8,54 | |
| 58834 | ZODAC GTT | gtt 1x20ml/0.2gm | LEX | CZ | | | |
| 473.4 | R06AK | kombinace antihistaminik | p.o. | 2 | DF | 1,08 | |
| | | | | | | | |
| 473.5 | R06AX | bisulepin | p.o. | 4 | MG | 3,96 | |
| 473.5 | R06AX | bisulepin | p.o. | 4 | MG | 4,14 | |
| 02479 | DITHIADEN | tbl 20x2mg | LEX | CZ | | | |
| 473.6 | R06AX01 | bamipin | p.o. | 0.1 | GM | 6,06 | |
| | | | | | | | |
| 473.7 | R06AX02 | cyproheptadin (pevné lékové formy) | p.o. | 12 | MG | 6,06 | |
| | | | | | | | |
| 473.8 | R06AX02 | cyproheptadin (tekuté lékové formy) | p.o. | 12 | MG | 8,99 | |
| 473.8 | R06AX02 | cyproheptadin (tekuté lékové formy) | p.o. | 12 | MG | 8,54 | |
| | | | | | | | |
| 473.9 | R06AX09 | azatadin | p.o. | 2 | MG | 6,06 | |
| | | | | | | | |
| 473.10 | R06AX11 | astemizol (pevné lékové formy) | p.o. | 10 | MG | 6,80 | |
| | | | | | | | |
| 473.11 | R06AX11 | astemizol (tekuté lékové formy) | p.o. | 10 | MG | 8,99 | |
| 473.11 | R06AX11 | astemizol (tekuté lékové formy) | p.o. | 10 | MG | 8,54 | |
| | | | | | | | |
| 473.12 | R06AX12 | terfenadin | p.o. | 0.12 | GM | 6,80 | |
| | | | | | | | |
| 473.13 | R06AX13 | loratadin (pevné lékové formy) | p.o. | 10 | MG | 7,25 | |
| 66059 | TERFENADIN AL 60 | tbl 20x60mg | APA | D | | | |
| 66058 | TERFENADIN AL 60 | tbl 50x60mg | APA | D | | | |
| 473.13 | R06AX13 | loratadin (pevné lékové formy) | p.o. | 10 | MG | 6,90 | |
| 58140 | LORATADIN 10-SL | tbl 30x10mg | SLO | SK | | | |
| 53639 | FLONIDAN | tbl 30x10mg | LEK | SLO | | | |
| 88734 | FLONIDAN | tbl 10x10mg | LEK | SLO | | | |
| 53639 | FLONIDAN | tbl 30x10mg | LEK | SLO | | | |
| 58140 | LORATADIN 10-SL | tbl 30x10mg | SLO | SK | | | |
| 58139 | LORATADIN 10-SL | tbl 10x10mg | SLO | SK | | | |
| 473.14 | R06AX13 | loratadin (tekuté lékové formy) | p.o. | 10 | MG | 8,99 | |
| | | | | | | | |
| 473.14 | R06AX13 | loratadin (tekuté lékové formy) | p.o. | 10 | MG | 8,54 | |
| 01700 | FLONIDAN | sus 1x120ml | LEK | SLO | | | |
| 473.15 | R06AX17 | ketotifen (pevné lékové formy) | p.o. | 2 | MG | 6,50 | |
| 66003 | KETOTIFEN AL | cps 50x1mg | APA | D | | | |
| 87171 | KETOTIFEN TROM | cps 30x1mg | TRM | D | | | |
| 66002 | KETOTIFEN AL | cps 100x1mg | APA | D | | | |
| 66004 | KETOTIFEN AL | cps 20x1mg | APA | D | | | |
| 473.16 | R06AX17 | ketotifen (tekuté lékové formy) | p.o. | 2 | MG | 8,99 | |
| 473.16 | R06AX17 | ketotifen (tekuté lékové formy) | p.o. | 2 | MG | 8,54 | |
| 44744 | ZADITEN 1MG/5ML | sir 1x100ml/20mg | SLO | SK | | | |
| 68574 | KETOF | sir 1x100ml 1mg/5ml | TRM | D | | | |
| 53181 | KETOF | sir 1x200ml 1mg/5ml | TRM | D | | | |
| 473.17 | R06AX18 | akrivastin | p.o. | 24 | MG | 6,80 | |
| | | | | | | | |
| 473.18 | R06AX25 | mizolastin | p.o. | 10 | MG | 7,25 | |
| | | | | | | | |
| 473.19 | R06AX26 | fexofenadin | p.o. | 120 | MG | 7,25 | |
| | | | | | | | |
| 473.20 | R06AX27 | desloratadin | p.o. | 5 | MG | 7,25 | |
| 473.18 | R06AX25 | mizolastin | p.o. | 10 | MG | 6,90 | |
| | | | | | | | |
| 473.19 | R06AX26 | fexofenadin | p.o. | 120 | MG | 6,90 | |
Desloratadin předepisuje alergolog/klinický imunolog nebo pneumolog u pacientů od 12 let věku v indikaci sezónní alergická rýma (SAR) pacientům po selháni léčby antihistaminiky I. A II. generace v kombinaci s intranasálními kortikosteroidy při splnění následujících kritérií:
- 1. u pacienta se SAR dochází v důsledku alergické rýmy v průběhu pylové sezony k prokazatelnému zvýšení bronchiální reaktivity (průkaz bronchomotorickým testem) až k projevům lehkého intermitentního astmatu (vyžadujícího dle potřeby inhal.SABA)
- 2. u pacienta se SAR a průduškovým astmatem, léčeným standardním způsobem, dochází v důsledku zhoršení alergické rýmy v průběhu pylové sezóny k prokazatelnému zhoršení příznaků astmatu.
| 473.20 | R06AX27 | desloratadin | p.o. | 5 | MG | 8,28 | P |
| 474 | R06AX | jiná antihistaminika k systémovému použití | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 474.1 | R06AX | bisulepin | parent. | 4 | MG | 25,12 | O |
| 474.1 | R06AX | bisulepin | parent. | 4 | MG | 26,28 | O |
| 04071 | DITHIADEN | inj 10x2ml/1mg | LEX | CZ | | | |
| 474.2 | R06AX | medosulepin/vápník | parent. | 2 | DF | 30,79 | O |
| 00508 | METHIADEN CALCIUM | inj 5x10ml | LEX | CZ | | | |
| 475 | R07AA | plicní surfaktanty | parent. | T | | | |
| 474.2 | R06AX | medosulepin/ vápník | parent. | 2 | DF | 30,79 | O |
| 475 R07AA | plicní surfaktanty | parent. | T | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 475.1 | R07AA01 | kolfosceril palmitát | parent. | 160 | MG | 20087,47 | T |
| | | | | | | | |
| 475.2 | R07AA02 | přirozené fosfolipidy (zvířecího původu) | parent. | 160 | MG | 20087,47 | T |
| | | | | | | | |
| 475.3 | R07AA30 | beraktant | parent. | 160 | MG | 20087,47 | T |
| 44278 | SURVANTA | sus 1x8ml/200mg | ABN | USA | | | |
| 44277 | SURVANTA | sus 1x4ml/100mg | ABN | USA | | | |
| 44278 | SURVANTA | sus 1x8ml/200mg | ABN | USA | | | |
| 476 | S01AA | antibiotika k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 476.1 | S01AA | neomycin/polymyxin/fenylefrin | lok. | 1 | ML | 19,55 | L/OPH |
| 476.1 | S01AA | neomycin/ polymyxin/ fenylefrin | lok. | 1 | ML | 19,55 | L/OPH |
| | | | | | | | |
| 476.2 | S01AA01 | chloramfenikol (lékové formy očních kapek) | lok. | 1 | ML | 2,79 | |
| | | | | | | | |
| 476.3 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1 | GM | 4,45 | |
| 476.3 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1 | GM | 4,64 | |
| 03016 | OPHTHALMO-CHLORAMPHENICOL LECIV | ung oph 1x5gm 1% | LEX | CZ | | | |
| 476.4 | S01AA11 | gentamicin | lok. | 1 | ML | 3,21 | |
| | | | | | | | |
@@ -7224,92 +7325,92 @@
| | | | | | | | |
| 476.6 | S01AA12 | tobramycin (lékové formy očních mastí) | lok. | 1 | GM | 3,21 | |
| | | | | | | | |
| 476.7 | S01AA20 | neomycin/bacitracin/hydrokortison | lok. | 1 | GM | 6,43 | |
| 01077 | OPHTHALMO-FRAMYKOIN COMPOSITUM | ung oph 1x5gm | LEX | CZ | | | |
| 476.7 | S01AA20 | neomycin/ bacitracin/ hydrokortison | lok. | 1 | GM | 6,43 | |
| | | | | | | | |
| 476.8 | S01AA20 | antibiotika v kombinaci s jinými léčivy | lok. | 1 | ML | 3,21 | |
| | | | | | | | |
| 476.9 | S01AA24 | kanamycin | lok. | 1 | ML | 3,21 | |
| | | | | | | | |
| 476.10 | S01AA25 | azidamfenikol | lok. | 1 | ML | 3,21 | |
| 90770 | OPHTHALMO-AZAPHENICOL | gtt oph 1x10ml | GNO | CZ | | | |
| 476.11 | S01AA30 | neomycin/bacitracin | lok. | 1 | GM | 5,82 | |
| | | | | | | | |
| 476.11 | S01AA30 | neomycin/ bacitracin | lok. | 1 | GM | 6,10 | |
| 01076 | OPHTHALMO-FRAMYKOIN | ung oph 1x5gm | LEX | CZ | | | |
| 476.12 | S01AA30 | neomycin/polymyxin | lok. | 1 | ML | 19,55 | L/OPH |
| 476.12 | S01AA30 | neomycin/ polymyxin | lok. | 1 | ML | 19,55 | L/OPH |
| 477 | S01AB | chemoteraputika k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 477.1 | S01AB | sulfathiazol | lok. | 1 | GM | 3,42 | |
| | | | | | | | |
| 477.2 | S01AB04 | sulfacetamid | lok. | 1 | ML | 7,75 | |
| 477.2 | S01AB04 | sulfacetamid | ,0k. | 1 | ML | 6,95 | |
| 93577 | SULPHACETAMID | gtt oph 12x0.5ml | POL | PL | | | |
| 478 | S01AD | antivirotika k lokálnímu podání | lok. | L/OPH | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 478.1 | S01AD02 | trifluorothimidin (lékové formy očních mastí) | lok. | 1 | GM | 79,92 | L/OPH |
| 478.1 | S01AD02 | trifluorothimidin (lékové formy očních mastí) | lok. | 1 | GM | 73,91 | L/OPH |
| | | | | | | | |
| 478.2 | S01AD02 | trifluorothimidin (lékové formy očních kapek) | lok. | 1 | ML | 53,23 | L/OPH |
| | | | | | | | |
| 478.3 | S01AD03 | acyklovir | lok. | 1 | GM | 79,92 | L/OPH |
| 478.3 | S01AD03 | acyklovir | lok. | 1 | GM | 73,91 | L/OPH |
| 53606 | XOROX | ung oph 1x4.5 gm | KWI | A | | | |
| 479 | S01AX | ostatní antiinfektiva | lok. | L/OPH | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 479.1 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 2,50 | |
| 00802 | OPHTHALMO-SEPTONEX | gtt oph 1x10ml | GNO | CZ | | | |
| 479.2 | S01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 4,30 | |
| 479.1 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 2,62 | |
| 00802 | OPHTHALMO-SEPTONEX | gtt oph 1x10ml | IVX | CZ | | | |
| 479.2 | IS01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 4,46 | |
| 00876 | OPHTHALMO-SEPTONEX | ung oph 1x5gm | LEX | CZ | | | |
| 479.3 | S01AX11 | Ofloxacin | lok. | 1 | ML | 18,00 | L/OPH |
| | | | | | | | |
| 479.4 | S01AX13 | Ciprofloxacin | lok. | 1 | ML | 22,00 | L/OPH, ORL |
| | | | | | | | |
| 479.5 | S01AX17 | lomefloxacin k lokálnímu podání | lok. | 1 | ML | 22,00 | L/OPH |
| 479.4 | S01AX13 | Ciprofloxacin | lok. | 1 | ML | 18,00 | L/OPH |
| | | | | | | | |
| 479.5 | S01AX17 | lomefloxacin k lokálnímu podání | lok. | 1 | ML | 18,00 | L/OPH |
| 480 | S01BA | kortikosteroidy k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 480.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1 | ML | 3,47 | |
| 480.1 | S01BA01 dexamethason (lékové formy očních kapek) | lok. | 1 | ML | 3,47 | | |
| | | | | | | | |
| 480.2 | S01BA01 | dexamethason (lékové formy očních mastí) | lok. | 1 | GM | 3,62 | |
| | | | | | | | |
| 480.3 | S01BA02 | hydrokortison | lok. | 1 | GM | 5,77 | |
| 480.3 | S01BA02 | hydrokortison | lok. | 1 | GM | 6,04 | |
| 02668 | OPHTHALMO-HYDROCORTISON LECIVA | ung oph 1x5gm 0.5% | LEX | CZ | | | |
| 480.4 | S01BA03 | kortison | lok. | 1 | ML | 19,55 | L/OPH |
| 00757 | CORTISON SPOFA | gtt oph 1x3ml | SPX | CZ | | | |
| 480.5 | S01BA04 | prednizolon (lékové formy očních kapek) | lok. | 1 | ML | 17,00 | L/OPH |
| | | | | | | | |
| 480.6 | S01BA04 | prednizolon (lékové formy očních mastí) | lok. | 1 | GM | 17,00 | L/OPH |
| | | | | | | | |
| 480.7 | S01BA07 | fluorometholon | lok. | 1 | ML | 17,00 | L/OPH |
| 481 | S01BC | nesteroidní protizánětlivá léčiva k lokálnímu podáni | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 481.1 | S01BC | alkylazuleny | lok. | 1 | GM | 3,81 | |
| 00874 | OPHTHALMO-AZULEN | ung oph 1x5gm | LEX | CZ | | | |
| 481.2 | S01BC02 | oxyfenbutazon | lok. | 1 | GM | 14,66 | |
| | | | | | | | |
| 481.3 | S01BC03 | diklofenak | lok. | 1 | ML | 28,90 | L/OPH |
| 56868 | FLUMETOL S | gttoph 1x10ml/0.02gm | FRM | I | | | |
| 481 | S01BC | nesteroidní protizánětlivá léčiva k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 481.1 | S01BC02 | oxyfenbutazon | lok. | 1 | GM | 14,66 | |
| | | | | | | | |
| 481.2 | S01BC03 | diklofenak | lok. | 1 | ML | 23,00 | L/OPH |
| 58230 | UNICLOPHEN UNIMED PHARMA | gtt oph 1x10ml 0.1% | UPA | SK | | | |
| 481.4 | S01BC04 | flurbiprofen | lok. | 1 | ML | 28,90 | L/OPH |
| 481.3 | S01BC04 | flurbiprofen | lok. | 1 | ML | 23,00 | L/OPH |
| 482 | S01CA | kortikosteroidy a antiinfektiva k lokálnímu podání | lok. | L/OPH | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 482.1 | S01CA | chloramfenikol/dexamethason | lok. | 1 | ML | 17,60 | L/OPH |
| | | | | | | | |
| 482.2 | S01CA | gentamicin/betamethason (lékové formy očních kapek) | lok. | 1 | ML | 12,05 | L/OPH,ORL |
| 91712 | GARASONE | gtt oph 1x5ml | SCH | B | | | |
| 482.3 | S01CA | gentamicin/betamethason (lékové formy očních mastí) | lok. | 1 | GM | 15,84 | L/OPH,ORL |
| 482.1 | S01CA | chloramfenikol/ dexamethason | lok. | 1 | ML | 17,60 | L/OPH |
| | | | | | | | |
| 482.2 | S01CA05 | gentamicin/ betamethason (lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH,ORL |
| 91712 | GARASONE | gtt oph/oto 1x5ml | SCH | B | | | |
| 482.3 | S01CA05 | gentamicin/ betamethason (lékové formy očních mastí) | lok. | 1 | GM | 15,40 | L/OPH,ORL |
| 91711 | GARASONE | ung oph 1x5gm | SCH | B | | | |
| 482.4 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních kapek) | lok. | | ML | 15,84 | L/OPH |
| | | | | | | | |
| 482.5 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních mastí) | lok. | | GM | 17,60 | L/OPH |
| | | | | | | | |
| 482.6 | S01CA01 | oxytetracyklin/dexamethason | lok. | | GM | 17,60 | L/OPH |
| | | | | | | | |
| 482.7 | S01CA01 | dexamethason a tobramycin (lékové formy očních kapek) | lok. | | ML | 15,84 | L/OPH |
| | | | | | | | |
| 482.8 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních kapek) | lok. | | ML | 17,60 | L/OPH |
| | | | | | | | |
| 482.9 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních mastí) | lok. | | GM | 17,60 | L/OPH |
| | | | | | | | |
| 482.10 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních mastí) | lok. | | GM | 17,60 | L/OPH |
| | | | | | | | |
| 482.11 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních kapek) | lok. | | ML | 17,60 | L/OPH |
| | | | | | | | |
| 482.12 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních kapek) | lok. | | ML | 19,55 | L/OPH |
| | | | | | | | |
| 482.13 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních mastí) | lok. | | GM | 24,44 | L/OPH |
| 482.4 | S01CA01 | dexamet./ neomycin/ polymyxin (lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH |
| | | | | | | | |
| 482.5 | S01CA01 | dexamet./ neomycin/ polymyxin (lékové formy očních mastí) | lok. | 1 | GM | 15,40 | L/OPH |
| | | | | | | | |
| 482.6 | S01CA01 | oxytetracyklin/ dexamethason | lok. | 1 | GM | 17,60 | L/OPH |
| | | | | | | | |
| 482.7 | S01CA01 | dexamethason a tobramycin (lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH |
| | | | | | | | |
| 482.8 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH |
| | | | | | | | |
| 482.9 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 15,40 | L/OPH |
| | | | | | | | |
| 482.10 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních mastí) | lok. | 1 | GM | 15,40 | L/OPH |
| | | | | | | | |
| 482.11 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH |
| | | | | | | | |
| 482.12 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 19,55 | L/OPH |
| | | | | | | | |
| 482.13 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních masti) | lok. | 1 | GM | 24,44 | L/OPH |
| 483 | S01EA | lokální sympatomimetika k léčbě glaukómu | lok. | L/OPH | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 483.1 | S01EA01 | epinefrin | lok. | 1 | ML | 26,65 | L/OPH |
@@ -7318,9 +7419,9 @@
| 54270 | OFTANEX | gtt oph 1x10ml | SOY | SF | | | |
| 59629 | OFTANEX | gtt oph 1x5ml | SOY | SF | | | |
| 483.3 | S01EA04 | klonidin | lok. | 1 | ML | 10,70 | L/OPH |
| 49501 | ARUCLONIN 1/16% | gtt oph 10ml | ANW | D | | | |
| 20766 | ARUCLONIN 1/8% | gtt oph 10ml | ANW | D | | | |
| 483.4 | S01EA05 | brimonidin | lok. | 1 | ML | 66,48 | P |
| 20766 | ARUCLONIN 1/8% | gtt oph 10ml | CHV | D | | | |
| 49501 | ARUCLONIN 1/16% | gtt oph 10ml | CHV | D | | | |
| 483.4 | S01EA05 | brimonidin | lok. | 1 | ML | 59,80 | P |
Léčbu brimonidinem indikuje oční lékař u pacientů s glaukomem při netoleranci nebo neúčinnosti betablokátorů.
@@ -7329,70 +7430,71 @@
| 484.1 | S01EB01 | pilokarpin (lékové formy gelu) | lok. | 1 | GM | 29,00 | |
| | | | | | | | |
| 484.2 | S01EB01 | pilokarpin (lékové formy olejových očních kapek) | lok. | 1 | ML | 9,70 | |
| 03865 | PILOCARPIN ANKERP. OCNI OLEJ 2% | gtt oph ole 1x10ml | CHV | D | | | |
| 01638 | PILOCARPIN ANKERP.OCNI OLEJ 2% | gtt oph ole 3x10ml | CHV | D | | | |
| 03865 | PILOCARPIN ANKERP.OCNI OLEJ 2% | gtt oph ole 1x10ml | CHV | D | | | |
| 484.3 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace do 1% včetně) | lok. | 1 | ML | 6,00 | |
| 44445 | PILOPOS 1% | gtt oph 1x10ml | URS | D | | | |
| 484.4 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace více než 1%) | lok. | 1 | ML | 6,87 | |
| 44446 | PILOPOS 2% | gtt oph 1x10ml | URS | D | | | |
| 56673 | PILOTONINA 2% | gtt oph 1x10ml | FRM | I | | | |
| 04146 | PILOCARPIN ANKERP.OCNI KAPKY 2% | gtt oph 1x10ml | CHV | D | | | |
| 57337 | PILOCARPIN ANKERP.OCNI KAPKY 2% | gtt oph 3x10ml | CHV | D | | | |
| 04146 | PILOCARPIN ANKERP.OCNI KAPKY 2% | gtt oph 1x10ml | CHV | D | | | |
| 56673 | PILOTONINA 2% | gtt oph 1x10ml | FRM | I | | | |
| 44446 | PILOPOS 2% | gtt oph 1x10ml | URS | D | | | |
| 484.5 | S01EB02 | karbachol (koncentrace do 1 % včetně) | lok. | 1 | ML | 8,50 | L/OPH |
| 484.5 | S01EB02 | karbachol (koncentrace do 1% včetně) | lok. | 1 | ML | 8,50 | L/OPH |
| | | | | | | | |
| 484.6 | S01EB02 | karbachol (koncentrace nad 1% do 1,5% včetně) | lok. | 1 | ML | 6,06 | L/OPH |
| | | | | | | | |
| 484.7 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | | ML | 6,60 | L/OPH |
| 484.7 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | 1 | ML | 6,60 | L/OPH |
| | | | | | | | |
| 484.8 | S01EB06 | neostigmin | lok. | 1 | ML | 13,88 | L/OPH |
| | | | | | | | |
| 484.9 | S01EB51 | pilokarpin v kombinaci s timololem | lok. | 1 | ML | 29,72 | L/OPH |
| 485 | S01EC | inhibitory karboanhydrázy k celkovému podání | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 485.1 | S01EC01 | acetazolamid | p.o. | 0.75 | GM | 6,18 | |
| 485.1 | S01EC01 | acetazolamid | p.o. | 0.75 | gm | 6,47 | |
| 00113 | DILURAN | tbl 20x250mg | LEX | CZ | | | |
| 485.2 | S01EC01 | acetazolamid (lékové formy s řízeným uvolňováním) | p.o. | 0.75 | GM | 29,33 | |
| | | | | | | | |
| 485.3 | S01EC02 | diklofenamid | p.o. | 0.1 | GM | 6,26 | |
| | | | | | | | |
| 485.4 | S01EC03 | dorzolamid | lok. | 1 | ML | 66,48 | P |
| 485.2 | S01EC01 | acetazolamid (lékové formy s řízeným uvolňováním) | p.o. | 0.75 | gm | 29,33 | |
| | | | | | | | |
| 485.3 | S01EC02 | diklofenamid | p.o. | 0.1 | gm | 6,26 | |
| | | | | | | | |
| 485.4 | S01EC03 | dorzolamid | lok. | 1 | ml | 59,80 | P |
Léčba dorzolamidem včetně kombinací je ordinována v případě neúčinnosti monoterapie betablokátory nebo alfamimetiky nebo v případě netolerance těchto léčiv.
| 485.5 | S01EC04 | brinzolamid | lok. | 1 | ML | 66,48 | P |
| 485.5 | S01EC04 | brinzolamid | lok. | 1 | ml | 59,80 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčba brinzolamidem včetně kombinací je ordinována v případě neúčinnosti monoterapie betablokátory nebo alfamimetiky nebo v případě netolerance těchto léčiv.
| 486 | S01ED | lokální beta-blokátory k léčbě glaukómu | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 486.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1 | ML | 14,25 | |
| 00113 | DILURAN | tbl 20x250mg | LEX | CZ | | | |
| 486.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1 | ml | 14,25 | |
| 54494 | OFTAN TIMOLOL 0.25% | gtt oph 3x5ml | SOY | SF | | | |
| 70474 | ARUTIMOL 0.25% | gtt oph 3x5ml | CHV | D | | | |
| 76186 | ARUTIMOL 0.25% | gtt oph 1x5ml | CHV | D | | | |
| 12729 | TIMOHEXAL 0.1% | gtt oph 1x5ml/5mg | HEX | D | | | |
| 01760 | TIMOLOL-POS 0.25% | gtt oph 3x5ml | URS | D | | | |
| 12730 | TIMOHEXAL 0.25% | gtt oph1x5ml/12.5mg | HEX | D | | | |
| 54476 | OFTAN TIMOLOL 0.25% | gtt oph 1x5ml | SOY | SF | | | |
| 96022 | OFTENSIN 0.25% | gtt oph 1x10ml | POL | PL | | | |
| 87113 | TIMOLOL-POS 0.25% | gtt oph 1x5ml | URS | D | | | |
| 98210 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.25% | LEX | CZ | | | |
| 44546 | TIMO-COMOD 0.25% | gtt oph 1x10ml/25mg | URS | D | | | |
| 12732 | TIMOHEXAL 0.1% | gtt oph 3x5ml/5mg | HEX | D | | | |
| 12733 | TIMOHEXAL 0.25% | gtt oph3x5ml/12.5mg | HEX | D | | | |
| 01760 | TIMOLOL-POS 0.25% | gtt oph 3x5ml | URS | D | | | |
| 98210 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.25% | LEX | CZ | | | |
| 12732 | TIMOHEXAL 0.1% | gtt oph 3x5ml/5mg | HEX | D | | | |
| 44546 | TIMO-COMOD 0.25% | gtt oph 1x10ml/25mg | URS | D | | | |
| 54476 | OFTAN TIMOLOL 0.25% | gtt oph 1x5ml | SOY | SF | | | |
| 87113 | TIMOLOL-POS 0.25% | gtt oph 1x5ml | URS | D | | | |
| 12729 | TIMOHEXAL 0.1% | gtt oph 1x5ml/5mg | HEX | D | | | |
| 76186 | ARUTIMOL 0.25% | gtt oph 1x5ml | CHV | D | | | |
| 54494 | OFTAN TIMOLOL 0.25% | gtt oph 3x5ml | SOY | SF | | | |
| 96022 | OFTENSIN 0.25% | gtt oph 1x10ml | POL | PL | | | |
| 70474 | ARUTIMOL 0.25% | gtt oph 3x5ml | CHV | D | | | |
| 12730 | TIMOHEXAL 0.25% | gtt oph1x5ml/12.5mg | HEX | D | | | |
| 96021 | OFTENSIN 0.25% | gtt oph 1x5ml | POL | PL | | | |
| 486.2 | S01ED01 | timolol (koncentrace nad 0,25%) | lok. | 1 | ML | 16,60 | |
| 54477 | OFTAN TIMOLOL 0.50% | gtt oph 1x5ml | SOY | SF | | | |
| 12731 | TIMOHEXAL 0.5% | gtt oph 1x5ml/25mg | HEX | D | | | |
| 70475 | ARUTIMOL 0.5% | gtt oph 3x5ml | CHV | D | | | |
| 12734 | TIMOHEXAL 0.5% | gtt oph 3x5ml/25mg | HEX | D | | | |
| 56123 | TIMOLOL 0.5% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | | | |
| 87114 | TIMOLOL-POS 0.5% | gtt oph 1x5ml | URS | D | | | |
| 76187 | ARUTIMOL 0.5% | gtt oph 1x5ml | CHV | D | | | |
| 96019 | OFTENSIN 0.5% | gtt oph 1x5ml | POL | PL | | | |
| 44547 | TIMO-COMOD 0.5% | gtt oph 1x10ml/50mg | URS | D | | | |
| 54477 | OFTAN TIMOLOL 0.50% | gtt oph 1x5ml | SOY | SF | | | |
| 12734 | TIMOHEXAL 0.5% | gtt oph 3x5ml/25mg | HEX | D | | | |
| 70475 | ARUTIMOL 0.5% | gtt oph 3x5ml | ANW | D | | | |
| 98211 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.50% | LEX | CZ | | | |
| 59928 | OFTAN TIMOLOL 0.50% | gtt oph 3x5ml | SOY | SF | | | |
| 01759 | TIMOLOL-POS 0.5% | gtt oph 3x5ml | URS | D | | | |
| 12731 | TIMOHEXAL 0.5% | gtt oph 1x5ml/25mg | HEX | D | | | |
| 59928 | OFTAN TIMOLOL 0.50% | gtt oph 3x5ml | SOY | SF | | | |
| 98211 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.50% | LEX | CZ | | | |
| 87114 | TIMOLOL-POS 0.5% | gtt oph 1x5ml | URS | D | | | |
| 56123 | TIMOLOL 0.5% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | | | |
| 76187 | ARUTIMOL 0.5% | gtt oph 1x5ml | ANW | D | | | |
| 486.3 | S01ED02 | betaxolol | lok. | 1 | ML | 20,00 | L/OPH |
| | | | | | | | |
| 486.4 | S01ED03 | levobunolol | lok. | 1 | ML | 20,00 | L/OPH |
@@ -7403,33 +7505,35 @@
| | | | | | | | |
| 486.7 | S01EX03 | latanoprost | lok. | 1 | ML | 240,00 | P |
| | | | | | | | |
| 486.8 | S01EX | unoproston | lok. | 1 | ML | 117,00 | P |
Latanoprost a unoprost:
| 486.8 | S01EX04 | unoproston | lok. | 1 | ML | 105,30 | P |
Latanoprost včetně kombinací a unoprost:
léčba je ordinována v případě, není-li po vyčerpání všech možností antiglaukomatosní terapie léčba dostatečně účinná a operační výkon není indikován.
| 486.9 | S01ED51 | timolol v kombinaci s dorzolamidem | lok. | 1 | ML | 92,38 | P |
| 486.9 | S01ED51 | timolol v kombinaci s dorzolamidem | lok. | 1 | ML | 74,05 | P |
| | | | | | | | |
| 486.10 | S01ED51 | timolol v kombinaci s latanoprostem | lok. | 1 | ML | 256,60 | P |
| 487 | S01F | mydriatika a cykloplegika | lok. | O/OPH | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 487.1 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1 | ML | 5,18 | |
| 487.1 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1 | ML | 5,00 | |
| 83770 | ATROPIN-POS 0.5% | gtt oph 1x10ml | URS | D | | | |
| 487.2 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1 | ML | 5,87 | |
| 487.2 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1 | ML | 5,66 | |
| 83771 | ATROPIN-POS 1% | gtt oph 1x10ml | URS | D | | | |
| 487.3 | S01FA04 | cyklopentolát | lok. | 1 | ML | 35,10 | O/OPH |
| | | | | | | | |
| 487.4 | S01FA06 | tropikamid | lok. | 1 | ML | 8,99 | O/OPH |
| 487.4 | S01FA06 | tropikamid | lok. | 1 | ML | 8,52 | O/OPH |
| 21155 | MYDRUM | gtt oph 1x10ml 0.5% | CHV | D | | | |
| 487.5 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1 | ML | 40,33 | O/OPH |
| 487.5 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. 1 | ML | 40,33 | O/OPH | |
| 488 | S01G | dekongestanty a antialergika | lok. | L/OPH,ALG | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 488.1 | S01GX | antazolin/tetryzolin | lok. | 1 | ML | 6,06 | L/OPH,ALG |
| 488.1 | S01GX | antazolin/ tetryzolin | lok. | 1 | ML | 6,06 | L/OPH,ALG |
| | | | | | | | |
| 488.2 | S01GX01 | natrium kromoglykát (lékové formy očních kapek) | lok. | 1 | ML | 4,06 | |
| | | | | | | | |
| 488.3 | S01GX01 | natrium kromoglykát (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,43 | L/OPH,ALG, ORL |
| 488.3 | S01GX01 | natrium kromoglykát (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,23 | L/OPH,ALG, ORL |
| 54241 | ALLERGOCROM EYE+NAS.KOMBI-PACK | oph 10ml+nas 15ml | URS | D | | | |
| 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D | | | |
| 54241 | ALLERGOCROM EYE+NAS.KOMBI-PACK | oph 10ml+nas 15ml | URS | D | | | |
| 488.4 | S01GX02 | levokabastin | lok. | 1 | ML | 17,60 | L/OPH,ALG |
| | | | | | | | |
| 488.5 | S01GX03 | kyselina spaglumová | lok. | 1 | ML | 14,66 | L/OPH,ALG |
@@ -7442,7 +7546,7 @@
| | | | | | | | |
| 488.9 | S01GX08 | ketotifen | lok. | 1 | ML | 27,14 | L/OPH, ALG |
| | | | | | | | |
| 488.10 | S01GA52 | tetryzolin/antihistaminikum | lok. | 1 | ML | 4,06 | L/OPH,ALG |
| 488.10 | S01GA52 | tetryzolin/ antihistaminikum | lok. | 1 | ML | 4,06 | L/OPH,ALG |
| 489 | S01HA | lokální místní anestetika | lok. | L/OPH | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 489.1 | S01HA | místní anestetika | lok. | 1 | ML | 11,83 | L/OPH |
@@ -7454,16 +7558,21 @@
| | | | | | | | |
| 490.2 | S01XA | jodid draselný a sodný | lok. | 1 | ML | 4,89 | |
| 56119 | JODID DRASELNY+SODNY 2% UNIM.PH | gtt oph 1x10ml | UPA | SK | | | |
| 490.3 | S01XA02 | retinol | lok. | 1 | GM | 2,93 | |
| 490.4 | S01XA04 | jodid draselný | lok. | 1 | ML | 4,89 | |
| 490.3 | S01XA01 | guajazulen | lok. | 1 | GM | 3,98 | |
| 00874 | OPHTHALMO-AZULEN | ung oph 1x5gm | LEX | CZ | | | |
| 490.4 | S01XA02 | retinol | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 490.5 | S01XA04 | jodid draselný | lok. | 1 | ML | 4,89 | |
| 56118 | JODID DRASELNY 2% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | | | |
| 490.5 | S01XA11 | nandrolon | lok. | 1 | ML | 11,20 | |
| | | | | | | | |
| 490.6 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 2,93 | |
| 490.6 | S01XA11 | nandrolon | lok. | 1 | ML | 11,20 | |
| | | | | | | | |
| 490.7 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 3,03 | |
| 04179 | LACRISYN | gtt oph 1x10ml | GNO | CZ | | | |
| 490.7 | S01XA20 | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 490.8 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1376,58 | Z |
| 490.8 | S01XA20 | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1 | GM | 3,03 | |
| | | | | | | | |
| 490.9 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1376,58 | Z |
| | | | | | | | |
| 490.10 | S02DA30 | kombinace fenazon a lidokain | lok. | 1 | GM | 3,80 | L/ORL |
| 491 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | L/ORL | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 491.1 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | ML | 27,37 | L/ORL |
@@ -7474,19 +7583,17 @@
| 84575 | OTOBACID N | gtt oto 1x6gm | ASH | D | | | |
| 492 | V01AA | extrakty alergenů | p.o. | L/ALG | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 492.1 | V01AA | extrakty alergenů (nestandardizované, úvodní dávka) | p.o. | 1 | DF | 88,46 | L/ALG |
| | | | | | | | |
| 492.2 | V01AA | extrakty alergenů (nestandardizované, udržovací dávka) | p.o. | 1 | DF | 415,47 | L/ALG |
| | | | | | | | |
| 492.3 | V01AA | extrakty alergenů (standardizované, úvodní dávka) | p.o. | 1 | DF | 228,70 | L/ALG |
| | | | | | | | |
| 492.4 | V01AA | extrakty alergenů (standardizované, udržovací dávka) | p.o. | 1 | DF | 498,16 | L/ALG |
| | | | | | | | |
| 492.5 | V01AA | extrakty alergenů (standardizované, pro sublinguální podání, úvodní dávka) | p.o. | 1 | DF | 355,64 | P |
Specifická alergenová imunoterapie standardizovanými sublinguálními alergeny je idikována alergologem nebo klinickým imunologem u IgE zprostředkované alergie pylové, roztočové, včelí a vosí, zvířecí (alergeny kočky), prokázané kožními testy a pozitivitou specifických IgE protilátek. Zahájení této terapie se provádí u dětí do 15.let.
| 492.6 | V01AA | extrakty alergenů (stadnardizované, pro sublinguální podání, udržovací dávka) | p.o. | 1 | DF | 692,22 | P |
| 492.1 | V01AA | I. generace (PNU), úvodní dávka | p.o. | 1 | DF | 88,46 | L/ALG |
| | | | | | | | |
| 492.2 | V01AA | I. generace (PNU), udržovací dávka | p.o. | 1 | DF | 415,47 | L/ALG |
| | | | | | | | |
| 492.3 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), úvodní dávka | p.o. | 1 | DF | 228,70 | L/ALG |
| | | | | | | | |
| 492.4 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), udržovací dávka | p.o. | 1 | DF | 498,16 | L/ALG |
| | | | | | | | |
| 492.5 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), pro sublng. podání, úvodní dávka | p.o. | 1 | DF | 308,40 | L/ALG |
| | | | | | | | |
| 492.6 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU),pro sublng. podání, udržovací dávka | p.o. | 1 | DF | 616,52 | L/ALG |
| 493 | V01AA | extrakty alergenů | intrader. | O/ALG | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 493.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | intrader. | 1 | BA | 134,61 | O/ALG |
@@ -7497,28 +7604,44 @@
| 494.2 | V01AA | extrakty alergenů (diagnostické, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG |
| 495 | V01AA | extrakty alergenů | parent. | L/ALG | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 495.1 | V01AA | extrakty alergenů (nestandardizované, vodné, úvodní dávka) | parent. | 1 | DF | 69,48 | L/ALG |
| | | | | | | | |
| 495.2 | V01AA | extrakty alergenů (nestandardizované, vodné, udržovací dávka) | parent. | 1 | DF | 442,69 | L/ALG |
| | | | | | | | |
| 495.3 | V01AA | extrakty alergenů (standardizované, vodné, úvodní dávka) | parent. | 1 | DF | 228,70 | L/ALG |
| | | | | | | | |
| 495.4 | V01AA | extrakty alergenů (standardizované, vodné, udržovací dávka) | parent. | 1 | DF | 749,06 | L/ALG |
| | | | | | | | |
| 495.5 | V01AA | extrakty alergenů (nestandardizované, depotní, úvodní dávka) | parent. | 1 | DF | 38,50 | L/ALG |
| 83558 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 250pnu/1ml | SEV | CZ | | | |
| 83552 | H-AL DMX SEVAC DEP.BYT.PR.OBOH. | inj 100pnu/1ml | SEV | CZ | | | |
| 83554 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 250pnu/1ml | SEV | CZ | | | |
| 495.1 | V01AA | I. generace (PNU), vodné, úvodní dávka | parent. | 1 | DF | 69,48 | L/ALG |
| | | | | | | | |
| 495.2 | V01AA | I. generace (PNU), vodné, udržovací dávka | parent. | 1 | DF | 442,69 | L/ALG |
| | | | | | | | |
| 495.3 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), vodné, úvodní dávka | parent. | 1 | DF | 228,70 | L/ALG |
| | | | | | | | |
| 495.4 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), vodné, udržovací dávka | parent. | 1 | DF | 749,06 | L/ALG |
| | | | | | | | |
| 495.5 | V01AA | I. generace (PNU), depotní, úvodní dávka | parent. | 1 | DF | 38,50 | L/ALG |
| 83560 | H-AL POL.SEVAC DEP.SM.PODZIMNI | inj 250pnu/1ml | SEV | CZ | | | |
| 83562 | H-AL POL.SEVAC DEP.SMES TRAV I | inj 250pnu/1ml | SEV | CZ | | | |
| 495.6 | V01AA | extrakty alergenů (nestandardizované, depotní, udržovací dávka) | parent. | 1 | BA | 265,93 | L/ALG |
| | | | | | | | |
| 495.7 | V01AA | extrakty alergenů (standardizované, depotní, úvodní dávka) | parent. | 1 | DF | 308,40 | L/ALG |
| | | | | | | | |
| 495.8 | V01AA | extrakty alergenů (standardizované, depotní, udržovací dávka) | parent. | 1 | DF | 1043,83 | L/ALG |
| 496 | V03A | všechny jiné terapeutické přípravky | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 496.1 | V03AX | antistafylokokový fág. lyzát | lok. | 20 | ML | 307,20 | |
| 83554 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 250pnu/1 ml | SEV | CZ | | | |
| 83558 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 250pnu/1ml | SEV | CZ | | | |
| 495.6 | V01AA | I. generace (PNU), depotní, udržovací dávka | parent. | 1 | BA | 265,93 | L/ALG |
| | | | | | | | |
| 495.7 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), depotní, úvodní dávka | parent. | 1 | BA | 1233,60 | L/ALG |
| | | | | | | | |
| 495.8 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), depotní, udržovací dávka | parent. | 1 | BA | 1043,83 | L/ALG |
| 496 | V03A | všechny jiné terapeutické přípravy | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu sevelamerem indikuje nefrolog se zkušenostmi s diagnostikou a léčbou komplikací renální osteopatie na pracovištích, kde jsou k dispozici všechny potřebné diagnostické metody a vazba na chirurgické pracoviště provádějící parathyreoidektomie, a to pouze pacinetům, kteří splňují alespoň jedno z následujících kriterií:
- a) hyperfosfatémie vyšší než 2,5mmol/l a hyperkalcémie (Ca více než 2,7mmol/l) při terapii kalcium karbonátem a to i přes použití dialyzačního roztoku s obsahem kalcia 1,25 mmol/l,
- b) nekontrolovatelná hyperfosfatemie (více než 3,2 mmol/l); či opakovaně zjišťovaná hodnota více než 2,5 mmol/l při prokázané dietě s omezením fosforu do 1200 mg/d, adekvátní dialyzační léčbě - Kt/V dle Daugirdase II více než 1,2 a spolupráci pacienta,
- c) parathyreoidektomie - k překlenutí období od indikace do operačního výkonu,
- d) tzv. fosfokalciový produkt více než 6,0 mmol/l exp.2 při splnění podmínek uvedených výše,
- e) prokázaná extraoseální kalcifikace (periartikulární, v jiných lokalizacích).
Kontroly účinnosti podávání sevelameru jsou prováděny nejméně jednou za 3 měsíce léčby. Podávání je ukončeno pokud je pří kontrole zjištna hyperfosaftamie vyšší než 2,5mmol/l.
| 496.1 | V03AE02 | sevelamer | p.o. | 1 | DF | 23,33 | P |
| | | | | | | | |
| 496.2 | V03AX | antistafylokokový fág. lyzát | lok. | 20 | ML | 321,60 | |
| 86170 | STAFAL | sus 1x10ml | SVF | CZ | | | |
| 497 | V03AB | antidota | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -7534,74 +7657,84 @@
| | | | | | | | |
| 497.6 | V03AB08 | dusitan sodný | parent. | | | plně | K |
| | | | | | | | |
| 497.7 | V03AB14 | Protamin | parent. | 1 | ML | 6,01 | K |
| 497.7 | V03AB14 | protamin | parent. | 1 | ML | 6,01 | K |
| | | | | | | | |
| 497.8 | V03AB15 | naloxon | parent. | 0.4 | MG | 11,83 | K |
| 88866 | INTRENON | inj 10x1ml/400rg | LEX | CZ | | | |
| 94763 | NALOXONE POLFA | inj 10x1ml/0.4mg | POL | PL | | | |
| 58832 | INTRENON SPOFA | inj 10x1ml/0.4mg | SPX | CZ | | | |
| 88866 | INTRENON | inj 10x1ml/400rg | LEX | CZ | | | |
| 497.9 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100 | ML | 20,43 | K |
| | | | | | | | |
| 497.10 | V03AB19 | fysostigmin | parent. | 1 | MG | 10,31 | K |
| | | | | | | | |
| 497.11 | V03AB24 | digitalisový antitoxin | parent. | 80 | MG | 32726,64 | K |
| | | | | | | | |
| 497.12 | V03AB25 | flumazenil | parent. | 0.5 | MG | 777,86 | K |
| 497.12 | V03AB25 | flumazenil | parent. | 0.5 | MG | 754,48 | K |
| 93214 | ANEXATE | inj 5x5ml/0.5mg | HLR | CH | | | |
| 498 | V03AF | antidota užívaná při léčbě cytostatiky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 498.1 | V03AF01 | mesna | p.o. | 1,2 | GM | 297,04 | B/ONK,HEM |
| 87251 | UROMITEXAN TABLETS 400MG | tbl obd 10x400mg | ASD | D | | | |
| 498.2 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 113,99 | |
| 498.1 | V03AF01 | mesna | p.o. | 1,2 | GM | 290,85 | B/ONK,HEM |
| 05883 | UROMITEXAN TABLETS 400MG | tbl obd 10x400mg | HOD | D | | | |
| 498.2 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 111,91 | |
| 54518 | LEUCOVORIN CA LACHEMA 15 | por tbl nob 30x15mg | PVL | CZ | | | |
| 96963 | CALCIUMFOLINAT-EBEWE | cps 20x15mg | EBW | A | | | |
| 54518 | LEUCOVORIN CA LACHEMA 15 | por tbl nob 30x15mg | PVL | CZ | | | |
| 498.3 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 117,55 | |
| 498.3 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 115,42 | |
| 96964 | CALCIUMFOLINAT-EBEWE | cps 20x100mg | EBW | A | | | |
| 01671 | LEUCOVORIN CA LACHEMA 25 | por tbl nob 30x25mg | PVL | CZ | | | |
| 499 | V03AF | antidota užívaná při léčbě cytostatiky | parent. | B/ONK,HEM | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 29,72 | B/ONK,HEM |
| | | | | | | | |
| 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 49,42 | B/ONK,HEM |
| 75274 i | UROMITEXAN 400MG | inj 15x4ml/400mg | ASD | D | | | |
| 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 29.72 | B/ONK,HEM |
| | | | | | | | |
| 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 48,39 | B/ONK,HEM |
| 05954 | UROMITEXAN 400MG | inj 15x4ml/400mg | HOD | D | | | |
| 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4391,10 | B/ONK,HEM |
| | | | | | | | |
| 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4329,50 | B/ONK,HEM |
| 96542 | CARDIOXANE | inj sic 1x500mg | CNC | NL | | | |
| 499.4 | V03AF03 | kalcium folinát | parent. | 60 | MG | 234,23 | B/ONK,HEM |
| 12831 | LEUCOVORIN-TEVA | inj 5x10ml/100mg | AIC | IL | | | |
| 96967 | CALCIUMFOLINAT EBEWE 100MG | inj 5x10ml/100mg | EBW | A | | | |
| 88636 | LEUCOVORIN CA LACHEMA 10 | inj sic 10x10mg | LCM | CZ | | | |
| 12440 | LEUCOVORIN CA LACHEMA 10 | inj 10x1ml/10mg | LCM | CZ | | | |
| 12441 | LEUCOVORIN CA LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | | | |
| 12442 | LEUCOVORIN CA LACHEMA 50 | inj 5x5ml/50mg | LCM | CZ | | | |
| 75005 | LEUCOVORIN CA LACHEMA 10 | inj sic 1x10mg | LCM | CZ | | | |
| 01668 | LEUCOVORIN CA LACHEMA 450 | inj sol 1x45ml | PVL | CZ | | | |
| 11184 | LEUCOVORIN-TEVA | inj 1x5ml/50mg | PHM | NL | | | |
| 11185 | LEUCOVORIN-TEVA | inj 1x10ml/100mg | PHM | NL | | | |
| 01669 | LEUCOVORIN CA LACHEMA 450 | inj sol 5x45ml | PVL | CZ | | | |
| 01668 | LEUCOVORIN CA LACHEMA 450 | inj sol 1x45ml | PVL | CZ | | | |
| 96966 | CALCIUMFOLINAT EBEWE 30MG | inj 5x3ml/30mg | EBW | A | | | |
| 12832 | LEUCOVORIN-TEVA | inj 1x5ml/50mg | AIC | IL | | | |
| 11188 | LEUCOVORIN-TEVA | inj 1x30ml/300mg | PHM | NL | | | |
| 11190 | LEUCOVORIN-TEVA | inj 1x50ml/500mg | PHM | NL | | | |
| 12440 | LEUCOVORIN CA LACHEMA 10 | inj sol 10x1ml/10mg | PVL | CZ | | | |
| 11186 | LEUCOVORIN-TEVA | inj 5x10ml/100mg | PHM | NL | | | |
| 11189 | LEUCOVORIN-TEVA | inj 1x35ml/350mg | PHM | NL | | | |
| 11187 | LEUCOVORIN-TEVA | inj 1x20ml/200mg | PHM | NL | | | |
| 58033 | CALCIUMFOLINAT EBEWE 100MG | inj 1x10ml/100mg | EBW | A | | | |
| 12833 | LEUCOVORIN-TEVA | inj 1x10ml/100mg | AIC | IL | | | |
| 12834 | LEUCOVORIN-TEVA | inj 1x20ml/200mg | AIC | IL | | | |
| 12835 | LEUCOVORIN-TEVA | inj 1x30ml/300mg | AIC | IL | | | |
| 12836 | LEUCOVORIN-TEVA | inj 1x35ml/350mg | AIC | IL | | | |
| 12837 | LEUCOVORIN-TEVA | inj 1x50ml/500mg | AIC | IL | | | |
| 57615 | LEUCOVORIN CA LACHEMA 150 INJ. | inj 10x15ml/150mg | LCM | CZ | | | |
| 57614 | LEUCOVORIN CA LACHEMA 150 INJ. | inj 1x15ml/150mg | LCM | CZ | | | |
| 12831 | LEUCOVORIN-TEVA | inj 5x10ml/100mg | AIC | IL | | | |
| 75004 | LEUCOVORIN CA LACHEMA 25 | inj plv sol 1x25mg | PVL | CZ | | | |
| 57615 | LEUCOVORIN CA LACHEMA 150 INJ. | inj 10x15ml/150mg | PVL | CZ | | | |
| 12771 | LEUCOVORIN-TEVA | inj sic 1x50mg | AIC | IL | | | |
| 91561 | LEUCOVORIN CA LACHEMA 25 | inj sic 10x25mg | LCM | CZ | | | |
| 12832 | LEUCOVORIN-TEVA | inj 1x5ml/50mg | AIC | IL | | | |
| 75004 | LEUCOVORIN CA LACHEMA 25 | inj sic 1x25mg | LCM | CZ | | | |
| 88636 | LEUCOVORIN CA LACHEMA 10 | inj plv sol 10x10mg | PVL | CZ | | | |
| 75005 | LEUCOVORIN CA LACHEMA 10 | inj plv sol 1x10mg | PVL | CZ | | | |
| 12441 | LEUCOVORIN CA LACHEMA 20 | inj sol 10x2ml/20mg | PVL | CZ | | | |
| 91561 | LEUCOVORIN CA LACHEMA 25 | inj plv sol 10x25mg | PVL | CZ | | | |
| 96966 | CALCIUMFOLINAT EBEWE 30MG | inj 5x3ml/30mg | EBW | A | | | |
| 96967 | CALCIUMFOLINAT EBEWE 100MG | inj 5x10ml/100mg | EBW | A | | | |
| 12442 | LEUCOVORIN CA LACHEMA 50 | inj sol 5x5ml/50mg | PVL | CZ | | | |
| 10791 | LEUCOVORIN-TEVA | inj sic 1x50mg | PHM | NL | | | |
| 57614 | LEUCOVORIN CA LACHEMA 150 INJ. | inj 1x15ml/150mg | PVL | CZ | | | |
| 499.5 | V03AF05 | amifostin | parent. | 1,7 | GM | 19500,00 | X |
| | | | | | | | |
| 499.6 | V03AF07 | rasburikaza | parent. | 1 | DF | 2500,00 | H |
| 500 | V03AK | tkáňová lepidla | lok. | X | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3227,24 | X |
| 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3219,90 | X |
| 90504 | TISSUCOL KIT | kit 1x2ml | IMM | A | | | |
| 90503 | TISSUCOL KIT | kit 1x1ml | IMM | A | | | |
| 90504 | TISSUCOL KIT | kit 1x2ml | IMM | A | | | |
| 90502 | TISSUCOL KIT | kit 1x0.5ml | IMM | A | | | |
| 90505 | TISSUCOL KIT | kit 1x5ml | IMM | A | | | |
| 90502 | TISSUCOL KIT | kit 1x0.5ml | IMM | A | | | |
| 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 177,53 | X |
| 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 177,24 | X |
| 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | | | |
| 89822 | TACHOCOMB (2.5X3X0.5CM) | spn 1x1ks | HNP | A | | | |
| 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | | | |
| 501 | V04CD | testy sekrece hormonů hypofýzy | p.o. | K/END | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 421,88 | K/END |
| 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 386,77 | K/END |
| 01359 | METOPIRONE | cps 50x250mg | CGC | CH | | | |
| 502 | V04CF | tuberkulinový test | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -7619,17 +7752,16 @@
| 84304 | D-AL PRICK TEST | sol 1x3ml pnu | SVF | CZ | | | |
| 84296 | D-AL PRICK TEST POLLENS | sol 1x3ml jsk,jsa | SVF | CZ | | | |
| 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | | | |
| 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | | | |
| 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | | | |
| 70500 | SOLUPRICK SQ | sol 1x3ml | AAS | DK | | | |
| 503.4 | V04CL | testy pro alergické choroby (diagnostické alergeny, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG |
| 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | | | |
| 504 | V04CX jiná diagnostika | p.o. | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 504.1 | V04CX | jiná diagnostika (přípravky uvolňující C02) | p.o. | 1 | DF | 22,88 | |
| 504 | V04CX | jiná diagnostika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 504.1 | V04CX | jiná diagnostika (přípravky uvolňující CO2) | p.o. | 1 | DF | 20,73 | |
| 46684 | CO2 GRANULAT GUERBET | gra 10x2.938gm | GMG | F | | | |
| 505 | V04CX | jiná diagnostika | intrader. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 505.1 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 127,09 | O |
| 505 | V04CX | jiná diagnostika j | intrader. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 505.1 | V04CX jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 114,51 | O | |
| 45918 | IMUNOSKINTEST | inj 2x1.5+6x1.3ml | SVF | CZ | | | |
| 505.2 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50 | MG | 251,00 | O |
| 506 | V04CX | jiná diagnostika | parent. | O | | | |
@@ -7661,11 +7793,12 @@
| 94078 | SINFEMIX | plv 1x250gm | IMA | SK | | | |
| 507.2 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,08 | L/J4 |
| 88063 | SINFENAL | plv 1x250gm | IMA | SK | | | |
| 507.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1 | GM | 12,81 | L/J4 |
| 507.3 | V06CA | výživa bez fenylaianinu (definované směsi aminokyselin) | p.o. | 1 | GM | 12,81 | L/J4 |
| 93089 | MILUPA PKU 3 | plv po 1 x500gm | MLP | D | | | |
| 93087 | MILUPA PKU 1 | plv po 1x500gm | MLP | D | | | |
| 93088 | MILUPA PKU 2 | plv po 1x500gm | MLP | D | | | |
| 93089 | MILUPA PKU 3 | plv po 1x500gm | MLP | D | | | |
| 93087 | MILUPA PKU 1 | plv po 1x500gm | MLP | D | | | |
| 507.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 18 měsíců) | p.o. | 1 | GM | 25,27 | L/J4 |
| | | | | | | | |
| 507.5 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1 | GM | 14,17 | L/J4 |
| 508 | V06DA | kombinace sacharidy/proteiny/minerály/vitamíny | p.o. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -7676,28 +7809,28 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 509.1 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100 | GM | 44,87 | H |
| 61454 | NUTRISON | plv 1x430gm | NUT | NL | | | |
| 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 79,38 | H |
| 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitaminy, komb. | p.o. | 500 | ML | 79,38 | H |
| 56245 | INKODIET FIBRE | sus por 1x500ml | NDP | D | | | |
| 509.3 | V06DC | kombinace sacharidů | p.o. | 100 | GM | 44,87 | H |
| 510 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | L/J7 | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 510.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5 | DF | 90,33 | L/J7 |
| 88115 | KETOSTERIL | tbl obd 100 | FRE | D | | | |
| 88116 | KETOSTERIL | tbl obd 300(3x100) | FRE | D | | | |
| 88115 | KETOSTERIL | tbl obd 100 | FRE | D | | | |
| 88117 | KETOSTERIL | tbl obd 1500=15x100 | FRE | D | | | |
| 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny | p.o. | L/J11 | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 511.1 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100 | GM | 26,88 | |
| | | | | | | | |
| 511.2 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100 | GM | 13,83 | L/J11 |
| | | | | | | | |
| 511.3 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100 | GM | 29,33 | L/J11 |
| | | | | | | | |
| 511.4 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100 | GM | 63,54 | L/J11 |
| | | | | | | | |
| 511.5 | V06 | kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) | p.o. | 100 | GM | 302,25 | P |
Přípravky obsahující kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) jsou ordinovány pacientům s těžkou potravinovou alergií, zvláště na bílkovinu kravského mléka (těžké reakce anafylaktického charakteru, neúspěch terapie extensivně hydrolyzovanými přípravky, potravinová alergie s projevy poškození střevní sliznice), s multiproteinovou alregií, u syndromu krátkého střeva, u malabsorpce při přechodu z parenterální na enterální výživu. Ve výše uvedených případech ordinuje dětem do 3 let věku lékař s atestací II. stupně v oboru pediatrie nebo s atestací I. stupně v oboru pediatrie a zároveň s nástavbovou specializací v oboru gastroenterologie nebo alergologie a klinické imunologie. Po 6 měsících by měl být proveden pokus o reexpozici proteinovým hydrolyzátem.
| 511.1 | V06DE | kombinace aminokyseliny/ sacharidy/ minerály/ vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100 | GM | 26,88 | |
| | | | | | | | |
| 511.2 | V06DE | kombinace aminokyseliny/ sacharidy/ minerály/ vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100 | GM | 13,83 | L/J11 |
| | | | | | | | |
| 511.3 | V06DE | kombinace aminokyseliny/ sacharidy/ minerály/ vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100 | GM | 29,33 | L/J11 |
| | | | | | | | |
| 511.4 | V06DE | kombinace aminokyseliny/ sacharidy/ minerály/ vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100 | GM | 63,54 | L/J11 |
| | | | | | | | |
| 511.5 | V06 | kombinace aminokyseliny/ sacharidy/ minerály/ vitamíny (jednotlivé aminokyseliny) | p.o. | 100 | GM | 302,25 | P |
Přípravky obsahující kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) jsou ordinovány pacientům s těžkou potravinovou alergii, zvláště na bílkovinu kravského mléka (těžké reakce anafylaktického charakteru, neúspěch terapie extensivně hydrolyzovanými přípravky, potravinová alergie s projevy poškození střevní sliznice), s multiproteinovou alregií, u syndromu krátkého střeva, u malabsorpce při přechodu z parenterální na enterální výživu. Ve výše uvedených případech ordinuje dětem do 3 let věku lékař s atestací II. stupně v oboru pediatrie nebo s atestací I. stupně v oboru pediatrie a zároveň s nástavbovou specializací v oboru gastroenterologie nebo alergologie a klinické imunologie. Po 6 měsících by měl být proveden pokus o reexpozic proteinovým hydrolyzátem.
| 512 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | L/J11 | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -7707,62 +7840,71 @@
| 513.1 | V06DX | MCT olej | p.o. | 100 | ML | 103,13 | L/J11 |
| | | | | | | | |
| 513.2 | V06DX | kombinace s vysokým obsahem mléčné bílkoviny a kalcia | p.o. | 100 | GM | 44,87 | L/J11 |
| 514 | V07AB | rozpouštědla a ředidla, včetně irigačních roztoků | parent. | | | | |
| 514 | V07AE3 | rozpouštědla a ředidla, včetně irigačních roztoků | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 514.1 | V07AB | voda pro injekci (do 2 ml v jedné ampuli včetně) | parent. | 1 | ML | 2,69 | |
| | | | | | | | |
| 514.2 | V07AB | voda pro injekci (nad 2 do 10 ml v jedné ampuli včetně) | parent. | 10 | ML | 3,32 | |
| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml | BTA | SK | | | |
| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50x10ml | BTA | SK | | | |
| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj 100x10ml | BTA | SK | | | |
| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50x10ml | BTA | SK | | | |
| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml | BTA | SK | | | |
| 514.3 | V07AB | voda pro injekci nad 10 ml v jedné ampuli nebo lahvi | parent. | 100 | ML | 13,98 | |
| 85900 | AQUA PRO INJECTIONE IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 85899 | AQUA PRO INJECTIONE IMUNA | inf 1x500ml(vak) | IMA | SK | | | |
| 85558 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 67802 | AQUA PRO INJECTIONE IMUNA | inf 1x500ml | IMA | SK | | | |
| 83943 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x500ml(vak) | MKS | CZ | | | |
| 00656 | AQUA PRO INJECTIONE IMUNA | inf 1x250ml | IMA | SK | | | |
| 00657 | AQUA PRO INJECTIONE IMUNA | inf 1x400ml | IMA | SK | | | |
| 97727 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 97726 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 97727 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 31428 | STERILE WATER F.INJ. FRESENIUS | inf 1x1000ml | FKI | I | | | |
| 67802 | AQUA PRO INJECTIONE IMUNA | inf 1x500ml | IMA | SK | | | |
| 31424 | STERILE WATER F.INJ. FRESENIUS | inf 1x250ml | FKI | I | | | |
| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml(sklo) | IHO | CZ | | | |
| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | | | |
| 89244 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x250ml | ARD | CZ | | | |
| 89245 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x400ml | ARD | CZ | | | |
| 31429 | STERILE WATER F.INJ. FRESENIUS | inf 6x1000ml | FKI | I | | | |
| 57773 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml(vak) | MKS | CZ | | | |
| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1x250ml(sklo) | IHO | CZ | | | |
| 31427 | STERILE WATER F.INJ. FRESENIUS | inf 12x500ml | FKI | I | | | |
| 31426 | STERILE WATER F.INJ. FRESENIUS | inf 1x500ml | FKI | I | | | |
| 31425 | STERILE WATER F.INJ. FRESENIUS | inf 16x250ml | FKI | I | | | |
| 85900 | AQUA PRO INJECTIONE IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 70484 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(plast) | BFF | I | | | |
| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ | | | |
| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml(vak) | MKS | CZ | | | |
| 44557 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 6x1000ml | SFR | I | | | |
| 43759 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x250ml | SFR | I | | | |
| 83943 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x500ml(vak) | MKS | CZ | | | |
| 43760 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x500ml | SFR | I | | | |
| 43761 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x1000ml | SFR | I | | | |
| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml(vak) | MKS | CZ | | | |
| 57776 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ | | | |
| 57773 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 70484 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(plast) | BFF | I | | | |
| 57775 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml(vak) | MKS | CZ | | | |
| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | | | |
| 85558 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 85557 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(plast) | BFF | I | | | |
| 85899 | AQUA PRO INJECTIONE IMUNA | inf 1x500ml(vak) | IMA | SK | | | |
| 80486 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x250ml | MVM | CZ | | | |
| 44559 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 16x250ml | SFR | I | | | |
| 44557 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 6x1000ml | SFR | I | | | |
| 43759 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x250ml | SFR | I | | | |
| 85557 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(plast) | BFF | I | | | |
| 89245 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x400ml | ARD | CZ | | | |
| 89244 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x250ml | ARD | CZ | | | |
| 43760 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x500ml | SFR | I | | | |
| 57776 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 57775 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 44560 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 12x500ml | SFR | I | | | |
| 69788 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x300ml | ARD | CZ | | | |
| 44560 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 12x500ml | SFR | I | | | |
| 515 | V08A | rozpustné nefrotropní RTG kontrastní látky | p.o. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 515.1 | V08AA05 | kyselina ioxitalamová | p.o. | 10 | ML | 59,19 | K |
| 93497 | TELEBRIX GASTRO | sol 1x100ml | BGL | D | | | |
| 59497 | TELEBRIX GASTRO | sol 10x100ml/30gm i | GUT | F | | | |
| 515.2 | V08AB04 | iopamidol | p.o. | 10 | ML | 59,19 | K |
| 516 | V08AA | rozpustné nefrotropní hyperosmolární RTG kontrastní látky | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 516.1 | V08A | meglumin amidotrizoát | parent. | 10 | ML | 73,51 | K |
| | | | | | | | |
| 516.1 | V08A | meglumin amidotrizoát | parent. | 10 | ML | 62,86 | K |
| 32571 | UROGRAFIN 76% | inj sol 1x200ml | SAG | D | | | |
| 32570 | UROGRAFIN 76% | inj sol 10x100ml | SAG | D | | | |
| 32568 | UROGRAFIN 76% | inj sol 10x50ml | SAG | D | | | |
| 01542 | UROGRAFIN 76% | inj sol 10x20ml | SAG | D | | | |
| 516.2 | V08AA03 | iodamid (koncentrace 300 mg l/ml) | parent. | 10 | ML | 41,06 | K |
| | | | | | | | |
| 516.3 | V08AA03 | iodamid (koncentrace 380 mg l/ml) | parent. | 10 | ML | 44,97 | K |
| | | | | | | | |
| 516.4 | V08AA03 | iodamid (koncentrace 410 mg l/ml) | parent. | 10 | ML | 87,40 | K |
| | | | | | | | |
| 516.5 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg l/ml) | parent. | 10 | ML | 57,00 | K |
| 516.5 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg l/ml) | parent. | 10 | ML | 54,73 | K |
| 92348 | TELEBRIX N 300 | inj 6x20ml | LEX | CZ | | | |
| 516.6 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg l/ml a více) | parent. | 10 | ML | 66,00 | K |
| 92350 | TELEBRIX N 380 | inj 6x20ml | LEX | CZ | | | |
@@ -7781,21 +7923,24 @@
| 517.2 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 199,40 | K |
| 04337 | OMNIPAQUE 240 | inj 25x20ml | NYI | N | | | |
| 517.3 | V08AB02 | iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 276,10 | K |
| | | | | | | | |
| 517.4 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K |
| | | | | | | | |
| 02956 | IOHEXOL 240 | inj sol 10x50ml | ITP | CZ | | | |
| 02955 | IOHEXOL 240 | inj sol 1x100ml | ITP | CZ | | | |
| 517.5 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K |
| 02938 | IOHEXOL 300 | inj sol 10x20ml | ITP | CZ | | | |
| 69029 | OMNIPAQUE 300 | inj 10x40ml-pp | NYI | N | | | |
| 517.6 | V08AB02 | iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 320,96 | K |
| | | | | | | | |
| 517.7 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K |
| | | | | | | | |
| 02939 | IOHEXOL 300 | inj sol 10x50ml | ITP | CZ | | | |
| 517.8 | V08AB02 | iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K |
| 30954 | IOHEXOL 350 | inj sol 10x20ml | ITP | CZ | | | |
| 69028 | OMNIPAQUE 350 | inj 10x40ml-pp | NYI | N | | | |
| 517.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K |
| | | | | | | | |
| 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 236,91 | K |
| | | | | | | | |
| 59545 | HEXABRIX 320 | | inj sol 25x50ml | GUT | F | | |
| 59544 | HEXABRIX 320 | | inj sol 1x50ml | GUT | F | | |
| 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K |
| | | | | | | | |
| 517.12 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 242,54 | K |
@@ -7818,66 +7963,124 @@
| 77024 | ULTRAVIST-300 | inj 10x20ml | SAG | D | | | |
| 517.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K |
| | | | | | | | |
| 517.22 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 207,38 | K |
| | | | | | | | |
| 517.23 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 429,71 | KIP |
| | | | | | | | |
| 517.24 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 534,28 | KIP |
| 517.22 V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 207,38 | K | |
| | | | | | | | |
| 517.23 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 429,71 | K/P |
| | | | | | | | |
| 517.24 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 534,28 | K/P |
| | | | | | | | |
| 517.25 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 119,48 | K |
| 68772 | OPTIRAY 160 | inj 10x50ml | MME | D | | | |
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K |
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. 10 | ML | 153,38 | K | |
| 66209 | OPTIRAY 240 | inj 10x100ml(typ a) | MME | USA | | | |
| 66210 | OPTIRAY 240 | inj 10x100ml(typ a) | MME | CND | | | |
| 98298 | OPTIRAY 240 | inj 10x50ml | MME | D | | | |
| 68922 | OPTIRAY 240 | inj 10x100ml | MME | D | | | |
| 98298 | OPTIRAY 240 | inj 10x50ml | MME | D | | | |
| 66210 | OPTIRAY 240 | inj 10x100ml(typa) | MME | CND | | | |
| 66209 | OPTIRAY 240 | inj 10x100ml(typ a) | MME | USA | | | |
| 517.27 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 320,96 | K |
| 92365 | OPTIRAY 300 | inj 10x10ml | MME | D | | | |
| 517.28 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K |
| 66212 | OPTIRAY 300 | inj 10x20ml(typ a) | MME | CND | | | |
| 66211 | OPTIRAY 300 | inj 10x20ml(typ a) | MME | USA | | | |
| 68923 | OPTIRAY 300 | inj 10x20ml | MME | D | | | |
| 66211 | OPTIRAY 300 | inj 10x20ml(typ a) | MME | USA | | | |
| 66212 | OPTIRAY 300 | inj 10x20ml(typ a) | MME | CND | | | |
| 517.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K |
| 66227 | OPTIRAY 300 | inj 10x200ml(typ a) | MME | USA | | | |
| 66226 | OPTIRAY 300 | inj 10x150ml(typ a) | MME | CND | | | |
| 92366 | OPTIRAY 300 | inj 10x75ml | MME | D | | | |
| 66228 | OPTIRAY 300 | inj 10x200ml(typ a) | MME | CND | | | |
| 68850 | OPTIRAY 300 | inj 10x50ml | MME | D | | | |
| 92366 | OPTIRAY 300 | inj 10x75ml | MME | D | | | |
| 92369 | OPTIRAY 300 | inj 10x200ml | MME | D | | | |
| 92368 | OPTIRAY 300 | inj 10x150ml | MME | D | | | |
| 92367 | OPTIRAY 300 | inj 10x100ml | MME | D | | | |
| 92368 | OPTIRAY 300 | inj 10x150ml | MME | D | | | |
| 66225 | OPTIRAY 300 | inj 10x150ml(typ a) | MME | USA | | | |
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K |
| 68773 | OPTIRAY 320 | inj 10x50ml | MME | D | | | |
| 517.31 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K |
| 66229 | OPTIRAY 350 | inj 10x30ml(typ a) | MME | USA | | | |
| 66230 | OPTIRAY 350 | inj 10x30ml(typ a) | MME | CND | | | |
| 66229 | OPTIRAY 350 | inj 10x30ml(typ a) | MME | USA | | | |
| 92370 OPTIRAY 350 | | inj 10x30ml | MME | D | | | |
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K |
| 92370 | OPTIRAY 350 | inj 10x30ml | MME | D | | | |
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. 10 | ML | 199,21 | K | |
| 68925 | OPTIRAY 350 | | inj 10x100ml | MME | D | | |
| 92371 | OPTIRAY 350 | | inj 10x200ml | MME | D | | |
| 66257 | OPTIRAY 350 | | inj 10x125ml(typ c) | MME | USA | | |
| 66258 | OPTIRAY 350 | inj 10x125ml(typ c) | MME | CND | | | |
| 68851 | OPTIRAY 350 | inj 10x50ml | MME | D | | | |
| 68925 | OPTIRAY 350 | inj 10x100ml | MME | D | | | |
| 92371 | OPTIRAY 350 | inj 10x200ml | MME | D | | | |
| 517.33 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 215,46 | K |
| 42402 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | NYI | N | | | |
| 45114 | VISIPAQUE 150MG l/ML | inj 10x50ml | NRI | IRL | | | |
| 45115 | VISIPAQUE 150MG l/ML | inj 6x200ml | NRI | IRL | | | |
| 45114 | VISIPAQUE 150MG l/ML | inj 10x50ml | NRI | IRL | | | |
| 42399 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | NRI | IRL | | | |
| 84340 | VISIPAQUE 150MG l/ML | inj 6x200ml | NYI | N | | | |
| 42404 | VISIPAQUE 150 MG l/ML | inj sol 10x50ml-amp | NYI | N | | | |
| 42398 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | NYI | N | | | |
| 42400 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | NYI | N | | | |
| 84339 | VISIPAQUE 150MG l/ML | inj 10x50ml | NYI | N | | | |
| 42401 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | NRI | IRL | | | |
| 42403 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | NRI | IRL | | | |
| 42405 | VISIPAQUE 150 MG l/ML | inj sol 10x50ml-amp | NRI | IRL | | | |
| 517.34 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli ) | parent. | 10 | ML | 336,60 | K |
| 45118 | VISIPAQUE 270MG l/ML | inj 10x20ml | NRI | IRL | | | |
| 42420 | VISIPAQUE 270 MG l/ML | inj sol 10x10ml-amp | NYI | N | | | |
| 42421 | VISIPAQUE 270 MG l/ML | inj sol 10x10ml-amp | NRI | IRL | | | |
| 42422 | VISIPAQUE 270 MG l/ML | inj sol 10x20ml-amp | NYI | N | | | |
| 42423 | VISIPAQUE 270 MG l/ML | inj sol 10x20ml-amp | NRI | IRL | | | |
| 84341 | VISIPAQUE 270MG l/ML | inj 10x20ml | NYI | N | | | |
| 45118 | VISIPAQUE 270MG l/ML | inj 10x20ml | NRI | IRL | | | |
| 517.35 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 282,14 | K |
| 45121 | VISIPAQUE 270MG l/ML | inj 6x200ml | NRI | IRL | | | |
| 45120 | VISIPAQUE 270MG l/ML | inj 10x100ml | NRI | IRL | | | |
| 45121 | VISIPAQUE 270MG l/ML | inj 6x200ml | NRI | IRL | | | |
| 84343 | VISIPAQUE 270MG l/ML | inj 10x100ml | NYI | N | | | |
| 84342 | VISIPAQUE 270MG l/ML | inj 10x50ml | NYI | N | | | |
| 45119 | VISIPAQUE 270MG l/ML | inj 10x50ml | NRI | IRL | | | |
| 84344 | VISIPAQUE 270MG l/ML | inj 6x200ml | NYI | N | | | |
| 84343 | VISIPAQUE 270MG l/ML | inj 10x100ml | NYI | N | | | |
| 84342 | VISIPAQUE 270MG l/ML | inj 10x50ml | NYI | N | | | |
| 517.36 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 357,46 | K |
| 42413 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | NRI | IRL | | | |
| 42426 | VISIPAQUE 270 MG l/ML | inj sol 10x50ml-amp | NYI | N | | | |
| 42425 | VISIPAQUE 270 MG l/ML | inj sol 10x40ml-amp | NRI | IRL | | | |
| 42424 | VISIPAQUE 270 MG l/ML | inj sol 10x40ml-amp | NYI | N | | | |
| 42419 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | NRI | IRL | | | |
| 42417 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | NRI | IRL | | | |
| 42407 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | NRI | IRL | | | |
| 42427 | VISIPAQUE 270 MG l/ML | inj sol 10x50ml-amp | NRI | IRL | | | |
| 42414 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | NYI | N | | | |
| 42418 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | NYI | N | | | |
| 42412 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | NYI | N | | | |
| 42411 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | NRI | IRL | | | |
| 42410 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | NYI | N | | | |
| 42409 | VISIPAQUE 270 MG l/ML | inj sol 10x75ml-pp | NRI | IRL | | | |
| 42408 | VISIPAQUE 270 MG l/ML | inj sol 10x75ml-pp | NYI | N | | | |
| 42406 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | NYI | N | | | |
| 42415 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | NRI | IRL | | | |
| 42416 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | NYI | N | | | |
| 517.36 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ml | 357,46 | K |
| 42442 | VISIPAQUE 320 MG l/ML | inj sol 10x10ml-amp | NYI | N | | | |
| 84345 | VISIPAQUE 320MG l/ML | inj 10x20ml | NYI | N | | | |
| 42445 | VISIPAQUE 320 MG l/ML | inj sol 10x20ml-amp | NRI | IRL | | | |
| 45122 | VISIPAQUE 320MG l/ML | inj 10x20ml | NRI | IRL | | | |
| 84345 | VISIPAQUE 320MG l/ML | inj 10x20ml | NYI | N | | | |
| 517.37 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 287,25 | K |
| 42444 | VISIPAQUE 320 MG l/ML | inj sol 10x20ml-amp | NYI | N | | | |
| 42443 | VISIPAQUE 320 MG l/ML | inj sol 10x10ml-amp | NRI | IRL | | | |
| 517.37 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ml | 287,25 | K |
| 42434 | VISIPAQUE 320 MG l/ML | inj sol 10x150ml-pp | NYI | N | | | |
| 42433 | VISIPAQUE 320 MG l/ML | inj sol 10x100ml-pp | NRI | IRL | | | |
| 42432 | VISIPAQUE 320 MG l/ML | inj sol 10x100ml-pp | NYI | N | | | |
| 42431 | VISIPAQUE 320 MG l/ML | inj sol 10x75ml-pp | NRI | IRL | | | |
| 84347 | VISIPAQUE 320MG l/ML | inj 10x100ml | NYI | N | | | |
| 42429 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-skl | NRI | IRL | | | |
| 84346 | VISIPAQUE 320MG l/ML | inj 10x50ml | NYI | N | | | |
| 45123 | VISIPAQUE 320MG l/ML | inj 10x50ml | NRI | IRL | | | |
| 45124 | VISIPAQUE 320MG l/ML | inj 10x100ml | NRI | IRL | | | |
| 45125 | VISIPAQUE 320MG l/ML | inj 6x200ml | NRI | IRL | | | |
| 42430 | VISIPAQUE 320 MG l/ML | inj sol 10x75ml-pp | NYI | N | | | |
| 42449 | VISIPAQUE 320 MG l/ML | inj sol 10x50ml-amp | NRI | IRL | | | |
| 42446 | VISIPAQUE 320 MG l/ML | inj sol 10x40ml-amp | NYI | N | | | |
| 42447 | VISIPAQUE 320 MG l/ML | inj sol 10x40ml-amp | NRI | IRL | | | |
| 42448 | VISIPAQUE 320 MG l/ML | inj sol 10x50ml-amp | NYI | N | | | |
| 84348 | VISIPAQUE 320MG l/ML | inj 6x200ml | NYI | N | | | |
| 45124 | VISIPAQUE 320MG l/ML | inj 10x100ml | NRI | IRL | | | |
| 45123 | VISIPAQUE 320MG l/ML | inj 10x50ml | NRI | IRL | | | |
| 45125 | VISIPAQUE 320MG l/ML | inj 6x200ml | NRI | IRL | | | |
| 42441 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | NRI | IRL | | | |
| 42440 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | NYI | N | | | |
| 42436 | VISIPAQUE 320 MG l/ML | inj sol 10x175ml-pp | NYI | N | | | |
| 42435 | VISIPAQUE 320 MG l/ML | inj sol 10x150ml-pp | NRI | IRL | | | |
| 42428 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-skl | NYI | N | | | |
| 42437 | VISIPAQUE 320 MG l/ML | inj sol 10x175ml-pp | NRI | IRL | | | |
| 42438 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | NYI | N | | | |
| 42439 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | NRI | IRL | | | |
| 517.38 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 115,90 | K |
| | | | | | | | |
| 517.39 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 137,12 | K |
@@ -7895,57 +8098,63 @@
| 517.45 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 285,86 | K |
| | | | | | | | |
| 517.46 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 219,87 | K |
| 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. | 10 | ML | 74,25 | K |
| | | | | | | | |
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. | 10 | ML | 37,39 | K |
| | | | | | | | |
| 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 39,35 | K |
| 518 | V08AC | rozpustné hepatotropní RTGkontrastní látky | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. 10 | ML | 74,25 | K | |
| | | | | | | | |
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. 10 | ML | 37,39 | K | |
| | | | | | | | |
| 518.3 | V08AC04 | adipiodon | parent. 10 | ML | 39,35 | K | |
| 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 300,70 | K |
| | | | | | | | |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 462,54 | K |
| 03552 | LIPIODOL ULTRA-FLUID | inj 5x5ml | BGL | D | | | |
| 59494 | LIPIODOL ULTRA-FLUIDE | inj 1x10ml/4.8gm i | GUT | F | | | |
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 520.1 | V08BA01 | síran barnatý | p.o. | 100 | GM | 33,29 | K |
| 520.1 | V08BA01 | síran barnatý | p.o. | 100 | GM | 32,15 | K |
| 59062 | MICROPAQUE | sus 1x2000ml | DEF | F | | | |
| 94370 | PRONTOBARIO 60% | sus 1x5lt | BCC | I | | | |
| 59062 | MICROPAQUE | sus 1x2000ml | DEF | F | | | |
| 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 150,30 | K |
| 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 147,52 | K |
| 46675 | MICROPAQUE CT | sus 1x2000ml/100gm | DEF | F | | | |
| 520.3 | V08BA01 | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 45,00 | K |
| 46673 | MICROPAQUE COLON | plv 1x800gm | DEF | F | | | |
| 520.3 | V08BA01 | RTG kontrastní přípravky obsahující síran barnatý (lékové formy kolon) | p.rect. | 100 | GM | 45,00 | K |
| | | | | | | | |
| 520.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 94,58 | K |
| | | | | | | | |
| 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,08 | K |
| 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 36,73 | K |
| 59063 | MICROPAQUE H.D. ORAL | plv 1x416gm | DEF | F | | | |
| 521 | V08CA | paramagnetické kontrastní látky | parent. | K | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 521.1 | V08CA | dimeglumin gadobenat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| | | | | | | | |
| 521.2 | V08CA | dimeglumin gadobenat ( nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.3 | V08CA | Gadobutrol | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.4 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| 44487 | MAGNEVIST | inj 5x10ml | SAG | D | | | |
| 75660 | MAGNEVIST | inj 1x10ml | SAG | D | | | |
| 75659 | MAGNEVIST | inj 1x5ml | SAG | D | | | |
| 521.5 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| 96352 | MAGNEVIST | inj 1x20ml | SAG | D | | | |
| 521.6 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| | | | | | | | |
| 521.7 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.8 | V08CA04 | gadoteridol (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| | | | | | | | |
| 521.9 | V08CA04 | gadoteridol (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.10 | V08CA05 | Manganfodipir | parent. | 10 | ML | 1249,06 | K |
| 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| | | | | | | | |
| 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.5 | V08CA04 | gadoteridol (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| | | | | | | | |
| 521.6 | V08CA04 | gadoteridol (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.7 | V08CA05 | manganfodipir | parent. | 10 | ML | 1145,88 | K |
| 49538 | TESLASCAN | sol 1x50ml | NYI | N | | | |
| 49539 | TESLASCAN | sol 10x50ml | NYI | N | | | |
| 521.11 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1 | DF | 2857,50 | H |
| 521.12 | V08DA02 | mikročástice galaktózy | parent. | 1 | GM | 1142,99 | H |
| 43916 | LEVOVIST | inj sic 1x4gm+solv. | SAG | D | | | |
| 521.8 | V08CA08 | dimeglumin gadobenat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| | | | | | | | |
| 521.9 | V08CA08 | dimeglumin gadobenat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.10 | V08CA09 | gadobutrol, koncentrace do 0,5 mmol/l včetně | parent. | 10 | ML | 1840,15 | K |
| | | | | | | | |
| 521.11 | V08CA09 | gadobutrol, koncentrace nad 0,5 mmol/l | parent. | 10 | ML | 2760,15 | K |
| | | | | | | | |
| 521.12 | V08CB | ferucarbotran, s obsahem do 0,9 ml včetně | parent. | 1 | DF | 5780,78 | H |
| | | | | | | | |
| 521.13 | V08CB | ferucarbotran, s obsahem nad 0,9 ml | parent. | 1 | DF | 6700,00 | H |
| | | | | | | | |
| 521.14 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1 | DF | 2857,50 | H |
| | | | | | | | |
| 521.15 | V08DA02 | mikročástice galaktózy | parent. | 1 | GM | 914,00 | H |
2001-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
2001-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
2000-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
2000-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
2000-03-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1999-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1999-09-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1999-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1999-04-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1998-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1998-09-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1998-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1998-04-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1997-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1997-09-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1997-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1997-05-13
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
1997-03-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb. — versión origina
původní verze
Text k tomuto datu